<SEC-DOCUMENT>0000902664-25-003536.txt : 20250812
<SEC-HEADER>0000902664-25-003536.hdr.sgml : 20250812
<ACCEPTANCE-DATETIME>20250812180055
ACCESSION NUMBER:		0000902664-25-003536
CONFORMED SUBMISSION TYPE:	SCHEDULE 13D/A
PUBLIC DOCUMENT COUNT:		5
FILED AS OF DATE:		20250812
DATE AS OF CHANGE:		20250812

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HERON THERAPEUTICS, INC. /DE/
		CENTRAL INDEX KEY:			0000818033
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				942875566
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-39444
		FILM NUMBER:		251208296

	BUSINESS ADDRESS:	
		STREET 1:		4242 CAMPUS POINT COURT, SUITE 200
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		8582514400

	MAIL ADDRESS:	
		STREET 1:		4242 CAMPUS POINT COURT, SUITE 200
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AP PHARMA INC /DE/
		DATE OF NAME CHANGE:	20010511

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ADVANCED POLYMER SYSTEMS INC /DE/
		DATE OF NAME CHANGE:	19920703

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Rubric Capital Management LP
		CENTRAL INDEX KEY:			0001687509
		ORGANIZATION NAME:           	
		EIN:				300934659
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A

	BUSINESS ADDRESS:	
		STREET 1:		155 EAST 44TH ST, SUITE 1630
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017
		BUSINESS PHONE:		2124181881

	MAIL ADDRESS:	
		STREET 1:		155 EAST 44TH ST, SUITE 1630
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13D/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13D" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13D/A</submissionType>
    <previousAccessionNumber>0000921895-23-000284</previousAccessionNumber>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: Rubric Capital Management LP -->
          <cik>0001687509</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>4</amendmentNo>
      <securitiesClassTitle>Common Stock, par value $0.01 per share</securitiesClassTitle>
      <dateOfEvent>08/08/2025</dateOfEvent>
      <previouslyFiledFlag>false</previouslyFiledFlag>
      <issuerInfo>
        <issuerCIK>0000818033</issuerCIK>
        <issuerCUSIP>427746102</issuerCUSIP>
        <issuerName>HERON THERAPEUTICS, INC. /DE/</issuerName>
        <address>
          <com:street1>4242 CAMPUS POINT COURT, SUITE 200</com:street1>
          <com:city>SAN DIEGO</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>92121</com:zipCode>
        </address>
      </issuerInfo>
      <authorizedPersons>
        <notificationInfo>
          <personName>Brian Kleinhaus</personName>
          <personPhoneNum>212-418-1888</personPhoneNum>
          <personAddress>
            <com:street1>Rubric Capital Management LP</com:street1>
            <com:street2>155 East 44th St, Suite 1630</com:street2>
            <com:city>New York</com:city>
            <com:stateOrCountry>NY</com:stateOrCountry>
            <com:zipCode>10017</com:zipCode>
          </personAddress>
        </notificationInfo>
        <notificationInfo>
          <personName>Ele Klein &amp; Adriana Schwartz</personName>
          <personPhoneNum>212-756-2000</personPhoneNum>
          <personAddress>
            <com:street1>McDermott Will &amp; Schulte LLP</com:street1>
            <com:street2>919 Third Avenue</com:street2>
            <com:city>New York</com:city>
            <com:stateOrCountry>NY</com:stateOrCountry>
            <com:zipCode>10022</com:zipCode>
          </personAddress>
        </notificationInfo>
      </authorizedPersons>
    </coverPageHeader>
    <reportingPersons>
      <reportingPersonInfo>
        <reportingPersonCIK>0001687509</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Rubric Capital Management LP</reportingPersonName>
        <fundType>AF</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>DE</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>29100728.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>29100728.00</sharedDispositivePower>
        <aggregateAmountOwned>29100728.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>17.5</percentOfClass>
        <typeOfReportingPerson>IA</typeOfReportingPerson>
        <typeOfReportingPerson>PN</typeOfReportingPerson>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonCIK>0001898677</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>David Rosen</reportingPersonName>
        <fundType>AF</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>X1</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>29100728.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>29100728.00</sharedDispositivePower>
        <aggregateAmountOwned>29100728.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>17.5</percentOfClass>
        <typeOfReportingPerson>IN</typeOfReportingPerson>
        <typeOfReportingPerson>HC</typeOfReportingPerson>
      </reportingPersonInfo>
    </reportingPersons>
    <items1To7>
      <item1>
        <securityTitle>Common Stock, par value $0.01 per share</securityTitle>
        <issuerName>HERON THERAPEUTICS, INC. /DE/</issuerName>
        <issuerPrincipalAddress>
          <com:street1>4242 CAMPUS POINT COURT, SUITE 200</com:street1>
          <com:city>SAN DIEGO</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>92121</com:zipCode>
        </issuerPrincipalAddress>
        <commentText>This Amendment No. 4 ("Amendment No. 4") amends and supplements the statement on Schedule 13D filed with the Securities and Exchange Commission on February 6, 2023 (the "Original Schedule 13D", and the Original Schedule 13D as amended, the "Schedule 13D"). This Amendment No. 4 supplements Items 4, 6 and 7 and amends and restates Items 3 and 5(a)-(c) as set forth below. Capitalized terms used herein and not otherwise defined in this Amendment No. 4 have the meanings set forth in the Schedule 13D.</commentText>
      </item1>
      <item3>
        <fundsSource>The Shares reported herein beneficially owned by Rubric Capital were purchased with the working capital of the Rubric Funds (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business). The aggregate purchase price of the (i) 29,100,728 Shares reported herein beneficially owned by Rubric Capital is approximately $31,713,490.50, including brokerage commissions, (ii) 94,610 Preferred Shares (as defined in Item 4) purchased by the Rubric Funds in the Private Placement (as defined in Item 4) is $1,419,150 and (iii) $35,000,000 aggregate principal amount of Notes (as defined in Item 4) purchased by the Rubric Funds in the Convertible Note Issuance (as defined in Item 4) is $33,250,000.</fundsSource>
      </item3>
      <item4>
        <transactionPurpose>On August 8, 2025, certain Rubric Funds entered into a securities purchase agreement (the "Securities Purchase Agreement") for a private placement (the "Private Placement") with the Issuer, pursuant to which certain Rubric Funds purchased (i) 2,387,225 Shares at a price of $1.50 per share and (ii) 94,610 shares (the "Preferred Shares") of the Issuer's Series A Convertible Preferred Stock, par value $0.01 per share (the "Preferred Stock"), which automatically convert, upon Stockholder Approval (as defined below), into 946,100 Shares  at an initial conversion price of $1.50, subject to adjustment as set forth in the Certificate of Designation of Rights, Preferences and Privileges of the shares of Preferred Stock, dated as of August 8, 2025 (the "Certificate of Designation").

In addition, on August 8, 2025, a certain Rubric Fund entered into a Note Purchase Agreement (the "Note Purchase Agreement") with the Issuer, pursuant to which the Issuer issued and sold to such Rubric Fund $35,000,000 aggregate principal amount of convertible senior unsecured promissory notes (the "Notes") for an aggregate purchase price of $33,250,000 (the "Convertible Note Issuance"). The Notes issued in the Convertible Note Issuance provides for the issuance of Notes with (i) a term of five years, (ii) a 5% original issuance discount, (iii) 5% per annum interest payable in cash, (iv) at the election of the Issuer, 7% per annum interest payable in kind for the first twelve months, and (v) a conversion right, subject to Stockholder Approval (as defined below), into Shares at an initial conversion rate of 555.5556 Shares per $1,000 principal amount of Notes, subject to adjustments as provided in the Note Purchase Agreement. Conversions of the Notes can be settled, at the Issuer's election, in cash, Shares or in a combination thereof. If all or any portion of any conversion is to be settled in cash, the amount of cash that the Issuer will be required to deliver with respect to such conversion in shall be the product of (a) the applicable percentage of the conversion rate on the applicable conversion date and (b) the arithmetic average of the daily weighted average prices of the Shares during the ten 10 consecutive trading day period ending on the trading day immediately preceding the applicable conversion date.

Each Rubric Fund's ability to convert the Preferred Shares or the Notes is subject to a blocker provision (the "Beneficial Ownership Limitation") that will prohibit any Rubric Fund (together with its affiliates, and any persons acting as a group together with such Rubric Fund or any of its affiliates) from beneficially owning more than 19.99% of the outstanding Shares at any time, determined in accordance with rules promulgated under the Securities Exchange Act of 1934, as amended. A holder may, upon notice to the Issuer, increase or decrease the Beneficial Ownership Limitation to any other percentage not in excess of 19.99% but any such increase will not be effective until the 61st day after such notice is delivered to the Issuer.

The Issuer intends to seek stockholder approval (the "Stockholder Approval") pursuant to the applicable rules of the Nasdaq Stock Market to approve the conversion of the Convertible Note Issuance and the Preferred Stock into Shares. The Issuer agreed to file a preliminary proxy statement for such Stockholder Approval within thirty days of the closing of the transactions described above. In addition, the Issuer has agreed to file a resale registration statement within thirty days of closing to register the Shares to be issued or issuable in connection with the transactions described above.

The Securities Purchase Agreement and the Note Purchase Agreement each contain customary representations and warranties, agreements (including customary resale registration rights) and obligations and termination provisions. The Private Placement and the Convertible Note Issuance each closed on August 12, 2025.

Rubric Capital also entered into a Cooperation Agreement with the Issuer (the "Cooperation Agreement") regarding the composition of the Issuer's Board of Directors (the "Board") and certain other matters.

Pursuant to the terms of the Cooperation Agreement, the Issuer agreed, among other things, to (i) fix the size of the Board at seven directors during the Cooperation Period (as defined below) unless mutually agreed to by the parties; (ii) appoint at the Closing a director nominated by Rubric Capital (the "New Director") as a director of the Issuer; and (iii) include the New Director in the Issuer's slate of nominees for the election of directors at the Issuer's 2025 annual meeting of stockholders (the "2025 Annual Meeting"). Rubric Capital has not yet identified a director to serve on the Board pursuant to the Cooperation Agreement.

Pursuant to the Cooperation Agreement, Rubric Capital is subject to certain customary standstill restrictions until the earlier of (a) 30 days prior to the deadline for director nominations and stockholder proposals for the Issuer's 2026 annual meeting of stockholders (the "2026 Annual Meeting"), (b) February 12, 2026, and (c) 120 days prior to the first anniversary of the 2025 Annual Meeting (the "Cooperation Period"). Pursuant to the terms of the standstill, Rubric Capital agreed not to acquire beneficial ownership of more than 19.99% of the outstanding Shares. In addition, during the Cooperation Period, Rubric Capital further agreed to appear in person or by proxy at each annual or special meeting of stockholders of the Issuer and vote all of its Shares (A) in favor of the slate of directors recommended by the Board, (B) against the election of any nominee for director not approved, recommended and nominated by the Board and (C) in accordance with the Board's recommendation with respect to any other matter presented at such meeting; provided, however, that if Institutional Shareholder Services Inc. ("ISS") or Glass Lewis &amp; Co., LLC ("Glass Lewis") make a recommendation that differs from the recommendation of the Board with respect to any proposal submitted to the Issuer's stockholders at any such meeting (other than as related to the election or removal of directors), Rubric Capital is permitted to vote in accordance with the ISS or Glass Lewis recommendation; provided, further, that Rubric Capital is permitted to vote in its sole discretion with respect to any proposals relating to an Extraordinary Transaction (as defined in the Cooperation Agreement).

The foregoing descriptions of the Securities Purchase Agreement, Certificate of Designation, Note Purchase Agreement and Cooperation Agreement do not purport to be complete and are qualified in their entireties by reference to the full texts of the Securities Purchase Agreement, Certificate of Designation, Note Purchase Agreement and Cooperation Agreement. For further information regarding the Securities Purchase Agreement, Certificate of Designation, Note Purchase Agreement and Cooperation Agreement reference is made to the texts of the Form of Securities Purchase Agreement, Certificate of Designation, Note Purchase Agreement and Cooperation Agreement, which have been filed as Exhibit 99.1, Exhibit 99.2, Exhibit 99.3 and Exhibit 99.4 hereto, respectively, and incorporated by reference herein.</transactionPurpose>
      </item4>
      <item5>
        <percentageOfClassSecurities>See rows (11) and (13) of the cover page to this Schedule 13D for the aggregate number of Shares and percentage of Shares beneficially owned by each Reporting Person. The aggregate percentage of Shares reported beneficially owned by each Reporting Person is based upon 166,517,025 Shares outstanding, which is the sum of: (i) 153,291,798 Shares outstanding as of July 31, 2025, as disclosed in the Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2025, filed by the Issuer with the Securities and Exchange Commission (the "SEC") on August 8, 2025 and (ii) 13,225,227 Shares issued by the Issuer in connection with the closing of the Private Placement on August 12, 2025.</percentageOfClassSecurities>
        <numberOfShares>See rows (7) through (10) of the cover page to this Schedule 13D for the Shares as to which each Reporting Person has the sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition.</numberOfShares>
        <transactionDesc>Except as set forth herein, no transactions in the Shares have been effected by the Reporting Persons during the past sixty (60) days.</transactionDesc>
      </item5>
      <item6>
        <contractDescription>Item 4 of this Amendment No. 4 is hereby incorporated herein.</contractDescription>
      </item6>
      <item7>
        <filedExhibits>Exhibit 99.1 - Form of Securities Purchase Agreement, dated as of August 8, 2025.

Exhibit 99.2 - Certificate of Designation of Rights, Preferences and Privileges of the Preferred Shares, dated as of August 8, 2025.

Exhibit 99.3 - Note Purchase Agreement, dated as of August 8, 2025.

Exhibit 99.4 - Cooperation Agreement, dated as of August 8, 2025.</filedExhibits>
      </item7>
    </items1To7>
    <signatureInfo>
      <signaturePerson>
        <signatureReportingPerson>Rubric Capital Management LP</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ David Rosen</signature>
          <title>By: Rubric Capital Management GP LLC, General Partner, By: David Rosen, Managing Member</title>
          <date>08/12/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>David Rosen</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ David Rosen</signature>
          <title>David Rosen, Individually</title>
          <date>08/12/2025</date>
        </signatureDetails>
      </signaturePerson>
    </signatureInfo>
  </formData>

</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>p25-1788exhibit99_1.htm
<DESCRIPTION>FORM OF SECURITIES PURCHASE AGREEMENT
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>FORM OF SECURITIES PURCHASE
AGREEMENT</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">This Securities Purchase
Agreement (this &ldquo;<I><U>Agreement</U></I>&rdquo;) is dated as of August 8, 2025, by and among Heron Therapeutics, Inc., a Delaware
corporation (the &ldquo;<I><U>Company</U></I>&rdquo;), and each purchaser identified on the signature pages hereto (each, including its
successors and permitted assigns, a &ldquo;<I><U>Purchaser</U></I>&rdquo; and collectively, the &ldquo;<I><U>Purchasers</U></I>&rdquo;).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>RECITALS</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company and each Purchaser are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded
by Section 4(a)(2) of the Securities Act of 1933, as amended (the &ldquo;<I><U>Securities Act</U></I>&rdquo;), and Rule 506 of Regulation
D (&ldquo;<I><U>Regulation D</U></I>&rdquo;) as promulgated by the United States Securities and Exchange Commission (the &ldquo;<I><U>Commission</U></I>&rdquo;)
under the Securities Act.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Purchaser wishes to purchase, and the Company wishes to sell, upon the terms and conditions stated in this Agreement, the number of (i)
shares of common stock, par value $0.01 per share (the &ldquo;<I><U>Common Stock</U></I>&rdquo;) of the Company and (ii) shares of Series
A Convertible Preferred Stock, par value $0.01 per share (the &ldquo;<I><U>Preferred Stock</U></I>&rdquo;) of the Company, having the
designation, preferences, conversion or other rights, voting powers, restrictions, limitations as to dividends, qualifications and terms
and conditions as specified in the Certificate of Designation attached hereto as <U>Exhibit A</U> (the &ldquo;<I><U>Certificate of Designation</U></I>&rdquo;),
set forth below such Purchaser&rsquo;s name on the signature page of this Agreement. The shares of Common Stock issuable upon conversion
of the Preferred Stock (the &ldquo;<I><U>Conversion Shares</U></I>&rdquo;), together with the shares of Common Stock and Preferred Stock
issued and sold hereunder, shall be collectively referred to herein as the &ldquo;<I><U>Securities</U></I>&rdquo;. The shares of Common
Stock and the Conversion Shares shall be collectively referred to herein as the &ldquo;<I><U>Shares</U></I>&rdquo;. The shares of Common
Stock and Preferred Stock are not required to be allocated pro-rata and may be allocated as agreed upon by the Company and each Purchaser
as set forth on the signature page hereto.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company shall not issue shares of Common Stock hereunder, as well as any shares of Common Stock issued in separate transactions that may
be aggregated with the transactions contemplated hereby pursuant to the rules of the Principal Trading Market, in excess of 30,658,359
shares of Common Stock in the aggregate, representing 19.99% of the Company&rsquo;s outstanding shares of Common Stock immediately prior
to the transactions contemplated by the Transaction Documents, in accordance with the rules of the Principal Trading Market (&ldquo;<I><U>Nasdaq
Conversion Limits</U></I>&rdquo;), and the shares of Preferred Stock may not be convertible into shares of Common Stock until the Company
receives the required stockholder approval as set forth in Section 4.14 herein.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>NOW, THEREFORE</B>,
IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy
of which are hereby acknowledged, the Company and the Purchasers hereby agree as follows:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>ARTICLE I.<FONT STYLE="text-transform: uppercase"><U><BR>
DEFINITIONS</U></FONT></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 1.1&#9;<U>Definitions</U>.
In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms shall have the meanings
indicated in this <U>Section 1.1</U>:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>2007 Plan</U></I>&rdquo;
has the meaning set forth in <U>Section 3.1(g)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Acquiring
Person</U></I>&rdquo; has the meaning set forth in <U>Section 4.5</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Action</U></I>&rdquo;
has the meaning set forth in <U>Section 3.1(kk)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Additional
Effectiveness Deadline</U></I>&rdquo; has the meaning set forth in <U>Section 4.11(a)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Affiliate</U></I>&rdquo;
means, with respect to any Person, any other Person that, now or in the future, directly or indirectly through one or more intermediaries,
controls, is controlled by or is under common control with such Person, as such terms are used in and construed under Rule 405 under the
Securities Act. With respect to a Purchaser, any investment fund or managed account that is managed on a discretionary basis by the same
investment manager as such Purchaser will be deemed to be an Affiliate of such Purchaser.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Aggregate
Purchase Price</U></I>&rdquo; means the Subscription Amount to be paid by each Purchaser.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Agreement</U></I>&rdquo;
has the meaning set forth in the Preamble.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Allowable
Grace Period</U></I>&rdquo; has the meaning set forth in <U>Section 4.11(d)(vii)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Anti-Bribery
and Anti-Money Laundering Laws</U></I>&rdquo; has the meaning set forth in <U>Section 3.1(ee)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Beneficial
Ownership Limitation</U></I>&rdquo; has the meaning set forth in <U>Section 2.1(a)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Board of Directors</U></I>&rdquo;
means the board of directors of the Company.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Business Day</U></I>&rdquo;
means any day except Saturday, Sunday, any day which is a federal legal holiday in the United States or any day on which banking institutions
in the States of New York or North Carolina are authorized or required by law or other governmental action to close.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Certificate
of Designation</U></I>&rdquo; has the meaning set forth in the Recitals.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Closing</U></I>&rdquo;
means the closing of the purchase and sale of the Securities pursuant to this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Closing Date</U></I>&rdquo;
means the Trading Day when all of the Transaction Documents have been executed and delivered by the applicable parties thereto, and all
of the conditions set forth in <U>Sections 2.1</U>, <U>2.2</U>, <U>5.1</U> and <U>5.2</U> hereof are satisfied or waived, in writing,
as the case may be, or such other date as the parties may agree.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Commission</U></I>&rdquo;
has the meaning set forth in the Recitals.</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Common Stock</U></I>&rdquo;
has the meaning set forth in the Recitals, and also includes any other class of securities into which the Common Stock may hereafter be
reclassified or changed into.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Common Stock
Equivalents</U></I>&rdquo; means any securities of the Company or any Subsidiary which would entitle the holder thereof to acquire, at
any time, Common Stock, including, without limitation, any debt, preferred stock, rights, options, warrants or other instrument that is,
at any time, convertible into or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock or other securities
that entitle the holder to receive, directly or indirectly, Common Stock.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Company</U></I>&rdquo;
has the meaning set forth in the Preamble.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Company Counsel</U></I>&rdquo;
means DLA Piper LLP (US).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Company&rsquo;s
Knowledge</U></I>&rdquo; means the actual or constructive knowledge of any director or executive officer (as defined in Rule 405 under
the Securities Act) of the Company, after due inquiry.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Control</U></I>&rdquo;
(including the terms &ldquo;controlling,&rdquo; &ldquo;controlled by&rdquo; or &ldquo;under common control with&rdquo;) means the possession,
direct or indirect, of the power to direct or cause the direction of the management and policies of a Person, whether through the ownership
of voting securities, by contract or otherwise.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Conversion
Shares</U></I>&rdquo; has the meaning set forth in the Recitals.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Covered Persons</U></I>&rdquo;
has the meaning set forth in <U>Section 3.1(rr)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Disclosure
Document</U></I>&rdquo; has the meaning set forth in <U>Section 4.4</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Disclosure
Time</U></I>&rdquo; has the meaning set forth in <U>Section 4.4</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Disqualification
Events</U></I>&rdquo; has the meaning set forth in <U>Section 3.1(rr)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>DTC</U></I>&rdquo;
has the meaning set forth in <U>Section 4.1(c)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>EDGAR</U></I>&rdquo;
has the meaning set forth in <U>Section 4.11(a)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Effective
Date</U></I>&rdquo; means the earliest of the date that (a) all of the Shares are covered by an effective Registration Statement, (b)
all of the Shares have been sold pursuant to Rule 144 or may be sold pursuant to Rule 144 without the requirement for the Company to be
in compliance with the current public information required under Rule 144 and without volume or manner-of-sale restrictions, (c) is the
one-year anniversary of the Closing Date; <I>provided</I>, that a holder of Securities is not an Affiliate of the Company, or (d) all
of the Shares may be sold pursuant to an exemption from registration under Section 4(a)(1) of the Securities Act without volume or manner-of-sale
restrictions and Company Counsel has delivered to such holders a standing written unqualified opinion that resales may then be made by
such holders of the Shares pursuant to such exemption which opinion shall be in form and substance reasonably acceptable to such holders.</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Effectiveness
Deadline</U></I>&rdquo; has the meaning set forth in <U>Section 4.11(a)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Effectiveness
Failure</U></I>&rdquo; has the meaning set forth in <U>Section 4.11(c)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Environmental
Laws</U></I>&rdquo; has the meaning set forth in <U>Section 3.1(cc)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Exchange Act</U></I>&rdquo;
means the Securities Exchange Act of 1934, as amended, or any successor statute, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Exchange Rules</U></I>&rdquo;
has the meaning set forth in <U>Section 3.1(s)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>FDA</U></I>&rdquo;
has the meaning set forth in <U>Section 3.1(q)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Filing Date</U></I>&rdquo;
has the meaning set forth in <U>Section 4.11(a)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Filing Deadline</U></I>&rdquo;
has the meaning set forth in <U>Section 4.11(a)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Filing Failure</U></I>&rdquo;
has the meaning set forth in <U>Section 4.11(c)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>GAAP</U></I>&rdquo;
means U.S. generally accepted accounting principles, as applied by the Company.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Grace Period</U></I>&rdquo;
has the meaning set forth in <U>Section 4.11(d)(xiv)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Health Care
Laws</U></I>&rdquo; has the meaning set forth in <U>Section 3.1(kk)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>HIPAA</U></I>&rdquo;
has the meaning set forth in <U>Section 3.1(kk)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Indebtedness</U></I>&rdquo;
has the meaning set forth in <U>Section 3.1(ss)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Inspectors</U></I>&rdquo;
has the meaning set forth in <U>Section 4.11(d)(vii)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Intellectual
Property</U></I>&rdquo; has the meaning set forth in <U>Section 3.1(p)</U></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Investment
Company Act</U></I>&rdquo; has the meaning set forth in <U>Section 3.1(w)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Irrevocable
Transfer Agent Instructions</U></I>&rdquo; has the meaning set forth in <U>Section 4.1(d)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Legend Removal
Date</U></I>&rdquo; has the meaning set forth in <U>Section 4.1(c)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Maintenance
Failure</U></I>&rdquo; has the meaning set forth in <U>Section 4.11(c)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Material Adverse
Effect</U></I>&rdquo; means an effect which is, or would reasonably be expected to, be material and adverse to (a) the assets, business,
operations, earnings, properties, condition (financial or otherwise), prospects, stockholders&rsquo; equity or results of operations of
the Company and its Subsidiary taken as a whole, and (b) the Company&rsquo;s ability to timely consummate the transactions contemplated
hereby; <I>provided</I>, <I>however</I>, that any of the following, either alone or in combination, shall not be deemed a Material Adverse
Effect: (i) effects caused by changes or circumstances affecting general market conditions in the U.S. economy or which are generally
applicable to the industry in which the Company operates, (ii) effects resulting from or relating to the announcement or disclosure of the sale
of the Securities or other transactions contemplated by the Transaction Documents, or (iii) effects caused by any event, occurrence or
condition resulting from or relating to the taking of any action in accordance with the Transaction Documents.</P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Nasdaq Conversion
Limits</U></I>&rdquo; has the meaning set forth in the Recitals.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>New Securities</U></I>&rdquo;
means, collectively, equity securities of the Company, whether or not currently authorized, as well as options or warrants to purchase
such equity securities, or securities of any type whatsoever that are convertible or exchangeable into or exercisable for such equity
securities, other than (a) any shares of capital stock or options to purchase shares of capital stock, or other equity-based awards (including
restricted stock units), issued or granted to employees (or prospective employees who have accepted an offer of employment), directors
or consultants of the Company or any of its subsidiaries, pursuant to any Company stock-based compensation plan approved by the Company&rsquo;
stockholders or in accordance with the rules of the Principal Trading Market or that exist as of the date of this Agreement; (b) any securities
issued by the Company upon the exercise, exchange or conversion of any securities that are exercisable or exchangeable for, or convertible
into, shares of capital stock and are outstanding as of the date of this Agreement or issued pursuant to this Agreement, <I>provided</I>
that such exercise, exchange or conversion is effected pursuant to the terms of such securities as in effect on the date of this Agreement;
(c) any securities issued by the Company as full or partial consideration in connection with a merger, acquisition, consolidation or purchase
of all or substantially all of the securities or assets of a corporation or other entity approved by the Company&rsquo;s Board of Directors,
(d) any securities issued by the Company in connection with a transaction with an unaffiliated third party approved by the Company&rsquo;s
Board of Directors that includes a bona fide commercial relationship with the Company (including any joint venture, marketing or distribution
arrangement, strategic alliance, collaboration agreement or corporate partnering, intellectual property license agreement or acquisition
agreement with the Company) and (e) any securities issued by the Company to banks, equipment lessors or other financial institutions,
or to real property lessors, pursuant to a debt financing, equipment leasing or real property leasing transaction approved by the Company&rsquo;s
Board of Directors. For clarity, New Securities does not include securities that may be issued pursuant to any Company at-the-market offering
facility.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>New York Courts</U></I>&rdquo;
means the state and federal courts sitting in the City of New York, Borough of Manhattan.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Off-Balance
Sheet Transaction</U></I>&rdquo; has the meaning set forth in <U>Section 3.1(ff)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Outside Date</U></I>&rdquo;
means the thirtieth (30th) day following the date of this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Permits</U></I>&rdquo;
has the meaning set forth in <U>Section 3.1(n)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Person</U></I>&rdquo;
means an individual, corporation, partnership, limited liability company, trust, business trust, association, joint stock company, joint
venture, sole proprietorship, unincorporated organization, governmental authority or any other form of entity not specifically listed
herein.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Placement
Agent</U></I>&rdquo; means Leerink Partners LLC with respect to the offer and sale of the Securities pursuant to this Agreement.</P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Plans</U></I>&rdquo;
has the meaning set forth in <U>Section 3.1(g)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Preferred
Stock</U></I>&rdquo; has the meaning set forth in the Recitals, and also includes any other class of securities into which the Preferred
Stock may hereafter be reclassified or changed into.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Principal
Trading Market</U></I>&rdquo; means the Trading Market on which the Common Stock is primarily listed and quoted for trading, which, as
of the date of this Agreement and the Closing Date, shall be the Nasdaq Capital Market.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Pro Rata Interest</U></I>&rdquo;
means the number of Securities purchased by each Purchaser, relative to the total number of Securities being sold hereunder.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Pro Rata Share</U></I>&rdquo;
means, with respect to a Purchaser, the percentage determined by dividing (a) the number of shares of Common Stock (including all shares
of Common Stock issuable or issued upon conversion or exercise of any other outstanding securities of the Company convertible or exercisable
in exchange for shares of Common Stock) collectively owned beneficially by such Purchaser immediately prior to the applicable proposed
offering of New Securities by (b) the total number of shares of outstanding Common Stock (including all shares of Common Stock issued
or issuable upon conversion or exercise of any other outstanding securities of the Company convertible or exercisable in exchange for
shares of Common Stock and all shares reserved for future issuance pursuant to any equity incentive or similar plan) immediately prior
to the applicable proposed offering of New Securities.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Proceeding</U></I>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an investigation or partial proceeding, such
as a deposition), whether commenced or threatened.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Programs</U></I>&rdquo;
has the meaning set forth in <U>Section 3.1(kk)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Purchase Price</U></I>&rdquo;
means (i) in the case of Common Stock, $1.50 per share of Common Stock and (ii) in the case of Preferred Stock, $1.50 per share of Preferred
Stock, each subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions
of the Common Stock that occur after the date of this Agreement and prior to the Closing Date.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Purchaser</U></I><U>&rdquo;
or &ldquo;<I>Purchasers</I></U>&rdquo; has the meaning set forth in the Preamble.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Purchaser
Deliverables</U></I>&rdquo; has the meaning set forth in <U>Section 2.2(b)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Records</U></I>&rdquo;
has the meaning set forth in <U>Section 4.11(d)(vii)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Registrable
Securities</U></I>&rdquo; has the meaning set forth in <U>Section 4.11(a)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Registration
Delay Payments</U></I>&rdquo; has the meaning set forth in <U>Section 4.11(c)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Registration
Statement</U></I>&rdquo; has the meaning set forth in <U>Section 4.11(a)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Regulation
D</U></I>&rdquo; has the meaning set forth in the Recitals.</P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Regulation
S-X</U></I>&rdquo; has the meaning set forth in <U>Section 3.1(i)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Reporting
Period</U></I>&rdquo; means the period commencing on the Closing Date and ending on the earliest of: (i) the date as of which the Purchasers
may sell all of the Securities under Rule 144 without volume or manner-of-sale restrictions and without the requirement for the Company
to be in compliance with the current public information requirements under Rule 144(c)(1) (or any successor thereto) promulgated under
the Securities Act; (ii) the second anniversary of the Closing Date; or (iii) the date on which such Purchaser shall have sold all of
the Securities pursuant to a Registration Statement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Required Approvals</U></I>&rdquo;
has the meaning set forth in <U>Section 3.1(e)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Rule 144</U></I>&rdquo;
means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time to time, or any similar
rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Sanctions</U></I>&rdquo;
has the meaning set forth in <U>Section 3.1(jj)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>SEC Report</U></I><U>s</U>&rdquo;
has the meaning set forth in <U>Section 3.1(h)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Securities</U></I>&rdquo;
has the meaning set forth in the Recitals.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Securities
Act</U></I>&rdquo; has the meaning set forth in the Recitals.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Shares</U></I>&rdquo;
has the meaning set forth in the Recitals.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Short Sales</U></I>&rdquo;
include, without limitation, (i) all &ldquo;short sales&rdquo; as defined in Rule 200 promulgated under Regulation SHO under the Exchange
Act, whether or not against the box, and all types of direct and indirect stock pledges, forward sale contracts, options, puts, calls,
short sales, swaps, &ldquo;put equivalent positions&rdquo; (as defined in Rule 16a-1(h) under the Exchange Act) and similar arrangements
(including on a total return basis), and (ii) sales and other transactions through non-U.S. broker dealers or foreign regulated brokers
(but shall not be deemed to include the location and/or reservation of borrowable shares of Common Stock), in each case, solely to the
extent it has the same economic effect as a &ldquo;short sales&rdquo; as defined in Rule 200 of Regulation SHO under the Exchange Act.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Solicitor</U></I>&rdquo;
has the meaning set forth in <U>Section 3.1(rr)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Staff</U></I>&rdquo;
means the staff of the Commission.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Stockholder
Approval Proposal</U></I>&rdquo; has the meaning set forth in <U>Section 4.14</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Subscription
Amount</U></I>&rdquo; means, with respect to each Purchaser, the aggregate amount to be paid for the Securities purchased hereunder as
indicated on such Purchaser&rsquo;s signature page to this Agreement next to the heading &ldquo;Subscription Amount&rdquo; in United States
dollars and in immediately available funds.</P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Subsidiary</U></I>&rdquo;
means Heron Therapeutics B.V., a consolidated subsidiary of the Company, and shall, where applicable, also include any direct or indirect
subsidiary of the Company formed or acquired after the date of this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Trading Affiliate</U></I>&rdquo;
has the meaning set forth in <U>Section 3.2(i)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Trading Day</U></I>&rdquo;
means (i) a day on which the Common Stock is listed or quoted and traded on the Principal Trading Market (other than the OTC Bulletin
Board), (ii) if the Common Stock is not listed on a Trading Market (other than the OTC Bulletin Board), a day on which the Common Stock
is traded in the over-the-counter market, as reported by the OTC Bulletin Board, or (iii) if the Common Stock is not quoted on any Trading
Market, a day on which the Common Stock is quoted in the over-the-counter market as reported in the &ldquo;pink sheets&rdquo; by Pink
Sheets LLC (or any similar organization or agency succeeding to its functions of reporting prices); <I>provided</I>, that in the event
that the Common Stock is not listed or quoted as set forth in (i), (ii) and (iii) hereof, then Trading Day shall mean a Business Day.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Trading Market</U></I>&rdquo;
means whichever of the New York Stock Exchange, the NYSE MKT, the Nasdaq Global Select Market, the Nasdaq Global Market, the Nasdaq Capital
Market or the OTC Bulletin Board on which the Common Stock is listed or quoted for trading on the date in question.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Transaction
Documents</U></I>&rdquo; means this Agreement, the Certificate of Designation, the exhibits attached hereto and any other documents or
agreements executed in connection with the transactions contemplated pursuant to this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Transfer Agent</U></I>&rdquo;
means Computershare Trust Company N.A., the current transfer agent of the Company, with a mailing address of 150 Royall Street, Canton,
MA 02021, or any successor transfer agent for the Company.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>Treasury</U></I>&rdquo;
has the meaning set forth in <U>Section 3.2(q)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>XBRL</U></I>&rdquo;
has the meaning set forth in <U>Section 3.1(i).</U></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>ARTICLE II.<FONT STYLE="text-transform: uppercase"><U><BR>
PURCHASE AND SALE</U></FONT></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 2.1&#9;<U>Closing</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Amount</U>.
Subject to the terms and conditions set forth in this Agreement, at the Closing, the Company shall issue and sell to each Purchaser,
and each Purchaser shall purchase from the Company such number of Securities, equal to the quotient resulting from dividing (1) the
Subscription Amount for such Purchaser by (2) the Purchase Price, rounded to the nearest whole share. Notwithstanding the foregoing,
the Company shall not issue and sell to a Purchaser, and such Purchaser shall not purchase from the Company any Securities to the
extent that such Purchaser determines, in its sole discretion, that such Purchaser (together with such Purchaser&rsquo;s Affiliates,
and any Person acting as a group together with such purchaser or any of such Purchaser&rsquo;s Affiliates) would beneficially own in
excess of the Beneficial Ownership Limitation. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% (or, at the
election of the Purchaser, 9.99% or 19.99%) of the number of shares of Common
Stock outstanding immediately after giving effect to the issuance of the shares of Common Stock on the Closing Date. A Purchaser may,
upon notice to the Company, increase or decrease the Beneficial Ownership Limitation, <I>provided</I> that the Beneficial Ownership Limitation
in no event exceeds 19.99% of the number of shares of the Common Stock outstanding at such time. Any increase in the Beneficial Ownership
Limitation will not be effective until the 61st day after such notice is delivered to the Company. This Section 2.1(a) shall be construed
and implemented in a manner otherwise than in strict conformity with its terms if necessary to correct this Section 2.1(a) (or any portion
hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation contained herein or to make changes or
supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this Section 2.1(a) shall
apply to a successor holder of Preferred Stock.</P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Closing</U>.
The Closing of the purchase and sale of the Securities shall take place remotely by electronic means on the Closing Date or at such other
locations or means as the parties may mutually agree.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Form
of Payment; Delivery of the Securities</U>. On or prior to the Closing Date, each Purchaser will pay its Subscription Amount by wire transfer
of immediately available funds in accordance with wire instructions provided prior to the Closing Date by the Company to the Purchasers.
On or before the Closing Date, the Company will instruct the Transfer Agent to make book-entry notations representing the Securities against
delivery to each Purchaser of its respective Subscription Amount and deliver to Purchaser as promptly as practicable after the Closing,
evidence from the Transfer Agent of the issuance to Purchaser of their Securities on and as of the Closing Date. The foregoing notwithstanding,
if the Purchaser has indicated to the Company at the time of execution of this Agreement a need to settle on a &ldquo;delivery versus
payment&rdquo; basis, then the Company shall make a book-entry notation reflecting ownership of the Securities whereupon, following receipt
of such written confirmation from the Transfer Agent that a book-entry notation has been made, the Purchaser shall then promptly wire
its Subscription Amount as provided in this <U>Article II</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 2.2&#9;<U>Closing
Deliveries</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At
or prior to the Closing, the Company shall issue, deliver or cause to be delivered to each Purchaser the following (the &ldquo;<I><U>Company
Deliverables</U></I>&rdquo;):</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;this
Agreement, duly executed by the Company;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Company shall have filed the Certificate of Designation;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a
legal opinion of Company Counsel, dated as of the Closing Date, executed by such counsel and addressed to the Purchasers and the Placement
Agent, in form and substance reasonably satisfactory to the Purchasers;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.5in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;duly
executed Irrevocable Transfer Agent Instructions instructing the Transfer Agent to deliver a book-entry statement evidencing the number
of Securities equal to such Purchaser&rsquo;s number of Securities set forth below such Purchaser&rsquo;s name on the signature page of
this Agreement registered in the name of such Purchaser; and</P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.5in">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Company shall have provided each Purchaser in writing with the Company&rsquo;s wire instructions, on Company letterhead and executed by
the Chief Financial Officer or her delegate.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At
or prior to the Closing, each Purchaser shall deliver or cause to be delivered to the Company the following (the &ldquo;<I><U>Purchaser
Deliverables</U></I>&rdquo;):</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;this
Agreement, duly executed by such Purchaser; and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;its
Subscription Amount in accordance with <U>Section 2.1(c)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>ARTICLE III.<FONT STYLE="text-transform: uppercase"><U><BR>
REPRESENTATIONS AND WARRANTIES</U></FONT></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 3.1&#9;<U>Representations
and Warranties of the Company</U>. Except as disclosed in the SEC Reports, the Company hereby represents and warrants as of the date hereof
and the Closing Date (except for the representations and warranties that speak as of a specific date, which shall be made as of such date),
to each of the Purchasers and the Placement Agent:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Subsidiaries</U>.
The Company does not own or control, directly or indirectly, any corporation, association or other entity other than its Subsidiary.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Organization
and Qualification</U>.&nbsp;The Company and its Subsidiary have been duly organized, are validly existing as corporations or limited liability
entities and are in good standing under the laws of their respective jurisdictions of organization. The Company and its Subsidiary are,
and will be, duly licensed or qualified as a foreign corporation for the transaction of business and in good standing under the laws of
each other jurisdiction in which their respective ownership or lease of property or the conduct of their respective businesses requires
such license or qualification, and have all corporate power and authority necessary to own or hold their respective properties and to
conduct their respective businesses as described in the SEC Reports.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Authorization</U>.
The Company has all requisite corporate power and authority to execute, deliver and perform its obligations contemplated by each of the
Transaction Documents to which it is a party. The execution and delivery of this Agreement and each of the other Transaction Documents
by the Company and the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary
action on the part of the Company and no further action is required by the Company, the Board of Directors or the Company&rsquo;s shareholders
in connection herewith or therewith other than in connection with the Required Approvals. Each of the Transaction Documents to which the
Company constitutes<U>&nbsp;</U>the valid and binding obligation of the Company enforceable against the Company in accordance with its
terms.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Conflicts</U>. The issue and sale of the Securities, the execution, delivery and performance of the Transaction Documents to which
the Company is a party and the consummation of the transactions contemplated by the Transaction Documents will not (i) conflict with
or result in a breach or violation of any of the terms or provisions of, impose any lien, charge or encumbrance upon any property or
assets of the Company and its Subsidiary, or constitute a default under, any indenture, mortgage, deed of trust, loan agreement,
license, lease or other agreement or instrument to which the Company
or its Subsidiary is a party or by which the Company or its Subsidiary is bound or to which any of the property or assets of the Company
or its Subsidiary is subject; (ii) result in any violation of the provisions of the certificate of incorporation, charter or bylaws (or
similar organizational documents) of the Company or its Subsidiary; or (iii) result in any violation of any statute or any judgment, order,
decree, rule or regulation of any court or governmental agency or body having jurisdiction over the Company or its Subsidiary or any of
their properties or assets.</P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Filings,
Consents and Approvals</U>. No consent, approval, authorization or order of, or filing, registration or qualification with, any court
or governmental agency or body having jurisdiction over the Company or its Subsidiary or any of their respective properties or assets
is required for the issue and sale of the Securities, the execution, delivery and performance by the Company of the Transaction Documents
to which the Company is a party, or the consummation of the transactions contemplated by the Transaction Documents, except for (i) such
consents, approvals, authorizations, orders, filings, registrations or qualifications as may be required under the Exchange Act, (ii)
the filing with the Commission of one or more Registration Statements in accordance with the requirements of <U>Section 4.11</U>, (iii)
filings required by applicable state or foreign securities laws, (iv) the filing of a Notice of Sale of Securities on Form D with the
Commission under Regulation D of the Securities Act, (v) the filing of any requisite notices and/or application(s) to the Principal Trading
Market for the issuance, sale and listing of the Shares for trading or quotation, as the case may be, thereon in the time and manner required
thereby, (vi) the filings required in accordance with <U>Section 4.4</U> and (vii) those that have been made or obtained prior to the
date of this Agreement (collectively, the &ldquo;<I><U>Required Approvals</U></I>&rdquo;).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Issuance
of Securities</U>. The shares of Common Stock and Preferred Stock have been duly authorized and, when issued and paid for in accordance
with the terms of the Transaction Documents, will be duly authorized and validly issued, fully paid and nonassessable and free and clear
of all liens, other than restrictions on transfer provided for in the Transaction Documents or imposed by applicable securities laws,
and shall not be subject to preemptive or similar rights. The Conversion Shares have been duly authorized and, when issued in accordance
with the terms of the Preferred Stock, will be validly issued, fully paid and nonassessable, free and clear of all liens imposed by the
Company other than restrictions on transfer provided in the Transaction Documents or imposed by applicable securities laws, and shall
not be subject to preemptive or similar rights. The Company has reserved from its duly authorized share capital the maximum number of
Common Stock issuable pursuant to the Transaction Documents. Assuming the accuracy of the representations and warranties of the Purchasers
in this Agreement, the Securities will be issued in compliance with all applicable federal and state securities laws.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Capitalization</U>.
The authorized capital of the Company as of the date hereof consists of 400,000,000 shares of Common Stock and 2,500,000 shares of
undesignated preferred stock, par value $0.01 per share, and upon filing of the Certificate of Designation, 524,141 shares will have
been designated as Series A Convertible Preferred Stock, which are convertible into 5,241,410 shares of Common Stock. As of June 30,
2025, there were issued and outstanding a total of 153,252,956 shares of Common Stock and no shares of preferred stock. Under the
Company&rsquo;s Plans (as defined below) (i) options to acquire 29,697,268 shares of Common Stock have been granted and are
outstanding, (ii) 4,132,902 restricted stock units have been granted and are outstanding, and (iii) 5,384,050 shares of Common Stock
remain available for future issuance to directors, executive officers, employees and
consultants of the Company pursuant to the Company&rsquo;s Amended and Restated 2007 Equity Incentive Plan (the &ldquo;<I><U>2007 Plan</U></I>&rdquo;).
Since June 30, 2025, the Company has not issued any equity securities, other than those issued pursuant to the 2007 Plan and any of the
Company&rsquo;s other equity incentive plans disclosed in the SEC Reports (including employee stock purchase plans and any inducement
equity plans or awards established in compliance with the rules of its Principal Trading Market) (collectively, together with the 2007
Plan, the &ldquo;<I><U>Plans</U></I>&rdquo;). Except as disclosed in the SEC Reports and other than the shares of Common Stock reserved
for issuance under the 2007 Plan, there are no outstanding options, rights (including conversion or preemptive rights and rights of first
refusal), proxy or shareholder agreements, or agreements of any kind for the purchase or acquisition from the Company of any of its securities.
The Company has an authorized capitalization as set forth in the SEC Reports, and all of the issued shares of the Company have been duly
authorized and validly issued, are fully paid and non-assessable, conform in all material respects to the description thereof contained
in the SEC Reports and were not issued in violation of any preemptive right, resale right, right of first refusal or similar right. All
of the Company&rsquo;s options and other rights to purchase or exchange any securities for shares of the Company&rsquo;s capital stock
have been duly authorized and validly issued, and conform in all material respects to the description thereof contained in the SEC Reports.
All of the issued shares of capital stock or other ownership interests of each Subsidiary of the Company have been duly authorized and
validly issued, are fully paid and non-assessable and are owned directly or indirectly by the Company, free and clear of all liens, encumbrances,
equities or claims, except for such liens, encumbrances, equities or claims as would not, individually or in the aggregate, reasonably
be expected to have a Material Adverse Effect. Except as disclosed in the SEC Reports, no Person is entitled to preemptive rights, rights
of first refusal, rights of participation or similar rights with respect to any securities of the Company, including with respect to the
issuance of Securities contemplated hereby. Except as disclosed in the SEC Reports, there are no voting agreements, registration rights
agreements or other agreements of any kind between the Company and any other Person relating to the securities of the Company, including
the Securities. All of the issued and outstanding shares of capital stock of the Company have been issued in compliance with all applicable
federal and state securities laws.</P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>SEC
Reports</U>. The Company has filed all reports, schedules, forms, statements and other documents required to be filed by it under
the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the two years preceding the date hereof (or such shorter
period as the Company was required by law or regulation to file such material) (the foregoing materials, including the exhibits
thereto and documents incorporated by reference therein, collectively referred to as the &ldquo;<I><U>SEC Reports</U></I>&rdquo;) on
a timely basis or has received a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration
of any such extension, except where the failure to file on a timely basis would not have or reasonably be expected to result in a
Material Adverse Effect (including, for this purpose only, any failure to qualify to register the Shares for resale on Form S-3 or
which would prevent any Purchaser from using Rule 144 to resell any Securities). As of their respective filing dates, or to the
extent corrected by a subsequent restatement, the SEC Reports complied in all material respects with the requirements of the
Securities Act and the Exchange Act and the rules and regulations of the Commission promulgated thereunder, and none of the SEC
Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated
therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not
misleading. The Company is not an issuer subject to Rule 144(i) under the Securities Act.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Financial
Statements</U>. The historical financial statements (including the related notes and supporting schedules) included in the SEC Reports
comply as to form in all material respects with the requirements of Regulation S-X under the Securities Act (&ldquo;<I><U>Regulation S-X</U></I>&rdquo;)
and present fairly, in all material respects, the financial condition, results of operations and cash flows of the entities purported
to be shown thereby at the dates and for the periods indicated and have been prepared in conformity with GAAP, except as may be otherwise
specified in such financial statements or the notes thereto, and except that unaudited financial statements may not contain all footnotes
required by GAAP, applied on a consistent basis throughout the periods involved. All disclosures contained in the SEC Reports regarding
&ldquo;non-GAAP financial measures&rdquo; (as defined by the rules and regulations of the Commission) comply with Regulation G of the
Exchange Act and Item 10 of Regulation S-K of the Securities Act, to the extent applicable. There are no financial statements (historical
or pro forma) that are required to be included in the SEC Reports that are not so included as required. The interactive data in eXtensible
Business Reporting Language (&ldquo;<I><U>XBRL</U></I>&rdquo;) included or incorporated by reference in the SEC Reports fairly present
the information called for in all material respects and have been prepared in accordance with the Commission&rsquo;s rules and guidelines
applicable thereto.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Material
Changes</U>. Except as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect, since the
date of the latest audited financial statements included in the SEC Reports, and, except as disclosed in a subsequent SEC Report filed
prior to the date hereof, neither the Company nor its Subsidiary has (i) sustained any loss or interference with its business from fire,
explosion, flood or other calamity, whether or not covered by insurance, or from any labor dispute or court or governmental action, order
or decree, (ii) issued or granted any securities (other than pursuant to employee benefit plans, qualified stock option plans or other
equity compensation plans or arrangements existing on the date hereof and disclosed in the SEC Reports), (iii) incurred any material liability
or obligation, direct or contingent, other than liabilities and obligations that were incurred in the ordinary course of business, (iv)
entered into any material transaction not in the ordinary course of business, or (v) declared or paid any dividend on its share capital;
and since such date, except as disclosed in the SEC Reports, there has not been any change in the share capital, long-term debt, net current
assets or short-term debt of the Company or its Subsidiary or any adverse change, or any development involving a prospective adverse change,
in or affecting the condition (financial or otherwise), prospects, results of operations, stockholders&rsquo; equity, properties, management
or business of the Company and its Subsidiary taken as a whole.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Litigation</U>.
Except as disclosed in the SEC Reports, there are no legal or governmental proceedings pending to which the Company or its Subsidiary
is a party or of which any property or assets of the Company or its Subsidiary is the subject that, if determined adversely to the Company,
would, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect or would, in the aggregate, reasonably
be expected to have a material adverse effect on the performance of the Transaction Documents or the consummation of the transactions
contemplated by the Transaction Documents; and to the Company&rsquo;s Knowledge, no such proceedings are threatened or contemplated by
governmental authorities or others.</P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Labor Dispute; Compliance with Labor Laws</U>. No labor disturbance by or dispute with the employees of the Company or its Subsidiary
exists or, to the Company&rsquo;s Knowledge, is imminent that would, individually or in the aggregate, reasonably be expected to have
a Material Adverse Effect. Neither the Company nor its Subsidiary is in violation of or has received written notice of any violation with
respect to any federal or state law relating to discrimination in the hiring, promotion or pay of employees, nor any applicable federal
or state wage and hour laws, nor any state law precluding the denial of credit due to the neighborhood in which a property is situated,
the violation of any of which would, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Default</U>. Except as disclosed in the SEC Reports, neither the Company nor its Subsidiary (i) is in violation of its certificate of
incorporation, charter or bylaws (or similar organizational documents), (ii) is in default, and no event has occurred that, with notice
or lapse of time or both, would constitute such a default, in the due performance or observance of any term, covenant, condition or other
obligation contained in any indenture, mortgage, deed of trust, loan agreement, license or other agreement or instrument to which it is
a party, by which it is bound or to which any of its properties or assets is subject, or (iii) is in violation of any statute or any order,
rule or regulation of any court or governmental agency or body having jurisdiction over it or its property or assets or (iv) has failed
to obtain any license, permit, certificate, franchise or other governmental authorization or permit necessary to the ownership of its
property or to the conduct of its business, except in the case of clauses (ii) and (iii), to the extent any such conflict, breach, violation
or default would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(n)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Regulatory
Permits</U>. The Company and its Subsidiary possess all material certificates, authorizations, clearances, approvals, registrations, exemptions,
licenses or permits required by state, federal or foreign regulatory agencies or bodies to conduct their respective businesses as currently
conducted and as described in the SEC Reports (&ldquo;<I><U>Permits</U></I>&rdquo;), and all such Permits are valid, current and in full
force and effect, except where the failure to so possess or be valid, current and in full force and effect would not, individually or
in the aggregate, reasonably be expected to result in a Material Adverse Effect. Neither the Company nor its Subsidiary is in violation
of, or in default under, any of the Permits or has received any notice of proceedings relating to the revocation or modification of, or
non-compliance with, any such certificate, authorization or permit. Neither the Company nor its Subsidiary has received any notice of
proceedings relating to the revocation or modification of any Permits which, singly or in the aggregate, if the subject of an unfavorable
decision, ruling or finding, would, individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect. The
Company has not received any written notice denying, revoking or modifying any &ldquo;approved enterprise,&rdquo; &ldquo;benefited enterprise&rdquo;
or &ldquo;preferred enterprise&rdquo; status with respect to any of the Company&rsquo;s facilities or operations.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(o)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Title
to Assets</U>. The Company and its Subsidiary have good and marketable title in fee simple to all real property and good and marketable
title to all personal property owned by them, that are material to the business of the Company, in each case free and clear of all liens,
encumbrances and defects, except for such liens, encumbrances and defects as do not materially affect the value of such property and do
not materially interfere with the use made and proposed to be made of such property by the Company and its Subsidiary. All assets held
under lease by the Company and its Subsidiary, that are material
to the business of the Company, are held by them under valid, subsisting and enforceable leases, with such exceptions as do not materially
interfere with the use made and proposed to be made of such assets by the Company and its Subsidiary.</P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(p)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Intellectual
Property</U>. The Company and the Subsidiary own, possess, or can acquire or license on reasonable terms, all Intellectual Property necessary
for the conduct of the Company&rsquo;s and the Subsidiary&rsquo;s businesses as now conducted and as proposed to be conducted as described
in the SEC Reports, except as such failure to own, possess, acquire or license such rights would not, individually or in the aggregate,
reasonably be expected to result in a Material Adverse Effect. Furthermore, (A) to the Company&rsquo;s Knowledge, there is no material
infringement, misappropriation or violation by third parties of any such Intellectual Property; (B) there is no pending or, to the Company&rsquo;s
Knowledge, threatened, action, suit, proceeding or claim by others challenging the Company&rsquo;s or the Subsidiary&rsquo;s rights in
or to any such Intellectual Property, and the Company is unaware of any facts which would form a reasonable basis for any such claim;
(C) the Intellectual Property owned by the Company and the Subsidiary, and to the Company&rsquo;s Knowledge, the Intellectual Property
licensed to the Company and the Subsidiary, has not been adjudged invalid or unenforceable, in whole or in part, and there is no pending
or, to the Company&rsquo;s Knowledge, threatened action, suit, proceeding or claim by others challenging the validity or scope of any
such Intellectual Property, and the Company is not aware of any facts which would form a reasonable basis for any such claim; (D) the
Company&rsquo;s Intellectual Property as currently or formerly owned, licensed or used by the Company or proposed to be used, and the
Company&rsquo;s conduct of its business as currently and formerly conducted and proposed to be conducted have not, do not and will not
infringe, violate or misappropriate the Intellectual Property of any Person, and, except as disclosed in the SEC Reports, the Company
has not received any communication and there is no prior, pending or, to the Company&rsquo;s Knowledge, threatened action, suit, proceeding
or claim by others that the Company or the Subsidiary infringes, misappropriates or otherwise violates any Intellectual Property or other
proprietary rights of others, neither the Company nor any Subsidiary has received any written notice of such claim and the Company is
not aware of any other fact which would form a reasonable basis for any such claim; and (E) each employee and consultant of the Company
has entered into an invention assignment agreement with the Company and to the Company&rsquo;s Knowledge, no employee of the Company or
the Subsidiary is in or has ever been in violation of any term of any employment contract, patent disclosure agreement, invention assignment
agreement, non-competition agreement, non-solicitation agreement, nondisclosure agreement or any restrictive covenant to or with a former
employer where the basis of such violation relates to such employee&rsquo;s employment with the Company or the Subsidiary or actions undertaken
by the employee while employed with the Company or the Subsidiary. &ldquo;<I><U>Intellectual Property</U></I>&rdquo; shall mean all confidential
information, formulas, designs, devices, research and development, methods, processes, compositions, patents, pending patent applications
and provisional applications and all issuances, divisions, continuations, continuations-in-part, reissues, extensions, reexaminations
and renewals of such patents and applications, trade and service marks, trade and service mark registrations, trade names, copyrights,
licenses, inventions, trade secrets, Internet domain names, technology, know-how and other intellectual property in the United States
and foreign jurisdictions.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-indent: 1in; font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">(q)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Insurance</U>.
Except as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect, the Company and its
Subsidiary maintain insurance from nationally recognized, in the applicable country, insurers in such amounts and covering such
risks as are commercially reasonable in accordance with all applicable statutes, rules and regulations of the U.S. Food and Drug
Administration (&ldquo;<I><U>FDA</U></I>&rdquo;) and comparable drug regulatory agencies outside of the United States to which such
trials and studies are subject and customary practices for companies engaged in similar businesses and similar industries for the
conduct of their respective businesses and the value of their respective properties and as are customary for companies engaged in
similar businesses in similar industries. All insurance policies of the Company and its Subsidiary are in full force and effect; the
Company and its Subsidiary are in compliance with the terms of such policies in all material respects; neither the Company nor its
Subsidiary has received notice from any insurer or agent of such insurer that capital improvements or other expenditures are
required or necessary to be made in order to continue such insurance; there are no material claims by the Company or its Subsidiary
under any such policy or instrument as to which any insurance company is denying liability or defending under a reservation of
rights clause; and neither the Company nor any such Subsidiary has any reason to believe that it will not be able to renew its
existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be
necessary to continue its business at a cost that would not, individually or in the aggregate, reasonably be expected to have a
Material Adverse Effect.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(r)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Transactions
With Affiliates and Employees</U>. No relationship, direct or indirect, exists between or among the Company, on the one hand, and the
directors, officers, stockholders, customers or suppliers of the Company, on the other hand, that is required to be described in the SEC
Reports that is not so described.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(s)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Internal
Accounting Controls</U>. The Company and the Subsidiary maintain a system of internal accounting controls sufficient to provide reasonable
assurances that (i) transactions are executed in accordance with management&rsquo;s general or specific authorization; (ii) transactions
are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain accountability for assets;
(iii) access to assets is permitted only in accordance with management&rsquo;s general or specific authorization; and (iv) the recorded
accountability for assets is compared with existing assets at reasonable intervals and appropriate action is taken with respect to any
differences. The Company&rsquo;s internal control over financial reporting is effective and none of the Company, its Board of Directors
and audit committee is aware of any &ldquo;significant deficiencies&rdquo; or &ldquo;material weaknesses&rdquo; (each as defined by the
Public Company Accounting Oversight Board) in its internal control over financial reporting, or any fraud, whether or not material, that
involves management or other employees of the Company or the Subsidiary who have a significant role in the Company&rsquo;s internal controls;
and since the end of the latest audited fiscal year, there has been no change in the Company&rsquo;s internal control over financial reporting
(whether or not remediated) that has materially affected, or is reasonably likely to materially affect, the Company&rsquo;s internal control
over financial reporting. The Company&rsquo;s Board of Directors has, subject to the exceptions, cure periods and the phase-in periods
specified in the applicable stock exchange rules (&ldquo;<I><U>Exchange Rules</U></I>&rdquo;), validly appointed an audit committee to
oversee internal accounting controls whose composition satisfies the applicable requirements of the Exchange Rules and the Company&rsquo;s
Board of Directors and/or the audit committee has adopted a charter that satisfies the requirements of the Exchange Rules in respect of
the audit committee.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-indent: 1in; font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">(t)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Sarbanes-Oxley
Compliance</U>. There is and has been no failure on the part of the Company or, to the Company&rsquo;s Knowledge, any of the Company&rsquo;s
directors or officers, in their capacities as such, to comply with any
provisions of the Sarbanes-Oxley Act that are applicable to the Company or its directors or officers in their capacities as directors
or officers of the Company.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(u)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Other Brokers</U>. Other than the Placement Agent, neither the Company nor its Subsidiary is a party to any contract, agreement or understanding
with any person that would give rise to a valid claim against any of them for a brokerage commission, finder&rsquo;s fee or like payment
in connection with the offering and sale of the Securities. The Purchasers shall have no obligation with respect to any fees or with respect
to any claims made by or on behalf of other Persons for fees of a type contemplated in this Section that may be due in connection with
the transactions contemplated by the Transaction Documents.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Private
Placement</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in <U>Section 3.2</U>, no registration
under the Securities Act is required for the offer and sale of the Securities by the Company to the Purchasers under the Transaction Documents.
Assuming the making and the obtaining of the Required Approvals, the issuance and sale of the Securities hereunder does not contravene
the rules and regulations of the Trading Market.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(w)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Investment
Company</U>. The Company is not, and will not be, after giving effect to the offer and sale of the Securities, (i) required to register
as an &ldquo;investment company&rdquo; (within the meaning of the Investment Company Act of 1940, as amended (the &ldquo;<I><U>Investment
Company Act</U></I>&rdquo;)) or (ii) a &ldquo;business development company&rdquo; (as defined in Section 2(a)(48) of the Investment Company
Act).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(x)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Registration
Rights</U>. Except as disclosed in the SEC Reports, and other than each of the Purchasers, there are no contracts, agreements or understandings
between the Company and any person granting such person the right to require the Company to file a registration statement under the Securities
Act with respect to any securities of the Company owned or to be owned by such person. There are no contracts, agreements or understandings
to require the Company to include any such securities in the Securities proposed to be offered pursuant to the Transaction Documents,
except for such contracts, agreements or understandings that have been validly waived in writing prior to the date hereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(y)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Exchange
Act Registration and Listing of the Common Stock</U>. The Company&rsquo;s Common Stock is registered pursuant to Section 12(b) of the
Exchange Act and listed on the Principal Trading Market; the Company has taken no action designed to, or reasonably likely to have the
effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Principal Trading
Market, nor has the Company received any notification that the Commission or the Financial Industry Regulatory Authority is contemplating
terminating such registration or listing. The Company has not, in the 12 months preceding the date hereof, received notice from any Trading
Market on which the shares of Common Stock are or have been listed or quoted to the effect that the Company is not in compliance with
the listing or maintenance requirement of such Trading Market. The Company is, and has no reason to believe that it will not in the foreseeable
future continue to be, in compliance with all such listing and maintenance requirements. The Securities are currently eligible for electronic
transfer through the Depository Trust Company or another established clearing corporation and the Company is current in payment
of the fees to the Depository Trust Company (or such other established clearing corporation) in connection with such electronic transfer.</P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(z)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Disclosure</U>.
The Company confirms that it has not provided, and to the Company&rsquo;s Knowledge, none of its officers or directors nor any other Person
acting on its or their behalf has provided any Purchaser or its respective agents or counsel with any information that it believes constitutes
material, non-public information regarding the Company or its Subsidiary except (i) such information, including the existence, provisions
and terms of the Transaction Documents and the proposed transactions hereunder. that may constitute such information, all of which will
be disclosed by the Company in the Press Release or Current Report on Form 8-K as contemplated by <U>Section 4.4</U> hereof or (ii) to
such Purchaser, prior to such disclosure, that has executed a written agreement regarding the confidentiality and use of such information.
All of the disclosure furnished by or on behalf of the Company to the Purchasers regarding the Company and its Subsidiaries, their respective
businesses and the transactions contemplated hereby is true and correct and does not contain any untrue statement of a material fact or
omit to state any material fact necessary in order to make the statements made therein, in the light of the circumstances under which
they were made, not misleading. The press releases disseminated by the Company during the twelve months preceding the date of this Agreement
taken as a whole do not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein
or necessary in order to make the statements therein, in the light of the circumstances under which they were made and when made, not
misleading. The Company acknowledges and agrees that no Purchaser makes or has made any representations or warranties with respect to
the transactions contemplated hereby other than those specifically set forth in <U>Section 3.2</U> hereof. The Company understands and
confirms that the Purchasers will rely on the foregoing representations in effecting transactions in securities of the Company.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(aa)&#9;<U>No Integrated
Offering</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in <U>Section 3.2</U>, none of the
Company, its Subsidiary nor any of its Affiliates or any Person acting on its behalf has, directly or indirectly, at any time within the
past six (6) months, made any offers or sales of any Company security or solicited any offers to buy any security under circumstances
that would (i) eliminate the availability of the exemption from registration under Regulation D under the Securities Act in connection
with the offer and sale by the Company of the Securities as contemplated hereby or (ii) cause the offering of the Securities pursuant
to the Transaction Documents to be integrated with prior offerings by the Company for purposes of any applicable law, regulation or stockholder
approval provisions, including, without limitation, under the rules and regulations of any Trading Market on which any of the securities
of the Company are listed or designated.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(bb)&#9;<U>Tax Matters</U>.
The Company and its Subsidiary have filed all federal, state, local and foreign tax returns required to be filed through the date hereof,
subject to permitted extensions (except where the failure to file would not, individually or in the aggregate, reasonably be expected
to have a Material Adverse Effect), and have paid all taxes due (except where the failure to pay would not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect), and no tax deficiency has been determined adversely to the Company or its Subsidiary,
nor does the Company have any knowledge of any tax deficiencies that have been, or would reasonably be expected to be, asserted against
the Company that would, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(cc)&#9;<U>Compliance with
Environmental Laws</U>. Except as disclosed in the SEC Reports, neither the Company nor its Subsidiary is in violation of any statute,
any rule, regulation, decision or order of any governmental authority or any court, domestic or foreign, relating to the use, disposal
or release of hazardous or toxic substances or relating to the protection or restoration of the environment or human exposure to hazardous
or toxic substances (collectively, &ldquo;<I><U>Environmental Laws</U></I>&rdquo;), owns or operates any real property contaminated with
any substance that is subject to any Environmental Laws, is liable for any off-site disposal or contamination pursuant to any Environmental
Laws, or is subject to any claim relating to any Environmental Laws, which violation, contamination, liability or claim would, individually
or in the aggregate, reasonably be expected to have a Material Adverse Effect; and the Company is not aware of any pending investigation
which might lead to such a claim. Neither the Company nor the Subsidiary anticipates incurring any material capital expenditures relating
to compliance with Environmental Laws.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(dd)&#9;<U>No General Solicitation</U>.
Neither the Company, nor any Person acting on behalf of the Company, has offered or sold any of the Securities by any form of general
solicitation or general advertising.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(ee)&#9;<U>Anti-Bribery and
Anti-Money Laundering Laws</U>. Each of the Company, the Subsidiary, any of their respective officers, directors, affiliates and employees,
and, to the Company&rsquo;s Knowledge, any of their respective agents has not violated, its participation in the offering will not violate,
and the Company and the Subsidiary have instituted and maintain policies and procedures designed to ensure continued compliance with,
each of the following laws: (i) anti-bribery laws, including but not limited to, any applicable law, rule or regulation of any locality,
including but not limited to any law, rule or regulation promulgated to implement the OECD Convention on Combating Bribery of Foreign
Public Officials in International Business Transactions, including the U.S. Foreign Corrupt Practices Act of 1977, as amended, the U.K.
Bribery Act 2010, or any other law, rule or regulation of similar purposes and scope or (ii) anti-money laundering laws, including but
not limited to, applicable federal, state, international, foreign or other laws, regulations or government guidance regarding anti-money
laundering, including, without limitation, Title 18 U.S.C. &sect;&sect; 1956 and 1957, the Patriot Act, the Bank Secrecy Act and international
anti-money laundering principles or procedures by an intergovernmental group or organization, such as the Financial Action Task Force
on Money Laundering, of which the United States is a member and with which designation the United States representative to the group or
organization continues to concur, all as amended, and any Executive order, directive or regulation pursuant to the authority of any of
the foregoing, or any orders or licenses issued thereunder (collectively, &ldquo;<I><U>Anti-Bribery and Anti-Money Laundering Laws</U></I>&rdquo;).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(ff)&#9;<U>Off-Balance Sheet
Arrangements</U>. There are no transactions, arrangements or other relationships between and/or among the Company, and/or, to the Company&rsquo;s
Knowledge, any of its Affiliates and any unconsolidated entity, including, but not limited to, any structural finance, special purpose
or limited purpose entity (each, an &ldquo;<I><U>Off-Balance Sheet Transaction</U></I>&rdquo;) that could reasonably be expected to materially
affect the Company&rsquo;s liquidity or the availability of or requirements for its capital resources, including those Off-Balance Sheet
Transactions described in the Commission&rsquo;s Statement about Management&rsquo;s Discussion and Analysis of Financial Conditions and
Results of Operations (Release Nos. 33-8056; 34-45321; FR-61), and are required to be described in the SEC Reports, which have not been
described as required.</P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(gg)&#9;<U>Acknowledgment
Regarding Purchasers&rsquo; Purchase of Securities</U>. The Company acknowledges and agrees that each of the Purchasers is acting solely
in the capacity of an arm&rsquo;s-length purchaser with respect to the Transaction Documents and the transactions contemplated hereby
and thereby. The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any
similar capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser
or any of their respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby
is merely incidental to the Purchasers&rsquo; purchase of the Securities. The Company further represents to each Purchaser that the Company&rsquo;s
decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the transactions
contemplated hereby by the Company and its representatives.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(hh)&#9;&nbsp;<U>Regulation M Compliance</U>.
The Company and its controlled affiliates have not taken, directly or indirectly, any action designed to or that has constituted or that
could reasonably be expected to cause or result in the stabilization or manipulation of the price of any security of the Company in connection
with the offering of the Securities.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>PFIC</U>.
Subject to the qualifications and assumptions set forth in the SEC Reports, the Company is not, and upon the sale of the Securities contemplated
hereby does not expect to become, a &ldquo;passive foreign investment company&rdquo; (as defined in Section 1297 of the Internal Revenue
Code of 1986, as amended, and the regulations promulgated thereunder).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(jj)&#9;<U>Office of Foreign
Assets Control</U>. Neither the Company nor the Subsidiary, nor any or their directors, officers or employees, nor, to the Company&rsquo;s
Knowledge, any agent, affiliate or representative of the Company or the Subsidiary, is an individual or entity that is, or is owned or
controlled by an individual or entity that is: (i) the subject of any sanctions administered or enforced by the U.S. Department of Treasury&rsquo;s
Office of Foreign Assets Control, the United Nations Security Council, the European Union, His Majesty&rsquo;s Treasury, or other relevant
sanctions authority (collectively, &ldquo;<I><U>Sanctions</U></I>&rdquo;), nor (ii) located, organized or resident in a country or territory
that is the subject of Sanctions (including, without limitation, Burma/Myanmar, Cuba, Iran, Libya, North Korea and Syria). Neither the
Company nor the Subsidiary will, directly or indirectly, use the proceeds of the offering, or lend, contribute or otherwise make available
such proceeds to any Subsidiary, joint venture partner or other individual or entity: (i) to fund or facilitate any activities or business
of or with any individual or entity or in any country or territory that, at the time of such funding or facilitation, is the subject of
Sanctions; or (ii) in any other manner that will result in a violation of Sanctions by any individual or entity (including any individual
or entity participating in the offering, whether as underwriter, advisor, investor or otherwise). For the past five years, neither the
Company nor the Subsidiary has knowingly engaged in, and is not now knowingly engaged in, any dealings or transactions with any individual
or entity, or in any country or territory, that at the time of the dealing or transaction is or was the subject of Sanctions.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-indent: 1in; font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">(kk)&#9;<U>Compliance with
Healthcare Laws and Regulations</U>. Except as disclosed in the SEC Reports, the Company and the Subsidiary and, to the Company&rsquo;s
Knowledge, their respective directors, employees and agents (while acting in such capacity) are in material compliance with all health
care laws applicable to the Company and the Subsidiary, or any of their products or activities, including, but not limited to, the federal
Anti-Kickback Statute (42 U.S.C. &sect; 1320a-7b(b)), the Civil Monetary Penalties
Law (42 U.S.C. &sect; 1320a-7a), the civil False Claims Act (31 U.S.C. &sect; 3729 et seq.), the criminal False Claims Law (42 U.S.C.
&sect; 1320a-7b(a)), the Stark law (42 U.S.C. &sect; 1395nn), the Physician Payments Sunshine Act (42 U.S.C. &sect; 1320a-7h), the Health
Insurance Portability and Accountability Act of 1996 (42 U.S.C. &sect; 1320d et seq.) as amended by the Health Information Technology
for Economic and Clinical Health Act (42 U.S.C. &sect; 17921 et seq.) (&ldquo;<I><U>HIPAA</U></I>&rdquo;), all criminal laws relating
to healthcare fraud and abuse, including but not limited to 18 U.S.C. &sect;&sect; 286 and 287, the healthcare fraud criminal provisions
under HIPAA, the exclusion laws (42 U.S.C. &sect; 1320a-7), the Federal Food, Drug, and Cosmetic Act (21 U.S.C. &sect; 301 et seq.), the
Controlled Substances Act (21 U.S.C. &sect; 801 et seq.), the Public Health Service Act (42 U.S.C. &sect; 201 et seq.), the Clinical Laboratory
Improvement Amendments of 1988 (42 U.S.C. &sect; 263a), Medicare (Title XVIII of the Social Security Act), Medicaid (Title XIX of the
Social Security Act), TRICARE (10 U.S.C. &sect; 1071 et seq.), any state corporate practice or fee-splitting prohibitions, and any state
or federal anti-markup or comparable laws or regulations, the regulations promulgated pursuant to such laws, and any other state, federal
or foreign law, accreditation standards, regulation, memorandum, opinion letter or other issuance which imposes requirements on the manufacturing,
development, testing, labeling, advertising, marketing or distribution of drugs, biologics and medical devices, kickbacks, patient or
program charges, recordkeeping, claims process, documentation requirements, medical necessity, referrals, the hiring of employees or acquisition
of services or supplies from those who have been excluded from government health care programs, quality, safety, privacy, security, licensure,
accreditation or any other aspect of providing health care, clinical laboratory or diagnostics products or services (collectively, &ldquo;<I><U>Health
Care Laws</U></I>&rdquo;). None of the Company, the Subsidiary or any of their respective officers, directors, employees or, to the Company&rsquo;s
Knowledge, agents, have engaged in activities which are, as applicable, cause for false claims liability, civil penalties, or mandatory
or permissive exclusion from Medicare, Medicaid, TRICARE or any other state or federal healthcare program (collectively, the &ldquo;<I><U>Programs</U></I>&rdquo;).
Except as disclosed in the SEC Reports, none of the Company or the Subsidiary has received any notification, correspondence or any other
written or, to the Company&rsquo;s Knowledge, oral communication, including notification of any pending or threatened claim, suit, proceeding,
hearing, enforcement, investigation, arbitration or other action (&ldquo;<I><U>Action</U></I>&rdquo;) from any governmental authority,
including, without limitation, the FDA, the EMA, Health Canada, the United States Federal Trade Commission, the United States Drug Enforcement
Administration, CMS, HHS&rsquo;s Office of Inspector General, the United States Department of Justice and state Attorneys General or similar
agencies of potential or actual non-compliance by, or liability of, the Company or the Subsidiary under any Health Care Laws, except,
with respect to any of the foregoing, such as would not, individually or in the aggregate, be material to the Company or the Subsidiary.
Except as disclosed in the SEC Reports, to the Company&rsquo;s Knowledge, there are no facts or circumstances that would reasonably be
expected to give rise to material liability of the Company or the Subsidiary under any Health Care Laws. Except as disclosed in the SEC
Reports, neither the Company nor its Subsidiary is a party to, and has any ongoing reporting obligations pursuant to any corporate integrity
agreement, deferred prosecution agreement, monitoring agreement, consent decree, settlement order, plan of correction or similar agreement
imposed by any governmental or regulatory authority. Additionally, none of the Company, its Subsidiary or any of its respective employees,
officers or directors, nor to the Company&rsquo;s Knowledge, any of its agents, has been excluded, suspended or debarred from participation
in any Program or human clinical research or, to the Company&rsquo;s Knowledge, is subject to a governmental inquiry, investigation, proceeding,
or other similar Action that could reasonably be expected to result in debarment,
suspension, or exclusion. The statements with respect to Health Care Laws and the Company&rsquo;s and the Subsidiary&rsquo;s compliance
therewith included in the SEC Reports fairly summarize the matters therein described.</P>


<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(ll)&#9;<U>Shell Company</U>.
The Company is not an &ldquo;ineligible issuer&rdquo; (as defined in Rule 405 promulgated under the Securities Act) and is not, and has
never been, an issuer identified in, or subject to, Rule 144(i)(1) of the Securities Act.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(mm)&#9;<U>No Additional
Agreements</U>. The Company does not have any agreement or understanding with any Purchaser with respect to the transactions contemplated
by the Transaction Documents other than as specified in the Transaction Documents or any written agreement regarding the confidentiality
and use of confidential information.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(nn)&#9;<U>Clinical Trials</U>.
The studies, tests and preclinical and clinical trials conducted by or on behalf of, or sponsored by, the Company or the Subsidiary, or
in which the Company or the Subsidiary have participated, that are described in the SEC Reports, or the results of which are referred
to in the SEC Reports, were and, if still pending, are being conducted in all material respects in accordance with the protocols, procedures
and controls established for each such study, test or preclinical or clinical trial and pursuant to, where applicable, accepted professional
and scientific standards for products or product candidates comparable to those being developed by the Company or the Subsidiary and all
applicable statutes, rules and regulations of the regulatory agencies to which they are subject, including without limitation the Health
Care Laws, including 21 C.F.R. Parts 50, 54, 56, 58, 312 and 812; the descriptions of the results of such studies, tests and trials contained
in the SEC Reports do not contain any misstatement of a material fact or omit a material fact necessary to make such statements not misleading;
the Company has no knowledge of any studies, tests or trials not described in the SEC Reports the results of which reasonably call into
question in any material respect the results of the studies, tests and trials described in the SEC Reports; and neither the Company nor
the Subsidiary has received any notices or other correspondence from the FDA, the EMA, Health Canada or any other foreign, state or local
governmental body exercising comparable authority or any Institutional Review Board or comparable authority requiring or threatening the
termination, suspension or material modification of any studies, tests or preclinical or clinical trials conducted by or on behalf of,
or sponsored by, the Company or in which the Company has participated, and, to the Company&rsquo;s Knowledge, there are no reasonable
grounds for the same. Except as disclosed in the SEC Reports, there has not been any violation of law or regulation by the Company or
the Subsidiary in their respective product development efforts, submissions or reports to any regulatory authority that could reasonably
be expected to require investigation, corrective action or enforcement action.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(oo)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Absence
of Settlement Agreements or Undertakings</U>. The Company is not a party to any corporate integrity agreements, monitoring agreements,
consent decrees, settlement orders, or similar agreements with or imposed by any governmental authority.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(pp)&#9;<U>Material Contracts</U>.
There are no contracts or other documents required to be described in the SEC Reports or filed as exhibits to the SEC Reports pursuant
to Item 601 of Regulation S-K that are not described and filed as required. The statements made in the SEC Reports, insofar as they purport
to constitute summaries of the terms of the contracts and other documents described and filed pursuant to Item 601 of Regulation S-K,
constitute accurate summaries of the terms of such contracts and
documents in all material respects. Except as disclosed in the SEC Reports, neither the Company nor its Subsidiary has knowledge that
any other party to any such contract or other document filed pursuant to Item 601 of Regulation S-K has any intention not to render full
performance as contemplated by the terms thereof.</P>


<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(qq)&#9;<U>Disclosure Controls</U>.
The Company has established and maintains disclosure controls and procedures (as defined in Rules 13a-14 and 15d-14 under the Exchange
Act) and such controls and procedures are effective in ensuring that material information relating to the Company, including the Subsidiary,
is made known to the principal executive officer and the principal financial officer. The Company has utilized such controls and procedures
in preparing and evaluating the disclosures in the SEC Reports.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(rr)&#9;<U>No &ldquo;Bad
Actor&rdquo; Disqualification</U>. The Company has exercised reasonable care, in accordance with Commission rules and guidance, to determine
whether any Covered Person (as defined below) is subject to any of the &ldquo;bad actor&rdquo; disqualifications described in Rule 506(d)(1)(i)
through (viii) under the Securities Act (&ldquo;<I><U>Disqualification Events</U></I>&rdquo;). To the Company&rsquo;s Knowledge, no Covered
Person is subject to a Disqualification Event, except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3) under the Securities
Act. The Company has complied, to the extent applicable, with any disclosure obligations under Rule 506(e) under the Securities Act. &ldquo;<I><U>Covered
Persons</U></I>&rdquo; are those persons specified in Rule 506(d)(1) under the Securities Act, including the Company; any predecessor
or affiliate of the Company; any director, executive officer, other officer participating in the offering, general partner or managing
member of the Company; any beneficial owner of 20% or more of the Company&rsquo;s outstanding voting equity securities, calculated on
the basis of voting power; any promoter (as defined in Rule 405 under the Securities Act) connected with the Company in any capacity at
the time of the sale of the Securities; and any person that has been or will be paid (directly or indirectly) remuneration for solicitation
of purchasers in connection with the sale of the Securities (a &ldquo;<I><U>Solicitor</U></I>&rdquo;), any general partner or managing
member of any Solicitor, and any director, executive officer or other officer participating in the offering of any Solicitor or general
partner or managing member of any Solicitor.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(ss)&#9;<U>Solvency</U>.
Except as disclosed in SEC Reports, based on the consolidated financial condition of the Company as of the Closing Date, after giving
effect to the receipt by the Company of the proceeds from the sale of the Securities hereunder, (i) the fair saleable value of the Company&rsquo;s
assets exceeds the amount that will be required to be paid on or in respect of the Company&rsquo;s existing Indebtedness (as defined
below) as they mature, (ii) the Company&rsquo;s assets do not constitute unreasonably small capital to carry on its business as now conducted
and as proposed to be conducted including its capital needs taking into account the particular capital requirements of the business conducted
by the Company, consolidated and projected capital requirements and capital availability thereof, and (iii) the current cash flow of
the Company, together with the proceeds the Company would receive, were it to liquidate all of its assets, after taking into account
all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of its liabilities when such amounts are required
to be paid. The Company does not intend to incur Indebtedness beyond its ability to pay such Indebtedness as they mature (taking into
account the timing and amounts of cash to be payable on or in respect of its Indebtedness). For the purposes of this Agreement, &ldquo;<U>Indebtedness</U>&rdquo;
means except as disclosed in the SEC Report<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><SUP></SUP></FONT>,
(x) any liabilities for borrowed money or amounts owed in excess of $50,000 (other than trade accounts payable incurred in the ordinary
course of business), (y) all guaranties, endorsements and other contingent obligations in respect of indebtedness of others, whether
or not the same are or should be reflected in the Company&rsquo;s consolidated balance sheet (or the notes thereto), except guaranties
by endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of business; and (z)
the present value of any lease payments in excess of $50,000 due under leases required to be capitalized in accordance with GAAP. Neither
the Company nor the Subsidiary is in default with respect to any Indebtedness.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 3pt; text-align: justify"></P>


<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(tt)&#9;<U>Form S-3 Eligibility</U>.
The Company is currently eligible to register the resale of the Shares by the Purchaser on Form S-3 promulgated under the Securities Act.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 3.2&#9;<U>Representations
and Warranties of the Purchasers</U>. Each Purchaser hereby, for itself and for no other Purchaser, represents and warrants as of the
date hereof and as of the Closing Date to the Company and the Placement Agent as follows:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Organization;
Authority</U>. Such Purchaser is an entity duly organized, validly existing and in good standing under the laws of the jurisdiction of
its organization with the requisite corporate, limited liability company or partnership power and authority to enter into and to consummate
the transactions contemplated by the applicable Transaction Documents and otherwise to carry out its obligations hereunder and thereunder.
The execution and delivery of this Agreement by such Purchaser and performance by such Purchaser of the transactions contemplated by this
Agreement have been duly authorized by all necessary corporate or, if such Purchaser is not a corporation, such partnership, limited liability
company or other applicable entity action, on the part of such Purchaser. Each Transaction Document to which it is a party has been duly
executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof, will constitute the valid and legally
binding obligation of such Purchaser, enforceable against it in accordance with its terms, except as such enforceability may be limited
by applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or similar laws relating to, or affecting generally the
enforcement of, creditors&rsquo; rights and remedies or by other equitable principles of general application.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Conflicts</U>. The execution, delivery and performance by such Purchaser of this Agreement and the consummation by such Purchaser of the
transactions contemplated hereby and thereby will not (i) result in a violation of the organizational documents of such Purchaser, (ii)
conflict with, or constitute a default (or an event which with notice or lapse of time or both would become a default) under, or give
to others any rights of termination, amendment, acceleration or cancellation of, any agreement, indenture or instrument to which such
Purchaser is a party, or (iii) result in a violation of any law, rule, regulation, order, judgment or decree (including federal and state
securities laws) applicable to such Purchaser, except in the case of clauses (ii) and (iii) above, for such conflicts, defaults, rights
or violations which would not, individually or in the aggregate, reasonably be expected to have a material adverse effect on the ability
of such Purchaser to perform its obligations hereunder.</P>


<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Investment
Intent</U>. Such Purchaser understands that the Securities are &ldquo;restricted securities&rdquo; and have not been registered under
the Securities Act or any applicable state securities law and is acquiring the Securities, as principal for its own account and not with
a view to, or for distributing or reselling such Securities or any part thereof in violation of the Securities Act or any applicable state
securities laws, <I>provided</I>, <I>however</I>, that by making the representations herein, such Purchaser does not agree to hold any
of the Securities for any minimum period of time and reserves the right, subject to the provisions of this Agreement, at all times to
sell or otherwise dispose of all or any part of such Securities pursuant to an effective registration statement under the Securities Act
or under an exemption from such registration and in compliance with applicable federal and state securities laws. Such Purchaser is acquiring
the Securities hereunder in the ordinary course of its business. Such Purchaser does not presently have any agreement, plan or understanding,
directly or indirectly, with any Person to distribute or effect any distribution of any of the Securities (or any securities which are
derivatives thereof) to or through any person or entity; such Purchaser is not a registered broker-dealer under Section 15 of the Exchange
Act or an entity engaged in a business that would require it to be so registered as a broker-dealer.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Purchaser
Status</U>. At the time such Purchaser was offered the Securities, it was, and at the date hereof it is, an &ldquo;accredited investor&rdquo;
as defined in Rule 501(a) under the Securities Act.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>General
Solicitation</U>. Such Purchaser acknowledges and agrees that the Purchaser is purchasing the Securities directly from the Company.
Such Purchaser became aware of this offering of the Securities solely by means of direct contact from the Placement Agent or
directly from the Company as a result of a pre-existing, substantive relationship with the Company or the Placement Agent, and/or
their respective advisors (including, without limitation, attorneys, accountants, bankers, consultants and financial advisors),
agents, control persons, representatives, Affiliates, directors, officers, managers, members, and/or employees, and/or the
representatives of such persons. The Securities were offered to such Purchaser solely by direct contact between the Purchaser and
the Company, the Placement Agent and/or their respective representatives. Such Purchaser did not become aware of this offering of
the Securities, nor were the Securities offered to the Purchaser, by any other means, and none of the Company, the Placement Agent
and/or their respective representatives acted as investment advisor, broker or dealer to such Purchaser. Such Purchaser is not
purchasing the Securities as a result of any general or public solicitation or general advertising, or publicly disseminated
advertisement, article, notice or other communication regarding the Securities published in any newspaper, magazine or similar media
or broadcast over television, radio or the internet or presented at any seminar or any other general solicitation or general
advertisement, including any of the methods described in Section 502(c) of Regulation D under the Securities Act.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Experience
of Such Purchaser</U>. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication and experience
in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities,
and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of an investment in the
Securities and, at the present time, is able to afford a complete loss of such investment.</P>


<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Acknowledgment
of Risks</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Such
Purchaser acknowledges and understands that its investment in the Securities involves a significant degree of risk, including, without
limitation: (i) the Company remains a development stage business with limited operating history and requires substantial funds in addition
to the proceeds from the sale of the Securities; (ii) an investment in the Company is speculative, and only Purchasers who can afford
the loss of their entire investment should consider investing in the Company and the Securities; (iii) such Purchaser may not be able
to liquidate its investment; (iv) transferability of the Securities is extremely limited; (v) in the event of a disposition of the Securities,
such Purchaser could sustain the loss of its entire investment; and (vi) the Company has not paid any dividends on its Common Stock since
inception and does not anticipate the payment of dividends in the foreseeable future. Such risks are more fully set forth in the public
filings made by the Company with the Commission;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Such
Purchaser is able to bear the economic risk of holding the Securities for an indefinite period, and has knowledge and experience in financial
and business matters such that it is capable of evaluating the risks of the investment in the Securities;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Such
Purchaser has, in connection with such Purchaser&rsquo;s decision to purchase Securities, not relied upon any representations or other
information (whether oral or written) other than as set forth in the representations and warranties of the Company contained in the Transaction
Documents and in the SEC Reports, and such Purchaser has, with respect to all matters relating to the Transaction Documents and the offer
and sale of the Securities, relied solely upon the advice of such Purchaser&rsquo;s own counsel and has not relied upon or consulted any
counsel to the Company; and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.5in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Such
Purchaser acknowledges that the Company is entering into this Agreement with such Purchaser in reliance on such Purchaser&rsquo;s understanding,
acknowledgment and agreement that the Company is privy to material non-public information regarding the Company (collectively, the &ldquo;<I><U>Non-Public
Information</U></I>&rdquo;), which Non-Public Information may be material to a reasonable investor, such as such Purchaser, when making
investment decisions, including the decision to enter into this Agreement. Such Purchaser&rsquo;s decision to enter into the this Agreement
is being made with full recognition and acknowledgment that the Company is privy to the Non-Public Information, irrespective of whether
such Non-Public Information has been provided to such Purchaser. Such Purchaser hereby waives any claim, or potential claim, it has or
may have against the Company relating to the Company&rsquo;s possession of Non-Public Information.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Access
to Information</U>. Such Purchaser acknowledges that it has had the opportunity to review the SEC Reports and has been afforded (i) the
opportunity to ask such questions as it has deemed necessary of, and to receive answers from, representatives of the Company concerning
the terms and conditions of the offering of the Securities and the merits and risks of investing in the Securities; (ii) access to information
about the Company and the Subsidiary and their respective financial condition, results of operations, business, properties, management
and prospects sufficient to enable it to evaluate its investment; and (iii) the opportunity to obtain such additional information that
the Company possesses or can acquire without unreasonable effort or expense that is necessary to make an informed investment decision
with respect to the investment. Neither such inquiries nor any other investigation conducted by or on behalf of such Purchaser or its representatives or counsel
shall modify, amend or affect such Purchaser&rsquo;s right to rely on the truth, accuracy and completeness of the SEC Reports and the
Company&rsquo;s representations and warranties contained in the Transaction Documents. Such Purchaser has sought such accounting, legal
and tax advice as it has considered necessary to make an informed decision with respect to its acquisition of the Securities.</P>


<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Certain
Trading Activities</U>. Other than with respect to the transactions contemplated herein, since the time that such Purchaser was first
contacted by the Company or any other Person regarding the transactions contemplated hereby, neither the Purchaser nor any Affiliate of
such Purchaser which (x) had knowledge of the transactions contemplated hereby, (y) has or shares discretion relating to such Purchaser&rsquo;s
investments or trading or information concerning such Purchaser&rsquo;s investments, including in respect of the Securities, and (z) is
subject to such Purchaser&rsquo;s review or input concerning such Affiliate&rsquo;s investments or trading (each a &ldquo;<I><U>Trading
Affiliate</U></I>&rdquo;) has directly or indirectly, nor has any Person acting on behalf of or pursuant to any understanding with such
Purchaser or Trading Affiliate, effected or agreed to effect any purchases or sales of the securities of the Company (including, without
limitation, any Short Sales involving the Company&rsquo;s securities). Notwithstanding the foregoing, in the case of a Purchaser and/or
Trading Affiliate that is, individually or collectively, a multi-managed investment bank or vehicle whereby separate portfolio managers
manage separate portions of such Purchaser&rsquo;s or Trading Affiliate&rsquo;s assets and the portfolio managers have no direct knowledge
of the investment decisions made by the portfolio managers managing other portions of such Purchaser&rsquo;s or Trading Affiliate&rsquo;s
assets, the representation set forth above shall apply only with respect to the portion of assets managed by the portfolio manager that
made the investment decision to purchase the Securities covered by this Agreement. Other than to other Persons party to this Agreement
or to such Purchaser&rsquo;s representatives, including, without limitation, its officers, directors, partners, legal and other advisors,
employees, agents and Affiliates, such Purchaser has maintained the confidentiality of all disclosures made to it in connection with this
transaction (including the existence and terms of this transaction). Notwithstanding the foregoing, for avoidance of doubt, nothing contained
herein shall constitute a representation or warranty, or preclude any actions, with respect to the identification of the availability
of, or securing of, available shares to borrow in order to effect Short Sales or similar transactions in the future.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Brokers
and Finders</U>. No Person will have, as a result of the transactions contemplated by this Agreement, any valid right, interest or claim
against or upon the Company or any Purchaser for any commission, fee or other compensation pursuant to any agreement, arrangement or understanding
entered into by or on behalf of the Purchaser.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Independent
Investment Decision</U>. Such Purchaser has independently evaluated the merits of its decision to purchase Securities pursuant to the
Transaction Documents, and such Purchaser confirms that it has not relied on the advice of any other Purchaser&rsquo;s business and/or
legal counsel in making such decision. Such Purchaser understands that nothing in this Agreement or any other materials presented by or
on behalf of the Company to the Purchaser in connection with the purchase of the Securities constitutes legal, tax or investment advice.
Such Purchaser has consulted such legal, tax and investment advisors as it, in its sole discretion, has deemed necessary or appropriate
in connection with its purchase of the Securities.</P>


<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Reliance
on Exemptions</U>. Such Purchaser understands that the Securities are being offered and sold to it in reliance on specific exemptions
from the registration requirements of United States federal and state securities laws and that the Company and the Placement Agent are
relying in part upon the truth and accuracy of, and such Purchaser&rsquo;s compliance with, the representations, warranties, agreements,
acknowledgements and understandings of such Purchaser set forth herein in order to determine the availability of such exemptions and the
eligibility of such Purchaser to acquire the Securities.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Governmental Review</U>. Such Purchaser understands that no United States federal or state agency or any other government or governmental
agency has passed on or made any recommendation or endorsement of the Securities or the fairness or suitability of the investment in the
Securities nor have such authorities passed upon or endorsed the merits of the offering of the Securities.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(n)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Regulation
M</U>. Such Purchaser is aware that the anti-manipulation rules of Regulation M under the Exchange Act may apply to sales of Common Stock
and other activities with respect to the Common Stock by the Purchasers.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(o)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Intentionally
Omitted</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(p)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Residency</U>.
Such Purchaser&rsquo;s residence (if an individual) or offices in which its investment decision with respect to the Securities was made
(if an entity) are located at the address immediately below such Purchaser&rsquo;s name on its signature page hereto.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(q)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Anti-Money
Laundering Laws</U>. Such Purchaser represents and warrants to, and covenants with, the Company that: (i) such Purchaser is in compliance
with the regulations administered by the U.S. Department of the Treasury (&ldquo;<I><U>Treasury</U></I>&rdquo;) Office of Foreign Assets
Control; (ii) such Purchaser, its parents, subsidiaries, affiliated companies, officers, directors and partners, and to such Purchaser&rsquo;s
knowledge, its stockholders, owners, employees, and agents, are not on the List of Specially Designated Nationals and Blocked Persons
maintained by Treasury and have not been designated by Treasury as a financial institution of primary money laundering concern subject
to special measures under Section 311 of the USA PATRIOT Act, Pub. L. 107-56; (iii) to such Purchaser&rsquo;s knowledge, the funds to
be used to acquire the Securities are not derived from activities that contravene applicable anti-money laundering laws and regulations;
(iv) such Purchaser is in compliance with all other applicable anti money laundering laws and regulations and has implemented anti money
laundering procedures that comply with applicable anti-money laundering laws and regulations, including, as applicable, the requirements
of the Bank Secrecy Act, as amended by the USA PATRIOT Act, Pub. L. 107 56; and (v) to the best of its knowledge (A) none of the funds
to be provided by such Purchaser are being tendered on behalf of a person or entity who has not been identified to such Purchaser, and
(B) upon the reasonable request of the Company, such Purchaser agrees to re-certify in writing the representations, warranties and covenants
provided in this paragraph.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(r)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
&ldquo;Bad Actor&rdquo; Disqualification Events</U>. Neither (i) the Purchaser, (ii) any of its directors, executive officers, other officers
that may serve as a director or officer of any company in which it invests, general partners or managing members, nor (iii) any beneficial
owner of the Company&rsquo;s voting equity securities (in accordance with Rule 506(d) of the Securities Act) held by the Purchaser is subject to any Disqualification
Event, except for Disqualification Events covered by Rule 506(d)(2)(ii) or (iii) or (d)(3) under the Securities Act and disclosed reasonably
in advance of the Closing in writing in reasonable detail to the Company.</P>


<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(s)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Representations
by Non-United States Persons</U>. If Purchaser is not a United States person, the Purchaser hereby represents that the Purchaser has satisfied
the laws of the Purchaser&rsquo;s jurisdiction in connection with any invitation to subscribe for the Securities or any use of the Transaction
Documents, including (i) the legal requirements within the Purchaser&rsquo;s jurisdiction for the purchase of the Securities, (ii) any
foreign exchange restrictions applicable to such purchase, (iii) any governmental or other consents that may need to be obtained and (iv)
the income tax and other tax consequences, if any, that may be relevant to the purchase, holding, redemption, sale or transfer of the
Securities. The Purchaser&rsquo;s subscription and payment for, and the Purchaser&rsquo;s continued beneficial ownership of, the Securities
will not violate any applicable securities or other laws of the Purchaser&rsquo;s jurisdiction.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 3.3&#9;<U>No Other
Representations and Warranties</U>. The Company and each of the Purchasers acknowledge and agree that no party to this Agreement has made
or makes any representations or warranties with respect to the transactions contemplated hereby other than those specifically set forth
in this Article III and the Transaction Documents.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>ARTICLE IV.<FONT STYLE="text-transform: uppercase"><U><BR>
OTHER AGREEMENTS OF THE PARTIES</U></FONT></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 4.1&#9;<U>Transfer
Restrictions</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Compliance
with Laws</U>. Notwithstanding any other provision of this <U>Article IV</U>, each Purchaser covenants that the Securities may be disposed
of only pursuant to an effective registration statement under, and in compliance with the requirements of, the Securities Act, or pursuant
to an available exemption from, or in a transaction not subject to, the registration requirements of the Securities Act, and in compliance
with any applicable state and federal securities laws. In connection with any transfer of the Securities other than (i) pursuant to an
effective registration statement, (ii) to the Company, (iii) pursuant to Rule 144 (<I>provided</I> that the Purchaser provides the Company
with reasonable assurances (in the form of seller and, if applicable, broker representation letters) that the securities may be sold pursuant
to such rule) or (iv) in connection with a bona fide pledge, as contemplated in <U>Section(b)</U>, the Company may require the transferor
thereof to provide to the Company an opinion of counsel selected by the transferor and reasonably acceptable to the Company, the form
and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that such transfer does not require registration
of such transferred Securities under the Securities Act or applicable state securities law. As a condition of transfer, any such transferee
shall agree in writing to be bound by the terms of this Agreement and shall have the rights and obligations of a Purchaser under this
Agreement with respect to such transferred Securities.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Legends</U>.
Any certificates or book-entry notations shall bear any legend as required by the &ldquo;blue sky&rdquo; laws of any state and a restrictive
legend in substantially the following form, until such time as they are not required under <U>Section <B>(</B>c)</U>:</P>


<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">THE OFFER AND SALE OF THESE SECURITIES AND
THE SECURITIES ISSUABLE UPON EXERCISE OF THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;<U>SECURITIES
ACT</U>&rdquo;), OR ANY APPLICABLE STATE SECURITIES LAWS. THE SECURITIES AND THE SECURITIES ISSUABLE UPON EXERCISE OF THESE SECURITIES
MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED, ASSIGNED OR OTHERWISE DISPOSED OF (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION
STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OR (B) AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
REQUIREMENTS OF THE SECURITIES ACT AND IN EACH CASE IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS OR BLUE SKY LAWS AS EVIDENCED
BY A LEGAL OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY AND ITS TRANSFER AGENT OR (II) UNLESS SOLD PURSUANT TO RULE 144 UNDER
THE SECURITIES ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES AND THE SECURITIES ISSUABLE UPON EXERCISE OF THESE SECURITIES MAY BE
PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES; PROVIDED THAT
IN CONNECTION WITH ANY FORECLOSURE OR TRANSFER OF THE SECURITIES, THE TRANSFEROR SHALL COMPLY WITH THE PROVISIONS HEREIN, IN THE SECURITIES
PURCHASE AGREEMENT, AND UPON FORECLOSURE OR TRANSFER OF THE SECURITIES, SUCH FORECLOSING PERSON OR TRANSFEREE SHALL COMPLY WITH ALL PROVISIONS
CONTAINED HEREIN, IN THE SECURITIES PURCHASE AGREEMENT.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 55.1pt">The Company acknowledges
and agrees that a Purchaser may from time to time pledge, and/or grant a security interest in, some or all of the legended Securities
in connection with applicable securities laws, pursuant to a bona fide margin agreement in compliance with a bona fide margin loan. Such
a pledge would not be subject to approval or consent of the Company and no legal opinion of legal counsel to the pledgee, secured party
or pledgor shall be required in connection with the pledge, but such legal opinion shall be required in connection with a subsequent transfer
or foreclosure following default by the Purchaser transferee of the pledge. No notice shall be required of such pledge, but Purchaser
shall promptly notify the Company of any such subsequent transfer or foreclosure. Each Purchaser acknowledges that the Company shall not
be responsible for any pledges relating to, or the grant of any security interest in, any of the Securities or for any agreement, understanding
or arrangement between any Purchaser and its pledgee or secured party. At the appropriate Purchaser&rsquo;s expense, the Company will
execute and deliver such reasonable documentation as such Purchaser may reasonably request in connection with a pledge or transfer of
the Securities, including the preparation and filing of any required prospectus supplement under Rule 424(b)(3) of the Securities Act
or other applicable provision of the Securities Act to appropriately amend the list of selling stockholders thereunder. Each Purchaser
acknowledges and agrees that, except as otherwise provided in Section (c), any Securities subject to a pledge or security interest as
contemplated by this Section (b) shall continue to bear the legend set forth in this Section (b) and be subject to the restrictions on
transfer set forth in Section (a).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>


<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-indent: 1in; font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Removal
of Legends</U>. The legend set forth in <U>Section <B>(</B>b)</U> above shall be removed and the Company shall issue a book-entry notation
(or certificate, as applicable) to suchholder or issue to such holder by electronic
delivery at the applicable balance account at the Depository Trust Company (&ldquo;<I><U>DTC</U></I>&rdquo;), if (i) such Securities are
registered for resale under the Securities Act (<I>provided</I> that, if the Purchaser is selling pursuant to the effective registration
statement registering the Securities for resale, the Purchaser hereby agrees to only sell such Securities during such time that such registration
statement is effective and not withdrawn or suspended, and only as permitted by such registration statement), (ii) such Securities are
sold or transferred pursuant to Rule 144, or (iii) such Securities are eligible for sale under Rule 144, without the requirement for the
Company to be in compliance with the current public information required under Rule 144 as to such Securities and without volume or manner-of-sale
restrictions. Following the earlier of (i) the Effective Date and (ii) Rule 144 becoming available for the resale of Securities, without
the requirement for the Company to be in compliance with the current public information required under Rule 144 as to such Securities
and without volume or manner-of-sale restrictions, the Company shall cause Company Counsel, or any subsequent counsel, to issue a legal
opinion to the Transfer Agent or the Purchaser promptly if required by the Transfer Agent to effect the removal of the legend hereunder.
Any fees (with respect to the Transfer Agent, Company Counsel or otherwise) associated with the issuance of such opinion or the removal
of such legend shall be borne by the Company. Following the Effective Date, or at such earlier time as a legend is no longer required
for certain Securities, the Company will, no later than two (2) Trading Days following the delivery by a Purchaser to the Company (with
written notice to the Company) of a book-entry notation representing Securities (endorsed or with stock powers attached, signatures guaranteed,
and otherwise in the form necessary to affect the reissuance and/or transfer) and an opinion of counsel to the extent required by <U>Section
4.1(a)</U> (such date, the &ldquo;<I><U>Legend Removal Date</U></I>&rdquo;), deliver or cause to be delivered to such Purchaser a book-entry
notation free from all restrictive and other legends. The Company may not make any notation on its records or give instructions to the
Transfer Agent that enlarge the restrictions on transfer set forth in this <U>Section (c)</U>. Book-entry notations subject to legend
removal hereunder may be transmitted by the Transfer Agent to the Purchasers by crediting the account of the Purchaser&rsquo;s prime broker
with DTC as directed by such Purchaser.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Irrevocable
Transfer Agent Instructions</U>. The Company shall issue irrevocable instructions to its Transfer Agent, and any subsequent Transfer Agent
to issue to the Purchasers (or in such nominee&rsquo;s name(s) as designated by a Purchaser) book-entry notations representing the Securities
set forth under &ldquo;<U>Purchase of Securities</U>&rdquo; on the signature pages hereto (the &ldquo;<I><U>Irrevocable Transfer Agent
Instructions</U></I>&rdquo;). The Company represents and warrants that no instruction other than the Irrevocable Transfer Agent Instructions
referred to in this <U>Section <B>(</B>d)</U> (or instructions that are consistent therewith) will be given by the Company to the Transfer
Agent in connection with this Agreement (other than those instructions contemplated in <U>Section 2.2(a)(iii)</U>) and that the Securities
shall otherwise be freely transferable on the books and records of the Company as and to the extent provided in this Agreement and the
other Transaction Documents and applicable law. The Company acknowledges that a breach by it of its obligations under this <U>Section
<B>(</B>d)</U> will cause irreparable harm to a Purchaser. Accordingly, the Company acknowledges that the remedy at law for a breach of
its obligations under this <U>Section <B>(</B>d)</U> will be inadequate and agrees, in the event of a breach by the Company of the provisions
of this <U>Section <B>(</B>d)</U>, that a Purchaser shall be entitled, in addition to all other available remedies, to an order and/or
injunction restraining any breach and requiring immediate issuance and transfer, without the necessity of showing economic loss and without
any bond or other security being required.</P>


<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Acknowledgement</U>.
Each Purchaser hereunder acknowledges its primary responsibilities under the Securities Act and accordingly will not sell or otherwise
transfer the Securities or any interest therein without complying with the requirements of the Securities Act. While the Registration
Statement remains effective, each Purchaser hereunder may sell the Securities in accordance with the plan of distribution contained in
the Registration Statement and if it does so it will comply therewith and with the related prospectus delivery requirements unless an
exemption therefrom is available. Each Purchaser, severally and not jointly with the other Purchasers, agrees that if it is notified by
the Company in writing at any time that the Registration Statement registering the resale of the Securities is not effective or that the
prospectus included in such Registration Statement no longer complies with the requirements of Section 10 of the Securities Act, the Purchaser
will refrain from selling such Securities until such time as the Purchaser is notified by the Company that such Registration Statement
is effective or such prospectus is compliant with Section 10 of the Securities Act, unless such Purchaser is able to, and does, sell such
Securities pursuant to an available exemption from the registration requirements of Section 5 of the Securities Act. Both the Company
and its Transfer Agent, and their respective directors, officers, employees and agents, may rely on this <U>Section <B>(</B>e)</U> and
each Purchaser hereunder will indemnify and hold harmless each of such persons from any breaches or violations of this <U>Section <B>(</B>e)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
the Company fails to (i) issue and deliver (or cause to be delivered) to a Purchaser by the Legend Removal Date a certificate representing
the shares of Common Stock so delivered to the Company by such Purchaser that is free from all restrictive and other legends or (ii) if
after the Legend Removal Date, such Purchaser purchases (in an open market transaction or otherwise) shares of Common Stock to deliver
in satisfaction of a sale by such Purchaser of all or any portion of the number of shares of Common Stock, or a sale of a number of shares
of Common Stock equal to all or any portion of the number of shares of Common Stock that such Purchaser anticipated receiving from the
Company without any restrictive legend, then, the Company shall pay to Purchaser, as such Purchaser&rsquo;s sole remedy, an amount equal
to the excess of such Purchaser&rsquo;s total purchase price (including brokerage commissions and other out-of-pocket expenses, if any)
for the shares of Common Stock so purchased (including brokerage commissions and other out-of-pocket expenses, if any) over the product
of (A) such number of Shares that the Company was required to deliver to such Purchaser by the Legend Removal Date multiplied by (B) the
lowest closing sale price of the Common Stock on any Trading Day during the period commencing on the date of the delivery by such Purchaser
to the Company of the applicable Shares and ending on the date of such delivery and payment under this clause (f).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 4.2&#9;<U>Furnishing
of Information</U>. In order to enable the Purchasers to sell the Shares under Rule 144, for a period of twelve (12) months from the Closing,
the Company shall use its commercially reasonable efforts to timely file (or obtain extensions in respect thereof and file within the
applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to the Exchange Act. During such
twelve (12)-month period, if the Company is not required to file reports pursuant to the Exchange Act, it will prepare and furnish to
the Purchasers and make publicly available in accordance with Rule 144(c) such information as is required for the Purchasers to sell the
Shares under Rule 144.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 4.3&#9;<U>Integration</U>.
The Company shall not, and shall use its commercially reasonable efforts to ensure that no Affiliate of the Company shall, sell, offer
for sale or solicit offers to buy or otherwise negotiate in respect
of any security (as defined in Section 2 of the Securities Act) that will be integrated with the offer or sale of the Securities in a
manner that would require the registration under the Securities Act of the sale of the Securities to the Purchasers, or that will be integrated
with the offer or sale of the Securities for purposes of the rules and regulations of any Trading Market such that it would require stockholder
approval prior to the closing of such other transaction unless stockholder approval is obtained before the closing of such subsequent
transaction.</P>


<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 4.4&#9;<U>Securities
Laws Disclosure; Publicity</U>. The Company shall, by 9:00 A.M., New York City time, on the first (1st) Business Day immediately following
the date of this Agreement (the &ldquo;<U>Disclosure Time</U>&rdquo;), issue a press release or file with the Commission a Current Report
on Form 8-K (the &ldquo;<U>Disclosure Document</U>&rdquo;) disclosing all material terms of this Agreement and the Transaction Documents
and the transactions contemplated hereby and thereby, the transaction and any other material, nonpublic information that the Company or
any of its representatives, Affiliates, officers, directors, or employees or agents has provided to the Purchasers or any of the Purchasers&rsquo;
Affiliates, attorneys, agents or representatives at any time prior to the issuance or filing of the Disclosure Document; <I>provided</I>,
that the Company shall provide the Purchasers with a draft of the Disclosure Document sufficiently in advance of the Disclosure Time to
provide the Purchasers with a reasonable opportunity to review and provide comments to the Company with respect to the Disclosure Document,
which comments the Company shall consider in good faith. Upon the issuance of the Disclosure Document, the Purchasers and the Purchasers&rsquo;
Affiliates, attorneys, agents and representatives shall not be in possession of any material, non-public information received from the
Company, any Subsidiary or any of their respective representatives, Affiliates, officers, directors, or employees or agents. Each Purchaser,
severally and not jointly with the other Purchasers, covenants that until the earlier of (a) the Disclosure Time and (b) the issuance
or filing of the Disclosure Document, such Purchaser will maintain the confidentiality of all disclosures made to it in connection with
this transaction (including the existence and terms of this transaction). Upon the earlier of (i) the Disclosure Time and (ii) the issuance
or filing of the Disclosure Document, each Purchaser shall no longer be subject to any confidentiality or similar obligations under any
current agreement, whether written or oral, with the Company, any Subsidiary or any of their respective representatives, Affiliates, officers,
directors, employees or agents. The Company understands and confirms that such Purchaser and its Affiliates will rely on the foregoing
representations in effecting transactions in securities of the Company. Notwithstanding anything in this Agreement to the contrary, the
Company (A) shall not publicly disclose the name of any Purchaser or any of its Affiliates or advisers, or include the name of such Purchaser
or any of its Affiliates or advisers in any press release, without the prior written consent of such Purchaser and (B) shall not publicly
disclose the name of any Purchaser or any of its Affiliates or advisers, or include the name of such Purchaser or any of its Affiliates
or advisers in any filing with the Commission or any regulatory agency or trading market, without the prior written consent of such Purchaser,
except (1) as required by the federal securities laws, rules or regulations and (2) to the extent such disclosure is required by other
laws, rules or regulations, at the request of the staff of the Commission or regulatory agency or under the regulations of the Principal
Trading Market, in which case of clause (1) or (2), the Company shall provide such Purchaser with prior written notice (including by e-mail)
of such permitted disclosure, and shall reasonably consult with such Purchaser regarding such disclosure.</P>


<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 4.5&#9;<U>Stockholder
Rights Plan</U>. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person, that any Purchaser
is an &ldquo;<U>Acquiring Person</U>&rdquo; under any control share acquisition, business combination, poison pill (including any distribution
under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by the Company, or that any Purchaser
could be deemed to trigger the provisions of any such plan or arrangement, in either case solely by virtue of receiving Securities under
the Transaction Documents or under any other written agreement between the Company and the Purchasers.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 4.6&#9;<U>Non-Public
Information</U>. (a) Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents,
including this Agreement and the information contained in it, or as expressly required by any applicable securities law, the Company covenants
and agrees that neither it, nor any other Person acting on its behalf, including its representatives, affiliates, officers, directors,
employees or agents, will provide any Purchaser or any of Purchaser&rsquo;s Affiliates, attorneys, agents or representatives with any
information regarding the Company that the Company believes constitutes material non-public information regarding the Company or its Subsidiary
without the express written consent of such Purchaser or any of Purchaser&rsquo;s Affiliates, attorneys, agents or representatives, unless
prior thereto such Purchaser shall have executed a written agreement regarding the confidentiality and use of such information. The Company
understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the
Company. To the extent that the Company delivers any material, non-public information to a Purchaser without such Purchaser&rsquo;s consent,
the Company hereby covenants and agrees that such Purchaser shall not have any duty of confidentiality to the Company or any of its officers,
directors, agents, employees or Affiliates, or a duty to the Company or any of its officers, directors, agents, employees or Affiliates,
not to trade on the basis of such material, non-public information, provided that the Purchaser shall remain subject to applicable law.
To the extent that any notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public information
regarding the Company or the Subsidiary, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report
on Form 8-K. The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions
in securities of the Company.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 4.7&#9;<U>Principal
Trading Market Listing</U>. Prior to the Closing, the Company shall prepare and file with such Principal Trading Market an additional
shares listing application covering all of the Shares and shall use its commercially reasonable efforts to take all steps necessary to
cause all of the Shares to be approved for listing on the Principal Trading Market as promptly as possible thereafter. The Company further
agrees, if the Company applies to have the Common Stock traded on any other Trading Market, it will then include in such application all
of the Shares, and will take such other action as is necessary to cause all of the Shares to be listed or quoted on such other Trading
Market as promptly as possible. The Company will then take all action reasonably necessary to continue the listing and trading of its
Common Stock on a Trading Market and will comply in all respects with the Company&rsquo;s reporting, filing and other obligations under
the bylaws or rules of the Trading Market. The Company agrees to maintain the eligibility of the Common Stock for electronic transfer
through the Depository Trust Company or another established clearing corporation, including, without limitation, by timely payment of
fees to the Depository Trust Company or such other established
clearing corporation in connection with such electronic transfer.</P>


<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 4.8&#9;<U>Form
D; Blue Sky</U>. The Company agrees to timely file a Form D with respect to the Securities as required under Regulation D. The Company,
on or before the Closing Date, shall take such action as the Company shall reasonably determine is necessary in order to obtain an exemption
for or to qualify the Securities for sale to the Purchasers under applicable securities or &ldquo;<U>Blue Sky</U>&rdquo; laws of the states
of the United States (or to obtain an exemption from such qualification).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 4.9&#9;<U>Delivery
of Shares After Closing</U>. Subject to the satisfaction of each Purchaser&rsquo;s obligations under the Transaction Documents, the Company
shall deliver, or cause to be delivered, a book-entry statement evidencing the Securities as promptly as practicable and in any event
no later than one Trading Day after the Closing.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 4.10&#9;<U>Short
Sales</U>. Each Purchaser covenants that neither it nor any Affiliates acting on its behalf or pursuant to any understanding with it will
execute any Short Sales or otherwise seek to hedge its position in the Company&rsquo;s securities during the period from the date hereof
until the earlier of (i) the Effective Date or (ii) the date this Agreement is terminated in full. Each Purchaser understands and acknowledges
that the Commission currently takes the position that coverage of short sales of Common Stock &ldquo;against the box&rdquo; prior to effectiveness
of a resale registration statement with securities included in such registration statement would be a violation of Section 5 of the Securities
Act, as set forth in Item 239.10 of the Securities Act Rules Compliance and Disclosure Interpretations compiled by the Office of Chief
Counsel, Division of Corporation Finance.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 4.11&#9;<U>Registration
Rights of Purchasers</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Mandatory
Registration</U>. The Company agrees that, within thirty (30) calendar days following the Closing Date (the &ldquo;<I><U>Filing Deadline</U></I>&rdquo;),
the Company will file with the Commission (at the Company&rsquo;s sole cost and expense) a registration statement on appropriate form
registering the resale of the full amount of Shares (and any other equity security issued or issuable with respect to the Shares by way
of share split, dividend, distribution, recapitalization, merger, exchange, or replacement, the &ldquo;<I><U>Registrable Securities</U></I>&rdquo;)
and naming each Purchaser as a selling shareholder thereunder (the &ldquo;<I><U>Registration Statement</U></I>&rdquo;), and the Company
shall use its commercially reasonable efforts to have the Registration Statement declared effective as soon as practicable after the filing
thereof, but in any event no later than sixty (60) calendar days after the Closing Date (the &ldquo;<I><U>Effectiveness Deadline</U></I>&rdquo;);
<I>provided</I>, that the Effectiveness Deadline shall be extended to ninety (90) calendar days after the Closing Date if the Registration
Statement is reviewed by, and comments thereto are provided from, the Commission; provided, further that the Company shall have the Registration
Statement declared effective within three (3) Business Days after the date the Company is notified (orally or in writing, whichever is
earlier) by the staff of the Commission that the Registration Statement will not be &ldquo;reviewed&rdquo; or will not be subject to further
review. Upon a Purchaser&rsquo;s timely request, the Company shall provide a draft of the Registration Statement to such Purchaser at
least three (3) Business Days in advance of the date of filing the Registration Statement with the Commission (the &ldquo;<I><U>Filing
Date</U></I>&rdquo;), and Purchaser shall provide any comments on the Registration Statement to the Company no later than two (2) Business
Daysimmediately preceding the Filing Date. Upon
notification by the Commission that any Registration Statement has been declared effective by the Commission, within two (2) Business
Day thereafter, the Company shall file the final prospectus under Rule 424 of the Securities Act. In no event shall a Purchaser be identified
as a statutory underwriter in the Registration Statement unless requested by the Commission; <I>provided</I>, that if the Commission requests
that Purchaser be identified as a statutory underwriter in the Registration Statement, such Purchaser will have the option, in its sole
and absolute discretion, to either (i) have the opportunity to withdraw from the Registration Statement, in which case the Company&rsquo;s
obligation to register the Registrable Securities will be deemed satisfied or (ii) be included as such in the Registration Statement.
Subject to any comments from the Staff, such Registration Statement shall include the plan of distribution attached hereto as <U>Exhibit
B</U>. Such Registration Statement shall not include any shares of Common Stock or other securities for the account of any other holder
without the prior written consent of the Purchasers beneficially owning (as determined pursuant to Rule 13d-3 under the Exchange Act)
a majority of the Registrable Securities. The Company shall notify the Purchasers by facsimile or e-mail as promptly as practicable, and
in any event, within twenty-four (24) hours, after the Registration Statement is declared effective or is supplemented and shall provide
the Purchasers with copies of any related prospectus to be used in connection with the sale or other disposition of the securities covered
thereby. The Company&rsquo;s obligations to furnish, provide, deliver or make available copies of any report or statement under this Agreement
shall be deemed satisfied if the same is filed with the Commission through its Electronic Data Gathering Analysis and Retrieval system
(&ldquo;<I><U>EDGAR</U></I>&rdquo;).</P>


<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Rule
415; Cutback</U>. Notwithstanding the foregoing, if the Commission prevents the Company from including any or all of the Registrable Securities
proposed to be registered under the Registration Statement due to limitations on the use of Rule 415 of the Securities Act for the resale
of the Registrable Securities by the applicable stockholders or otherwise (and notwithstanding that the Company used diligent efforts
to advocate with the staff of the Commission for the registration of all or a greater portion of the Registrable Securities), such Registration
Statement shall register for resale such number of Registrable Securities which is equal to the maximum number of Registrable Securities
as is permitted by the Commission. In such event, the number of Registrable Securities or other shares to be registered for each selling
stockholder named in the Registration Statement shall be reduced pro rata among all such selling stockholders and as promptly as practicable
after being permitted to register additional shares under Rule 415 under the Securities Act, the Company shall amend the Registration
Statement or file one or more new Registration Statement(s) (such amendment or new Registration Statement shall also be deemed to be a
Registration Statement hereunder) to register such additional Registrable Securities and cause such amendment or Registration Statement(s)
to become effective as promptly as practicable after the filing thereof, but in any event no later than 45 calendar days after the filing
of such Registration Statement (the &ldquo;<I><U>Additional Effectiveness Deadline</U></I>&rdquo;); <I>provided</I>, that the Additional
Effectiveness Deadline shall be extended to 90 calendar days after the filing of such Registration Statement if such Registration Statement
is reviewed by, and comments thereto are provided from, the Commission; <I>provided</I>, <I>further</I>, that the Company shall have the
Registration Statement declared effective within three (3) Business Days after the date the Company is notified (orally or in writing,
whichever is earlier) by the staff of the Commission that the Registration Statement will not be &ldquo;reviewed&rdquo; or will not be
subject to further review. Any failure by the Company to file a Registration Statement by the Effectiveness Deadline or Additional Effectiveness
Deadline shall not otherwise relieve the Company of its obligations to file or effect a Registration Statement as set forth in this <U>Section
4.11(b)</U>.</P>




<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Effect
of Failure to File and Obtain and Maintain Effectiveness of Registration Statement</U>. Subject to paragraph <B><U>(</U></B><U>b)</U>
above, if either: (i) a Registration Statement covering all of the Registrable Securities required to be covered thereby and required
to be filed by the Company pursuant to this Agreement is: (A) not filed with the Commission on or before the Filing Deadline (a &ldquo;<I><U>Filing
Failure</U></I>&rdquo;), or (B) not declared effective by the Commission on or before the Effectiveness Deadline or Additional Effectiveness
Deadline, as the case may be (an &ldquo;<I><U>Effectiveness Failure</U></I>&rdquo;), or (ii) on any day during the Reporting Period and
after the Effective Date, sales of all of the Registrable Securities required to be included on such Registration Statement cannot be
made (other than (A) during an Allowable Grace Period (as defined below) or (B) if the Registration Statement is on Form S-1, for a period
of fifteen (15) days following the date the Company files a post-effective amendment to incorporate the Company&rsquo;s Annual Report
on Form 10-K) pursuant to such Registration Statement (including, without limitation, because of a failure to keep such Registration Statement
effective, to disclose such information as is necessary for sales to be made pursuant to such Registration Statement or to register a
sufficient number of shares of Common Stock) (a &ldquo;<I><U>Maintenance Failure</U></I>&rdquo;), then, in addition to any other rights
the holders may have under the Transaction Documents or under applicable law, the Company shall pay to each holder of Registrable Securities
relating to such Registration Statement an amount in cash equal to one percent (1.0%) of such holder&rsquo;s Pro Rata Interest in the
Aggregate Purchase Price on each of the following dates: (x) the day of a Filing Failure and on every thirtieth (30th) day (prorated for
periods totaling less than thirty (30) days) thereafter until such Filing Failure is cured; (y) the day of an Effectiveness Failure and
on every thirtieth (30th) day (prorated for periods totaling less than thirty (30) days) thereafter until such Effectiveness Failure is
cured; and (z) the initial day of a Maintenance Failure and on every thirtieth (30th) day (prorated for periods totaling less than thirty
(30) days) thereafter until such Maintenance Failure is cured. The payments to which a holder shall be entitled pursuant to this <U>Section
<B>(</B>c)</U> are referred to herein as &ldquo;<I><U>Registration Delay Payments</U></I>&rdquo;; <I>provided</I>, that no Registration
Delay Payments shall be required following the termination of the Reporting Period; <I>provided further</I>, that in no event shall the
aggregate Registration Delay Payments accruing under this <U>Section <B>(</B>c)</U> exceed ten percent (10%) of a holder&rsquo;s Pro Rata
Interest in the Aggregate Purchase Price (i.e., corresponding to a total delay of six (6) months). The first such Registration Delay Payment
shall be paid within three (3) Business Days after the event or failure giving rise to such Registration Delay Payment occurred and all
other Registration Delay Payments shall be paid on the earlier of (I) the last day of the calendar month during which such Registration
Delay Payments are incurred and (II) the third (3rd) Business Day after the event or failure giving rise to the Registration Delay Payments
is cured.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Related
Obligations</U>. At such time as the Company is obligated to file a Registration Statement with the Commission pursuant to <U>Section
<B>(</B>a)</U> hereof, the Company will use commercially reasonable efforts to effect the registration of the Registrable Securities in
accordance with the intended method of disposition thereof and, pursuant thereto, the Company shall have the following obligations:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company shall submit to the Commission, within three (3) Business Days after the Company learns that no review of a particular
Registration Statement will be made by the Staff or that the Staff has no further comments on a particular Registration Statement,
as the case may be, a request for acceleration of effectiveness of such Registration Statement to a time and date not later than two
(2) Business Days after the submission of such request. The Company shall keep each Registration Statement effective at all times
with respect to each Purchaser&rsquo;s Registrable Securities
until the expiration of the Reporting Period. The Company shall ensure that each Registration Statement (including any amendments or supplements
thereto and prospectuses contained therein) shall not contain any untrue statement of a material fact or omit to state a material fact
required to be stated therein, or necessary to make the statements therein (in the case of prospectuses, in the light of the circumstances
in which they were made) not misleading.</P>


<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company shall prepare and file with the Commission such amendments (including post-effective amendments) and supplements to a Registration
Statement and the prospectus used in connection with such Registration Statement, which prospectus is to be filed pursuant to Rule 424
promulgated under the Securities Act, as may be necessary to keep such Registration Statement effective at all times during the Reporting
Period, and, during such period, comply with the provisions of the Securities Act with respect to the disposition of all Registrable Securities
of the Company covered by such Registration Statement until such time as all of such Registrable Securities shall have been disposed of
in accordance with the intended methods of disposition by the seller or sellers thereof as set forth in such Registration Statement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon
request of a Purchaser, the Company shall furnish to such Purchaser without charge, (A) promptly after the Registration Statement including
such Purchaser&rsquo;s Registrable Securities is prepared and filed with the Commission, at least one copy of such Registration Statement
and any amendment(s) thereto, including financial statements and schedules, all documents incorporated therein by reference, and if requested
by the Purchaser, all exhibits and each preliminary prospectus, (B) upon the effectiveness of any Registration Statement, ten (10) copies
of the prospectus included in such Registration Statement and all amendments and supplements thereto (or such other number of copies as
the Purchaser may reasonably request) and (C) such other documents, including copies of any preliminary or final prospectus, as the Purchaser
may reasonably request from time to time in order to facilitate the disposition of the Registrable Securities.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.5in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company shall notify the Purchasers in writing of the happening of any event, as promptly as practicable after becoming aware of such
event, as a result of which the prospectus included in a Registration Statement, as then in effect, includes an untrue statement of a
material fact or omission to state a material fact required to be stated therein or necessary to make the statements therein, in the light
of the circumstances under which they were made, not misleading (<I>provided</I>, that in no event shall such notice contain any material,
nonpublic information), and promptly prepare a supplement or amendment to such Registration Statement to correct such untrue statement
or omission, and upon request deliver ten (10) copies of such supplement or amendment to the Purchasers (or such other number of copies
as the Purchasers may reasonably request). Unless such information is publicly available, the Company shall also promptly notify the Purchasers
in writing (A) when a prospectus or any prospectus supplement or post-effective amendment has been filed, and when a Registration Statement
or any post-effective amendment has become effective (notification of such effectiveness shall be delivered to the Purchasers by electronic
mail on the same day of such effectiveness), (B) of any request by the Commission for amendments or supplements to a Registration Statement
or related prospectus or related information, and (C) of the Company&rsquo;s reasonable determination that a post-effective amendment
to a Registration Statement would be appropriate.</P>




<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.5in">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company shall use commercially reasonable efforts to prevent the issuance of any stop order or other suspension of effectiveness of a
Registration Statement, or the suspension of the qualification of any of the Registrable Securities for sale in any jurisdiction and,
if such an order or suspension is issued, to obtain the withdrawal of such order or suspension at the earliest possible moment and to
notify the Purchaser who holds Registrable Securities being sold of the issuance of such order and the resolution thereof or its receipt
of notice of the initiation or threat of any proceeding for such purpose.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.5in">(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
a Purchaser is required under applicable securities law to be described in the Registration Statement as an underwriter, at the reasonable
request of the Purchaser, the Company shall furnish to the Purchaser, on the date of the effectiveness of the Registration Statement and
thereafter from time to time on such dates as the Purchaser may reasonably request, (A) a letter, dated such date, from the Company&rsquo;s
independent certified public accountants in form and substance as is customarily given by independent certified public accountants to
underwriters in an underwritten public offering, addressed to the Purchaser, and (B) an opinion, dated as of such date, of counsel representing
the Company for purposes of such Registration Statement, in form, scope and substance as is customarily given in an underwritten public
offering, addressed to the Purchaser.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.5in">(vii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
a Purchaser is required under applicable securities law to be described in the Registration Statement as an underwriter, upon the written
request of the Purchaser in connection with the Purchaser&rsquo;s due diligence requirements, if any, the Company shall make available
for inspection by (A) the Purchaser and its legal counsel and (B) one (1) firm of accountants or other agents retained by the Purchaser
(collectively, the &ldquo;<I><U>Inspectors</U></I>&rdquo;), all pertinent financial and other records, and pertinent corporate documents
and properties of the Company (collectively, the &ldquo;<I><U>Records</U></I>&rdquo;), as shall be reasonably deemed necessary by each
Inspector solely for the purpose of establishing a due diligence defense under underwriter liability under the Securities Act, and cause
the Company&rsquo;s officers, directors and employees to supply all information which any Inspector may reasonably request; <I>provided</I>,
<I>however</I>, that each Inspector shall agree to hold in strict confidence and shall not make any disclosure (except to the Purchaser)
or use of any Record or other information which the Company determines in good faith to be confidential, and of which determination the
Inspectors are so notified, unless (1) the disclosure of such Records is necessary to avoid or correct a misstatement or omission in any
Registration Statement or is otherwise required under the Securities Act, (2) the release of such Records is ordered pursuant to a final,
non-appealable subpoena or order from a court or government body of competent jurisdiction, or (3) the information in such Records has
been made generally available to the public other than by disclosure in violation of this Agreement or any other agreement. The Purchaser
agrees that it shall, upon learning that disclosure of such Records is sought in or by a court or governmental body of competent jurisdiction
or through other means, give prompt notice to the Company and allow the Company, at its expense, to undertake appropriate action to prevent
disclosure of, or to obtain a protective order preventing disclosure of, the Records deemed confidential. Nothing herein (or in any other
confidentiality agreement between the Company and the Purchaser) shall be deemed to limit the Purchaser&rsquo;s ability to sell Registrable
Securities in a manner which is otherwise consistent with applicable laws.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.5in"></P>


<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-indent: 1.5in; font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">(viii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company shall hold in confidence and not make any disclosure of information concerning the Purchasers provided to the Company unless (A)
disclosure of such information is necessary to comply with federal
or state securities laws, (B) the disclosure of such information is necessary to avoid or correct a misstatement or omission in any Registration
Statement, (C) the release of such information is ordered pursuant to a subpoena or other final, non-appealable order from a court or
governmental body of competent jurisdiction or (D) such information has been made generally available to the public other than by disclosure
in violation of this Agreement or any other agreement. The Company agrees that it shall, upon learning that disclosure of such information
concerning the Purchasers is sought in or by a court or governmental body of competent jurisdiction or through other means, give prompt
written notice to the Purchasers and allow the Purchasers, at each Purchaser&rsquo;s expense, to undertake appropriate action to prevent
disclosure of, or to obtain a protective order preventing disclosure of, such information.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.5in">(ix)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company shall cooperate with the Purchasers and, to the extent applicable, facilitate the timely preparation and delivery of certificates
(not bearing any restrictive legend) representing the Registrable Securities to be offered pursuant to a Registration Statement and enable
such certificates to be in such denominations or amounts, as the case may be, as the Purchasers may reasonably request and registered
in such names as the Purchasers may request.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.5in">(x)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
requested by a Purchaser, the Company shall, as soon as practicable, (A) incorporate in a prospectus supplement or post-effective amendment
such information as the Purchaser reasonably requests to be included therein relating to the sale and distribution of Registrable Securities,
including, without limitation, information with respect to the number of Registrable Securities being offered or sold, the purchase price
being paid therefor and any other terms of the offering of the Registrable Securities to be sold in such offering; (B) make all required
filings of such prospectus supplement or post-effective amendment after being notified of the matters to be incorporated in such prospectus
supplement or post-effective amendment; and (C) supplement or make amendments to any Registration Statement if reasonably requested by
the Purchaser.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.5in">(xi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company shall use commercially reasonable efforts to cause the Registrable Securities covered by a Registration Statement to be registered
with or approved by such other governmental agencies or authorities as may be necessary to consummate the disposition of such Registrable
Securities.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.5in">(xii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company shall otherwise use commercially reasonable efforts to comply with all applicable rules and regulations of the Commission in connection
with any registration hereunder.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.5in">(xiii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Within
two (2) Business Days after a Registration Statement that covers Registrable Securities is declared effective by the Commission, the Company
shall deliver to the transfer agent for such Registrable Securities (with copies to the Purchasers) confirmation that such Registration
Statement has been declared effective by the Commission.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.5in"></P>


<!-- Field: Page; Sequence: 37 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-indent: 1.5in; font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">(xiv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding
anything to the contrary herein, at any time after the Effective Date, the Company may delay the disclosure of material, non-public information
concerning the Company the disclosure of which at the time is not, in the good faith opinion of the Board of Directors and its counsel,
in the best interest of the Company and, in the opinion of outside counsel to the Company, otherwise required
(a &ldquo;<I><U>Grace Period</U></I>&rdquo;); <I>provided</I>, that the Company shall promptly (A) notify the Purchasers in writing of
the existence of material, non-public information giving rise to a Grace Period (<I>provided</I> that in each notice the Company will
not disclose the content of such material, non-public information to the Purchasers or subject the Purchasers to any duty of confidentiality)
and the date on which the Grace Period will begin, and (B) notify the Purchasers in writing of the date on which the Grace Period ends
(<I>provided</I> that in each notice the Company will not disclose the content of such material, non-public information to the Purchasers
or subject the Purchasers to any duty of confidentiality); and, <I>provided further</I>, that there shall be no more than two (2) Grace
Periods and each such Grace Periods shall not exceed an aggregate of thirty (30) consecutive Trading Days during any three hundred and
sixty-five (365) day period and the first day of any Grace Period must be at least fifteen (15) days after the last day of any prior Grace
Period (each, an &ldquo;<I><U>Allowable Grace Period</U></I>&rdquo;). For purposes of determining the length of a Grace Period above,
the Grace Period shall begin on and include the date the Purchasers receive the notice referred to in clause (a) and shall end on and
include the later of the date the Purchasers receive the notice referred to in clause (b) and the date referred to in such notice. The
provisions of <U>Section (v)</U> hereof shall not be applicable during the period of any Allowable Grace Period. Upon expiration of the
Grace Period, the Company shall again be bound by the first sentence of <U>Section (iv)</U> with respect to the information giving rise
thereto unless such material, non-public information is no longer applicable. Notwithstanding anything to the contrary, the Company shall
cause its transfer agent to deliver unlegended shares of Common Stock to a transferee of any Purchaser in accordance with the terms of
this Agreement in connection with any sale of Registrable Securities with respect to which a Purchaser has entered into a contract for
sale, and delivered a copy of the prospectus included as part of the applicable Registration Statement (unless an exemption from such
prospectus delivery requirement exists), prior to the Purchaser&rsquo;s receipt of the notice of a Grace Period and for which the Purchaser
has not yet settled.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.5in">(xv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither
the Company nor any Subsidiary or affiliate thereof shall identify any Purchaser as an underwriter in any public disclosure or filing
with the Commission or any applicable Trading Market without the prior written consent of such Purchaser, and any Purchaser being deemed
an underwriter by the Commission shall not relieve the Company of any obligations it has under this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>


<!-- Field: Page; Sequence: 38 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-indent: 1in; margin: 0 0 12pt; text-align: justify">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Indemnification
by the Company</U>. The Company shall indemnify and hold harmless each Purchaser, the officers, directors, members, partners, agents,
investment advisors and employees (and any other Persons with a functionally equivalent role of a Person holding such titles, notwithstanding
a lack of such title or any other title) of each of them, each Person who controls any such Purchaser (within the meaning of Section 15
of the Securities Act or Section 20 of the Exchange Act) and the officers, directors, members, stockholders, partners, agents and employees
(and any other Persons with a functionally equivalent role of a Person holding such titles, notwithstanding a lack of such title or any
other title) of each such controlling Person, to the fullest extent permitted by applicable law, from and against any and all losses,
claims, damages, liabilities, costs (including, without limitation, reasonable attorneys&rsquo; fees) and expenses (collectively, &ldquo;<I><U>Losses</U></I>&rdquo;),
as incurred, arising out of or relating to (i) any untrue or alleged untrue statement of a material fact contained in a Registration Statement,
any Prospectus or any form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of
or relating to any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein
(in the case of any Prospectus or supplement thereto, in light of the circumstances under which they
were made) not misleading or (ii) any violation or alleged violation by the Company of the Securities Act, the Exchange Act or any state
securities law, or any rule or regulation thereunder, in connection with the performance of its obligations under this Agreement, except
to the extent, but only to the extent, that (A) such untrue statements or omissions are based solely upon information regarding such Purchaser
furnished in writing to the Company by such Purchaser expressly for use therein, or to the extent that such information relates to such
Purchaser or such Purchaser&rsquo;s proposed method of distribution of Registrable Securities and was reviewed and expressly approved
in writing by such Purchaser expressly for use in a Registration Statement, such Prospectus or in any amendment or supplement thereto
(it being understood that the Purchaser has approved <U>Exhibit B</U> hereto for this purpose) or (B) the use by such Purchaser of an
outdated, defective or otherwise unavailable Prospectus after the Company has notified such Purchaser in writing that the Prospectus is
outdated, defective or otherwise unavailable for use by such Purchaser. The Company shall notify the Purchasers promptly of the institution,
threat or assertion of any Proceeding arising from or in connection with the transactions contemplated by this Agreement of which the
Company is aware. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of such indemnified
person and shall survive the transfer of any Registrable Securities by any of the Purchaser.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Indemnification
by Purchaser</U>. Each Purchaser shall, severally and not jointly with any other Purchaser or selling stockholder named in the Registration
Statement, indemnify and hold harmless the Company, its directors, officers, agents and employees, each Person who controls the Company
(within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), to the fullest extent permitted by applicable
law, from and against all Losses, as incurred, to the extent arising out of or based solely upon: any untrue or alleged untrue statement
of a material fact contained in any Registration Statement, any Prospectus, or in any amendment or supplement thereto or in any preliminary
prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be stated therein or necessary
to make the statements therein (in the case of any Prospectus or supplement thereto, in light of the circumstances under which they were
made) not misleading (i) to the extent, but only to the extent, that such untrue statement or omission is contained in any information
so furnished in writing by such Purchaser to the Company expressly for inclusion in such Registration Statement or such Prospectus or
(ii) to the extent, but only to the extent, that such information relates to such Purchaser&rsquo;s information provided to the Company
for inclusion in the Registration Statement and was reviewed and expressly approved in writing by such Purchaser expressly for use in
a Registration Statement (it being understood that the Purchaser has approved <U>Exhibit B</U> hereto for this purpose), such Prospectus
or in any amendment or supplement thereto. In no event shall the liability of a selling Purchaser be greater in amount than the dollar
amount of the proceeds (net of all expenses paid by such Purchaser in connection with any claim relating to this <U>Section <B>4.11</B>(f)</U>
and the amount of any damages such Purchaser has otherwise been required to pay by reason of such untrue statement or omission) received
by such Purchaser upon the sale of the Registrable Securities included in the Registration Statement giving rise to such indemnification
obligation.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Conduct
of Indemnification Proceedings</U>. If any Proceeding shall be brought or asserted against any Person entitled to indemnity hereunder
(an &ldquo;<I><U>Indemnified Party</U></I>&rdquo;), such Indemnified Party shall promptly notify the Person from whom indemnity is sought
(the &ldquo;<I><U>Indemnifying Party</U></I>&rdquo;) in writing, and the Indemnifying Party shall have the right to assume the defense
thereof, including the employment of counsel reasonably satisfactory to the Indemnified Party and the payment of all reasonable and
documented fees and expenses incurred in connection with defense thereof, <I>provided</I> that the failure of any Indemnified Party to
give such notice shall not relieve the Indemnifying Party of its obligations or liabilities pursuant to this Agreement, except (and only)
to the extent that it shall be finally determined by a court of competent jurisdiction (which determination is not subject to appeal or
further review) that such failure shall have materially and adversely prejudiced the Indemnifying Party.</P>


<!-- Field: Page; Sequence: 39 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;An
Indemnified Party shall have the right to employ separate counsel in any such Proceeding and to participate in the defense thereof, but
the reasonable and documented fees and expenses of such counsel shall be at the expense of such Indemnified Party(ies) unless: (A) the
Indemnifying Party has agreed in writing to pay such reasonable and documented fees and expenses, (B) the Indemnifying Party shall have
failed promptly to assume the defense of such Proceeding and to employ counsel reasonably satisfactory to such Indemnified Party in any
such Proceeding, or (C) the named parties to any such Proceeding (including any impleaded parties) include both such Indemnified Party
and the Indemnifying Party, and counsel to the Indemnified Party shall reasonably believe that a material conflict of interest is likely
to exist if the same counsel were to represent such Indemnified Party and the Indemnifying Party (in which case, if such Indemnified Party
notifies the Indemnifying Party in writing that it elects to employ separate counsel at the expense of the Indemnifying Party, the Indemnifying
Party shall not have the right to assume the defense thereof and the reasonable and documented fees and expenses of no more than one separate
counsel shall be at the expense of the Indemnifying Party). The Indemnifying Party shall not be liable for any settlement of any such
Proceeding effected without its written consent, which consent shall not be unreasonably withheld or delayed. No Indemnifying Party shall,
without the prior written consent of the Indemnified Party, effect any settlement of any pending Proceeding in respect of which any Indemnified
Party is a party, unless such settlement includes an unconditional release of such Indemnified Party from all liability on claims that
are the subject matter of such Proceeding.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject
to the terms of this Agreement, all reasonable and documented fees and expenses of the Indemnified Party (including reasonable and documented
fees and expenses to the extent incurred in connection with investigating or preparing to defend such Proceeding in a manner not inconsistent
with this Section) shall be paid to the Indemnified Party, as incurred, within ten (10) Trading Days of written notice thereof to the
Indemnifying Party, <I>provided</I> that the Indemnified Party shall promptly reimburse the Indemnifying Party for that portion of such
reasonable and documented fees and expenses applicable to such actions for which such Indemnified Party is finally determined by a court
of competent jurisdiction (which determination is not subject to appeal or further review) not to be entitled to indemnification hereunder.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>


<!-- Field: Page; Sequence: 40 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-indent: 1in; font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Contribution</U>.
If the indemnification under <U>Sections 4.11(e)</U> or <B><U>(</U></B><U>f)</U> is unavailable to an Indemnified Party or insufficient
to hold an Indemnified Party harmless for any Losses, then each Indemnifying Party shall contribute to the amount paid or payable by
such Indemnified Party, in such proportion as is appropriate to reflect the relative fault of the Indemnifying Party and Indemnified
Party in connection with the actions, statements or omissions that resulted in such Losses as well as any other relevant equitable considerations.
The relative fault of such Indemnifying Party and Indemnified Party shall be determined by reference to, among other things, whether
any action in question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission of a material
fact, has been taken or made by, or relates to information supplied by, such Indemnifying Party or Indemnified Party, and the parties&rsquo;
relative intent, knowledge, access to information and opportunity to correct or prevent such action, statement or omission. The amount
paid or payable by a party as a result of any Losses shall be deemed to include, subject to the limitations set forth in this Agreement,
any reasonable and documented attorneys&rsquo; or other fees or expenses incurred by such party in connection with any Proceeding to
the extent such party would have been indemnified for such reasonable and documented fees or expenses if the indemnification provided
for in this Section was available to such party in accordance with its terms. The parties hereto agree that it would not be just and
equitable if contribution pursuant to this <U>Section (h)</U> were determined by pro rata allocation or by any other method of allocation
that does not take into account the equitable considerations referred to in the immediately preceding paragraph. In no event shall the
contribution obligation of a Purchaser of Registrable Securities be greater in amount than the dollar amount of the proceeds received
by it upon the sale of the Registrable Securities giving rise to such contribution obligation. The indemnity and contribution agreements
contained in this Section are in addition to any liability that the Indemnifying Parties may have to the Indemnified Parties.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
purposes of this <U>Section 4.11</U> of this Agreement, &ldquo;<U>Purchaser</U>&rdquo; shall include any person to which the rights under
this <U>Section 4.11</U> shall have been duly assigned.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Preservation
of Rights</U>. During the period between the Closing Date and the Effective Date, the Company shall not (i) grant any registration rights
to third parties which are more favorable than or inconsistent with the rights granted hereunder, or (ii) enter into any agreement, take
any action, or permit any change to occur, with respect to its securities that violates or subordinates the rights expressly granted to
the holders of Registrable Securities in this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 4.12&#9;<U>Use
of Proceeds</U>. The Company shall use the net proceeds from the sale of the Securities hereunder for working capital purposes attached
hereto, and shall not use such proceeds in violation of Anti-Bribery and Anti-Money Laundering Laws or Sanctions.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 4.13&#9;<U>Reservation
of Common Stock</U>. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep available at all
times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company to issue Shares
pursuant to the Transaction Documents.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 4.14&#9;<U>Stockholder
Approval</U>. The Company agrees that, within the Filing Deadline, the Company will prepare and file with the Commission (at the Company&rsquo;s
sole cost and expense) a preliminary proxy statement, as it may be amended or supplemented from time to time, related to the consideration
of the proposal to approve the issuance of the Conversion Shares upon conversion of the Preferred Stock (the &ldquo;<I><U>Stockholder
Approval Proposal</U></I>&rdquo;) at an annual or special meeting of stockholders. Upon receipt of the requisite votes of the Company&rsquo;s
stockholders required to approve the Stockholder Approval Proposal, the shares of Preferred Stock shall automatically convert into Common
Stock, and the Company shall promptly deliver notice of the approval of the Stockholder Approval Proposal to each Purchaser and file with
the Commission a Current Report on Form 8-K disclosing the same.</P>


<!-- Field: Page; Sequence: 41 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>ARTICLE V.<FONT STYLE="text-transform: uppercase"><U><BR>
CONDITIONS PRECEDENT TO CLOSING</U></FONT></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 5.1&#9;<U>Conditions
Precedent to the Obligations of the Purchasers to Purchase Securities</U>. The obligation of each Purchaser to purchase and acquire Securities
at the Closing is subject to the fulfillment to such Purchaser&rsquo;s satisfaction, on or prior to the Closing Date, of each of the following
conditions, any of which may be waived in writing by such Purchaser (as to itself only):</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Representations</U>.
The representations and warranties of the Company contained herein shall be true and correct in all material respects (except for those
representations and warranties which are qualified as to materiality or Material Adverse Effect, in which case such representations and
warranties shall be true and correct in all respects) as of the date when made and as of the Closing Date, as though made on and as of
such date, except for such representations and warranties that speak as of a specific date which shall be true and correct in all material
respects (except for those representations and warranties which are qualified as to materiality or Material Adverse Effect, in which case
such representations and warranties shall be true and correct in all respects) as of such date.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Performance</U>.
The Company shall have performed, satisfied and complied in all material respects with all covenants, agreements and conditions required
by the Transaction Documents to be performed, satisfied or complied with by it at or prior to the Closing.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Injunction</U>. No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated
or endorsed by any court or governmental authority of competent jurisdiction that prohibits the consummation of any of the transactions
contemplated by the Transaction Documents.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Consents</U>.
The Company shall have obtained in a timely fashion any and all consents, permits, approvals, registrations and waivers necessary for
consummation of the purchase and sale of the Securities (including all Required Approvals), all of which shall be and remain so long as
necessary in full force and effect.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Adverse
Changes</U>. Since the date hereof, no event or series of events shall have occurred that has had or would, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Suspensions of Trading in Common Stock</U>. The Common Stock shall not have been suspended, as of the Closing Date, by the Commission
or the Principal Trading Market from trading on the Principal Trading Market nor shall suspension by the Commission or the Principal Trading
Market have been threatened, as of the Closing Date, either (A) in writing by the Commission or the Principal Trading Market or (B) by
falling below the minimum listing maintenance requirements of the Principal Trading Market.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Company
Deliverables</U>. The Company shall have delivered the Company Deliverables in accordance with <U>Section 2.2(a)</U>.</P>


<!-- Field: Page; Sequence: 42 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Termination</U>.
This Agreement shall not have been terminated as to such Purchaser in accordance with <U>Section 6.19</U> herein.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 5.2&#9;<U>Conditions
Precedent to the Obligations of the Company to Sell Securities</U>. The Company&rsquo;s obligation to sell and issue the Securities at
the Closing to the Purchasers is subject to the fulfillment to the satisfaction of the Company on or prior to the Closing Date of the
following conditions, any of which may be waived by the Company:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Representations
and Warranties</U>. The representations and warranties made by the Purchasers contained herein shall be true and correct in all material
respects (except for those representations and warranties which are qualified as to materiality, in which case such representations and
warranties shall be true and correct in all respects) as of the date when made, and as of the Closing Date as though made on and as of
such date, except for representations and warranties that speak as of a specific date.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Performance</U>.
Such Purchaser shall have performed, satisfied and complied in all material respects with all covenants, agreements and conditions required
by the Transaction Documents to be performed, satisfied or complied with by such Purchaser at or prior to the Closing Date.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Injunction</U>. No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated
or endorsed by any court or governmental authority of competent jurisdiction that prohibits the consummation of any of the transactions
contemplated by the Transaction Documents.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Purchasers
Deliverables</U>. Such Purchaser shall have delivered its Purchaser Deliverables in accordance with <U>Section 2.2(b)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Concurrently
with the Closing of the transactions contemplated in the Transaction Documents, the Company shall have entered into (i) the second amendment
to the working capital facility agreement with Hercules Capital, Inc., as administrative agent and collateral agent and the lenders party
thereto, which provides for an aggregate principal amount of $110,000,000 on the Closing Date, (ii) the exchange agreement to repurchase,
exchange or convert the outstanding $150,000,000 aggregate principal amount of the Company&rsquo;s 1.5% senior convertible notes due 2026
(the &ldquo;<U>2026 Senior Convertible Notes</U>&rdquo;) and (iii) a note purchase agreement with the purchasers party thereto pursuant
to which the Company shall offer and sell $35,000,000 aggregate principal amount of 5.0% senior convertible notes due 2031.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>ARTICLE VI.<FONT STYLE="text-transform: uppercase"><U><BR>
MISCELLANEOUS</U></FONT></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 6.1&#9;<U>Fees
and Expenses</U>. The Company and the Purchasers shall each pay the fees and expenses of their respective advisers, counsel, accountants
and other experts, if any, and all other expenses incurred by such party in connection with the negotiation, preparation, execution, delivery
and performance of this Agreement; <I>provided</I>, that the Company shall pay the reasonable and documented fees and expenses of legal
counsel for the Purchasers in connection with the negotiation, preparation, execution, delivery and performance of this Agreement, which
in no event shall exceed $50,000 in the aggregate. The Company shall pay all Transfer Agent fees, stamp taxes and other taxes and duties levied
in connection with the sale and issuance of the Securities to the Purchasers. The Company shall pay all Placement Agent fees relating
to or arising out of the transactions contemplated by this Agreement.</P>


<!-- Field: Page; Sequence: 43 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 6.2&#9;<U>Entire
Agreement</U>. The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding of the parties
with respect to the subject matter hereof and supersede all prior agreements, understandings, discussions and representations, oral or
written, with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules. At
or after the Closing, and without further consideration, the Company and the Purchasers will execute and deliver to the other such further
documents as may be reasonably requested in order to give practical effect to the intention of the parties under the Transaction Documents.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 6.3&#9;<U>Notices</U>.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall
be deemed given and effective on the earliest of (a) the date of transmission, if such notice or communication is delivered via electronic
mail (provided the sender receives a machine-generated confirmation of successful transmission) at the electronic mail address specified
in this Section 6.3 prior to 5:00 P.M., New York City time, on a Trading Day, (b) the next Trading Day after the date of transmission,
if such notice or communication is delivered via electronic mail at the electronic mail address specified in this Section 6.3 on a day
that is not a Trading Day or later than 5:00 P.M., New York City time, on any Trading Day, (c) the Trading Day following the date of mailing,
if sent by U.S. nationally recognized overnight courier service with next day delivery specified, and (d) upon actual receipt by the party
to whom such notice is required to be given. The address for such notices and communications shall be as follows:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 46%; padding-right: 5.4pt; padding-left: 5.4pt; font: 12pt Times New Roman, Times, Serif">If to the Company:</TD>
    <TD STYLE="width: 54%; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Heron Therapeutics, Inc.</P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">100 Regency Forest Drive, Suite 300</P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cary, North Carolina 27518</P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Telephone No.: (858) 251-4400</P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Email: iduarte@herontx.com</P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt">Attention: Ira Duarte, Executive Vice President, Chief Financial
    Officer</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt">With a copy to (which shall not constitute notice):</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">DLA Piper LLP (US)</P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">51 John F. Kennedy Parkway, Suite 120</P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Short Hills, New Jersey 07078</P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Telephone No.: (973) 520-2553</P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Email: Andrew.Gilbert@us.dlapiper.com</P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt">Attention: Andrew P. Gilbert</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt">If to a Purchaser:</TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">To the address set forth under such Purchaser&rsquo;s name on the signature page hereof;</TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">or such other address as may be designated
in writing hereafter, in the same manner, by such Person.</P>


<!-- Field: Page; Sequence: 44 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 6.4&#9;<U>Amendments;
Waivers; No Additional Consideration</U>. No provision of this Agreement may be waived, modified, supplemented or amended except in a
written instrument signed, in the case of an amendment, by the Company and the Purchasers of at least a majority in interest of the Securities
then held by Purchasers, or, in the case of a waiver, by the party against whom enforcement of any such waiver is sought; provided that
if any amendment or waiver disproportionately and adversely affects a Purchaser (or group of Purchasers) in any material respect, the
consent of such disproportionately affected Purchaser (or group of Purchasers) shall also be required. No waiver of any default with respect
to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any
subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of either party
to exercise any right hereunder in any manner impair the exercise of any such right. No consideration shall be offered or paid to any
Purchaser to amend or consent to a waiver or modification of any provision of any Transaction Document unless the same consideration is
also offered to all Purchasers who then hold Securities. Notwithstanding the foregoing or anything else herein to the contrary, no amendment,
modification, alteration, change or waiver of this Section 6.4 shall be valid without the prior written consent of the Placement Agent,
which consent shall not be unreasonably withheld or delayed.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 6.5&#9;<U>Construction</U>.
The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any
of the provisions hereof. The language used in this Agreement will be deemed to be the language chosen by the parties to express their
mutual intent, and no rules of strict construction will be applied against any party. This Agreement shall be construed as if drafted
jointly by the parties, and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship
of any provisions of this Agreement or any of the Transaction Documents.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 6.6&#9;<U>Successors
and Assigns</U>. The provisions of this Agreement shall inure to the benefit of and be binding upon the parties and their successors and
permitted assigns. This Agreement may not be assigned by the Company without the prior written consent of each Purchaser. Any Purchaser
may assign its rights hereunder in whole or in part to any Person, including upon an assignment or transfer of any Securities in compliance
with the Transaction Documents and applicable law, provided such transferee shall agree in writing to be bound, with respect to the transferred
Securities, by the terms and conditions of this the Transaction Documents that apply to the &ldquo;<U>Purchasers</U>.&rdquo;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>


<!-- Field: Page; Sequence: 45 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 6.7&#9;<U>Reliance
by and Exculpation of Placement Agents</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Purchaser agrees for the express benefit of the Placement Agent, its affiliates and its representatives that (i) the Placement Agent,
its affiliates and its representatives have not made, and will not make, any representations or warranties with respect to the Company
or the offer and sale of the Securities, and the Purchaser will not rely on any statements made by the Placement Agent, orally or in
writing, to the contrary, (ii) the Purchaser will be responsible for conducting its own due diligence investigation with respect to the
Company and the offer and sale of the Securities, (iii) the Purchaser will be purchasing Securities based on the results of its own due
diligence investigation of the Company, and the Placement Agent and each of their directors, officers, employees, representatives, and
controlling persons have made no independent investigation with respect to the Company, the Securities, or the accuracy, completeness,
or adequacy of any information supplied to the Purchaser by the Company, (iv) the Purchaser has negotiated the offer and sale of the
Securities directly with the Company, and the Placement Agent will not be responsible for the ultimate success of any such investment
and (v) the decision to invest in the Company will involve a significant degree of risk, including a risk of total loss of such investment.
Each Purchaser further represents and warrants to the Placement Agent that it, including any fund or funds that it manages or advises
that participates in the offer and sale of the Securities, is permitted under its constitutive documents (including, without limitation,
all limited partnership agreements, charters, bylaws, limited liability company agreements, all applicable side letters with investors,
and similar documents) to make investments of the type contemplated by this Agreement. This Section 6.7 shall survive any termination
of this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company agrees and acknowledges that the Placement Agent may rely on its representations, warranties, agreements and covenants contained
in this Agreement and each Purchaser agrees that the Placement Agent may rely on such Purchaser&rsquo;s representations and warranties
contained in this Agreement as if such representations and warranties, as applicable, were made directly to the Placement Agent.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither
the Placement Agent nor any of its affiliates or representatives (i) shall be liable for any improper payment made in accordance with
the information provided by the Company; (ii) make any representation or warranty, or have any responsibilities as to the validity, accuracy,
value or genuineness of any information, certificates or documentation delivered by or on behalf of the Company pursuant to the Transaction
Agreements or in connection with any of the transactions contemplated therein; or (iii) shall be liable (1) for any action taken, suffered
or omitted by any of them in good faith and reasonably believed to be authorized or within the discretion or rights or powers conferred
upon them by the Transaction Agreements or (2) for anything which any of them may do or refrain from doing in connection with the Transaction
Agreements, except in each case for such party&rsquo;s own gross negligence or willful misconduct.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company agrees that the Placement Agent, its affiliates and its representatives shall be entitled to (i) rely on, and shall be protected
in acting upon, any certificate, instrument, notice, letter or any other document or security delivered to any of them by or on behalf
of the Company, and (ii) be indemnified by the Company for acting as the placement agent hereunder pursuant to the indemnification provisions
set forth in the applicable letter agreement between the Company and the Placement Agent.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 6.8&#9;<U>No Third-Party
Beneficiaries</U>. This Agreement is intended for the benefit of the parties hereto and their respective successors and permitted assigns
and is not for the benefit of, nor may any provision hereof be enforced by, any other Person. Notwithstanding the foregoing, the Placement
Agent is an intended third-party beneficiary of the representations and warranties of the Company and of each Purchaser set forth in Article
III, as well as Section 6.7 of this Agreement and any certificates delivered to confirm the matters set forth in Sections 5.1(a) and 5.2(a)
of this Agreement at the Closing.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>


<!-- Field: Page; Sequence: 46 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-indent: 0.5in; font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">Section 6.9&#9;<U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by and
construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of
law thereof. Each party agrees that all Proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective Affiliates,
directors, officers, shareholders, employees or agents) shall be commenced exclusively in the New York Courts. Each party hereto hereby
irrevocably submits to the exclusive jurisdiction of the New York Courts for the adjudication of any dispute hereunder or in connection
herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction
Documents), and hereby irrevocably waives, and agrees not to assert in any Proceeding, any claim that it is not personally subject to
the jurisdiction of any such New York Court, or that such Proceeding has been commenced in an improper or inconvenient forum. Each party
hereto hereby irrevocably waives personal service of process and consents to process being served in any such Proceeding by mailing a
copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect
for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice
thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by applicable
law. <B>EACH PARTY HERETO HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY
JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 6.10&#9;<U>Survival</U>.
Subject to applicable statute of limitations, the representations, warranties, agreements and covenants contained herein shall survive
the Closing and the delivery of the Securities.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 6.11&#9;<U>Execution</U>.
This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and delivered to the other party, it being understood that
both parties need not sign the same counterpart. In the event that any signature is delivered by electronic mail delivery of a &ldquo;.pdf&rdquo;
format data file (including an electronic submission complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com or www.echosign.com),
such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with
the same force and effect as if such electronic mail signature page were an original thereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 6.12&#9;<U>Severability</U>.
If any provision of this Agreement is held to be invalid or unenforceable in any respect, the validity and enforceability of the remaining
terms and provisions of this Agreement shall not in any way be affected or impaired thereby and the parties will attempt to agree upon
a valid and enforceable provision that is a reasonable substitute therefor, and upon so agreeing, shall incorporate such substitute provision
in this Agreement so long as this Agreement as so modified continues to express, without material change, the original intentions of the
parties as to the subject matter hereof and the prohibited nature, invalidity or unenforceability of the provision(s) in question does
not substantially impair the respective expectations or reciprocal obligations of the parties or the practical realization of the benefits
that would otherwise be conferred upon the parties. The parties will endeavor in good faith negotiations to replace the prohibited, invalid
or unenforceable provision(s) with a valid provision(s), the effect of which comes as close as possible to that of the prohibited, invalid
or unenforceable provision(s).</P>


<!-- Field: Page; Sequence: 47 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 6.13&#9;<U>Rescission
and Withdrawal Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) the Transaction
Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction Document and the Company does not
timely perform its related obligations within the periods therein provided, then such Purchaser may rescind or withdraw, in its sole discretion
from time to time upon written notice to the Company, any relevant notice, demand or election in whole or in part without prejudice to
its future actions and rights, unless such rescission or withdrawal would materially prejudice the Company.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 6.14&#9;<U>Replacement
of Securities</U>. If any certificate or instrument evidencing any Security mutilated, lost, stolen or destroyed, the Company shall issue
or cause to be issued in exchange and substitution for and upon cancellation thereof, or in lieu of and substitution therefor, a new certificate
or instrument, but only upon receipt of evidence reasonably satisfactory to the Company and the Transfer Agent of such loss, theft or
destruction and the execution by the holder thereof of a customary lost certificate affidavit of that fact and an agreement to indemnify
and hold harmless the Company and the Transfer Agent for any losses in connection therewith or, if required by the Transfer Agent, a bond
in such form and amount as is required by the Transfer Agent. The applicants for a new certificate or instrument under such circumstances
shall also pay any reasonable third-party costs associated with the issuance of such replacement Security. If a replacement certificate
or instrument evidencing any Security is requested due to a mutilation thereof, the Company may require delivery of such mutilated certificate
or instrument as a condition precedent to any issuance of a replacement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 6.15&#9;<U>Remedies</U>.
In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of the Purchasers
and the Company will be entitled to specific performance under the Transaction Documents. Except as expressly set forth in the Transaction
Documents, the parties agree that monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations
described in the foregoing sentence and hereby agree to waive in any action for specific performance of any such obligation (other than
in connection with any action for a temporary restraining order) the defense that a remedy at law would be adequate.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 6.16&#9;<U>Payment
Set Aside</U>. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document or a Purchaser
enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or any part
thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by or are required
to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other person under any law (including, without
limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such restoration
the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect as if such
payment had not been made or such enforcement or setoff had not occurred.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 6.17&#9;<U>Adjustments
in Share Numbers and Prices</U>. In the event of any stock split, subdivision, dividend or distribution to all stockholders of the Company
payable in shares of Common Stock (or other securities or rights convertible into, or entitling the holder thereof to receive directly
or indirectly shares of Common Stock), combination or other similar recapitalization or event occurring after the
date hereof and prior to the Closing, each reference in any Transaction Document to a number of shares or a price per share shall be deemed
to be amended to appropriately account for such event.</P>


<!-- Field: Page; Sequence: 48 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 6.18&#9;<U>Independent
Nature of Purchasers&rsquo; Obligations and Rights</U>. The obligations of each Purchaser under any Transaction Document are several and
not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance of the obligations
of any other Purchaser under any Transaction Document. The decision of each Purchaser to purchase Securities pursuant to the Transaction
Documents has been made by such Purchaser independently of any other Purchaser and independently of any information, materials, statements
or opinions as to the business, affairs, operations, assets, properties, liabilities, results of operations, condition (financial or otherwise)
or prospects of the Company or any Subsidiary which may have been made or given by any other Purchaser or by any agent or employee of
any other Purchaser, and no Purchaser and any of its agents or employees shall have any liability to any other Purchaser (or any other
Person) relating to or arising from any such information, materials, statement or opinions. Nothing contained herein or in any Transaction
Document, and no action taken by any Purchaser pursuant thereto, shall be deemed to constitute the Purchasers as a partnership, an association,
a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group
with respect to such obligations or the transactions contemplated by the Transaction Documents. Each Purchaser acknowledges that no other
Purchaser has acted as agent for such Purchaser in connection with making its investment hereunder and that no Purchaser will be acting
as agent of such Purchaser in connection with monitoring its investment in the Securities or enforcing its rights under the Transaction
Documents. Each Purchaser shall be entitled to independently protect and enforce its rights, including without limitation the rights arising
out of this Agreement or out of the other Transaction Documents, and it shall not be necessary for any other Purchaser to be joined as
an additional party in any proceeding for such purpose. Each Purchaser has been represented by its own separate legal counsel in its review
and negotiation of the Transaction Documents. Each Purchaser also acknowledges that DLA Piper LLP (US) has rendered legal advice to the
Company and not such Purchaser. The Company has elected to provide all Purchasers with the same terms and Transaction Documents for the
convenience of the Company and not because it was required or requested to do so by any Purchaser.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 6.19&#9;<U>Termination</U>.
This Agreement may be terminated and the sale and purchase of the Securities abandoned at any time prior to the Closing by either the
Company or any Purchaser (with respect to itself only) upon written notice to the other, if the Closing has not been consummated on or
prior to 5:00 P.M., New York City time, on the Outside Date; provided, however, that the right to terminate this Agreement under this
Section 6.19 shall not be available to any Person whose failure to comply with its obligations under this Agreement has been the cause
of or resulted in the failure of the Closing to occur on or before such time. Nothing in this Section 6.19 shall be deemed to release
any party from any liability for any breach by such party of the terms and provisions of this Agreement or the other Transaction Documents
or to impair the right of any party to compel specific performance by any other party of its obligations under this Agreement or the
other Transaction Documents. In the event of a termination pursuant to this Section 6.19, the Company shall promptly notify all non-terminating
Purchasers in writing. Upon a termination in accordance with this Section 6.19, the Company and the terminating Purchaser(s) shall not
have any further obligation or liability (including arising from such termination) to the other, and no Purchaser will have any liability
to any other Purchaser under the Transaction Documents as a result therefrom.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt; text-align: center">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 49 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B><U>EXHIBIT A</U></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>FORM OF CERTIFICATE OF DESIGNATION OF</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt; text-align: center"><B>SERIES A CONVERTIBLE PREFERRED STOCK</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 50 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B><U>EXHIBIT B</U></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>PLAN OF DISTRIBUTION</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">We are registering the
shares of common stock and the shares of common stock issuable upon conversion of Series A convertible preferred stock (collectively,
the &ldquo;shares&rdquo;) previously issued in the private placement to permit the resale of these shares of common stock by the holders
thereof from time to time after the date of this prospectus. We will not receive any of the proceeds from the sale by the selling stockholder
of the shares of common stock. We will bear all fees and expenses incident to our obligation to register the shares of common stock.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The selling stockholders,
which shall include donees, pledgees, transferees or other successors-in-interest selling shares of common stock or interests in shares
of common stock received after the date of this prospectus from a selling stockholder as a gift, pledge, partnership distribution or other
transfer, may, from time to time, sell, transfer or otherwise dispose of any or all of their shares of common stock or interests in shares
of common stock on any stock exchange, market or trading facility on which the shares are traded or in private transactions. These dispositions
may be at fixed prices, at prevailing market prices at the time of sale, at prices related to the prevailing market price, at varying
prices determined at the time of sale, or at negotiated prices.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The selling stockholders
may use any one or more of the following methods when disposing of shares or interests therein:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>on any national securities exchange or quotation service on which the securities may be listed or quoted at the time of sale;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>block trades in which the broker-dealer will attempt to sell the shares as agent, but may position and resell a portion of the block
as principal to facilitate the transaction;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>purchases by a broker-dealer as principal and resale by the broker-dealer for its own account;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>an exchange distribution in accordance with the rules of the applicable exchange;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>privately negotiated transactions;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>short sales;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>through the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>through agreements between broker-dealers and the selling stockholders to sell a specified number of such shares at a stipulated price
per share;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>a combination of any such methods of sale; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>any other method permitted by applicable law.</TD></TR></TABLE>


<!-- Field: Page; Sequence: 51 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The selling stockholders
may, from time to time, pledge or grant a security interest in some or all of the shares of common stock owned by them and, if they default
in the performance of their secured obligations, the pledgees or secured parties may offer and sell the shares of common stock, from time
to time, under this prospectus, or under an amendment to this prospectus under Rule 424(b) or other applicable provision of the Securities
Act amending the list of selling stockholders to include the pledgee, transferee or other successors in interest as selling stockholders
under this prospectus. The selling stockholders also may transfer the shares of common stock in other circumstances, in which case the
pledgees, transferees or other successors in interest will be the selling beneficial owners for purposes of this prospectus.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">In connection with the
sale of our common stock or interests therein, the selling stockholders may enter into hedging transactions with broker-dealers or other
financial institutions, which may in turn engage in short sales of the common stock in the course of hedging the positions they assume.
The selling stockholders may also sell shares of our common stock short and deliver these securities to close out their short positions,
or loan or pledge the common stock to broker-dealers that in turn may sell these securities. The selling stockholders may also enter into
options or other transactions with broker-dealers or other financial institutions or the creation of one or more derivative securities
which require the delivery to each such broker-dealer or other financial institution of shares offered by this prospectus, which shares
such broker-dealer or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The aggregate proceeds
to the selling stockholders from the sale of the common stock offered by them will be the purchase price of the common stock less discounts
or commissions, if any. Each of the selling stockholders reserves the right to accept and, together with its agents from time to time,
to reject, in whole or in part, any proposed purchase of common stock to be made directly or through agents. We will not receive any of
the proceeds from this offering.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The selling stockholders
also may resell all or a portion of the shares in open market transactions in reliance upon Rule 144 under the Securities Act of 1933,
provided that they meet the criteria and conform to the requirements of that rule.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">There can be no assurance
that any selling stockholder will sell any or all of the shares of common stock registered pursuant to the registration statement, of
which this prospectus forms a part.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The selling stockholders
and any underwriters, broker-dealers or agents that participate in the sale of the common stock or interests therein may be &ldquo;underwriters&rdquo;
within the meaning of Section 2(11) of the Securities Act. Any discounts, commissions, concessions or profit they earn on any resale of
the shares may be underwriting discounts and commissions under the Securities Act. Selling stockholders who are &ldquo;underwriters&rdquo;
within the meaning of Section 2(11) of the Securities Act will be subject to the prospectus delivery requirements of the Securities Act.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">To the extent required,
the shares of our common stock to be sold, the names of the selling stockholders, the respective purchase prices and public offering prices,
the names of any agents, dealer or underwriter, and any applicable commissions or discounts with respect to a particular offer will be set forth in an accompanying
prospectus supplement or, if appropriate, a post-effective amendment to the registration statement that includes this prospectus.</P>


<!-- Field: Page; Sequence: 52 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">In order to comply with
the securities laws of some states, if applicable, the common stock may be sold in these jurisdictions only through registered or licensed
brokers or dealers. In addition, in some states the common stock may not be sold unless it has been registered or qualified for sale or
an exemption from registration or qualification requirements is available and is complied with.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">We have advised the selling
stockholders that the anti-manipulation rules of Regulation M under the Exchange Act may apply to sales of shares in the market and to
the activities of the selling stockholders and their affiliates. In addition, to the extent applicable, we will make copies of this prospectus
(as it may be supplemented or amended from time to time) available to the selling stockholders for the purpose of satisfying the prospectus
delivery requirements of the Securities Act. The selling stockholders may indemnify any broker-dealer that participates in transactions
involving the sale of the shares against certain liabilities, including liabilities arising under the Securities Act.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">We are required to pay
all fees and expenses incident to the registration of our securities. We have agreed to indemnify the selling stockholders against liabilities,
including liabilities under the Securities Act and state securities laws, relating to the registration of the shares offered by this prospectus.
Once sold under the registration statement, of which this prospectus forms a part, the shares of common stock will be freely tradable
in the hands of persons other than our affiliates.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">We have agreed with the
selling stockholders to keep the registration statement of which this prospectus constitutes a part effective until the earlier of (1)
such time as all of the shares covered by this prospectus have been disposed of pursuant to and in accordance with the registration statement
or (2) the date on which all of the shares may be sold without restriction pursuant to Rule 144 of the Securities Act.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">* * *</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">&nbsp;</P>










<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>p25-1788exhibit99_2.htm
<DESCRIPTION>CERTIFICATE OF DESIGNATION OF RIGHTS, PREFERENCES AND PRIVILEGES OF THE PREFERRED SHARES
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>CERTIFICATE OF DESIGNATION OF<BR>
RIGHTS, PREFERENCES AND PRIVILEGES OF<BR>
SERIES A CONVERTIBLE PREFERRED STOCK OF<BR>
HERON THERAPEUTICS, INC.</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">PURSUANT TO SECTION 151 OF THE<BR>
DELAWARE GENERAL CORPORATION LAW</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">THE UNDERSIGNED DOES HEREBY
CERTIFY, on behalf of Heron Therapeutics, Inc., a Delaware corporation (the &#8220;Corporation&#8221;), that the Board of Directors of
the Corporation (the &#8220;Board of Directors&#8221;) duly adopted by unanimous written consent the following resolution in accordance
with the provisions of Section 151 of the General Corporation Law of the State of Delaware, as amended, which provides for the designation
of 524,141 shares of Series A Convertible Preferred Stock, $0.01 per share:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">RESOLVED, that the Board
of Directors, pursuant to authority expressly vested in it by the provisions of the certificate of incorporation, as amended (the &#8220;Certificate
of Incorporation&#8221;) of the Corporation, hereby authorizes the issuance from time to time of the Series A Convertible Preferred Stock
of the Corporation and hereby fixes the powers, designations, preferences, limitations, restrictions and relative rights of the Series
A Convertible Preferred Stock of the Corporation, in addition to those set forth in said Certificate of Incorporation, to be in their
entirety as follows.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 1.<FONT STYLE="letter-spacing: 2pt">&#9;</FONT><U>Definitions</U>.
For the purposes hereof, the following terms shall have the following meanings:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&#8220;<U>Affiliate</U>&#8221;
means, with respect to any Person, any other Person that, now or in the future, directly or indirectly through one or more intermediaries,
controls, is controlled by or is under common control with such Person, as such terms are used in and construed under Rule 405 under the
Securities Act. With respect to a Holder, any investment fund or managed account that is managed on a discretionary basis by the same
investment manager as such Holder will be deemed to be an Affiliate of such Holder.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&#8220;<U>Beneficial Ownership
Limitation</U>&#8221; shall have the meaning set forth in Section 6(d).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&#8220;<U>Board of Directors</U>&#8221;
means the board of directors of the Corporation.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&#8220;<U>Business Day</U>&#8221;
means any day except Saturday, Sunday, any day which is a federal legal holiday in the United States or any day on which banking institutions
in the States of New York or North Carolina are authorized or required by law or other governmental action to close.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify">&#8220;<U>Buy-In</U>&#8221; shall
have the meaning set forth in Section <FONT STYLE="letter-spacing: -0.1pt">6(c)(iv).</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in">&#8220;<U>Certificate of Designation</U>&#8221; means this
Certificate of Designation of Rights, Preferences and Privileges of the Series A Convertible Preferred Stock.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&#8220;<U>Change of Control
Transaction</U>&#8221; means the occurrence after the date hereof of any of (a) an acquisition after the date hereof by an individual
or legal entity or &#8220;group&#8221; (as described in <FONT STYLE="letter-spacing: -0.2pt">Rule 13d-5(b)(1) promulgated under the Exchange
Act) of effective control (whether through legal or beneficial ownership of capital stock of the Corporation, by contract or otherwise)
of in excess of 50% of the voting securities of the Corporation (other than by means of conversion or exercise of Preferred Stock and
the Securities issued together with the Preferred Stock or upon conversion of any currently outstanding convertible securities in accordance
with the terms thereof as in effect on the date hereof), (b) the Corporation merges into or consolidates with any other Person, or any
Person merges into or consolidates with the Corporation and, after giving effect to such transaction, the stockholders of the Corporation
immediately prior to such transaction own less than 51% of the aggregate voting power of the Corporation or the successor entity of such
transaction, (c) the Corporation sells or transfers all or substantially all of its assets to another Person and the stockholders of
the Corporation immediately prior to such transaction own less than 51% of the aggregate voting power of the acquiring entity immediately
after the </FONT><FONT STYLE="letter-spacing: -0.1pt">transaction,</FONT> <FONT STYLE="letter-spacing: -0.2pt">(d) a replacement at one
time or within a one year period of more than one-half of the members of the Board of Directors which is not approved by a majority of
those individuals who are members of the Board of Directors on the Original Issue Date (or by those individuals who are serving as members
of the Board of Directors on any date whose nomination to the Board of Directors was approved by a majority of the members of the Board
of Directors who are members on the Original Issue Date), or (e) the execution by the Corporation of an agreement to which the Corporation
is a party or by which it is bound, providing for any of the events set forth in clauses (a) through (d) </FONT><FONT STYLE="letter-spacing: -0.1pt">above.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Closing</U>&#8221;
means the closing of the purchase and sale of the Securities pursuant to the Purchase Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&nbsp;&#8220;<U>Closing
Date</U>&#8221; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties
thereto, and all conditions set forth in Sections 2.1, 2.2, 5.1 and 5.2 of the Purchase Agreement are satisfied or waived, in writing,
as the case may be, or such other date as the parties may agree.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in">&#8220;<U>Commission</U>&#8221; means the United States Securities
and Exchange <FONT STYLE="letter-spacing: -0.1pt">Commission.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&#8220;<U>Common Stock</U>&#8221;
means the Corporation&#8217;s common stock, par value $0.01 per share, and also includes any other class of securities into which the
Common Stock may hereafter be reclassified or changed into.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&#8220;<U>Common Stock
Equivalents</U>&#8221; means any securities of the Corporation or any Subsidiary which would entitle the holder thereof to acquire, at
any time, Common Stock, including, without limitation, any debt, preferred stock, rights, options, warrants or other instrument that is,
at any time, convertible into or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock or other securities
that entitle the holder to receive, directly or indirectly, Common <FONT STYLE="letter-spacing: -0.1pt">Stock.</FONT></P>

<P STYLE="font: 12pt/186% Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in">&#8220;<U>Conversion Amount</U>&#8221; means the sum
of the Stated Value at issue.</P>

<P STYLE="margin: 0 0 12pt 0.5in; font: 12pt/186% Times New Roman, Times, Serif">&#8220;<U>Conversion Date</U>&#8221; shall have the meaning
set forth in Section 6(a).</P>




<P STYLE="font: 12pt/186% Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in">&#8220;<U>Conversion Price</U>&#8221; shall have the
meaning set forth in Section 6(b).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&#8220;<U>Conversion Shares</U>&#8221;
means, collectively, the shares of Common Stock issuable upon conversion of the shares of Preferred Stock in accordance with the terms
hereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&#8220;<U>Conversion Shares
Registration Statement</U>&#8221; means a registration statement that registers the resale of all Conversion Shares, so long as such Conversion
Shares are Registrable Securities, of the Holders, who shall be named as &#8220;selling stockholders&#8221; therein and meets the requirements
of Section 4.11 of the Purchase Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in">&#8220;<U>Corporation</U>&#8221; means Heron Therapeutics,
Inc., a Delaware <FONT STYLE="letter-spacing: -0.1pt">corporation.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&#8220;<U>Exchange Act</U>&#8221;
means the Securities Exchange Act of 1934, as amended, or any successor statute, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in">&#8220;<U>Holder</U>&#8221; shall have the meaning given such
term in Section <FONT STYLE="letter-spacing: -0.25pt">2.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&#8220;<U>Junior Securities</U>&#8221;
means the Common Stock and all other Common Stock Equivalents of the Corporation other than those securities which are explicitly senior
or <U>pari passu</U> to the Preferred Stock in dividend rights or liquidation preference.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in">&#8220;<U>Liquidation</U>&#8221; shall have the meaning set
forth in Section <FONT STYLE="letter-spacing: -0.25pt">5.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&#8220;<U>New York Courts</U>&#8221;
means the state and federal courts sitting in the City of New York, Borough of Manhattan.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&#8220;<U>Original Issue
Date</U>&#8221; means the date of the first issuance of any shares of the Preferred Stock regardless of the number of transfers of any
particular shares of Preferred Stock and regardless of the number of certificates which may be issued to evidence such Preferred Stock.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&#8220;<U>Person</U>&#8221;
means an individual, corporation, partnership, limited liability company, trust, business trust, association, joint stock company, joint
venture, sole proprietorship, unincorporated organization, governmental authority or any other form of entity not specifically listed
herein.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in">&#8220;<U>Preferred Stock</U>&#8221; shall have the meaning
set forth in Section <FONT STYLE="letter-spacing: -0.25pt">2.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&#8220;<U>Principal Trading
Market</U>&#8221; means the Trading Market on which the Common Stock is primarily listed and quoted for trading, which, as of the date
of this Agreement and the Closing Date, shall be the Nasdaq Capital Market.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Proceeding</U>&#8221;
means an action, claim, suit, investigation or proceeding (including, without limitation, an investigation or partial proceeding, such
as a deposition), whether commenced or <FONT STYLE="letter-spacing: -0.1pt">threatened.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.1pt"></FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.1pt"></FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.1pt">&nbsp;&#8220;<U>Purchase
Agreement</U>&#8221; means the Securities Purchase Agreement, dated on or about the Original Issue Date, among the Corporation and the
original Holders, as amended, modified or supplemented from time to time in accordance with its terms for the purchase and sale of Common
Stock and Preferred Stock.</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&nbsp;&#8220;<U>Registrable
Securities</U>&#8221; means the shares of Common Stock and Conversion Shares (and any other equity security issued or issuable with respect
to such shares by way of share split, dividend, distribution, recapitalization, merger, exchange, or replacement) registered for resale
on a registration statement on appropriate form to be filed with the Commission.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&#8220;<U>Securities</U>&#8221;
means the Common Stock, the Preferred Stock and the Conversion Shares to be issued and sold subject to the Purchase Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&#8220;<U>Securities Act</U>&#8221;
means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in">&#8220;<U>Share Delivery Date</U>&#8221; shall have the meaning
set forth in Section <FONT STYLE="letter-spacing: -0.1pt">6(c).</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&#8220;<U>Stated Value</U>&#8221;
shall have the meaning set forth in Section 2, as the same may be increased pursuant to Section 3.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in">&#8220;<U>Stockholder Approval</U>&#8221; shall have the meaning
set forth in Section <FONT STYLE="letter-spacing: -0.1pt">6(a).</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&#8220;<U>Subsidiary</U>&#8221;
means any subsidiary of the Corporation as defined under Section 1.1 of the Purchase Agreement and shall, where applicable, also include
any direct or indirect subsidiary of the Corporation formed or acquired after the date of the Purchase Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&#8220;<U>Trading Day</U>&#8221;
means (i) a day on which the Common Stock is listed or quoted and traded on the Principal Trading Market (other than the OTC Bulletin
Board), (ii) if the Common Stock is not listed on a Trading Market (other than the OTC Bulletin Board), a day on which the Common Stock
is traded in the over-the-counter market, as reported by the OTC Bulletin Board, or (iii) if the Common Stock is not quoted on any Trading
Market, a day on which the Common Stock is quoted in the over-the-counter market as reported in the &#8220;pink sheets&#8221; by Pink
Sheets LLC (or any similar organization or agency succeeding to its functions of reporting prices); <I>provided</I>, that in the event
that the Common Stock is not listed or quoted as set forth in (i), (ii) and (iii) hereof, then Trading Day shall mean a Business Day.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&#8220;<U>Trading Market</U>&#8221;
means whichever of the New York Stock Exchange, the NYSE MKT, the Nasdaq Global Select Market, the Nasdaq Global Market, the Nasdaq Capital
Market or the OTC Bulletin Board on which the Common Stock is listed or quoted for trading on the date in <FONT STYLE="letter-spacing: -0.1pt">question.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&#8220;<U>Transaction Documents</U>&#8221;
means this Certificate of Designation, the Purchase Agreement, all exhibits and schedules attached thereto and hereto and any other documents
or agreements executed in connection with the transactions contemplated pursuant to the Purchase Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&#8220;<U>Transfer Agent</U>&#8221;
means Computershare Trust Company N.A., the current transfer agent of the Corporation, with a mailing address of 150 Royall Street, Canton,
MA, 02021, or any successor transfer agent for the Corporation.</P>




<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&#8220;<U>VWAP</U>&#8221;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding <FONT STYLE="letter-spacing: -0.1pt">date)</FONT>
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if the OTC Bulletin Board is not a Trading Market, the volume weighted
average price of the Common Stock for such date (or the nearest preceding date) on the OTC Bulletin Board, (c) if the Common Stock is
not then listed or quoted for trading on the OTC <FONT STYLE="letter-spacing: -0.1pt">Bulletin Board and if prices for the Common Stock
are then reported in the &#8220;Pink Sheets&#8221; published </FONT>by Pink OTC Markets, Inc. (or a similar organization or agency succeeding
to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d) in all other cases,
the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Holders of a
majority in interest of the Preferred Stock then outstanding and reasonably acceptable to the Corporation, the fees and expenses of which
shall be paid by the Corporation.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Section 2. <U>Designation, Amount
and Par Value</U>. The series of preferred stock shall be designated as the Corporation&#8217;s Series A Convertible Preferred Stock
(the &#8220;<U>Preferred Stock</U>&#8221;) and the number of shares so designated shall be 524,141 (which shall not be subject to increase
without the written consent of all of the holders of the Preferred Stock (each, a &#8220;<U>Holder</U>&#8221; and collectively, the &#8220;<U>Holders</U>&#8221;)).
Each share of Preferred Stock shall have a par value of $0.01 per share and a stated value equal to $15.00, subject to increase set forth
in Section 3 below (the &#8220;<U>Stated <FONT STYLE="letter-spacing: -0.1pt">Value</FONT></U>&#8221;).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.1pt">Section
</FONT><FONT STYLE="letter-spacing: -0.25pt">3.</FONT><FONT STYLE="letter-spacing: -0.1pt">&#9;<U>Dividends</U>.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="letter-spacing: -0.1pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Holders
shall be entitled to receive, and the Corporation shall pay, dividends on shares of Preferred Stock equal (on an as-if-converted-to-Common-Stock
basis) to and in the same form as dividends (other than dividends in the form of Common Stock) actually paid on shares of the Common Stock
or other Junior Securities when, as and if such dividends (other than dividends in the form of Common Stock) are paid on shares of the
Common Stock or other Junior Securities. Other than as set forth in the previous sentence, no other dividends shall be paid on shares
of Preferred Stock; and the Corporation shall pay no dividends (other than dividends in the form of Common Stock) on shares of the Common
Stock or other Junior Securities unless it simultaneously complies with the previous sentence. All declared but unpaid dividends on shares
of Preferred Stock shall increase the Stated Value of such shares, but when such dividends are actually paid any such increase in the
Stated Value shall be rescinded.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="letter-spacing: -0.1pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>So
long as any shares of Preferred Stock remain outstanding, neither the Corporation nor any Subsidiary thereof shall redeem, purchase or
otherwise acquire directly or indirectly any material amount of Junior Securities.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 4. <U>Voting Rights</U>.
Except as otherwise provided herein or as otherwise required by law, the Preferred Stock shall have no voting rights. However, as long
as any shares of Preferred Stock are outstanding, the Corporation shall not, without the affirmative vote of the Holders of at least
a majority in Stated Value of Preferred Stock, except as may be necessary to increase the authorized shares of Common Stock in order
to account for any increase in the number of shares issuable upon conversion of the Preferred Stock, (a) alter or change adversely the
powers, preferences or rights given to the Preferred Stock or alter or amend this Certificate of <FONT STYLE="letter-spacing: -0.1pt">Designation,</FONT>
(b) authorize or create any class of stock ranking as to dividends, redemption or distribution of assets upon a Liquidation (as defined
in Section 5) senior to, or otherwise <U>pari passu</U> with, <FONT STYLE="letter-spacing: -0.25pt">the</FONT> Preferred Stock, (c) amend
its certificate of incorporation or other charter documents in any manner that adversely affects any rights of the Holders, (d) increase
the number of authorized shares of Preferred Stock, or (e) enter into any agreement with respect to any of the foregoing.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 5. <U>Liquidation</U>.
Upon any liquidation, dissolution or winding-up of the Corporation, whether voluntary or involuntary (a &#8220;<U>Liquidation</U>&#8221;),
the assets of the Corporation available for distribution to its stockholders shall be distributed <U>pari passu</U> among the holders
of the shares of Common Stock and Preferred Stock, pro rata based on the number of shares held by each such holder, treating for this
purpose all such securities as if they had been converted to Common Stock, pursuant to the terms of the Articles of Incorporation immediately
prior to such <FONT STYLE="letter-spacing: -0.1pt">liquidation, dissolution or winding up of the Corporation. The Corporation shall mail
written notice </FONT>of any such Liquidation, not less than 45 days prior to the payment date stated therein, to each <FONT STYLE="letter-spacing: -0.1pt">Holder.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in">Section <FONT STYLE="letter-spacing: -0.25pt">6.</FONT>&#9;<FONT STYLE="letter-spacing: -0.1pt"><U>Conversion</U>.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="letter-spacing: -0.1pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Automatic
Conversion upon Stockholder Approval</U>. Upon receipt of the requisite votes of the Corporation&#8217;s stockholders required to approve
the issuance of the Conversion Shares upon conversion of the Preferred Stock pursuant to the applicable rules of the Principal Trading
Market (&#8220;<U>Stockholder Approval</U>&#8221;), each share of Preferred Stock shall, without any further action on the part of the
Holder thereof or the Corporation, automatically be converted into a number of fully paid and nonassessable shares of Common Stock as
determined by dividing the Stated Value by the Conversion Price then in effect. The Preferred Stock shall not be convertible into Common
Stock until receipt of Stockholder Approval.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Conversion
Price</U>. The conversion price for the Preferred Stock shall equal $1.50, subject to adjustment herein (the &ldquo;<U>Conversion Price</U>&rdquo;).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Mechanics
of Conversion.</U></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="letter-spacing: -0.05pt">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Delivery
of Certificate Upon Conversion</U>. Not later than three (3) Trading Days after each Conversion Date (the &#8220;<U>Share Delivery Date</U>&#8221;),
the Corporation shall deliver, or cause to be delivered, to the converting Holder (A) a certificate or certificates free of restrictive
legends representing the number of Conversion Shares being acquired upon the conversion of the Preferred Stock, and (B) a bank check
in the amount of accrued and unpaid dividends. If requested by the Holder, the Corporation shall use its best efforts to deliver any
certificate or certificates required to be delivered by the Corporation under this Section 6 electronically through the Depository Trust
Company or another established clearing corporation performing similar functions.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.5in">&nbsp;<FONT STYLE="letter-spacing: -0.05pt">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Failure
to Deliver Certificates</U>. If, in the case of any Notice of Conversion, such certificate or certificates are not delivered to or as
directed by the applicable Holder by the Share Delivery Date, the Holder shall be entitled to elect by written notice to the Corporation
at any time on or before its receipt of such certificate or certificates, to rescind such Conversion, in which event the Corporation
shall promptly return to the Holder any original Preferred Stock certificate delivered to the Corporation and the Holder shall promptly
return to the Corporation the Common Stock certificates issued to such Holder pursuant to the rescinded Conversion Notice.</P>



<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>


<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Reservation
of Shares Issuable Upon Conversion</U>. The Corporation covenants that it will at all times reserve and keep available out of its authorized
and unissued shares of Common Stock for the sole purpose of issuance upon conversion of the Preferred Stock as herein provided, free from
preemptive rights or any other actual contingent purchase rights of Persons other than the Holder (and the other holders of the Preferred
Stock), not less than such aggregate number of shares of the Common Stock as shall (subject to the terms and conditions set forth in the
respective Purchase Agreement) be issuable (taking into account the adjustments and restrictions of Section 7) upon the conversion of
the then outstanding shares of Preferred Stock. The Corporation covenants that all shares of Common Stock that shall be so issuable shall,
upon issue, be duly authorized, validly issued, fully paid and nonassessable and, if the Conversion Shares Registration Statement is then
effective under the Securities Act, shall be registered for public resale in accordance with such Conversion Shares Registration Statement
(subject to such Holder&rsquo;s compliance with its obligations under Section 4.11 of the Purchase Agreement).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="letter-spacing: -0.05pt">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Fractional
Shares</U>. No fractional shares or scrip representing fractional shares shall be issued upon the conversion of the Preferred Stock. As
to any fraction of a share which the Holder would otherwise be entitled to purchase upon such conversion, the Corporation shall at its
election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Conversion
Price or round up to the next whole <FONT STYLE="letter-spacing: -0.1pt">share.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="letter-spacing: -0.05pt">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Transfer
Taxes</U>. The issuance of certificates for shares of the Common Stock on conversion of the Preferred Stock shall be made without charge
to any Holder for any documentary stamp or similar taxes that may be payable in respect of the issue or delivery of such certificates,
provided that the Corporation shall not be required to pay any tax that may be payable in respect of any transfer involved in the issuance
and delivery of any such certificate upon conversion in a name other than that of the Holders of such shares of Preferred Stock and the
Corporation shall not be required to issue or deliver such certificates unless or until the Person or Persons requesting the issuance
thereof shall have paid to the Corporation the amount of such tax or shall have established to the satisfaction of the Corporation that
such tax has been paid.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="letter-spacing: -0.1pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Beneficial
Ownership Limitation</U>. The Corporation shall not effect any conversion of the Preferred Stock, and a Holder shall not have the right
to convert any portion of the Preferred Stock, to the extent that, after giving effect to the conversion set forth on the applicable
Notice of Conversion, such Holder (together with such Holder&#8217;s Affiliates, and any Persons acting as a group together with such
Holder or any of such Holder&#8217;s Affiliates) would beneficially own in excess of the Beneficial Ownership Limitation (as defined
below). For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by such Holder and its Affiliates
shall include the number of shares of Common Stock issuable upon conversion of the Preferred Stock with respect to which such determination
is being made, but shall exclude the number of shares of Common Stock which are issuable upon (i) conversion of the remaining, unconverted
Stated Value of Preferred Stock beneficially owned by such Holder or any of its Affiliates and (ii) exercise or conversion of the unexercised
or unconverted portion of any other securities of the Corporation subject to a limitation on conversion or exercise analogous to the
limitation contained herein (including, without limitation, the Preferred Stock) beneficially owned by such Holder or any of its Affiliates.
Except as set forth in the preceding sentence, for purposes of this Section 6(d), beneficial ownership shall be calculated in accordance
with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. To the extent that the limitation contained
in this Section 6(d) applies, the determination of whether the Preferred Stock is convertible (in relation to other securities owned
by such Holder together with any Affiliates) and of how many shares of Preferred Stock are convertible shall be in the sole discretion
of such Holder, and the submission of a Notice of Conversion shall be deemed to be such Holder&#8217;s determination of whether the shares
of Preferred Stock may be converted (in relation to other securities owned by such Holder together with any Affiliates) and how many
shares of the Preferred Stock are convertible, in each case subject to the Beneficial Ownership Limitation. To ensure compliance with
this restriction, each Holder will be deemed to represent to the Corporation each time it delivers a Notice of Conversion that such Notice
of Conversion has not violated the restrictions set forth in this paragraph and the Corporation shall have no obligation to verify or
confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall be determined
in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder<FONT STYLE="color: blue">.
</FONT>For purposes of this Section 6(d), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number
of outstanding shares of Common Stock as stated in the most recent of the following:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0">(i) the Corporation&#8217;s most recent periodic
or annual report filed with the Commission, as the case may be, (ii) a more recent public announcement by the Corporation or (iii)
a more recent written notice by the Corporation or the Transfer Agent setting forth the number of shares of Common Stock outstanding.
Upon the written or oral request of a Holder, the Corporation shall within two Trading Days confirm orally and in writing to such Holder
the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined
after giving effect to the conversion or exercise of securities of the Corporation, including the Preferred Stock, by such Holder or
its Affiliates since the date as of which such number of outstanding shares of Common Stock was reported. The &#8220;<U>Beneficial Ownership
Limitation</U>&#8221; shall be 4.99% (or, at the election of a Holder, 9.99% or 19.99%) of the number of shares of Common Stock outstanding
immediately after giving effect to the issuance of shares of Common Stock issuable upon conversion of Preferred Stock held by the applicable
Holder. A Holder may, upon notice to the Corporation, increase or decrease the Beneficial Ownership Limitation, <I>provided</I> that
the Beneficial Ownership Limitation in no event exceeds 19.99% of the number of shares of the Common Stock outstanding at such time.
Any increase in the Beneficial Ownership Limitation will not be effective until the 61st day after such notice is delivered to the Corporation.
This Section 6(d) shall be construed and implemented in a manner otherwise than in strict conformity with its terms if necessary to correct
this Section 6(d) (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation contained
herein or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained
in this Section 6(d) shall apply to a successor holder of Preferred Stock.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in">Section <FONT STYLE="letter-spacing: -0.25pt">7.</FONT>&#9;<U>Certain
<FONT STYLE="letter-spacing: -0.1pt">Adjustments</FONT></U><FONT STYLE="letter-spacing: -0.1pt">.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="letter-spacing: -0.1pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Stock
Dividends and Stock Splits</U>. If the Corporation, at any time while the Preferred Stock is outstanding: (i) pays a stock dividend or
otherwise makes a distribution or distributions payable in shares of Common Stock on shares of Common Stock or any other Common Stock
Equivalents (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Corporation upon conversion of
the Preferred Stock), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by
way of a reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues, in the event of a reclassification
of shares of the Common Stock, any shares of capital stock of the Corporation, then the Conversion Price shall be multiplied by a fraction
of which the numerator shall be the number of shares of Common Stock (excluding any treasury shares of the Corporation) outstanding immediately
before such event, and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event.
Any adjustment made pursuant to this Section 7(a) shall become effective immediately after the record date for the determination of stockholders
entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision,
combination or <FONT STYLE="letter-spacing: -0.1pt">reclassification.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="letter-spacing: -0.1pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Subsequent
Rights Offerings</U>. If the Corporation, at any time while the Preferred Stock is outstanding, shall issue rights, options or warrants
to all holders of Common Stock (and not proportionately to the Holders) entitling them to subscribe for or purchase shares of Common Stock
at a price per share that is lower than the VWAP on the record date for such issuance, and do not offer the same rights to the Holders,
then the Holder will be entitled to acquire, upon conversion of the Preferred Stock, such rights, options or warrants which the Holder
could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete conversion of such Holder&#8217;s
Preferred Stock (without regard to any limitations on the conversion of such Preferred Stock) immediately before the date on which a record
is taken for the issuance of such rights, options or warrants, or, if no such record is taken, the date as of which the record holders
of shares of Common Stock are to be determined for the issuance of such rights, options or warrants.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="letter-spacing: -0.1pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Pro
Rata Distributions</U>. If the Corporation, at any time while the Preferred Stock is outstanding, distributes to all holders of Common
Stock (and not to the Holders) evidences of its indebtedness or assets (including cash and cash dividends) or rights or warrants to subscribe
for or purchase any security, then in each such case the Conversion Price shall be adjusted by multiplying such Conversion Price in effect
immediately prior to the record date fixed for determination of stockholders entitled to receive such distribution by a fraction of which
the denominator shall be the VWAP determined as of the record date mentioned above, and of which the numerator shall be such VWAP on
such record date less the then fair market value at such record date of the portion of such assets or evidence of indebtedness or rights
or warrants so distributed applicable to one outstanding share of the Common Stock as determined by the Board of Directors of the Corporation
in good faith. In either case the adjustments shall be described in a statement delivered to the Holders describing the portion of assets
or evidences of indebtedness so distributed or such subscription rights applicable to one share of Common Stock. Such adjustment shall
be made whenever any such distribution is made and shall become effective immediately after the record date mentioned above.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&nbsp;<FONT STYLE="letter-spacing: -0.1pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Change
of Control Transaction</U>. If, at any time while the Preferred Stock is outstanding, (i) the Corporation, directly or indirectly, in
one or more related transactions effects a Change of Control Transaction, then, upon any subsequent conversion of the Preferred Stock,
the Holder shall have the right to receive, for each Conversion Share that would have been issuable upon such conversion immediately
prior to the occurrence of such Change of Control Transaction (without regard to any limitation in Section 6(d) on the conversion of
the Preferred Stock), the number of shares of Common Stock of the successor or acquiring corporation or of the Corporation, if it is
the surviving corporation, and any additional consideration receivable as a result of such Change of Control Transaction by a holder
of the number of shares of Common Stock for which the Preferred Stock is convertible immediately prior to such Change of Control Transaction
(without regard to any limitation in Section 6(d) on the conversion of the Preferred Stock). Upon the occurrence of any such Change of
Control Transaction, the successor entity shall succeed to, and be substituted for (so that from and after the date of such Change of
Control Transaction, the provisions of this Certificate of Designation and the other Transaction Documents referring to the &#8220;Corporation&#8221;
shall refer instead to the successor entity), and may exercise every right and power of the Corporation and shall assume all of the obligations
of the Corporation under this Certificate of Designation and the other Transaction Documents with the same effect as if such successor
entity had been named as the Corporation herein.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="letter-spacing: -0.1pt">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Calculations</U>.
All calculations under this Section 7 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 7, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding any treasury shares of the Corporation) issued and outstanding.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 35.95pt"><FONT STYLE="letter-spacing: -0.1pt">(f)</FONT></TD><TD>Notice to the <FONT STYLE="letter-spacing: -0.1pt">Holders.</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="letter-spacing: -0.05pt">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Adjustment
to Conversion Price</U>. Whenever the Conversion Price is adjusted pursuant to any provision of this Section 7, the Corporation shall
promptly deliver to each Holder a notice setting forth the Conversion Price after such adjustment and setting forth a brief statement
of the facts requiring such adjustment.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.5in">&nbsp;<FONT STYLE="letter-spacing: -0.05pt">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Notice
to Allow Conversion by Holder</U>. If (A) the Corporation shall declare a dividend (or any other distribution in whatever form) on the
Common Stock, (B) the Corporation shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Corporation shall authorize the granting to all holders of the Common Stock of rights or warrants to subscribe for or purchase any shares
of capital stock of any class or of any rights, (D) the approval of any stockholders of the Corporation shall be required in connection
with any reclassification of the Common Stock, any consolidation or merger to which the Corporation is a party, any sale or transfer
of all or substantially all of the assets of the Corporation, or any compulsory share exchange whereby the Common Stock is converted
into other securities, cash or property or (E) the Corporation shall authorize the voluntary or involuntary dissolution, liquidation
or winding up of the affairs of the Corporation, then, in each case, the Corporation shall cause to be filed at each office or agency
maintained for the purpose of conversion of the Preferred Stock, and shall cause to be delivered to each Holder at its last address as
it shall appear upon the stock books of the Corporation, at least ten (10) calendar days prior to the applicable record or effective
date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution,
redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to
be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification,
consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected
that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or <FONT STYLE="letter-spacing: -0.1pt">other</FONT>
property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange, provided that the failure to
deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to
be specified in such notice. To the extent that any notice provided hereunder constitutes, or contains, material, non-public information
regarding the Corporation or any of the Subsidiaries, the Corporation shall simultaneously file such notice with the Commission pursuant
to a Current Report on Form 8-K. The Holder shall remain entitled to convert the Conversion Amount of the Preferred Stock (or any part
hereof) during the 10-day period commencing on the date of such notice through the effective date of the event triggering such notice
except as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in">Section <FONT STYLE="letter-spacing: -0.25pt">8.</FONT>&#9;<FONT STYLE="letter-spacing: -0.1pt"><U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="letter-spacing: -0.1pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Notices</U>.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall
be deemed given and effective on the earliest of (a) the date of transmission, if such notice or communication is delivered via electronic
mail (provided the sender receives a machine-generated confirmation of successful transmission) at the electronic mail address specified
in this Section 8 prior to 5:00 P.M., New York City time, on a Trading Day, (b) the next Trading Day after the</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0">date of transmission, if
such notice or communication is delivered via electronic mail at the electronic mail address specified in this Section 8 on a day that
is not a Trading Day or later than 5:00 P.M., New York City time, on any Trading Day, (c) the Trading Day following the date of mailing,
if sent by U.S. nationally recognized overnight courier service with next day delivery specified, and (d) upon actual receipt by the party
to whom such notice is required to be given. The address for such notices and communications shall be as set forth in the Purchase Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="letter-spacing: -0.1pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Absolute
Obligation</U>. Except as expressly provided herein, no provision of this Certificate of Designation shall alter or impair the obligation
of the Corporation, which is absolute and unconditional, to pay liquidated damages, accrued dividends and accrued interest, as applicable,
on the shares of Preferred Stock at the time, place, and rate, and in the coin or currency, herein prescribed.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="letter-spacing: -0.1pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Lost
or Mutilated Preferred Stock Certificate</U>. If a Holder&#8217;s Preferred Stock certificate shall be mutilated, lost, stolen or destroyed,
the Corporation shall execute and deliver, in exchange and substitution for and upon cancellation of a mutilated certificate, or in lieu
of or in substitution for a lost, stolen or destroyed certificate, a new certificate for the shares of Preferred Stock so mutilated,
lost, stolen or destroyed, but only upon receipt of evidence of such loss, theft or destruction of such certificate, and of the ownership
hereof reasonably satisfactory to the <FONT>Corporation.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="letter-spacing: -0.1pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Certificate of Designation
shall be governed by and construed and enforced in accordance with the internal laws of the State of Delaware, without regard to the
principles of conflicts of law thereof. Each party agrees that all Proceedings concerning the interpretations, enforcement and
defense of the transactions contemplated by any of the Transaction Documents (whether brought against a party hereto or its
respective Affiliates, directors, officers, shareholders, employees or agents) shall be commenced exclusively in the New York
Courts. Each party hereto hereby irrevocably submits to the exclusive jurisdiction of the New York Courts for the adjudication of
any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including with
respect to the enforcement of any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any
Proceeding, any claim that it is not personally subject to the jurisdiction of any such New York Court, or that such Proceeding has
been commenced in an improper or inconvenient forum. Each party hereto hereby irrevocably waives personal service of process and
consents to process being served in any such Proceeding by mailing a copy thereof via registered or certified mail or overnight
delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Certificate of Designation
and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein
shall be deemed to limit in any way any right to serve process in any other manner permitted by applicable law. <B>EACH PARTY HERETO
HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL
PROCEEDING ARISING OUT OF OR RELATING TO THIS CERTIFICATE OF DESIGNATION OR THE TRANSACTIONS CONTEMPLATED <FONT STYLE="letter-spacing: -0.1pt">HEREBY.</FONT></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="letter-spacing: -0.1pt">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Waiver</U>.
Any waiver by the Corporation or a Holder of a breach of any provision of this Certificate of Designation shall not operate as or be construed
to be a waiver of any other breach of such provision or of any breach of any other provision of this Certificate of Designation or a waiver
by any other Holders. The failure of the Corporation or a Holder to insist upon strict adherence to any term of this Certificate of Designation
on one or more occasions shall not be considered a waiver or deprive that party (or any other Holder) of the right thereafter to insist
upon strict adherence to that term or any other term of this Certificate of Designation on any other occasion. Any waiver by the Corporation
or a Holder must be in writing.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="letter-spacing: -0.1pt">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Execution</U>.
In the event that any signature is delivered by electronic mail delivery of a &#8220;.pdf&#8221; format data file (including an electronic
submission complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com or www.echosign.com), such signature shall create
a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect
as if such electronic mail signature page were an original <FONT>thereof.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&nbsp;<FONT STYLE="letter-spacing: -0.1pt">&nbsp;(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Severability</U>.
If any provision of this Certificate of Designation is held to be invalid or unenforceable in any respect, the validity and enforceability
of the remaining terms and provisions of this Certificate of Designation shall not in any way be affected or impaired thereby and the
parties will attempt to agree upon a valid and enforceable provision that is a reasonable substitute therefor, and upon so agreeing,
shall incorporate such substitute provision in this Certificate of Designation so long as this Certificate of Designation as so modified
continues to express, without material change, the original intentions of the parties as to the subject matter hereof and the prohibited
nature, invalidity or unenforceability of the provision(s) in question does not substantially impair the respective expectations or reciprocal
obligations of the parties or the practical realization of the benefits that would otherwise be conferred upon the parties. The parties
will endeavor in good faith negotiations to replace the prohibited, invalid or unenforceable provision(s) with a valid provision(s),
the effect of which comes as close as possible to that of the prohibited, invalid or unenforceable provision(s).&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="letter-spacing: -0.1pt">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Next
Business Day</U>. Whenever any payment or other obligation hereunder shall be due on a day other than a Business Day, such payment shall
be made on the next succeeding Business Day.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="letter-spacing: -0.1pt">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Construction</U>.
The headings herein are for convenience only, do not constitute a part of this Certificate of Designation and shall not be deemed to limit
or affect any of the provisions hereof. The language used in this Agreement will be deemed to be the language chosen by the parties to
express their mutual intent, and no rules of strict construction will be applied against any party. This Certificate of Designation shall
be construed as if drafted jointly by the parties, and no presumption or burden of proof shall arise favoring or disfavoring any party
by virtue of the authorship of any provisions of this Certificate of Designation or any of the Transaction Documents.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="letter-spacing: -0.1pt">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Status
of Converted Preferred Stock</U>. Shares of Preferred Stock may only be issued pursuant to the Purchase Agreement. If any shares of Preferred
Stock shall be converted or reacquired by the Corporation, such shares shall resume the status of authorized but unissued shares of preferred
stock and shall no longer be designated as Series A Convertible Preferred Stock.</P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 3.95pt 0 12pt; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>, the undersigned
has duly executed this Certificate of Designation on behalf of the Corporation this 8<SUP>th</SUP> day of August 2025.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="padding-right: 0.7pt; padding-left: 5.4pt"><B>HERON THERAPEUTICS, <FONT STYLE="letter-spacing: -0.2pt">INC.</FONT></B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="padding-right: 0.7pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="padding-right: 0.7pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.7pt; padding-left: 5.4pt"><FONT STYLE="letter-spacing: -0.2pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; padding-right: 0.7pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 0.7pt; padding-left: 5.75pt">Name:</TD>
    <TD STYLE="padding-right: 0.7pt; padding-left: 5.4pt">Ira Duarte</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 0.7pt; padding-left: 5.75pt">Title:</TD>
    <TD STYLE="padding-right: 0.7pt; padding-left: 5.4pt">Executive Vice President, Chief Financial Officer</TD></TR>
  <TR>
    <TD STYLE="width: 48%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 43%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">&nbsp;&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><I>[Signature Page to Certificate of Designation
of Series A Convertible Preferred <FONT STYLE="letter-spacing: -0.1pt">Stock]</FONT></I></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>4
<FILENAME>p25-1788exhibit99_3.htm
<DESCRIPTION>NOTE PURCHASE AGREEMENT
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 3.95pt 0 12pt; text-align: right; text-indent: 0.5in"><B><I>Execution <FONT STYLE="letter-spacing: -0.1pt">Version</FONT></I></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><B>NOTE PURCHASE <FONT STYLE="letter-spacing: -0.1pt">AGREEMENT</FONT></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">This Note Purchase Agreement
(this &#8220;<U>Agreement</U>&#8221;) is entered into as of August 8, 2025 (the &#8220;<U>Execution Date</U>&#8221;) by and among Heron
Therapeutics, Inc., a Delaware corporation (the &#8220;<U>Company</U>&#8221;), the purchasers from time to time party hereto (each, a
&#8220;<U>Purchaser</U>&#8221;, and collectively, the &#8220;<U>Purchasers</U>&#8221;), and Rubric Capital Management LP, as agent for
the Purchasers (in such capacity, the &#8220;<U>Designated Agent</U>&#8221;).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><FONT STYLE="letter-spacing: -0.1pt"><B>RECITALS</B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">WHEREAS, the Purchasers
are willing, pursuant to the terms and conditions of this Agreement, to purchase from the Company convertible senior unsecured promissory
notes, in substantially the form attached hereto as Exhibit A (each as amended, restated, amended and restated, supplemented or otherwise
modified from time to time, the &#8220;Notes&#8221;) in an aggregate principal amount of up to $35,000,000, for an aggregate purchase
price of $33,250,000 (the &#8220;Purchase Price&#8221;), which Note purchases are, and are deemed to be, part of a single loan issued
pursuant to this Agreement;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">WHEREAS, the Notes will
be subordinated to all existing and future secured debt of the Company and its Subsidiaries and pari passu to all existing and future
unsecured debt of the Company and its Subsidiaries and any cash payment in connection with the Notes will be subject to the terms <FONT STYLE="font-size: 11pt">of
the Company&#8217;s second amendment to the working capital facility agreement, dated as of August 8, 2025, by and among the Company and
Hercules Capital, Inc. as administrative agent and collateral agent and the lenders party thereto;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">WHEREAS, the Notes are
subject to conversion into shares of Common Stock of the Company on the terms and subject to the conditions set forth herein; and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, for good
and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><B>AGREEMENT</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000"><B>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><B><FONT STYLE="letter-spacing: -0.1pt">DEFINITIONS.</FONT></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">1.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Certain
Defined Terms. As used in this Agreement, the following terms shall have the following respective meanings:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>1%
Exception</U>&#8221; has the meaning specified in Section 4.4(h) hereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Affiliate</U>&#8221;
of any Person means (a) any other Person which, directly or indirectly, controls or is controlled by or is under common control with such
Person and (b) any officer or director of such Person. A Person shall be deemed to be &#8220;controlled by&#8221; any other Person if
such Person possesses, directly or indirectly, power to vote 20% or more of the securities (on a fully diluted basis) having ordinary
voting power for the election of directors or managers or power to direct or cause the direction of the management and policies of such
Person whether by contract or otherwise. Unless expressly stated otherwise herein, no Purchaser shall be deemed an Affiliate of the Company.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Authorized
Denomination</U>&#8221; means, with respect to a Note, a principal amount thereof equal to $1,000 or any integral multiple of $1,000 in
excess thereof.</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Board
of Directors</U>&#8221; means either the board of directors of the Company or any duly authorized committee of that board.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Business
Day</U>&#8221; means any day other than Saturday, Sunday or other day on which commercial banks in the City of New York are authorized
or required by law to remain closed.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Capital
Stock</U>&#8221; means, for any Person, any and all shares, interests, rights to purchase, warrants, options, participations or other
equivalents of or interests in (however designated) the equity of such Person, but excluding any debt securities convertible into such
equity.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Close
of Business</U>&#8221; means 5:00 p.m., New York City time.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Commission</U>&#8221;
or the &#8220;<U>SEC</U>&#8221; means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Common
Equity</U>&#8221; of any Person means the Capital Stock of such Person that is generally entitled (a) to vote in the election of directors
of such Person or (b) if such Person is not a corporation, to vote or otherwise participate in the selection of the governing body, partners,
managers or others that will control the management or policies of such Person.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Common
Stock</U>&#8221; means the Common Stock of the Company, par value $0.01 per share. &#8220;Common Stock Change Event&#8221; has the meaning
specified in Section 4.7(a) hereof. &#8220;Conversion Consideration&#8221; has the meaning specified in Section 4.3(b)(i) hereof. &#8220;Conversion
Date&#8221; has the meaning specified in Section 4.2(a) hereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Conversion
Notice</U>&#8221; has the meaning specified in Section 4.2(a) hereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Conversion
Price</U>&#8221; means, in respect of each Note, as of any date, $1,000 divided by the Conversion Rate in effect on such date.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Conversion
Rate</U>&#8221; means initially 555.5556 shares of Common Stock per $1,000 principal amount of Notes, subject to adjustment as set forth
herein.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Cooperation
Agreement</U>&#8221; means that certain cooperation agreement entered into between the parties hereto of even date herewith.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Daily
VWAP</U>&#8221; means, for any VWAP Trading Day, the per share volume-weighted average price of the Common Stock as displayed under the
heading &#8220;Bloomberg VWAP&#8221; on Bloomberg page &#8220;HRTX &lt;EQUITY&gt; AQR&#8221; (or its equivalent successor if such page
is not available) in respect of the period from the scheduled open of trading until the scheduled close of trading of the primary trading
session on such VWAP Trading Day (or if such volume-weighted average price is unavailable, the market value of one Common Stock on such
VWAP Trading Day, reasonably determined, using a volume-weighted average method, by a nationally recognized independent investment banking
firm retained for this purpose by the Company. The Daily VWAP will be determined without regard to after-hours trading or any other trading
outside of the regular trading session trading hours.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Disclosure
Document</U>&#8221; has the meaning specified in Section 9.6(c) hereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Distributed
Property</U>&#8221; has the meaning specified in Section 4.4(c) hereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000"></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&nbsp;&#8220;<U>Effective
Date</U>&#8221; means, with respect to a Fundamental Change or a Make-Whole Fundamental Change, as applicable, the date such Fundamental
Change or Make-Whole Fundamental Change, as applicable, occurs or becomes effective.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Eligible
Market</U>&#8221; means The New York Stock Exchange, the Nasdaq Capital Market, the Nasdaq Global Select Market or the Nasdaq Global Market</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Exchange
Cap</U>&#8221; has the meaning specified in Section 4.11 hereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Exchange
Cap Allocation</U>&#8221; has the meaning specified in Section 4.11 hereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Ex-Dividend
Date</U>&#8221; means the first date on which the Common Stock trades on the applicable exchange or in the applicable market, regular
way, without the right to receive the issuance, dividend or distribution in question.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Exchange
Act</U>&#8221; means the U.S. Securities Exchange Act of 1934, as amended, and the rules and regulations of the Commission promulgated
thereunder.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Form
of Assignment and Transfer</U>&#8221; means the &#8220;Form of Assignment and Transfer&#8221; attached as <U>Attachment 3</U> to the
Form of Note attached hereto as <U>Exhibit A</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Form
of Fundamental Change Purchase Notice</U>&#8221; means the &#8220;Form of Fundamental Change Purchase Notice&#8221; attached as <U>Attachment
2</U> to the Form of Note attached hereto as <U>Exhibit A</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Form
of Notice of Conversion</U>&#8221; means the &#8220;Form of Notice of Conversion&#8221; attached as <U>Attachment 1</U> to the Form of
Note attached hereto as <U>Exhibit A</U>. A &#8220;<U>Fundamental Change</U>&#8221; shall be deemed to have occurred at the time after
the Notes are originally issued when any of the following occurs:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a
&#8220;person&#8221; or &#8220;group&#8221; within the meaning of Section 13(d) of the Exchange Act, other than the Company, its Subsidiaries
or the employee benefit plans of the Company or its Subsidiaries, files a Schedule TO or any schedule, form or other report under the
Exchange Act disclosing that such person or group has become the direct or indirect &#8220;beneficial owner,&#8221; as defined in Rule
13d-3 under the Exchange Act, of the Company&#8217;s Common Equity representing more than 50.0% of the voting power of the Company&#8217;s
Common Equity (or the Company becomes aware that such a filing is required but has not been made);</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">(2)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;consummation
of (A) any recapitalization, reclassification or change of the Common Stock (other than changes resulting from a subdivision or combination)
pursuant to which the Common Stock would be converted into, or exchanged for, or represent solely the right to receive, shares, stock,
other securities, other property or assets (including cash or any combination thereof), (B) any share exchange, consolidation, merger
or similar event involving the Company pursuant to which the Common Stock will be converted into, or exchanged for, or represent solely
the right to receive, shares, stock, other securities, other property or assets (including cash or any combination thereof) or (C) any
sale, lease or other transfer in one transaction or a series of transactions of all or substantially all of the consolidated assets of
the Company and its Subsidiaries, taken as a whole, to any Person other than one or more of the Company&#8217;s wholly-owned Subsidiaries
(any such share exchange, consolidation, merger, similar event, transaction or series of transactions being referred to in this clause
(2) as an &#8220;<U>Event</U>&#8221;); provided, however, that any such Event described in clause (A) or (B) above where the Persons
that &#8220;beneficially owned,&#8221; directly or indirectly, the Company&#8217;s voting shares immediately prior to such event &#8220;beneficially
own&#8221;, directly or indirectly, more than 50.0% of the total voting power of all outstanding classes of voting shares or stock of
the continuing or surviving Person or transferee or the parent thereof immediately after such Event and such holders&#8217; proportional
voting power immediately after such transaction vis-&agrave;-vis each other with respect to the securities such holders receive in such
transaction will be in substantially the same proportions as their respective voting power vis-&agrave;-vis each other immediately prior
to such transaction will not constitute a &#8220;Fundamental Change&#8221;;</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">(3)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
holders of the Common Stock approve any plan or proposal for the Company&#8217;s liquidation or dissolution; or</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">(4)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Common Stock ceases to be listed or admitted for trading on an Eligible Market(or any successor to the foregoing) (each such exchange
or market, a &#8220;Permitted Exchange&#8221;), or the announcement by any such Permitted Exchange on which the Common Stock (or such
other Common Equity) are then listed or admitted for trading that the Common Stock (or such other Common Equity) will no longer be so
listed or admitted for trading, unless the Common Stock (or such other Common Equity) has been accepted for listing or admitted for trading
on another Permitted Exchange.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">If any transaction in which the Common Stock is replaced by the securities of another entity occurs, following
completion of any related Make-Whole Fundamental Change Period and any related Fundamental Change Purchase Date, references to the Company
in this definition of &#8220;Fundamental Change&#8221; will apply to such other entity instead.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Fundamental
Change Company Notice</U>&#8221; has the meaning specified in Section 10.1(b) hereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Fundamental
Change Expiration Time</U>&#8221; has the meaning specified in Section 10.1(d) hereof</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Fundamental
Change Purchase Date</U>&#8221; has the meaning specified in Section 9.1(a) hereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Fundamental
Change Purchase Notice</U>&#8221; has the meaning specified in Section 9.1(d) hereof</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Fundamental
Change Purchase Price</U>&#8221; has the meaning specified in Section 9.1(a) hereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>GAAP</U>&#8221;
means generally accepted accounting principles as in effect in the United States of America.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in; color: #010000">&#8220;<U>Governmental
Entity</U>&#8221; means any national, federal, state, municipal, local, territorial, foreign or other government or any department, commission,
board, bureau, agency, regulatory authority, self-regulatory organization or instrumentality thereof, or any court, judicial, administrative
or arbitral body or public or private tribunal.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Holder</U>&#8221;
means a holder of Notes from time to time.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in; color: #010000">&#8220;<U>Indebtedness</U>&#8221;
of any Person means without duplication, (a) all indebtedness of such Person for borrowed money, (b) all indebtedness evidenced by bonds,
debentures, notes or similar instruments, (c) all obligations of such Person as lessee under capital leases which have been or should
be recorded as liabilities on a balance sheet of such Person in accordance with GAAP, (d) all obligations of such Person to pay the deferred
purchase price of property or services (excluding trade accounts payable in the ordinary course of business), (e) all indebtedness secured
by a Lien on the property of such Person, whether or not such indebtedness shall have been assumed by such Person (with the amount thereof
being measured as the fair market value of such property), (f) all obligations, contingent or otherwise, with respect to letters of credit
(whether or not drawn), banker&#8217;s acceptances and surety bonds issued for the account of such Person, (g) all obligations for which
such Person is obligated pursuant to any interest rate swap, interest rate cap, interest rate collar or other interest rate hedging agreement
or derivative agreements or arrangements, and (h) all guarantees or other contingent obligations of such Person in respect of any of the
foregoing.</P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in; color: #010000">&#8220;<U>Interest
Payment Date</U>&#8221; means, with respect to the payment of interest on the Notes, each March 1 and September 1, commencing March 1,
2026.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>IRC</U>&#8221;
has the meaning specified in Section 6.5 hereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&#8220;<U>Last Reported
Sale Price</U>&#8221; of the Common Stock for any Trading Day means the closing sale price per share (or, if no closing sale price is
reported, the average of the last bid and last ask prices per share or, if more than one in either case, the average of the average last
bid and the average last ask prices per share) on that Trading Day as reported in composite transactions for the principal U.S. national
or regional securities exchange on which the Common Stock is traded. The Last Reported Sale Price will be determined without regard to
after-hours trading or any other trading outside of the regular trading session trading hours. If the Common Stock is not listed for trading
on a U.S. national or regional securities exchange on the relevant Trading Day, the &#8220;Last Reported Sale Price&#8221; will be the
last quoted bid price per share for the Common Stock in the over- the-counter market on the relevant date as reported by OTC Markets Group
Inc. or a similar organization. If the Common Stock is not so quoted, the &#8220;Last Reported Sale Price&#8221; will be the average of
the mid-point of the last bid and last ask prices per share for the Common Stock on the relevant Trading Day from each of at least three
nationally recognized independent investment banking firms selected by the Company for this purpose. Any such determination will be conclusive
absent manifest error.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Lien</U>&#8221;
means any mortgage, deed of trust, or pledge, security interest, hypothecation, assignment, assigned deposit, arrangement, encumbrance,
encroachment, lien (statutory or otherwise), claim, option, reservation or defect of any kind, or preference, or priority, or other security
agreement or preferential arrangement of any kind of or nature whatsoever (including, without limitation, any conditional sale or other
title retention agreement, any financing statement under the UCC, or under the comparable law of any other jurisdiction).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Liquidity
Conditions</U>&#8221; will be satisfied with respect to a Redemption if:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;either
(x) each Conversion Share would be eligible to be offered, sold or otherwise transferred by the Holder of such share pursuant to Rule
144 under the Securities Act (or any successor rule thereto), without any requirements as to volume, manner of sale, availability of current
public information (whether or not then satisfied) or notice; or (y) the offer and sale of such Conversion Share by such Holder are registered
pursuant to an effective registration statement under the Securities Act and such registration statement is reasonably expected by the
Company to remain effective and usable by the Holder to sell such Conversion Share continuously during the period from, and including,
the applicable Redemption Notice Date to, and including, the thirtieth (30th) calendar day after the date such Conversion Share is issued;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">(2)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;each
Conversion Share referred to in clause (1) above (x) will, when sold or otherwise transferred pursuant to, in the case of clause (1)(x)
above, Rule 144, or, in the case of clause (1)(y) above, the registration statement referred to in such clause be admitted for book-entry
settlement through the Depositary with an &#8220;unrestricted&#8221; CUSIP number, (y) will not be represented by a certificate that bears
a legend referring to transfer restrictions under the Securities Act or other securities laws unless required by law; and (z) will, when
issued, be listed and admitted for trading, without suspension or material limitation on trading, on an Eligible Market;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">(3)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;each
Conversion Share referred to in clause (1) above may be issued in full without violating Section 4.10 hereof and without violating the
rules or regulations of the applicable Eligible Market on which the Common Stock is then listed for trading;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">(4)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(x)
the Company has not received any written threat or notice of delisting or suspension by the applicable exchange referred to in clause
(2)(z) above with a reasonable prospect of delisting, after giving effect to all applicable notice and appeal periods; and (y) no such
delisting or suspension is reasonably likely to occur or is pending based on the Company falling below the minimum listing maintenance
requirements of such exchange;</P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; color: #010000"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">(5)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Company has not delivered a notice pursuant to Section 9.1(b) with respect to an anticipated Fundamental Change (unless such notice has
been subsequently withdrawn pursuant to Section 9.1(g)); and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">(6)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Company shall not have provided such Holder any information that, at any time during the period from the applicable Redemption Notice
Date through and including the related Redemption Date, constitutes material non-public information under the U.S. federal securities
laws regarding the Company.</P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0pt 12pt; text-indent: 40pt; text-align: justify; color: #010000">&#8220;<U>Make-Whole Fundamental
Change</U>&#8221; means any event that is a Fundamental Change (subject to any exceptions or exclusions to the definition other than
the exclusion in the proviso to clause (2) of the definition of &#8220;Fundamental Change&#8221;).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Make-Whole
Fundamental Change Effective Date</U>&#8221; means with respect to a Make-Whole Fundamental Change, the date on which such Make-Whole
Fundamental Change occurs or becomes effective.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Market
Disruption Event</U>&#8221; means, if the Common Stock is listed for trading on the Nasdaq Capital Market or listed on another U.S. national
or regional securities exchange, the occurrence or existence during the one half-hour period ending on the scheduled close of trading
on any Scheduled Trading Day of any material suspension or limitation imposed on trading (by reason of movements in price exceeding limits
permitted by the stock exchange or otherwise) in the Common Stock or in any options, contracts or futures contracts relating to the Common
Stock.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in; color: #010000">&#8220;<U>Material
Adverse Effect</U>&#8221; means any material adverse effect on the condition (financial or otherwise), properties, assets, liabilities,
business, prospects or operations of the Company or any of its Subsidiaries taken as a whole.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Material
Contract</U>&#8221; means all written and oral contracts, agreements, deeds, mortgages, leases, subleases, licenses, instruments, notes,
commitments, commissions, undertakings, arrangements and understandings: (i) the breach of which by the Company or any Subsidiary or the
termination of which would reasonably be expected to have a Material Adverse Effect, or (ii) that have been required to be filed as exhibits
by the Company with the Commission pursuant to Items 601(b)(1), 601(b)(2), 601(b)(4), 601(b)(9) or 601(b)(10) of Regulation S-K promulgated
by the Commission.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Net
Operating Losses</U>&#8221; has the meaning specified in Section 9.6(b) hereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Note
Documents</U>&#8221; have the meaning specified in Section 11.3 hereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Open
of Business</U>&#8221; means 9:00 a.m., New York City time.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&nbsp;&#8220;<U>Outstanding</U>&#8221;
means, with respect to the Notes any Notes executed and delivered by the Company except (i) Notes replaced pursuant to Section 11.13
hereof, on and after the time such Note is replaced (unless the Company receives proof satisfactory to them that such Note is held by
a bona fide purchaser), (ii) Notes converted pursuant to Section 4 hereof, on and after their Conversion Date, (iii) any and all Notes,
as of the Maturity Date, if the Company has deposited with the Purchasers thereof money sufficient to pay all of the Notes of such Purchaser
then payable, and (iv) any and all Notes owned by the Company or any other obligor upon the Notes, or for purposes of votes or consents,
any Affiliate of the Company or of such other obligor.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Person</U>&#8221;
means any natural person, corporation, limited liability company, trust, joint venture, association, company, partnership, governmental
authority or other entity.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Purchase
Price</U>&#8221; has the meaning specified in the Recitals.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Purchaser</U>&#8221;
has the meaning specified in the preamble hereof and shall include, where applicable, Holders.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Redemption</U>&#8221;
means the repurchase of any Note by the Company pursuant to Section 9.5.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Redemption
Date</U>&#8221; means the date fixed for the repurchase of any Notes by the Company pursuant to a Redemption.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Redemption
Notice</U>&#8221; has the meaning specified in Section 9.5(e) hereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Redemption
Notice Date</U>&#8221; means, with respect to a Redemption, the date on which the Company sends the Redemption Notice for such Redemption
pursuant to Section 9.5(e).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Redemption
Period</U>&#8221; means the period from, and including, the relevant Redemption Notice Date until the close of business on the Scheduled
Trading Day immediately preceding the related Redemption Date or, if the Company defaults in the payment of the Redemption Price, until
the Redemption Price has been paid or duly provided for.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Redemption
Price</U>&#8221; means the cash price payable by the Company to redeem any Note upon its Redemption, calculated pursuant to Section 9.5(d).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Redemption
Price Condition</U>&#8221; has the meaning specified in Section 9.5(b) hereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Reference
Property</U>&#8221; has the meaning specified in Section 4.7(a) hereof. &#8220;Reference Property Unit&#8221; has the meaning specified
in Section 4.7(a) hereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Reporting
Period</U>&#8221; means the period commencing on the Closing Date and ending on the earliest of: (i) the date as of which the Purchasers
may sell all of the Conversion Shares under Rule 144 without volume or manner-of-sale restrictions and without the requirement for the
Company to be in compliance with the current public information requirements under Rule 144(c)(1) (or any successor thereto) promulgated
under the Securities Act; (ii) the first anniversary of the conversion of all of the Notes, or (iii) the date on which such Purchaser
shall have sold all of the Conversion Shares.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Requisite
Purchasers</U>&#8221; means Purchasers holding at least a majority of the aggregate principal amount of the Notes then Outstanding.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Required
Purchasers</U>&#8221; means Purchasers holding at least 25% of the aggregate principal amount of the Notes then Outstanding.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Scheduled
Trading Day</U>&#8221; means (i) for all purposes other than for purposes of determining amounts due upon conversion, a day that is scheduled
to be a Trading Day on the principal U.S. national or regional securities exchange or market on which the Common Stock is listed or admitted
for trading; and (ii) for purposes of determining amounts due upon conversion, a day that is scheduled to be a VWAP Trading Day on the
principal U.S. national or regional securities exchange or market on which the Common Stock is listed or admitted for trading. If in
each of clauses (i) and (ii) above the Common Stock is not so listed or admitted for trading, then, for these purposes, &#8220;Scheduled
Trading Day&#8221; means a Business Day.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Securities
Act</U>&#8221; means the U.S. Securities Act of 1933, as amended, and the rules and regulations of the Commission promulgated thereunder.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Significant
Subsidiary</U>&#8221; means, with respect to any Person, a Subsidiary of such Person that would constitute a &#8220;significant subsidiary&#8221;
as such term is defined in Article 1, Rule 1-02(w) of Regulation S-X, promulgated pursuant to the Securities Act, as in effect on the
original date of issuance of the Notes.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Spin-Off</U>&#8221;
has the meaning specified in Section 4.4(c) hereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Spin-Off
Valuation Period</U>&#8221; has the meaning specified in Section 4.4(c) hereof. &#8220;Standard Settlement Period&#8221; means the standard
settlement period, expressed in a number of Trading Days, on the principal securities exchange or securities market on which the Common
Stock is then traded as in effect on the date of delivery of the applicable Notice of Conversion.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Stockholder
Approval</U>&#8221; has the meaning specified in Section 9.6(a) hereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Stockholder
Meeting</U>&#8221; has the meaning specified in Section 9.6(a) hereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Stockholder
Meeting Deadline</U>&#8221; has the meaning specified in Section 9.6(a) hereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Stock
Price</U>&#8221; has the meaning specified in Section 4.4(c) hereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Subsidiary</U>&#8221;
of a Person means a corporation, partnership, joint venture, limited liability company or other business entity of which a majority of
the shares of securities or other interests having ordinary voting power for the election of directors or other governing body are at
the time beneficially owned, or the management of which is otherwise controlled (as determined in accordance with GAAP), or both, by such
Person.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Successor
Company</U>&#8221; has the meaning specified in Section 10 hereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">&#8220;<U>Trading
Day</U>&#8221; means a Scheduled Trading Day on which (i) trading in the Common Stock generally occurs on the Nasdaq Capital Market or,
if the shares of Common Stock are not then listed on the Nasdaq Capital Market, on the principal other U.S. national or regional securities
exchange on which the shares of Common Stock are then listed or, if the shares of Common Stock are not then listed on a U.S. national
or regional securities exchange, on the principal other market on which the shares of Common Stock are then traded and (ii) there is no
Market Disruption Event. If the shares of Common Stock are not so listed or traded, then, for these purposes, &#8220;Trading Day&#8221;
means a Business Day.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&#8220;<FONT STYLE="color: #010000"><U>VWAP</U></FONT><U>
Market Disruption Event</U>&#8221; means (i) a failure by the primary U.S. national or regional securities exchange or market on which
the Common Stock is listed or admitted for trading to open for trading during its regular trading session or (ii) the occurrence or existence
prior to 1:00 p.m., New York City time, on any Scheduled Trading Day for the Common Stock for more than a one half-hour period in the
aggregate during regular trading hours of any suspension or limitation imposed on trading (by reason of movements in price exceeding limits
permitted by the relevant stock exchange or otherwise) in the Common Stock or in any options, contracts or future contracts relating to
the Common Stock.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&nbsp;&#8220;<U>VWAP
Trading Day</U>&#8221; means a day on which (i) there is no VWAP Market Disruption Event, and (ii) trading in the shares of Common
Stock generally occurs on the Nasdaq Capital Market or, if the shares of Common Stock are not then listed on the Nasdaq Capital
Market, on the principal other U.S. national or regional securities exchange on which the Common Stock is then listed or, if the
Common Stock is not then listed on a U.S. national or regional securities exchange, on the principal other market on which the
Common Stock is then listed or admitted for trading. <FONT STYLE="letter-spacing: -0.1pt">If the Common Stock not so listed or
admitted for trading, &#8220;VWAP Trading Day&#8221; means a Business </FONT><FONT STYLE="letter-spacing: -0.2pt">Day.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000"><B>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><B>NOTE
<FONT STYLE="letter-spacing: -0.1pt">PURCHASE.</FONT></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">2.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Upon
the terms and subject to the conditions herein contained, the Company agrees to sell to each Purchaser, and each Purchaser agrees to purchase
from the Company, Notes in consideration for the amounts set forth on each Purchaser&#8217;s signature page attached hereto.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">2.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>At
or prior to the Closing Date, each Purchaser will pay the Purchase Price set forth on such Purchaser&#8217;s signature pages attached
hereto by wire transfer of immediately available funds in accordance with wire instructions provided by the Company to the Purchasers
at least two Business Days prior to the Closing Date. On the Closing Date, the Company will issue and deliver the Notes against delivery
of the Purchase Price. The foregoing notwithstanding, if the Purchaser has <FONT STYLE="color: #010000">indicated to the Company at the
time of execution of this Agreement a need to settle on a &#8220;delivery versus payment&#8221; basis, then the Company shall either deliver
to such Purchaser (or such Purchaser&#8217;s designated custodian) the original Notes, whereupon following receipt of such instruments,
then the Purchaser shall then promptly wire the Purchase Price as provided in this Section 2.2.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">2.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Closing</U>.
Subject to the satisfaction of the closing conditions set forth in Section 8, the closing with respect to the transactions contemplated
in Section 2 hereof with respect to the Purchase Price (the &#8220;<U>Closing</U></FONT>&#8221;), shall take place remotely via the exchange
of documents and signatures on the second Trading Day after the Execution Date (the &#8220;<U>Closing Date</U>&#8221;), or at such other
time as the Company and Purchasers may agree in writing.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000"><B>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><B>TERM;
REPAYMENT; <FONT STYLE="letter-spacing: -0.1pt">INTEREST.</FONT></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">3.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Term</U>.
The then-outstanding principal of the Notes, all accrued and unpaid interest thereon and <FONT STYLE="color: #010000">any and all other
sums payable to the Purchasers hereunder shall be due and payable in full in cash by wire transfer of immediately available funds on
the fifth anniversary of the Closing Date (the &#8220;<U>Maturity Date</U>&#8221;).</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">3.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Interest</U>.
The Notes will bear cash interest at a rate of 5.0% per year until maturity, provided that the Company has the right, at its election,
upon at least five (5) Business Day written notice to the Purchasers, to pay all accrued and unpaid interest prior to September 1, 2026
in new Notes at a rate of 7.0% per year. Interest on the Notes will accrue from, and including, the most recent date on which interest
has been paid or duly provided for or, if no interest has been paid or duly provided for, from</FONT>, and including, the Closing Date.
Interest will be paid semiannually in arrears on each Interest Payment Date. Interest on the Notes shall be computed on the basis of a
360-day year consisting of twelve 30-day months.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000"><B>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><B><FONT STYLE="letter-spacing: -0.1pt">CONVERSION</FONT></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">4.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Right
to Convert</U>. Subject to and upon compliance with the provisions herein, after the later of (i) the receipt of Stockholder
Approval or (ii) December 31, 2025, each Purchaser shall have the right, at such Purchaser&#8217;s option, to convert all of its
Notes or any portion thereof having a principal amount equal to an integral multiple of $1,000, in accordance with this Section 4,
at any time prior to the Close of Business on the second Scheduled Trading Day immediately preceding the Maturity Date.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">4.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Conversion
<FONT STYLE="letter-spacing: -0.1pt">Procedures</FONT></U><FONT STYLE="letter-spacing: -0.1pt">.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Generally.
</I>To exercise the conversion privilege with respect to any Notes, the Purchaser of such Notes shall:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.05pt">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>complete
and manually or electronically sign a conversion notice in the form set forth in the Form of Notice of Conversion (the &#8220;<U>Conversion
Notice</U>&#8221;);</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.05pt">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>deliver
the Conversion Notice, which is irrevocable, and the Note <FONT STYLE="letter-spacing: -0.25pt">to</FONT> the Company; </P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.05pt">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>if
<FONT STYLE="letter-spacing: -0.1pt">required, furnish appropriate endorsements</FONT> <FONT STYLE="letter-spacing: -0.25pt">and</FONT>
<FONT STYLE="letter-spacing: -0.1pt">transfer documents; and </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.1pt"></FONT><FONT STYLE="color: #010000; letter-spacing: -0.05pt">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="letter-spacing: -0.1pt">if
required, pay all transfer or similar taxes as set forth in Section 4.2(d)</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Notwithstanding anything
herein or in the Notes to the contrary, (i) if the Company calls any Note for Redemption pursuant to Section 9.5, then (x) the Purchaser
of such Note may not convert such Note after the Close of Business on the Business Day immediately before the applicable Redemption Date,
except to the extent the Company fails to pay the Redemption Price for such Note in accordance with this Agreement and (y) so long as
the Purchase delivers the Conversion Notice prior to the Close of Business on the Business Day immediately before the applicable Redemption
Date, shall be deemed to have properly exercised such conversion right as of such date, provided the Company shall not be obligated to
actually issue Common Stock until such Purchaser complies with the remainder of this Section 4.2 and (ii) if a Note has been submitted
for repurchase pursuant to a Fundamental Change Purchase Notice such Note may not be converted except to the extent such Fundamental Change
Purchase Notice is withdrawn in accordance with Section 10.5 hereof prior to the relevant Fundamental Change Expiration Time. A Purchaser
of the Notes shall deliver to the Company the original Note so converted pursuant to this Section 4 as promptly as practicable after delivery
of the Conversion Notice with respect to such Note.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">For any Note, the date on
which the Purchaser of such Note satisfies all of the applicable requirements set forth above with respect to such Note (except for any
requirement to deliver to the Company such original of such converted Note) shall be the &#8220;Conversion Date&#8221; with respect to
such Note, and upon such Conversion Date, conversion shall be deemed to have been effected as to any such Note.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">For the avoidance of doubt,
until a Purchaser is deemed to become the holder of record of Common Stock, if any, issuable upon conversion of such Purchaser&#8217;s
Notes as contemplated in the immediately preceding sentence, such Purchaser shall not have any rights as a holder of Common Stock with
respect to such Common Stock issuable upon conversion of such Notes. At the Close of Business on the Conversion Date for a Note, the converting
Purchaser shall no longer be the holder of such Note.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: rgb(1,0,0)">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Endorsement</I>.
Any Notes surrendered for conversion shall, unless Common Stock issuable on conversion are to be issued in the same name as the registration
of such Notes, be duly endorsed by, or be accompanied by instruments of transfer in form satisfactory to the Company duly executed by,
the Purchaser or its duly authorized attorney.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(c</FONT>)&#9;<I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Partially
Converted Notes. </I>If any Notes in a denomination greater than$1,000 shall be surrendered for partial conversion, the Company shall
execute and deliver to the Purchaser of the Notes so surrendered, without charge, new Notes in Authorized Denominations in an aggregate
principal amount equal to the unconverted portion of the surrendered Notes.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(d)<I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Taxes
Due upon Conversion. </I>If a Purchaser converts a Note, the Company will pay any documentary, stamp or similar issue or transfer tax
due on the issue of any Common Stock upon the conversion, unless the tax is due because the Purchaser requests that any shares be issued
in a name other than the Purchaser&#8217;s name, in which case the Purchaser will pay that <FONT STYLE="letter-spacing: -0.2pt">tax.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">4.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Settlement
Upon <FONT STYLE="letter-spacing: -0.1pt">Conversion</FONT></U><FONT STYLE="letter-spacing: -0.1pt">.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12.05pt 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Settlement</I>.
Upon the conversion of any Note, the Company shall, at the Company&#8217;s election as indicated in the applicable Notice of Conversion,
settle such conversion, on or before the earlier of (i) the first (1<SUP>st</SUP>) Trading Day and (ii) the number of Trading Days comprising
the Standard Settlement Period, in each case, following the date on which such Purchaser has delivered the applicable Notice of Conversion
to the Company, by delivering, as provided in this Section 4, cash, shares of Common Stock, or a combination of cash and shares of Common
Stock, together, if applicable, with cash in lieu of fractional shares as provided in Section 4.3(b).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Conversion
<FONT STYLE="letter-spacing: -0.1pt">Consideration.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.05pt">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Generally</I>.
The type and amount of consideration (the &#8220;<U>Conversion Consideration</U>&#8221;) due in respect of each $1,000 principal amount
of a Note to be converted will be paid by the Company, at it&#8217;s option, in cash, a number of shares of Common Stock equal to the
Conversion Rate in effect on the Conversion Date for such conversion, or a combination of cash and shares of Common Stock based on the
Conversion Rate in effect on the Conversion Date for such conversion. If all or any portion of such conversion is to be settled in shares
of Common Stock, the number of shares of Common Stock that the Company will be required to deliver with respect to such conversion shall
be a number of shares of Common Stock equal to the applicable percentage of the Conversion Rate in effect on the Conversion Date. If all
or any portion of such conversion is to be settled in cash, the amount of cash that the Company will be required to deliver with respect
to such conversion in shall be the product of (a) the to the applicable percentage of the Conversion Rate on the applicable Conversion
Date and (b) the arithmetic average of the Daily VWAPs of the Common Stock during the ten (10) consecutive VWAP Trading Day period ending
on the VWAP Trading Day immediately preceding the applicable Conversion Date.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.05pt">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Cash
in Lieu of Fractional Shares</I>. If upon conversion of a Note, the number of shares of Common Stock deliverable pursuant to Section 4.3(b)(i)
upon such conversion is not a whole number, then such number will be rounded down to the nearest whole number and the Company will deliver,
in addition to the other consideration due upon such conversion, cash in lieu of the related fractional share in an amount equal to the
product of (1) such fraction and (2) the Daily VWAP on the Conversion Date for such conversion (or, if such Conversion Date is not a VWAP
Trading Day, the immediately preceding VWAP Trading Day).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Conversion
of Multiple Notes by a Single Purchaser</I>. If a Purchaser converts more than one (1) Note on a single <FONT STYLE="color: #010000; letter-spacing: -0.05pt">Conversion
Date, then the Conversion Consideration due in respect of such conversion</FONT> will be computed based on the total principal amount
of Notes converted on such Conversion Date by such Purchaser.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-indent: 1in; margin-top: 0; margin-right: 0; margin-bottom: 12pt; text-align: justify">&nbsp;<FONT STYLE="color: #010000; letter-spacing: -0.1pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Delivery
of the Conversion Consideration</I>. Except as set forth in Section 4.4, Section 4.6 or Section 4.7, the Company will pay or deliver,
as applicable, to the Purchaser the Conversion <FONT STYLE="color: #010000; letter-spacing: -0.1pt">Consideration due upon the conversion
of any of its Notes on or before the second (2nd) Business Day immediately after the Conversion Date for such conversion.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-right: 0; margin-bottom: 12pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>&nbsp;Accrued
but unpaid Interest</I>. Accrued but unpaid interest to but not including the Conversion Date of a Note shall be due and payable by the
Company to the Purchaser thereof concurrently with the delivery of any shares of Common Stock upon the conversion of such Note</FONT>,
and the Company will not adjust the Conversion Rate to account for any such accrued and unpaid interest on such Note.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">4.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Adjustment
of Conversion Rate</U>. The Conversion Rate will be adjusted as described in this Section 4.4, except that the Company shall not make
any adjustment to the Conversion Rate if each Purchaser participates (other than in the case of (x) a share split or share combination
or (y) a tender or exchange offer), at the same time and upon the same terms as holders of the Common Stock and as a result of holding
the Notes, in any of the transactions described below without having to convert its Notes, as if it held a number of shares of Common
Stock equal to the applicable Conversion Rate, multiplied by the principal amount (expressed in thousands) of Notes held by such Purchaser.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>If
the Company issues exclusively Common Stock as a dividend or distribution on all or substantially all Common Stock, or if the Company
effects a share split or share combination, the Conversion Rate will be adjusted based on the following formula:</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 73%; padding-bottom: 12pt; padding-left: 2.5pt; font: 12pt/12.3pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">CR1
    = CR0 <FONT STYLE="letter-spacing: -0.5pt">x &nbsp;OS1</FONT></TD>
    <TD STYLE="width: 27%; padding-bottom: 12pt; padding-left: 3.25pt; font: 12pt/12.3pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.25pt"><U></U></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="letter-spacing: -0.1pt">where,</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in">CR0 =the Conversion
Rate in effect immediately prior to the Open of Business on the Ex-Dividend Date of such dividend or distribution, or immediately prior
to the Open of Business on the effective date of such share split or combination, as applicable;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in">CR1 =the Conversion Rate in
effect immediately after the Open of Business on such Ex-Dividend Date or such effective date, as applicable;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in">OS0 =the number of shares of
Common Stock outstanding immediately prior to the Open of Business on such Ex-Dividend Date or such effective date, as applicable; and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in">OS1 =the number of shares of
Common Stock that would be outstanding immediately after giving effect to such dividend or distribution, or immediately after the effectiveness
of such share split or share combination, as applicable.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in">Any adjustment made under this
Section 4.4(a) shall become effective immediately after the Open of Business on the Ex-Dividend Date for such dividend or distribution,
or immediately after the Open of Business on the effective date for such share split or share combination. If any dividend or distribution
of the type described in this Section 4.4(a) is declared but not so paid or made or any share split or share combination of the type described
in this Section 4.4(a) is announced but not consummated, the Conversion Rate shall be immediately readjusted, effective as of the date
the Board of Directors determines not to pay such dividend or distribution or to effect such share split or share combination, to the
Conversion Rate that would then be in effect if such dividend or distribution had not been declared or share split or share combination
had been announced.</P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12.05pt 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>If
the Company issues to all or substantially all holders of the Common Stock any rights, options or warrants entitling them to subscribe
for or purchase Common Stock, at a price per share less than the average of the Last Reported Sale Prices of the Common Stock for the
10 consecutive Trading Day period ending on, and including, the Trading Day immediately preceding the date of announcement for such issuance,
the Conversion Rate will be increased based on the following formula:</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 22%; padding-top: 7.5pt; padding-bottom: 12pt; padding-left: 2.5pt; font: 12pt/13.15pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">CR1
    = CR0 <FONT STYLE="letter-spacing: -0.5pt">x</FONT></TD>
    <TD STYLE="font: 12pt/11.3pt Times New Roman, Times, Serif; width: 78%; text-align: left; text-indent: 10pt"><FONT STYLE="letter-spacing: -0.3pt"><U>&nbsp;</U></FONT><U>OS0 + <FONT STYLE="letter-spacing: -0.5pt">X</FONT>&#9;</U></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; padding-bottom: 12pt; text-align: justify; text-indent: 0.5in">&nbsp;</TD>
    <TD STYLE="font: 12pt/12.65pt Times New Roman, Times, Serif; padding-bottom: 12pt; padding-left: 2.6pt; text-align: justify; text-indent: 10pt">OS0 + <FONT STYLE="letter-spacing: -0.5pt">Y</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in">CR0 =the Conversion Rate
in effect immediately prior to the Open of Business on the Ex-Dividend Date for such issuance;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in">CR1 =the Conversion Rate in
effect immediately after the Open of Business on such Ex-Dividend <FONT STYLE="letter-spacing: -0.1pt">Date;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in">OS0 =the number of shares of
Common Stock outstanding immediately prior to the Open of Business on such Ex-Dividend Date;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in">X =the total number
of shares of Common Stock issuable pursuant to such rights, options or warrants; and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in">Y =the number of shares of
Common Stock equal to the aggregate price payable to exercise such rights, options or warrants <I>divided by</I> the average of the Last
Reported Sale Prices of the Common Stock for the 10 consecutive Trading Day period ending on, and including, the Trading Day immediately
preceding the date of announcement of such issuance.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Any increase made under this
Section 4.4(b) will be made successively whenever any such rights, options or warrants are issued and shall become effective immediately
after the Open of Business on the Ex-Dividend Date for such issuance. To the extent that such rights, options or warrants are not exercised
prior to their expiration or Common Stock is not delivered upon the expiration of such rights, options or warrants, the Conversion Rate
shall be readjusted to the Conversion Rate that would then be in effect had the increase in the Conversion Rate with respect to the issuance
of such rights, options or warrants been made on the basis of delivery of only the number of shares of Common Stock actually delivered.
If such rights, options or warrants are not so issued, or if such rights, options or warrants are not exercised prior to their expiration,
the Conversion Rate shall be readjusted to be the Conversion Rate that would then be in effect if such issuance had not occurred.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">For purposes of this Section
4.4(b) hereof, in determining whether any rights, options or warrants entitle the holders of the Common Stock to subscribe for or purchase
Common Stock at a price per share less than such average of the Last Reported Sale Prices of the Common Stock for the 10 consecutive
Trading Day period ending on, and including, the Trading Day immediately preceding the date of announcement of such issuance, and in
determining the aggregate offering price of such Common Stock, there shall be taken into account any consideration received by the Company
for such rights, options or warrants and any amount payable on exercise thereof, the value of such consideration, if other than cash,
to be determined by the Board of Directors.</P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify; text-indent: 0.5in">&nbsp;<FONT STYLE="color: #010000; letter-spacing: -0.1pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>If
the Company distributes &#8220;shares&#8221; (which term, for purposes of this Section 4.4(c), shall be deemed to mean Capital Stock),
evidences of its indebtedness, other assets or property of the Company or rights, options or warrants to acquire its shares or other
securities, to all or substantially all holders of the Common Stock, excluding:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.05pt">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>dividends,
distributions, rights, options or warrants as to which an adjustment is effected (or would have been effected without regard to the 1%
Exception) pursuant to Section 4.4(a) hereof or Section 4.4(b) hereof;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.05pt">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>dividends
or distributions paid exclusively in cash as to which an adjustment is effected (or would have been effected without regard to the 1%
Exception) pursuant to Section 4.4(d) hereof; and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.05pt">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Spin-Offs,
as to which the provisions set forth below in this <FONT STYLE="letter-spacing: -0.1pt">Section</FONT> 4.4(c) shall <FONT STYLE="letter-spacing: -0.1pt">apply;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0pt">(any of such shares of Capital Stock, evidences of indebtedness, assets, property, rights, options or warrants to acquire Capital Stock
or other securities of the Company, the &#8220;<U>Distributed Property</U>&#8221;), then the Conversion Rate shall be increased based
on the following formula:</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD ROWSPAN="2" STYLE="width: 22%; padding-top: 7.65pt; padding-bottom: 12pt; padding-left: 2.5pt; font: 12pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">CR1 = CR0 <FONT STYLE="letter-spacing: -0.5pt">x</FONT></TD>
    <TD STYLE="font: 12pt/13.3pt Times New Roman, Times, Serif; width: 78%; padding-bottom: 12pt; text-align: left; text-indent: 10pt"><U>&#9;<FONT STYLE="letter-spacing: -0.25pt">SP</FONT>&#9;</U></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt/12.8pt Times New Roman, Times, Serif; padding-top: 1pt; padding-bottom: 12pt; padding-left: 1.3pt; text-align: left; text-indent: 10pt">SP - <FONT STYLE="letter-spacing: -0.25pt">FMV</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.1pt">where,</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">CR0 =the Conversion Rate
in effect immediately prior to the Open of Business on the Ex-Dividend Date for such distribution;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">CR1 =the Conversion
Rate in effect immediately after the Open of Business on such Ex-Dividend <FONT STYLE="letter-spacing: -0.1pt">Date;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">SP =the average of the Last
Reported Sale Prices of the Common Stock for the 10 consecutive Trading Day period ending on, and including, the Trading Day immediately
preceding the Ex- Dividend Date for such distribution; and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">FMV =the fair market value
(as determined by the Board of Directors) of Distributed Property distributed with respect to each outstanding share of Common Stock as
of the Open of Business on the Ex-Dividend Date for such distribution.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">If &#8220;FMV&#8221; (as
defined above) is equal to or greater than the &#8220;SP&#8221; (as defined above), in lieu of the foregoing increase, each Purchaser
shall receive, in respect of each $1,000 principal amount of Notes it holds, at the same time and upon the same terms as holders of the
Common Stock, the amount and kind of Distributed Property that such Purchaser would have received as if such Purchaser owned a number
of shares of Common Stock equal to the Conversion Rate in effect immediately prior to the record date for the distribution.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Any increase made pursuant
to the immediately preceding formula in this Section 4.4(c) will become effective immediately after the Open of Business on the Ex-Dividend
Date for such distribution. If such distribution is not so paid or made, the Conversion Rate shall be readjusted to be the Conversion
Rate that would then be in effect if such distribution had not been declared.</P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 31%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify; text-indent: 0.5in">With respect to an adjustment
pursuant to this Section 4.4(c) where there has been a payment of a dividend or other distribution on the Common Stock of any class or
series of shares, or any similar equity interest, of or relating to any Subsidiaries of the Company or business units of the Company,
and such shares or similar equity interest are or is listed or quoted (or will be listed or quoted upon the consummation of the distribution)
on a U.S. national securities exchange or a reasonably comparable non-U.S. equivalent (a &#8220;<U>Spin-Off</U>&#8221;), the Conversion
Rate will be increased based on the following formula:</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD ROWSPAN="2" STYLE="width: 24%; padding-top: 7.65pt; padding-bottom: 12pt; padding-left: 2.5pt; font: 12pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">CR1 = CR0 x <FONT STYLE="letter-spacing: 4pt"><U>&nbsp;</U></FONT></TD>
    <TD STYLE="font: 12pt/13.3pt Times New Roman, Times, Serif; width: 76%; padding-bottom: 12pt; padding-left: 130pt; text-align: justify; text-indent: -130pt"><U>FMV0 + <FONT STYLE="letter-spacing: -0.25pt">MP0</FONT>&#9;</U></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt/12.8pt Times New Roman, Times, Serif; padding-top: 1pt; padding-bottom: 12pt; padding-left: 150pt; text-align: justify; text-indent: -150pt"><FONT STYLE="letter-spacing: -0.25pt">MP0</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="letter-spacing: -0.1pt">where,</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in">CR0 =the Conversion Rate in
effect immediately prior to the Open of Business on the Ex-Dividend Date for such Spin-Off;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in">CR1 =the Conversion
Rate in effect immediately after the Open of Business on the Ex-Dividend Date for such Spin-Off;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in">FMV0 =the average of the Last
Reported Sale Prices of the shares or similar equity interest distributed to holders of shares of Common Stock applicable to one Common
Share over the first 10 consecutive Trading Day period after, but excluding, the effective date of the Spin-Off (the &#8220;<U>Spin-Off
Valuation Period</U>&#8221;); and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in">MP0 =the average of the Last
Reported Sale Prices of the shares of Common Stock over the Spin- Off Valuation Period.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Any increase made pursuant
to the immediately preceding formula in this Section 4.4(c), will be calculated as of the Close of Business on the last Trading Day of
the Spin-Off Valuation Period but will be given effect immediately after the Open of Business on the Ex-Dividend Date for the Spin-Off,
with retroactive effect. If a Note is converted and the Conversion Date occurs during the Spin-Off Valuation Period, then, notwithstanding
anything to the contrary herein or in the Notes, the Company will, if necessary, delay the settlement of such conversion until the second
Business Day after the last Trading Day of the Spin-Off Valuation Period.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>If
any cash dividend or distribution is made to all or substantially all holders of the Common Stock, the Conversion Rate shall be adjusted
based on the following formula:</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD ROWSPAN="2" STYLE="width: 23%; padding-top: 7.65pt; padding-bottom: 12pt; padding-left: 2.5pt; font: 12pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">CR1 = CR0 x <U>&#9;</U></TD>
    <TD STYLE="font: 12pt/13.3pt Times New Roman, Times, Serif; width: 77%; padding-bottom: 12pt; padding-left: -20pt; text-align: justify; text-indent: 0pt"><FONT STYLE="letter-spacing: -0.25pt"><U>SP</U></FONT><U>&#9;</U></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt/12.8pt Times New Roman, Times, Serif; padding-top: 1pt; padding-bottom: 12pt; padding-left: 20pt; text-align: justify; text-indent: -20pt">SP - <FONT STYLE="letter-spacing: -0.5pt">D</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="letter-spacing: -0.1pt">where,</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify; text-indent: 0in">CR0 =the Conversion Rate in
effect immediately prior to the Open of Business on the Ex-Dividend Date for such dividend or distribution;</P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify">CR1 =the Conversion Rate in effect immediately
after the Open of Business on the Ex-Dividend Date for such dividend or distribution;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify; text-indent: 0in">SP =the average of the Last
Reported Sale Prices of the Common Stock on the three consecutive Trading Day period immediately preceding the Ex-Dividend Date for such
dividend or distribution; and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify; text-indent: 0in">D =the amount in cash per share
that the Company distributes to all or substantially all holders of the Common Stock.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in">If &#8220;D&#8221; (as defined
above) is equal to or greater than &#8220;SP&#8221; (as defined above), then, in lieu of the foregoing increase, each Purchaser shall
receive, for each $1,000 principal amount of Notes it holds, at the same time and upon the same terms as holders of Common Stock, the
amount of cash that such Purchaser would have received if such Purchaser had owned a number of shares of Common Stock equal to the Conversion
Rate in effect immediately prior to the record date for such cash dividend or distribution. Any increase under this Section 4.4(d) shall
become effective immediately after the Open of Business on the Ex-Dividend Date for such dividend or distribution. If such dividend or
distribution is not so paid, the Conversion Rate shall be readjusted, <FONT STYLE="letter-spacing: -0.1pt">effective</FONT> as of the
date the Board of Directors determines not to pay such dividend or distribution, to the Conversion Rate that would then be in effect if
such dividend or distribution had not been <FONT STYLE="letter-spacing: -0.1pt">declared.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>If
the Company or any of its Subsidiaries make a payment in respect of a tender offer or exchange offer for the Common Stock, to the extent
that the cash and value of any other consideration included in the payment per Common Stock exceeds the Last Reported Sale Price of the
Common Stock on the Trading Day next succeeding the last date on which tenders or exchanges may be made pursuant to such tender or exchange
offer (such last date, the &#8220;<U>Offer Expiration Date</U>&#8221;), the Conversion Rate shall be increased based on the following
<FONT STYLE="letter-spacing: -0.1pt">formula:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 1.7pt 0 0.05pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24%">
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0.8pt 0 12pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; text-align: justify; text-indent: 0.5in">CR1 = CR0
    <FONT STYLE="letter-spacing: -0.5pt">x</FONT></P></TD>
    <TD STYLE="width: 76%">
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0pt 0pt; text-align: left">AC + (SP1 <FONT STYLE="letter-spacing: -0.5pt">x<BR>
</FONT><FONT STYLE="letter-spacing: -0.2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;OS1)</FONT></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; padding-bottom: 12pt; text-align: justify; text-indent: 0.5in">&nbsp;</TD>
    <TD STYLE="font: 12pt/12.8pt Times New Roman, Times, Serif; text-indent: -340pt; padding-left: -40pt; padding-bottom: 12pt; text-align: center">&nbsp;&nbsp;&nbsp;OS0 x <FONT STYLE="letter-spacing: -0.25pt">SP1</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="letter-spacing: -0.1pt">where,</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in">CR0 =the Conversion Rate in
effect immediately prior to the Close of Business on the Offer Expiration Date;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in">CR1 =the Conversion Rate in
effect immediately after the Close of Business on the Offer Expiration Date</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in">AC =the aggregate value of
all cash and any other consideration (as determined by the Board of Directors) paid or payable for Common Stock purchased in such tender
or exchange offer;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify; text-indent: 0in">&nbsp;OS0 =the number of
shares of Common Stock outstanding immediately prior to the expiration time of the tender or exchange offer on the Offer Expiration
Date (prior to giving effect to the purchase of all shares accepted for purchase or exchange in such tender or exchange offer);</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify; text-indent: 0in">OS1 =the number of shares of
Common Stock outstanding immediately after the expiration time of the tender or exchange offer on the Offer Expiration Date (after giving
effect to the purchase of all shares accepted for purchase or exchange in such tender or exchange offer); and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify; text-indent: 0in">SP1 =the average of the Last
Reported Sale Prices of the Common Stock over the 10 consecutive Trading Day period commencing on, and including, the Trading Day next
succeeding the Offer Expiration Date (the &#8220;<U>Tender/Exchange Offer Valuation Period</U>&#8221;).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify; text-indent: 0in">provided, however, that the
Conversion Rate will in no event be adjusted down pursuant to this Section 4.4(e), except to the extent provided in the last sentence
of this paragraph. The adjustment to the Conversion Rate pursuant to this Section 4.4(e) will be calculated as of the Close of Business
on the last Trading Day of the Tender/Exchange Offer Valuation Period but will be given effect immediately after Close of Business on
the Offer Expiration Date, with retroactive effect. If a Note <FONT STYLE="letter-spacing: -0.1pt">is converted and the Conversion Date
occurs on the Expiration Date or during the Tender/Exchange </FONT>Offer Valuation Period, then, notwithstanding anything to the contrary
in this Agreement or the Notes, the Company will, if necessary, delay the settlement of such conversion until the second <FONT STYLE="letter-spacing: -0.1pt">(2nd)
Business Day after the last day of the Tender/Exchange Offer Valuation Period. To the extent</FONT> such tender or exchange offer is announced
but not consummated (including as a result of the Company being precluded from consummating such tender or exchange offer under applicable
law), or any purchases or exchanges of Common Stock in such tender or exchange offer are rescinded, the Conversion Rate will be readjusted
to the Conversion Rate that would then be in effect had the adjustment been made on the basis of only the purchases or exchanges of Common
Stock, if any, actually made, and not rescinded, in such tender or exchange offer. If the Company pays any dividend partially in partially
in Common Stock, partially in Distributed Property and/or partially in cash or other property, the provisions of Section 4.4(a), Section
4.4(c) and this Section 4.4(d) shall each apply as applicable, and the Company shall effectuate such adjustments in the order that results
in the greatest benefit to the Purchasers.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Special
Settlement <FONT STYLE="letter-spacing: -0.1pt">Provisions.</FONT> Notwithstanding anything to the contrary herein or in the Notes, if
a Purchaser converts a Note and:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.05pt">(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the
record date, effective date or Offer Expiration Date for any event that requires an adjustment to the Conversion Rate under any of Section
4.4(a) through (e) hereof occurs, but an adjustment to the Conversion Rate for such event has not yet become effective as of such Conversion
Date;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.25in; text-align: justify; text-indent: 0.5in; color: #010000"><FONT STYLE="letter-spacing: -0.05pt">(2)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Conversion Consideration due upon such conversion includes any whole shares of Common Stock; and</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.05pt">(3)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;such
shares of Common Stock are not entitled to participate in such event (because they were not</FONT> held on the related record date or
otherwise),</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.25in; text-align: justify; text-indent: 0pt">then, solely for purposes of such conversion, (x) the Company will, without duplication, give effect to such adjustment on
such Conversion Date; and (y) if the date the Company is otherwise required to deliver the Conversion Consideration due upon such conversion
is before the first date on which the amount of such adjustment can be determined, then the Company will delay the settlement of such
conversion until the second (2nd) Business Day after such first date.</P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify; text-indent: 0.5in">In addition, notwithstanding
anything to the contrary herein, <FONT STYLE="letter-spacing: -0.25pt">if:</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.05pt">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>a
Conversion Rate adjustment for any dividend or distribution becomes effective on any Ex-Dividend Date pursuant to Section 4.4(a) through
(e);</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.05pt">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>a
Note is to be <FONT STYLE="letter-spacing: -0.1pt">converted;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.05pt">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the
Conversion Date for such conversion occurs on or after such Ex- Dividend Date and on or before the related record date;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.05pt">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the
Conversion Consideration due upon such conversion includes any whole shares of Common Stock based on a Conversion Rate that is adjusted
for such dividend or distribution; and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 3.95pt 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.05pt">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>such
shares of Common Stock would be entitled to participate in such dividend or distribution,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 3.95pt 0 12pt 0.5in; text-align: justify; text-indent: 0pt">then, although the Company will otherwise treat
such Purchaser as the holder of record of such shares of Common Stock on the Conversion Date, the Company shall not permit such Purchaser
to participate in such event on account of such Common Stock; provided, however, and for the avoidance of doubt, if such Conversion Rate
does not include any adjustment for such dividend or distribution, such Purchaser shall be entitled to participate in such dividend or
distribution as if such Purchaser were a holder of shares of Common Stock equal to the shares of Common Stock into which such Purchaser&#8217;s
Notes are converted.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Poison
Pill</I>. If a Purchaser converts a Note, the Purchaser converting such Note will receive, in addition to any shares of Common Stock to
which it is entitled in connection with such conversion, the rights under any shareholders rights plan of the Company in effect at such
time, unless prior to the applicable Conversion Date, the rights have separated from the Common Stock, in which case, the Conversion Rate
will be adjusted at the time of separation as if the Company distributed to all holders of the Common Stock, Distributed Property as described
in Section 4.4(c) hereof, subject to readjustment in the event of the expiration, termination or redemption of such rights. In all other
cases, the issuance of rights pursuant to a rights plan will not result in an adjustment to the Conversion Rate pursuant to Section 4.4(c)
<FONT STYLE="letter-spacing: -0.1pt">hereof.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Deferral
of Adjustments</I>. Notwithstanding anything to the contrary herein, the Company will not be required to adjust the Conversion Rate unless
such adjustment would require an increase or decrease of at least one percent (1%) in the Conversion Rate; provided, however, that the
Company shall carry forward any adjustment that is less than one percent (1%) of the Conversion Rate, shall take such carried-forward
adjustments into account in any subsequent adjustment, and shall make such carried-forward adjustments, regardless of whether the aggregate
adjustment is less than one percent (1%), (i) annually on the anniversary of the first date of issue of the Notes; and (ii) otherwise,
(1) on each Conversion Date; and (2) if a Fundamental Change occurs or the Company calls the Notes for Redemption, in each case unless
such adjustment has already been made. The provisions of this Section 4.4(h) are referred to as the &#8220;<U>1% Exception</U>.&#8221;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Limitation
on Adjustments</I>. Except as stated in this Section 4.4, the Company will not adjust the Conversion Rate for the issuance of Common
Stock or any securities convertible into or exchangeable for Common Stock or the right to purchase Common Stock or such convertible
or exchangeable securities. Notwithstanding anything herein or in the Notes to the contrary, if the application of the formulas in
Section 4.4(a) through (e) hereof would result in a decrease in the Conversion Rate, then, except to the extent of any readjustment
to the Conversion Rate, no adjustment to the Conversion Rate will be made (other than as a result of a reverse share split or share
combination).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">In addition, notwithstanding
anything to the contrary herein, the Conversion Rate will not be adjusted:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.05pt">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>on
account of share repurchases that are not tender offers referred to in Section 4.4(e) hereof, including structured or derivative transactions,
or transactions pursuant to a share repurchase program approved by the Board of Directors or otherwise;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.05pt">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>upon
the issuance of any Common Stock pursuant to any present or future plan providing for the reinvestment of dividends or interest payable
on the Company&#8217;s securities and the investment of additional optional amounts in Common Stock under any plan;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.05pt">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>upon
the issuance of any Common Stock or options or rights to purchase those shares pursuant to any present or future employee, director or
consultant benefit plan, program or agreement of or assumed by the Company or any of its Subsidiaries;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.05pt">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>upon
the issuance of any Common Stock pursuant to any option, warrant, right or exercisable, exchangeable or convertible security not described
in Section 4.4(i)(iii) above and outstanding as of the date the Notes were first issued;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.05pt">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>for
a change in the par value of the Common Stock; or</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;for
accrued and unpaid interest on the Notes, if <FONT STYLE="letter-spacing: -0.2pt">any.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">In addition, the Company
will not undertake any action that would result in the Company being required, pursuant to this Agreement, to adjust the Conversion Rate
such that the Conversion Price per share of Common Stock will be less than the par value per share of Common Stock.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000"><FONT STYLE="letter-spacing: -0.1pt">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
purposes of this Section 4.4, the number of shares of Common Stock at any time outstanding shall not include shares held in the treasury
of the Company so long as the Company does not pay any dividend or make any distribution on Common Stock held in the treasury of the Company,
but shall include shares issuable in respect of scrip certificates issued in lieu of fractional shares of Common Stock.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Whenever
the Company is required to calculate or make adjustments to the Conversion Rate, the Company</FONT> will do so to the nearest 1/10,000th
of a share of Common Stock, rounding any additional decimal places up or down in a commercially reasonable manner.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">4.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Discretionary
and Voluntary <FONT STYLE="letter-spacing: -0.1pt">Adjustments</FONT></U><FONT STYLE="letter-spacing: -0.1pt">.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Discretionary
Adjustments</I>. Whenever any provision of this Agreement requires the Company to calculate the Last Reported Sale Prices, the Daily VWAPs
or any function thereof over a span of multiple days (including the Stock Price for purposes of a Make- Whole Fundamental Change), the
Company will make appropriate adjustments to each to account <FONT STYLE="color: #010000; letter-spacing: -0.1pt">for any adjustment to
the Conversion Rate that becomes effective, or any event requiring an adjustment to the Conversion Rate where the effective date, Ex-Dividend
Date or Offer Expiration Date, as applicable, of the event occurs, at any time during the period when such Last Reported Sale Prices,
the Daily VWAPs or function thereof is to be calculated.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt"></FONT></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000"><FONT STYLE="letter-spacing: -0.1pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Voluntary
Adjustments</I>. To the extent permitted by applicable law and applicable requirements of the Nasdaq Capital Market, the Company is permitted
to increase the Conversion Rate of the Notes by any amount for a period of at least 20 Business Days if the Board of Directors determines
that such increase would be in the Company&#8217;s best interest. To the extent permitted by applicable law and applicable requirements
of the Nasdaq Capital Market, the Company may also (but is not required to) increase the Conversion Rate to avoid or diminish income
tax to holders of Common Stock or rights to purchase Common Stock in connection with a dividend or distribution of shares (or rights
to acquire shares) or similar event.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">4.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Adjustment
to Conversion Rate Upon Conversion in Connection with a Make- Whole Fundamental Change</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000"><FONT STYLE="letter-spacing: -0.1pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Increase
in the Conversion Rate</I>. If a Make-Whole Fundamental Change occurs and a Purchaser elects to convert its Notes in connection with
such Make-Whole Fundamental Change, then the Company shall, to the extent provided herein, increase the Conversion Rate for the Notes
so surrendered for conversion by a number of additional shares of Common Stock (the &#8220;<U>Additional Shares</U>&#8221;), as described
in this Section 4.6. A conversion of Notes shall be deemed for these purposes to be &#8220;in connection with&#8221; a Make-Whole Fundamental
Change if the relevant Conversion Notice is received by the Conversion Agent during the period from, and including, the Make-Whole Fundamental
Change Effective Date up to, and including, the Close of <FONT STYLE="letter-spacing: -0.1pt">Business on the Business Day immediately
prior to the related Fundamental Change Purchase Date or, if such Make-Whole Fundamental Change is not also a Fundamental Change, the
35th Business Day immediately following the Make-Whole Fundamental Change Effective Date (such period, the &#8220;<U>Make-Whole Fundamental
Change Period</U>&#8221;).</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Cash
Mergers</I>. Notwithstanding anything to the contrary herein, if the consideration paid to holders of the Common Stock in any Make-Whole
Fundamental Change described in clause (2) of the definition of &#8220;Fundamental Change&#8221; is comprised entirely of cash, then,
for any conversion of Notes with a Conversion Date that is on or after the Make-Whole Fundamental Change Effective Date, then (i) in
respect of all conversions whose Conversion Date occurs on or after</FONT> <FONT STYLE="color: #010000">the Make-Whole Fundamental Change
Effective Date, the payment and delivery obligations upon the conversion of a Note shall be calculated based solely on the Stock Price
for such Make-Whole Fundamental Change and shall be deemed to be a cash amount equal to the applicable Conversion Rate (including any
adjustment as described in this Article 4) multiplied by such Stock Price; and (ii) the Company&#8217;s conversion obligation will be
determined and paid to Purchasers in cash on </FONT>or before the earlier of (i) the first (1<SUP>st</SUP>) Trading Day and (ii) the
number of Trading Days comprising the Standard Settlement Period, in each case, following <FONT STYLE="color: #010000">the applicable
Conversion Date. Otherwise, the Company will settle any conversion of the Notes following the Make-Whole Fundamental Change Effective
Date in accordance with Section 4.3 hereof (but subject to Section 4.4 hereof).</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000"><FONT STYLE="letter-spacing: -0.1pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Determining
the Number of Additional Shares</I>. The number of Additional Shares, if any, by which the Conversion Rate will be increased for a
Purchaser that converts its Notes in connection with a Make-Whole Fundamental Change shall be determined by reference to the table
attached as <U>Schedule A</U> hereto, based on the Make-Whole Fundamental Change Effective Date and the price (the &#8220;<U>Stock
Price</U>&#8221;) paid (or deemed paid) per share of Common Stock in the Make-Whole Fundamental Change, as determined under the two
immediately following sentences. In the case of a Make-Whole Fundamental Change described in clause (2) of the definition of
&#8220;Fundamental Change,&#8221; where holders of the Company&#8217;s Common Stock receive only cash in such Make-Whole Fundamental
Change, the Stock Price shall be the cash amount paid per share of Common Stock. Otherwise, the Stock Price shall be the average of
the Last Reported Sale Prices of the Common Stock over the 5 consecutive Trading Day period ending on, and including, the Trading
Day immediately preceding the Make-Whole Fundamental Change Effective Date.</P>


<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Interpolation
and Limits</I>. The exact Stock Prices and Make-Whole Fundamental Change Effective Dates may not be set forth in the table in <U>Schedule
A</U>, in which <FONT STYLE="letter-spacing: -0.1pt">case:</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.05pt">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>if
the Stock Price is between two Stock Prices in the table or the Make-Whole Fundamental Change Effective Date is between two dates in the
table, the number of Additional Shares shall be determined by a straight-line interpolation between the number of Additional Shares set
forth for the higher and lower Stock Prices and the earlier and later dates, as applicable, based on a 365- or 366-day year, as applicable;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;if
the Stock Price is greater than $10.00 per share (subject to adjustment in the same manner as the Stock Prices set forth in the column
headings of the table in <U>Schedule A</U> hereof), no Additional Shares will be added to the Conversion Rate; and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;if
the Stock Price is less than $1.50 per share (subject to adjustments in the same manner as the Stock Prices set forth in the column headings
of the table in <U>Schedule A</U> hereof), no Additional Shares will be added <FONT STYLE="color: #010000">to the Conversion Rate.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">Notwithstanding
the foregoing, in no event will the Conversion Rate be increased on account of a Make-Whole Fundamental Change to exceed 633.3333 shares
of Common Stock per $1,000 principal amount of Notes, subject to adjustments in the same manner as the Conversion Rate is required to
be adjusted as set forth in Section 4.4 hereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000">The
Stock Prices set forth in the column headings of the table in <U>Schedule A</U> hereto shall be adjusted as of any date on which the Conversion
Rate of the Notes is otherwise required to be adjusted. The adjusted Stock Prices shall equal the Stock Prices applicable immediately
prior to such adjustment, multiplied by a fraction, the numerator of which is the Conversion Rate immediately prior to such adjustment
giving rise to the Stock Price adjustment and the denominator of which is the Conversion Rate as so adjusted. The number of Additional
Shares set forth in such table shall be adjusted in the same manner and at the same time as the Conversion Rate is required to be adjusted
as set forth in Section 4.4.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in; color: #010000"><FONT STYLE="letter-spacing: -0.1pt">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Notices</I>.
The Company shall notify the Purchasers of any Make-Whole Fundamental Change Effective Date no later than five Business Days after such
Make-Whole Fundamental Change Effective Date.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">4.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Effect
of Recapitalization, Reclassification, Consolidation, Merger or <FONT STYLE="letter-spacing: -0.1pt">Sale</FONT></U><FONT STYLE="letter-spacing: -0.1pt">.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Common
Stock Change Event. In the case <FONT STYLE="letter-spacing: -0.25pt">of:</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.05pt">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>any
recapitalization, reclassification or change of the Common Stock (other than a change in par value, or from par value to no par value,
or from no par value to par value, or as a result of a split, subdivision or combination);</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
consolidation, merger or combination involving the Company;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
sale, lease or other transfer to a third party of the consolidated assets of the Company and its Subsidiaries substantially as an entirety;
or</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any binding share <FONT STYLE="letter-spacing: -0.1pt">exchange;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.25in; text-align: justify; text-indent: 0pt">and, in each case,
as a result of which the Common Stock would be converted into, or exchanged for, or represent solely the right to receive, shares, stock,
other securities, other property or assets (including cash or any combination thereof) (such shares, stock, securities, property or assets,
<U>&#8220;Reference Property</U>,&#8221; and the amount and kind of Reference Property that a holder of one share of Common Stock would
be entitled to receive on account of such transaction, a &#8220;<U>Reference Property Unit</U>&#8221;) (any such event, a &#8220;<U>Common
Stock Change Event</U>&#8221;), then, notwithstanding anything to the contrary herein or in the Notes, at the effective time of such
Common Stock Change Event, (i) the consideration due upon conversion of any Notes, and the conditions to any such conversion, will be
determined in the same manner as if each reference to any number of shares of Common Stock in this Article 4 were instead a reference
to the same number of Reference Property Units, (ii) for purposes of Section 10.5(b) or (c), each reference to Common Stock in such Section
(or in any related definitions) will instead be deemed to be a reference to the same number of Reference Property Units and (iii) for
purposes of the definition of &#8220;Fundamental Change&#8221; and &#8220;Make-Whole Fundamental Change,&#8221; the term &#8220;Common
Stock&#8221; and &#8220;common equity&#8221; will be deemed to mean the common equity, if any, forming part of such Reference Property.
If any Reference Property Unit consists entirely of cash, then the Company will settle all such conversions within two Business Days
of the relevant Conversion Date. For these purposes, the Daily VWAP or Last Reported Sale Price of any Reference Property Unit or portion
thereof that does not consist of a class of securities will be the fair value of such Reference Property Unit or portion thereof, as
applicable, determined in good faith by the Company (or in the case of cash denominated in U.S. Dollars, the face amount thereof). The
Company (and such other Persons, if any, specified in the immediately following paragraph) shall, as a condition precedent to such Common
Stock Change Event execute and deliver to the Purchasers a form of amendment hereto in form reasonably satisfactory to the Requisite
Purchasers giving effect to the provisions of this Section 4.7.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The Company shall
not become a party to any Common Stock Change Event unless its terms are consistent with this Section 4.7. Such amendment described in
the first paragraph of this Section 4.7(a) shall provide for adjustments which shall be as nearly equivalent to the adjustments provided
for in this Section 4 in the judgment of the Board of Directors or the board of directors of the successor Person. If, in the case of
any such Common Stock Change Event, the Reference Property receivable thereupon by a holder of Common Stock includes shares of stock,
securities or other property or assets (including cash or any combination thereof) of a Person other than the successor or purchasing
Person, as the case may be, in such Common Stock Change Event, then such amendment shall also be executed by such other Person.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Composition
of the Reference Property Unit</I>. If the Reference Property in any Common Stock Change Event consists of more than a single type of
consideration (determined based in part upon any form of shareholder election), then the composition of the Reference Property Unit will
be deemed to be the weighted average, per share of Common Stock, of the types and amounts of consideration actually received by the holders
of Common Stock. The Company shall notify Holders of the weighted average as soon as practicable after such determination is made.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">4.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Certain
Covenants</U>. The Company covenants that all Common Stock that may be issued upon conversion of Notes shall be issued in book-entry format,
shall be newly issued shares or treasury shares, shall be duly authorized, validly issued, fully paid and non-assessable and shall be
free from preemptive rights and free from any tax, lien or charge (other than those created by the Purchaser or due to a change in registered
owner). The Company shall list or cause to have quoted any shares of Common Stock to be issued upon conversion of Notes on each national
securities exchange or over-the-counter or other domestic market on which the Common Stock is then listed or quoted.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">4.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Notice
to <FONT STYLE="letter-spacing: -0.1pt">Holders</FONT></U><FONT STYLE="letter-spacing: -0.1pt">.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Notice
to Holders Prior to Certain Actions</I>. The Company shall deliver written notices of the events specified below at the times specified
below and containing the information specified below unless, in each case, (i) pursuant to this Agreement, the Company is already required
to deliver notice of such event containing at least the information specified below at an earlier time or (ii) the Company, at the time
it is required to deliver a notice, does not have knowledge of all of the information required to be included in such notice, in which
case, the Company shall (A) deliver notice at such time containing only the information that it has knowledge of at such time (if it has
knowledge of any such information at such time), and (B) promptly upon obtaining knowledge of any such information not already included
in a notice delivered by the Company, deliver notice to each Purchaser containing such information. In each case, the failure by the Company
to give such notice, or any defect therein, shall not affect the legality or validity of such event.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.05pt">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Issuances,
Distributions, and Dividends and Distributions</I>. If the Company (A) announces any issuance of any rights, options or warrants that
would require an adjustment in the Conversion Rate pursuant to Section 4.4(b) hereof; (B) authorizes any distribution that would require
an adjustment in the Conversion Rate pursuant to Section 4.4(c) hereof (including any separation of rights from the Common Stock described
in Section 4.4(g) hereof); or (C) announces any dividend or distribution that would require an adjustment in the Conversion Rate pursuant
to Section 4.4(d) hereof, then the Company shall deliver to the Purchasers, as promptly as practicable after the holders of the Common
Stock are notified of such event, notice describing such issuance, dividend or distribution, as the case may be, and stating the expected
Ex-Dividend Date and record date for such issuance, dividend or distribution, as the case may be. In addition, the Company shall deliver
to the Purchasers written notice if the consideration included in such issuance, dividend or distribution, or the Ex-Dividend Date or
record date of such issuance, dividend or distribution, as the case may be, changes.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.05pt">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Tender
and Exchange Offers</I>. If the Company announces any tender or exchange offer that could require an adjustment in the Conversion Rate
pursuant to Section 4.4(e) hereof, the Company shall deliver to the Purchasers on the day it announces such tender or exchange offer,
and, if the Company is required to file with the Commission a Schedule TO in connection with such tender or exchange offer, an additional
written notice (i) when the Company first files such Schedule TO, which notice shall include the address at which such Schedule TO is
available on the Commission&#8217;s EDGAR system (or any successor thereto), and (ii) whenever the <FONT STYLE="letter-spacing: -0.1pt">Company
files an amendment to such Schedule TO, which notice shall include the address at which </FONT>such amendment is available on the Commission&#8217;s
EDGAR system (or any successor thereto).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.05pt">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Voluntary
Increases</I>. If the Company increases the Conversion Rate pursuant to Section 4.5(b), the Company shall deliver notice to the Holders
at least two Scheduled Trading Days prior to the date on which such increase will become effective, which notice shall state the date
on which such increase will become effective and the amount by which the Conversion Rate will be increased.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.05pt">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Dissolutions,
Liquidations and Winding-Ups</I>. If there is a voluntary or involuntary dissolution, liquidation or winding-up of the Company, the
Company shall deliver notice to the Purchasers at promptly as possible, but in any event prior to the earlier of (i) the date on
which such dissolution, liquidation or winding-up, as the case may be, is expected to become effective or occur, and (ii) the date
as of which it is expected that holders of Common Stock of record shall be entitled to exchange their Common Stock for securities or
other property deliverable upon such dissolution, liquidation or winding-up, as the case may be, which notice shall state the
expected effective date and record date for such event, as applicable, and the amount and kind of property that a holder of one
share of Common Stock is expected to be entitled, or may elect, to receive in such event. The Company shall deliver an additional
written notice to Purchasers, as promptly as practicable, whenever the expected effective date or record date, as applicable, or the
amount and kind of property that a holder of one share of Common Stock is expect to be entitled to receive in such event,
changes.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">4.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Beneficial
Ownership Conversion Limits</U>. Notwithstanding Section 4.1, a Purchaser shall not have the right to convert all or any portion of the
Notes held by such Purchaser pursuant to Section 4.1 or otherwise, to the extent that immediately prior to, or immediately after giving
effect to such conversion such Purchaser (together with its Affiliates and any other Persons acting as a group together with such Purchaser
or any of such Purchaser&#8217;s Affiliates (such Persons, collectively, the &#8220;<U>Attribution Parties</U>&#8221;)), would beneficially
own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number of shares
of Common Stock beneficially owned by the Purchaser and its Affiliates and Attribution Parties shall not include the number of shares
of Common Stock that would be issuable upon (i) conversion of the non-converted portion of the Notes beneficially owned by the Purchaser
or any of its Affiliates or Attribution parties and (ii) exercise or conversion of the unexercised or unconverted portion of any other
securities of the Company in each case to the extent subject to a limitation on conversion or exercise analogous to the limitation contained
herein beneficially owned by the Purchaser or any of its Affiliates or Attribution Parties. For purposes of this Section 4.10, beneficial
ownership shall be calculated in accordance with Section 13(d) of the Exchange Act, it being acknowledged by each Purchaser that the Company
is not representing to such Purchaser that such calculation is in compliance with Section 13(d) of the Exchange Act and such Purchaser
is solely responsible for any schedules required to be filed in accordance therewith. A determination as to any &#8220;group&#8221; status
as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder. For purposes of this Section 4.10, in determining the number of outstanding shares of Common Stock, a Purchaser may rely on
the number of outstanding shares of Common Stock as reflected in <FONT STYLE="letter-spacing: -0.25pt">(A)</FONT> the Company&#8217;s
most recent periodic or annual report filed with the SEC, as the case may be, (B) a more recent public announcement by the Company or
(C) a more recent written notice by the Company setting forth the number of shares of Common Stock outstanding. Upon the written request
of a Purchaser, the Company shall, within one Trading Day, confirm orally and in writing to such Purchaser the number of shares of Common
Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion
or exercise of securities of the Company by such Purchaser or its Affiliates or Attribution Parties since the date as of which such number
of outstanding shares of Common Stock was last publicly reported or confirmed to the Purchaser. The &#8220;<U>Beneficial Ownership Limitation</U>&#8221;
shall initially be 19.99% of the number of shares of Common Stock outstanding immediately prior to, and immediately after giving effect
to, the conversion of all or any portion of the Notes. A Purchaser, upon written notice to the Company, may increase or decrease the Beneficial
Ownership Limitation provisions in this Section 4.10, provided that the Beneficial Ownership Limitation in no event exceeds 19.99% of
the number of shares of the Common Stock outstanding immediately prior to, and immediately after giving effect to, the conversion of all
or any portion of the Notes. Any increase in the Beneficial Ownership Limitation will not be effective until the 61st day after such notice
is delivered to the Company.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">4.11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Nasdaq
Conversion Limits</U>. Notwithstanding anything to the contrary in the Note Documents, until the receipt of Stockholder Approval, in
no event shall the Company be required to issue shares of Common Stock upon conversion of the Notes in excess of 30,658,359 shares
in the aggregate (the &#8220;<U>Exchange Cap</U>&#8221;). Until such approval is obtained, no Purchaser shall be issued in the
aggregate, pursuant to the terms of the Notes, shares of Common Stock in an amount greater than the product of the Exchange Cap
multiplied by a fraction, the numerator of which is the principal amount of Notes issued to such Purchaser pursuant to this
Agreement on the Closing Date and the denominator of which is the aggregate principal amount of all Notes issued to the Purchasers
pursuant to this Agreement on the Closing Date (with respect to each Purchaser, the &#8220;<U>Exchange Cap Allocation</U>&#8221;).
In the event that any Purchaser shall sell or otherwise transfer any of such Purchaser&#8217;s Notes, the transferee shall be
allocated a pro rata portion of such Purchaser&#8217;s Exchange Cap Allocation with respect to such portion of such Notes
transferred, and the restrictions of the prior sentence shall apply to such transferee with respect to the portion of the Exchange
Cap Allocation allocated to such transferee. In the event that any Holder of Notes shall convert all of such Holder&#8217;s Notes
into a number of shares of Common Stock which, in the aggregate, is less than such Holder&#8217;s Exchange Cap Allocation, then the
difference between such Holder&#8217;s Exchange Cap Allocation and the number of shares of Common Stock actually issued to such
Holder shall be allocated to the respective Exchange Cap Allocations of the remaining Holders of Notes on a pro rata basis in
proportion to the aggregate principal amount of the Notes then held by each such Holder.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000"><B>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><B>REPRESENTATIONS
AND WARRANTIES</B>. The Company hereby represents and warrants to the Purchasers as of the Closing Date as follows:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">5.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Organization,
Good Standing and Qualification</U>. The Company is a corporation duly organized, validly existing and in good standing under, and by
virtue of, the laws of the State of Delaware and has all requisite corporate power and authority to own its properties and assets and
to carry on its business as now conducted and as presently proposed to be conducted. The Company is qualified to do business as a foreign
corporation in each jurisdiction where failure to be so qualified would have a material adverse effect on the financial condition, business,
or operations of the Company taken as a whole.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">5.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Corporate
Power and Authority; Valid Issuance of <FONT STYLE="letter-spacing: -0.1pt">Shares</FONT></U><FONT STYLE="letter-spacing: -0.1pt">.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
Company has all requisite corporate power and has taken all necessary corporate action required for the due authorization, execution,
delivery and performance by the Company of this Agreement and the other Note Documents and the consummation of the transactions contemplated
hereby and thereby. The execution, delivery and performance by the Company of this Agreement and the consummation by the Company of the
transactions contemplated hereby, have been duly authorized by the Company&#8217;s board of directors or a duly authorized committee thereof
and no further consent or authorization of the Company, its board of directors or its stockholders is required (other than Stockholder
Approval with respect to issuances of shares of Common Stock pursuant to the terms of the Notes in excess of the Exchange Cap). This Agreement
has been duly executed and delivered by the Company, and the other instruments referred to herein to which it is a party and any Note
Document to which it is a party will be duly executed and delivered by the Company, and each such instrument or Note Document constitutes
or will constitute a legal, valid and binding obligation of the Company enforceable against it in accordance with its terms, except to
the extent that enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance, and any other
laws of general application affecting enforcement of creditors&#8217; rights generally, and as limited by laws relating to the availability
of specific performance, injunctive relief, or other equitable remedies.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
shares of Common Stock underlying the Notes (the &#8220;<U>Conversion Shares</U>&#8221;) have been duly and validly authorized and, when
issued and paid for pursuant to this Agreement, the Conversion Shares will be validly issued, fully paid and non-assessable, and shall
be free and clear of all encumbrances (other than restrictions on transfer under the Note Documents arising under applicable federal and
state securities laws), and will not be subject to preemptive rights or other similar rights of stockholders of the Company.</P>


<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Notes have been duly and validly authorized by all necessary corporate action, have been duly and validly executed and delivered, and
constitute valid and binding obligations of the Company.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">5.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Consents</U>.
Neither the execution, delivery or performance of this Agreement by the Company, nor the consummation by it of the obligations and transactions
contemplated hereby (including, without limitation, the issuance, the reservation for issuance and the delivery of the Conversion Shares
and the provision to the Purchaser of the rights contemplated by the Note Documents) requires any consent of, authorization by, exemption
from, filing with or notice to any Governmental Entity or any other Person, other than filings required under applicable U.S. federal
and state securities laws.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">5.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>No
<FONT STYLE="letter-spacing: -0.1pt">Conflicts</FONT></U><FONT STYLE="letter-spacing: -0.1pt">.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
execution, delivery and performance of this Agreement and the consummation of the transactions contemplated hereby (including, without
limitation, the issuance, the reservation for issuance and the delivery of the Conversion Shares and the provision to the Purchasers
of the rights contemplated by the Note Documents) will not (i) result in a violation of the certificate of incorporation, as amended
or the by-laws, as amended, or any equivalent organizational document of the Company or any Subsidiary (the &#8220;<U>Charter Documents</U>&#8221;)
or require the approval of the Company&#8217;s stockholders, (ii) violate, conflict with or result in the breach of the terms, conditions
or provisions of or constitute a default (or an event which with notice or lapse of time or both would become a default) under, or give
rise to any right of termination, acceleration or cancellation under, any Material Contract, (iii) result in a violation of any law,
rule, regulation, order, judgment or decree (including, without <FONT STYLE="letter-spacing: -0.1pt">limitation, U.S. federal and state
securities laws and regulations and regulations of any self-regulatory organizations to which the Company or its securities are subject)
applicable to the Company or any Subsidiary or by which any property or asset of the Company or any Subsidiary is bound or affected,
(iv) result in a violation of or require stockholder approval under any rule or regulation of The Nasdaq Stock Market that has not been
so obtained, or (v) except as set forth in this Agreement, result in the creation of any encumbrance upon any of the Company&#8217;s
or any of its Subsidiary&#8217;s assets, except under clauses (ii) through (v) any violation, breach, default or encumbrance as would
not result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Neither
the Company nor any Subsidiary is (i) in violation of its Charter Documents, (ii) in default (and no event has occurred which, with notice
or lapse of time or both, would cause the Company or any Subsidiary to be in default) under, nor has there occurred any event giving others
(with notice or lapse of time or both) any rights of termination, amendment, acceleration or cancellation of, any material agreement,
indenture or instrument to which the Company or any Subsidiary is a party, nor has the Company or any Subsidiary received written notice
of a claim that it is in default under, or that it is in violation of, any Material Contract (whether or not such default or violation
has been waived), (iii) in violation of, or in receipt of written notice that it is in violation of, any law, ordinance or regulation
of any Governmental Entity, except where the violation would not result in a Material Adverse Effect, and (iv) in violation of any order
of any Governmental Entity having jurisdictional over the Company or any Subsidiary or any of the Company&#8217;s or any Subsidiary&#8217;s
properties or assets.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">5.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="letter-spacing: -0.1pt"><U>Capitalization</U>.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>As
of the Execution Date, the authorized capital stock of the Company consists of 402,500,000 shares of capital stock, of which 400,000,000
are designated as Common Stock and 2,500,000 are designated as preferred stock, $0.01 par value per share (&#8220;<U>Preferred Stock</U>&#8221;).
As of June 30, 2025, (i) 153,252,956 shares of Common Stock were issued and outstanding and no shares of preferred stock; (ii) 29,697,268
shares of Common Stock were issuable (and such number was reserved for issuance) upon exercise of options to purchase Common Stock (the
&#8220;<U>Options</U>&#8221;) outstanding as of such date; (iii) 4,132,902 shares of Common Stock were issuable (and such number was
reserved for issuance) upon vesting of restricted stock units for the issuance of Common Stock (the &#8220;<U>RSUs</U>&#8221;) outstanding
as of such date; (iv) 1,460,510 shares of Common Stock were issuable (and such number was reserved for issuance) upon exercise of warrants
to purchase Common Stock (the &#8220;<U>Outstanding Warrants</U>&#8221;) outstanding as of such date; and (v) 9,819,300 shares of Common
Stock were issuable (and such number was reserved for issuance) upon conversion of the 1.5% senior convertible notes due 2026 (the <FONT STYLE="letter-spacing: -0.1pt">&#8220;<U>2026</U></FONT><U>
Senior Convertible Notes</U>&#8221;) under the terms of the Original Agreement outstanding as of such <FONT STYLE="letter-spacing: -0.1pt">date.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="letter-spacing: -0.1pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>As
of June 30, 2025, except for: (i) the Options, (ii) the RSUs, (iii) the Outstanding Warrants, and (iv) the 2026 Senior Convertible Notes,
there were no options, warrants or other rights to acquire Equity Securities from the Company.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There
are no securities or instruments containing anti-dilution or similar provisions that will be triggered by the issuance of the Notes.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">5.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Subsidiaries</U>.
Except for Heron Therapeutics B.V., organized in the Netherlands, the Company does not have any Subsidiaries, and such Subsidiary is wholly
owned by the <FONT STYLE="letter-spacing: -0.1pt">Company.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">5.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="letter-spacing: -0.1pt"><U>Material
Contracts</U>. Each Material Contract is the legal, valid and binding obligation </FONT>of the Company or a Subsidiary, as the case may
be, enforceable against the Company or such Subsidiary, as the case may be, in accordance with its terms, except to the extent that enforceability
may be limited by bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance, and any other laws of general application
affecting enforcement of creditors&#8217; rights generally, and as limited by laws relating to the availability of specific performance,
injunctive relief, or other equitable remedies. The Company and each Subsidiary, as the case may be, is in compliance with all material
terms of the Material Contracts to which it is party, and there has not occurred any breach, violation or default or any event that, with
the lapse of time, the giving of notice or the election of any Person, or any combination thereof, would constitute a breach, violation
or default by the Company or any Subsidiary under any such Material Contract or, to the knowledge of the Company and each Subsidiary,
by any other Person to any such contract except where such breach, violation or default would not have a Material Adverse Effect. Neither
the Company nor any Subsidiary has been notified that any party to any Material Contract intends to cancel, terminate, not renew or exercise
an option under any Material Contract, whether in connection with the transactions contemplated hereby or otherwise.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">5.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>The
Nasdaq Stock Market</U>. The Common Stock is listed on The Nasdaq Capital Market (&#8220;<U>Nasdaq</U>&#8221;) and, at the time of the
issuance, the Conversion Shares will be listed for trading on Nasdaq. To the Company&#8217;s knowledge, there are no proceedings to revoke
or suspend such listing or the listing of the Conversion Shares. The Company is in compliance with the requirements of Nasdaq for continued
listing of the Common Stock thereon and any other Nasdaq listing and maintenance requirements, and the execution, delivery and performance
of this Agreement by the Company and the consummation by the Company of the transactions contemplated hereby (including the issuance of
the Conversion Shares) will not result in any noncompliance by the Company with any such requirements.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>


<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">5.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>SEC
Reports; Financial Statements; Shell Company <FONT STYLE="letter-spacing: -0.1pt">Status</FONT></U><FONT STYLE="letter-spacing: -0.1pt">.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
Company&#8217;s Common Stock is registered under Section 12(b) of the Exchange Act. The Company has filed all reports, schedules, forms,
statements and other documents required to be filed by the Company under the Exchange Act, including pursuant to Section 13(a) or 15(d)
thereof (the foregoing materials, including the exhibits thereto and documents incorporated by reference therein, being collectively
referred to herein as the &#8220;<U>SEC Reports</U>&#8221;) on a timely basis or has received a valid extension of such time of filing
and has filed any such SEC Reports prior to the expiration of any such extension. As of their respective dates, the SEC Reports complied
in all material respects with the requirements of the Exchange Act and, in each case, to the rules promulgated thereunder, as applicable,
and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required
to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made,
not misleading.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
financial statements and the related notes of the Company included in the SEC Reports comply in all material respects with applicable
accounting requirements and the rules and regulations of the Commission with respect thereto as in effect at the time of filing. Such
financial statements have been prepared in accordance with GAAP, except as may be otherwise specified in such financial statements or
the notes thereto and except that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present the
consolidated financial position of the Company as of and for the dates thereof and the consolidated results of operations and cash flows
for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments. There is
no transaction, arrangement, or other relationship between the Company or any Subsidiary and an unconsolidated or other off balance sheet
entity that is required to be disclosed by the Company in SEC Reports and is not so disclosed and would have or reasonably be expected
to result in a Material Adverse Effect.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company is not, and has never been, an issuer identified in Rule 144(i)(1) under the Securities Act.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">5.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Disclosure
Controls and Procedures; Internal Controls Over Financial <FONT STYLE="letter-spacing: -0.1pt">Reporting</FONT></U><FONT STYLE="letter-spacing: -0.1pt">.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
Company has established and maintains disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) that
are effective in all material respects to ensure that material information relating to the Company, including any consolidated Subsidiaries,
is made known to its principal executive officer and principal financial officer by others within those entities. The Company&#8217;s
certifying officers have evaluated the effectiveness of the Company&#8217;s disclosure controls and procedures as of the end of the period
covered by the most recently filed quarterly or annual periodic report under the Exchange Act (such date, the &#8220;<U>Evaluation Date</U>&#8221;).
The Company presented in its most recently filed quarterly or annual periodic report under the Exchange Act the conclusions of the certifying
officers about the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12.05pt 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
Company maintains internal control over financial reporting (as such term is defined in Exchange Act Rule 13a-15(f) and 15d-15(f)) designed
to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external
purposes in accordance with GAAP and such internal control over financial reporting is effective. The Company presented in its most recently
filed annual report under the Exchange Act the conclusions of the certifying officers about the effectiveness of the Company&#8217;s internal
control over financial reporting based on their evaluations as of the end of the period covered by such report. Since the Evaluation Date,
there have been no significant changes in the Company&#8217;s internal control over financial reporting or, to the Company&#8217;s knowledge, in other factors
that could significantly affect the Company&#8217;s internal control over financial reporting.</P>


<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 12.05pt 0 12pt; text-align: justify"><FONT STYLE="color: #010000">5.11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Absence
of Litigation</U>. There is no claim, action, suit, arbitration, investigation or other proceeding pending against, or to the knowledge
of the Company and each Subsidiary, threatened against or affecting, the Company, any Subsidiary or any of the Company&#8217;s or any
Subsidiary&#8217;s properties or, to the knowledge of the Company and each Subsidiary, any of its respective officers or directors before
any Governmental Entity, in each case other than legal proceedings that are not reasonably expected to result in a Material Adverse Effect.
Neither the Company nor any Subsidiary, nor any director or officer thereof, is or has been the subject of any action involving a claim
of violation of or liability under federal or state securities laws or a claim of breach of fiduciary duty relating to the Company or
any Subsidiary. There has not been, and to the knowledge of the Company and each Subsidiary, there is not pending or contemplated, any
investigation by the Commission of the Company or any Subsidiary or any current or former director or officer of the Company or any Subsidiary.
The Company has not received any stop order or other order suspending the effectiveness of any registration statement filed by the Company
under the Exchange Act or the Securities Act and, to the Company&#8217;s knowledge, the SEC has not issued any such order.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">5.12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Due
Authorization; Consents</U>. All corporate action on the part of the Company necessary for (a) the authorization, execution and delivery
of, and the performance of all obligations of the Company under Note Documents, (b) the authorization, issuance, execution and delivery
of the Notes by the Company and (c) other than Stockholder Approval with respect to issuances of shares of Common Stock pursuant to the
terms of the Notes in excess of the Exchange Cap, the authorization, issuance, reservation for issuance and delivery by the Company of
all of the equity securities issuable upon conversion of the Notes has been taken. This Agreement and the Notes constitute a valid and
binding obligation of the Company, enforceable in accordance with their respective terms, subject, as to enforcement of remedies, to applicable
bankruptcy, insolvency, moratorium, reorganization and similar laws affecting creditors&#8217; rights generally and to general equitable
principles. All consents, approvals and authorizations of, and registrations, qualifications and filings with, any federal or state governmental
agency, authority or body, or any third party, required in connection with the execution, delivery and performance of this Agreement and
the Notes and the consummation of the transactions contemplated hereby and thereby have been obtained; provided, however, that with respect
to any required filings under Regulation D or any other federal or state securities filings, the Company will make such filings within
fifteen business days after the Execution Date.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">5.13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Valid
Issuance of Stock</U>. The outstanding shares of the capital stock of the Company have been duly and validly issued and are fully paid
and non-assessable. Such shares of capital stock, and all outstanding options and other securities of the Company have been issued in
compliance with the registration and prospectus delivery requirements of the Securities Act of 1933, as amended (the &#8220;<U>Securities
Act</U>&#8221;), and the registration and qualification requirements of applicable state securities laws, or in compliance with applicable
exemptions therefrom, and all other provisions of applicable federal and state securities laws, including, without limitation, anti- fraud
provisions.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>


<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">5.14&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Compliance
with <FONT STYLE="letter-spacing: -0.2pt">Laws</FONT></U><FONT STYLE="letter-spacing: -0.2pt">.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Except
as would not result in a Material Adverse Effect: (i) the Company is and has been in compliance with statutes, laws, ordinances, rules
and regulations applicable to the Company for the ownership, testing, development, manufacture, packaging, processing, use, labeling,
storage, or disposal of any product manufactured by or on behalf of the Company or out-licensed by the Company (a &#8220;<U>Company Product</U>&#8221;),
including without limitation, the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. &sect; 301, et seq., the Public Health Service Act,
42 U.S.C.&sect; 262, similar laws of other Governmental Entities and the regulations promulgated pursuant to <FONT STYLE="letter-spacing: -0.1pt">such
laws (collectively, &#8220;<U>Applicable Laws</U>&#8221;); (ii) the Company possesses all licenses, certificates, </FONT>approvals, authorizations,
permits and supplements or amendments thereto required by any such Applicable Laws and/or for the ownership of its properties or the
conduct of its business as it relates to a Company Product and as described in the SEC Reports (collectively, &#8220;<U>Authorizations</U>&#8221;)
and such Authorizations are valid and in full force and effect and the Company is not in violation of any term of any such Authorizations;
(iii) the Company has not received any written notice of adverse finding, warning letter or other written correspondence or notice from
the U.S. Food and Drug Administration (the &#8220;<U>FDA</U>&#8221;) or any other Governmental Entity alleging or asserting noncompliance
with any Applicable Laws or Authorizations relating to a Company Product; (iv) the Company has not received written notice of any ongoing
claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration or other action from any Governmental Entity or third
party alleging that any Company Product, operation or activity related to a Company Product is in violation of any Applicable Laws or
Authorizations or has any knowledge that any such Governmental Entity or third party is considering any such claim, <FONT STYLE="letter-spacing: -0.1pt">litigation,
arbitration, action, suit, investigation or proceeding, nor, to the Company&#8217;s knowledge, </FONT>has there been any noncompliance
with or violation of any Applicable Laws by the Company that would reasonably be expected to require the issuance of any such written
notice or result in an investigation, corrective action, or enforcement action by the FDA or similar Governmental Entity with respect
to a Company Product; (v) the Company has not received written notice that any Governmental Entity has taken, is taking or intends to
take action to limit, suspend, modify or revoke any Authorizations or has any knowledge that any such Governmental Entity has threatened
or is considering such action with respect to a Company Product; and (vi) the Company has filed, obtained, maintained or submitted all
reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments as required by any Applicable
Laws or Authorizations and that all such reports, documents, forms, notices, applications, records, claims, submissions and supplements
or amendments were complete, correct and not misleading on the date filed (or were corrected or supplemented by a subsequent <FONT STYLE="letter-spacing: -0.1pt">submission).</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>To
the Company&#8217;s knowledge, neither the Company nor any of its directors, officers, employees or agents, has made, or caused the making
of, any false statements on, or material omissions from, any other records or documentation prepared or maintained to comply with the
requirements of the FDA or any other Governmental Entity.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
clinical studies and tests conducted by the Company or on behalf of the Company, have been and, if still pending, are being conducted
in all material respects pursuant to all Applicable Laws and Authorizations; the descriptions of the results of such clinical studies
and tests contained in the SEC Reports are accurate and complete in all material respects and fairly present the data derived from such
clinical studies and tests; the Company is not aware of any clinical studies or tests, the results of which the Company believes reasonably
call into question the research, nonclinical or clinical study or test results described or referred to in the SEC Reports when viewed
in the context in which such results are described; and the Company has not received any written notices or correspondence from any Governmental
Entity requiring the termination, suspension or material modification of any clinical study or test conducted by or on behalf of the Company.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>


<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-indent: 0.5in; font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">5.15&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Intellectual
Property Matters</U>. The Company owns, possesses, licenses or has other rights to use, on reasonable terms, all patents, patent applications,
trade and service marks, trade and service mark registrations, trade names, copyrights, licenses, inventions, trade secrets, technology,
know-how and other intellectual property (collectively, the &#8220;<U>Intellectual Property</U>&#8221;) necessary for the conduct of
the Company&#8217;s business as now conducted or as proposed in the SEC Reports to be conducted (the &#8220;<U>Company Intellectual Property</U>&#8221;),
except for such Intellectual Property the failure of which to own or have a license or other right to use would not reasonably be expected
to have, either individually or in the aggregate, a Material Adverse Effect. To the knowledge of the Company, there are no rights of
third parties to any Company Intellectual Property, other than as licensed by the Company. To the knowledge of the Company, there is
no infringement by third parties of any Company Intellectual Property. There is no pending or, to the Company&#8217;s knowledge, threatened
action, suit, proceeding or claim by others challenging the Company&#8217;s rights in or to any Company Intellectual Property that would
reasonably be expected to have, either individually or in the aggregate, a Material Adverse Effect. There is no pending or, to the Company&#8217;s
knowledge, threatened action, suit, proceeding or claim by others challenging the validity or scope of any Company Intellectual Property
that would reasonably be expected to have, either individually or in the aggregate, a Material Adverse Effect. There is no pending or,
to the Company&#8217;s knowledge, threatened action, suit, proceeding or claim by others that the Company infringes or otherwise violates
any patent, trademark, copyright, trade secret or other proprietary rights of others that would reasonably be expected to have, either
individually or in the aggregate, a Material Adverse Effect. The Company is not aware of any facts required to be disclosed to the USPTO
which have not been disclosed to the USPTO and which would preclude the grant of a patent in connection with any patent application of
the Company Intellectual Property or could form the basis of a finding of invalidity with respect to any issued patents of the Company
Intellectual Property.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">5.16&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Absence
of Changes. Since December 31, 2024</U>: (a) there has not been any Material Adverse Effect or any event or events that individually or
in the aggregate would reasonably be expected to have a Material Adverse Effect; (b) there has not been any dividend or distribution of
any kind declared, set aside for payment, paid or made by the Company on any class of capital stock, (c) neither the Company nor any Subsidiary
has sustained any material loss or interference with the Company&#8217;s or any Subsidiary&#8217;s business from fire, explosion, flood
or other calamity, whether or not covered by insurance, or from any labor disturbance or dispute or any action, order or decree of any
court or arbitrator or governmental or regulatory authority, and (d) neither the Company nor any Subsidiary has incurred any material
liabilities except in the ordinary course of business.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">5.17&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Application
of Takeover Protections</U>. The Company and its Board of Directors have taken all necessary action, if any, in order to render inapplicable
any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar
anti-takeover provision under the Company&#8217;s Charter Documents or the laws of its state of incorporation (including Section 203 of
the Delaware General Corporation Law) that is or could become applicable to each Purchaser as a result of such Purchaser and the Company
fulfilling their obligations or exercising their rights under this Agreement, including without limitation as a result of the Company&#8217;s
issuance of the Conversion Shares and such Purchaser&#8217;s ownership of the Conversion Shares.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">5.18&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Investment
Company Act</U>. Neither the Company nor any of its Subsidiaries is an &#8220;investment company&#8221; or a company &#8220;controlled&#8221;
by an &#8220;investment company&#8221; or a &#8220;subsidiary&#8221; of an &#8220;investment company&#8221;, within the meaning of the
Investment Company Act of 1940.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">5.19&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Ownership
of <FONT STYLE="letter-spacing: -0.1pt">Properties</FONT></U><FONT STYLE="letter-spacing: -0.1pt">.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
Company and each of its Subsidiaries has valid and legal title to, or valid leasehold interests in, all property necessary or used in
the ordinary conduct of its business, except as would not, individually or in the aggregate, reasonably be expected to have a Material
Adverse Effect.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>


<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-indent: 0.5in; font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
the knowledge of the Company, no other Person has contested any right, title or interest of the Company in any Company Intellectual
Property, or any anticipated products and applications derived or expected to be derived therefrom, in each case that would reasonably
be expected to have, either individually or in the aggregate, a Material Adverse <FONT STYLE="letter-spacing: -0.1pt">Effect.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12.05pt 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
property of the Company and each of its Subsidiaries is subject to <FONT STYLE="letter-spacing: -0.25pt">no</FONT> <FONT STYLE="letter-spacing: -0.1pt">Liens.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">5.20&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Disclosure</U>.
The Company understands and confirms that the Purchaser will rely on the foregoing representations in effecting transactions in securities
of the Company. No representation or warranty by the Company contained in this Agreement contains any untrue statement of a material fact
or omits to state any material fact necessary in order to make the statements made therein, in light of the circumstances under which
they were made, not misleading. The Company acknowledges and agrees that the Purchaser does not make and has not made any representations
or warranties with respect to the transactions contemplated hereby other than those specifically set forth in Section 6 hereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000"><B>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><B>REPRESENTATIONS
AND WARRANTIES OF PURCHASERS.</B> Each <FONT STYLE="letter-spacing: -0.1pt">Purchaser,</FONT> severally but not jointly, represents and
warrants to the Company as follows as of the Closing Date as follows:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">6.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Investigation;
Economic Risk</U>. Each Purchaser acknowledges that it has had an opportunity to discuss the business, affairs and current prospects of
the Company with its officers. Each Purchaser further acknowledges having had access to information about the Company that it has requested.
Each Purchaser acknowledges that it is able to fend for itself in the transactions contemplated by this Agreement and has the ability
to bear the economic risks of its investment pursuant to this Agreement. Each Purchaser further acknowledges that it has obtained its
own attorneys, business advisors and tax advisors as to legal, business and tax advice (or has decided not to obtain such advice) and
has not relied on the Company or any of its Subsidiaries for such <FONT STYLE="letter-spacing: -0.1pt">advice.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">6.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Purchase
for Own Account</U>. Each Note issued to each Purchaser will be acquired by such Purchaser for its own account, not as a nominee or agent,
and not with a view to or in connection with the sale or distribution of any part thereof in violation of applicable securities <FONT STYLE="letter-spacing: -0.1pt">laws.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">6.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Exempt
from Registration; Restricted Securities.</U> Each Purchaser understands that the sale of the Notes will not be registered under the Securities
Act on the grounds that the sale provided for in this Agreement is exempt from registration under of the Securities Act, and that the
reliance on such exemption is predicated in part on each Purchaser&#8217;s representations set forth in this Agreement. Each Purchaser
understands that the Notes and the Conversion Shares are restricted securities within the meaning of Rule 144 under the Securities Act,
and must be held indefinitely unless they are subsequently registered or an exemption from such registration is <FONT STYLE="letter-spacing: -0.1pt">available.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">6.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Accredited
Investor</U>. Each Purchaser is an &#8220;accredited investor&#8221; within the meaning of Rule 501 of Regulation D of the Securities
and Exchange Commission.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">6.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Foreign
Purchasers.</U> If a Purchaser is not a United States person (as defined by Section 7701(a)(30) of the Internal Revenue Code of 1986,
as amended (the &#8220;<U>IRC</U>&#8221;)), such Purchaser hereby represents that it has satisfied itself as to the full observance of
the laws of its jurisdiction in connection with any invitation to purchase the Notes or any use of this Agreement, including (i) the legal
requirements within its jurisdiction for the purchase of the Notes, (ii) any foreign exchange restrictions applicable to such purchase,
(iii) any government or other consents that may need to be obtained, and (iv) the income tax and other tax consequences, if any, that
may be relevant to the purchase, holding, redemption, sale or transfer of the Notes or any equity securities
which the Notes may be converted into or exercised for pursuant to the terms hereof. The Company&#8217;s offer and sale and Purchaser&#8217;s
acquisition of and payment for and continued beneficial ownership of the Notes or any equity securities which the Notes may be converted
into pursuant to the terms hereof will not violate any applicable securities or other laws of such Purchaser&#8217;s jurisdiction.</P>


<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">6.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>No
Disqualification Events</U>. No (i) Purchaser, (ii) any of their directors, executive officers, other officers that may serve as a director
or officer of any company in which a Purchaser invests, general partners or managing members, nor (iii) any beneficial owner of the Company&#8217;s
voting equity securities (in accordance with Rule 506(d) of the Securities Act held by a Purchaser is subject to any of the &#8220;bad
actor&#8221; disqualifications described in Rule 506(d)(1)(i) through (viii) under the Securities Act (&#8220;<U>Disqualification Events</U>&#8221;)),
except for Disqualification Events covered by Rule 506(d)(2)(ii) or (iii) or (d)(3) under the Securities Act and disclosed reasonably
in advance of a Closing in writing in reasonable detail to the Company.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000"><B>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><B><FONT STYLE="letter-spacing: -0.1pt">DEFAULT.</FONT></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">7.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Events
of Default</U>. For purposes of this Agreement, the term &#8220;<U>Event of Default</U>&#8221; shall mean any of the following:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 3.95pt 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>default
in any payment of interest on any Note when due and payable, and the default continues for a period of 15 calendar days;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>default
in the payment of the principal or premium, if any, on any Note (including the Redemption Price and Fundamental Change Purchase Price)
when due and payable on the Maturity Date, upon required repurchase, redemption, upon declaration of acceleration or otherwise;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>failure
by the Company to comply with its obligations under Section 4 hereof to convert the Notes upon exercise of a Purchaser&#8217;s conversion
right and such failure continues for three (3) Business Days;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.1pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>failure
by the Company to comply with its obligations under Section <FONT STYLE="letter-spacing: -0.25pt">10</FONT> <FONT STYLE="letter-spacing: -0.1pt">hereof;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.1pt">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>failure
by the Company to issue a notice in accordance with the <FONT STYLE="letter-spacing: -0.1pt">provisions</FONT> of Section 10.1 <FONT STYLE="letter-spacing: -0.1pt">hereof;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>failure
by the Company for 30 days after written notice from the Required Purchasers has been received by the Company to comply with any of its
other agreements contained in the Notes or this Agreement (other than (i) a covenant or warranty a default in whose performance or whose
breach is elsewhere in this Section 7.1 specifically provided for or that is not applicable to the Notes and (ii) Section 12, the failure
to comply with which shall be governed solely by the terms of Section 12 and shall not constitute an Event of Default), which notice
shall state that it is a &#8220;<U>Notice of Default</U>&#8221; hereunder;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
representation or warranty made by the Company under or in connection with this Agreement shall prove to have been incorrect in any material
respect when made;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;failure
by the Company for 30 days after written notice from the Required Purchasers has been received by the Company to cure any default by the
Company or any of its Subsidiaries with respect to any mortgage, agreement or other instrument under which there may be outstanding, or
by which there may be secured or evidenced, any Indebtedness for borrowed money in excess of $10,000,000 in the aggregate of the Company and/or any of the
Subsidiaries of the Company, whether such Indebtedness now exists or shall hereafter be created resulting in such Indebtedness becoming
or being declared due and payable or resulting in such Indebtedness being required to be repurchased, prepaid, defeased or redeemed;</P>


<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the
Company or any Significant Subsidiary of the Company shall commence a voluntary case or other proceeding seeking liquidation, reorganization
or other relief with respect to the Company or such Significant Subsidiary or its debts under any bankruptcy, insolvency or other similar
law now or hereafter in effect or seeking the appointment of a trustee, receiver, liquidator, custodian or other similar official of the
Company or such Significant Subsidiary of the Company or any substantial part of the Company&#8217;s or such Significant Subsidiary of
the Company&#8217;s property, or shall consent to any such relief or to the appointment of or taking possession by any such official in
an involuntary case or other proceeding commenced against it, or shall make a general assignment for the benefit of creditors, or shall
fail generally to pay its debts as they become due;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;an
involuntary case or other proceeding shall be commenced against the Company or any Significant Subsidiary of the Company seeking liquidation,
reorganization or other relief with respect to the Company or such Significant Subsidiary of the Company or its debts under any bankruptcy,
insolvency or other similar law now or hereafter in effect or seeking the appointment of a trustee, receiver, liquidator, custodian or
other similar official of the Company or such Significant Subsidiary of the Company or any substantial part of its property, and such
involuntary case or other proceeding shall remain undismissed and unstayed for a period of 60 consecutive days;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a
final judgment or judgments for the payment of money aggregating in excess of $10,000,000 are rendered against the Company or any of its
Subsidiaries and which judgments are not, within thirty (30) days after the entry thereof, bonded, discharged or stayed pending appeal,
or are not discharged within thirty (30) days after the expiration of such stay; provided, however, that any judgment which is covered
by insurance or an indemnity from a credit worthy party shall not be included in calculating the $10,000,000 amount set forth above so
long as the Company provides the Purchasers a written statement from such insurer or indemnity provider (which written statement shall
be reasonably satisfactory to the Purchasers) to the effect that such judgment is covered by insurance or an indemnity and the Company
or such Subsidiary (as the case may be) will receive the proceeds of such insurance or indemnity within thirty (30) days of the issuance
of such judgment;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000"><FONT STYLE="letter-spacing: -0.1pt">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>any
Material Adverse Effect occurs; <FONT STYLE="letter-spacing: -0.25pt">or</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.1pt">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="color: #010000">(A)
the suspension of the Common Stock from trading on an Eligible Market for a period of two (2) consecutive Trading Days or for more than
an aggregate of ten (10) Trading Days in any 365-day period or (B) the failure of the Common Stock to be listed on an Eligible Market</FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">7.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Acceleration;
Rescission and <FONT STYLE="letter-spacing: -0.1pt">Annulment</FONT></U><FONT STYLE="letter-spacing: -0.1pt">.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>After
the occurrence and during the continuance of an Event of Default, the Required Purchasers or the Designated Agent at the direction of
the Required Purchasers may declare 100% of the principal of, premium, if any, and accrued and unpaid interest, if any, on all the Notes
then Outstanding to be due and payable immediately. If an Event of Default specified in Section 7.1(h<FONT STYLE="color: #010000">), Section
7.1(i) or Section 7.1(j) with respect to the Company occurs and is continuing, 100% of the principal of, premium, if any, and accrued
and unpaid interest, if any, on all Notes shall automatically become due and payable.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; color: #010000"></P>


<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-indent: 0.5in; font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding
anything to the contrary herein, the provisions of Section 7.2(a), however, are subject to the conditions that if, at any
time after the principal of, premium, if any, and accrued and unpaid interest, if any, on, the Notes shall have been so declared due and
payable, and before any judgment or decree for the payment of the monies due shall have been obtained as herein provided:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.05pt">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the
Company pays or delivers, as the case may be, an amount of cash and the number of shares of Common Stock, if any (solely to settle outstanding
conversions), sufficient to pay all matured installments of interest upon all the Notes, all Conversion Consideration, if any, due upon
the conversion of any and all converted Notes, and the principal of and accrued and unpaid interest, if any, on all Notes which shall
have become due otherwise than by acceleration (with interest on such principal and, to the extent that payment of such interest is enforceable
under applicable law, on overdue installments of interest, at the rate or rates, if any, specified in the Notes to the date of such payment
or deposit), and such amount as shall be sufficient to cover all amounts owing under this Agreement and the Notes to the Purchasers;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.05pt">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>rescission
would not conflict with any judgment or decree of a court of competent jurisdiction; and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
and all Events of Default under this Agreement, other than the non-payment of the principal of the Notes that became due because of the
acceleration, shall have been cured, waived or otherwise remedied as provided herein, then, the Required Purchasers, by written notice
to the Company, may waive all Defaults and Events of Default with respect to the Notes (other than a Default or an Event of Default resulting
from the failure to pay the Fundamental Change Purchase Price or Redemption Price, to pay or deliver, as the case may be, the Conversion
Consideration due upon conversion of a Note, or with respect to another covenant or provision of this Agreement or the Notes that cannot
be modified or amended without the consent of each affected Holder) and may rescind and annul the declaration of acceleration resulting
from such Defaults or Events of Default (other than those resulting from the failure to pay the Fundamental Change Purchase Price or Redemption
Price, to pay or deliver, as the case may be, the Conversion Consideration due upon conversion of a Note, or with respect to another covenant
or provision of this Agreement or the Notes that cannot be modified or amended without the consent of each affected Holder) and their
consequences; provided, however, that no such rescission or annulment will extent to or will affect any subsequent Default or shall impair
any right consequent on such <FONT STYLE="letter-spacing: -0.1pt">Default.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">7.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Control
by Majority</U>. At any time, the Required Purchasers may direct in writing the time, method and place of conducting any proceeding for
any remedy available to the Designated Agent or of exercising any trust or power conferred on the Designated Agent. However, the Designated
Agent may refuse to follow any direction that conflicts with law or this Agreement or that the Designated Agent determines to be unduly
prejudicial to the rights of a Purchaser, or that would involve the Designated Agent in personal liability. Prior to taking any action
hereunder, the Designated Agent will be entitled to indemnification satisfactory to it in its sole discretion against all losses and expenses
caused by taking or not taking such action.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">7.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Limitation
on Suits</U>. No Purchaser may pursue a remedy with respect to this Agreement or the Notes unless:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>such
Holder has previously delivered to the Designated Agent written notice that an Event of Default has occurred and is continuing;</P>


<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Required
Purchasers deliver to the Designated Agent a written request that the Designated Agent pursue a remedy with respect to such Event of Default;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>such
Purchaser or Purchasers have offered and, if requested, provided to the Designated Agent reasonable indemnity satisfactory to the Designated
Agent against any loss, liability or other expense of compliance with such written request;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the
Designated Agent has not complied with such written request within 60 days after receipt of such written request and offer of indemnity
or security; and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>during
such 60-day period, the Required Purchasers did not deliver to the Designated Agent a direction inconsistent with such written request.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000"><B>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><B>CONDITIONS
PRECEDENT</B>. This Agreement shall become effective and binding upon the parties hereto on the Execution Date only if the following conditions
precedent have been <FONT STYLE="letter-spacing: -0.1pt">satisfied:</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
Purchasers shall have received (i) a counterpart of this Agreement signed on behalf of each party hereto and (ii) a Note payable to each
Purchaser signed by the Company;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Purchasers shall have received true and complete copies of the resolutions of the Board of Directors of the Company approving this Agreement,
the transactions contemplated hereby and each Note Document to which it is or is to be a party;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company shall have paid or caused to be paid by means of a deduction from the Purchase Price such reasonably incurred and documented fees
and expenses of the Purchasers in connection with the negotiation and preparation of the Note Documents, including the reasonable and
documented fees and expenses of counsel to the Purchasers;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Purchasers shall have received the executed Cooperation Agreement and such other documents as any Purchaser shall have reasonably requested
in connection with this Agreement and the other Note Documents; and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Concurrently
with the Closing of the transactions contemplated in the Note Documents, the Company shall have entered into (i) the second amendment
to the working capital facility agreement with Hercules Capital, Inc., as administrative agent and collateral agent and the lenders party
thereto, which provides for an aggregate principal amount of $110,000,000 on the Closing Date, (ii) the exchange agreement to repurchase,
exchange or convert the outstanding $150,000,000 aggregate principal amount of the 2026 Senior Convertible Notes and (iii) a securities
purchase agreement with the purchasers party thereto pursuant to which the Company shall offer and sell shares of common stock and Series
A convertible preferred stock for aggregate gross proceeds of $27,700,000.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000"><B>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><B>REPURCHASE
AND REDEMPTION; <FONT STYLE="letter-spacing: -0.1pt">COVENANTS.</FONT></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">9.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Purchase
at Option of Purchasers upon a Fundamental <FONT STYLE="letter-spacing: -0.1pt">Change</FONT></U><FONT STYLE="letter-spacing: -0.1pt">.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>If
a Fundamental Change occurs at any time, then each Purchaser shall have the right at such Purchaser&#8217;s option, to require the Company
to purchase for cash any or all of such Purchaser&#8217;s Notes, or any portion thereof in an Authorized Denomination, on a date (the
&#8220;<U>Fundamental Change Purchase Date</U>&#8221;) specified by the Company that is not less than 20 Business Days or more than 35
Business Days following the date on which the Company delivers the Fundamental Change Company Notice, at a purchase price equal to 100%
of the principal amount of the Notes to be purchased, plus accrued and unpaid interest thereon, if any, to, but excluding, the Fundamental
Change Purchase Date (the &#8220;<U>Fundamental Change Purchase Price</U>&#8221;).</P>


<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
or before the fifth (5th) Business Day after the occurrence of a Fundamental Change, the Company shall provide to all Purchasers a written
notice (the &#8220;<U>Fundamental Change Company Notice</U>&#8221;) of the occurrence of such Fundamental Change and of the purchase
right at the option of the Purchasers arising as a result thereof. Such notice shall be sent in accordance with Section 12.5 hereof.
Each Fundamental Change Company Notice shall specify:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.05pt">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the
events causing the Fundamental <FONT STYLE="letter-spacing: -0.1pt">Change;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.05pt">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the
Effective Date of the Fundamental Change, whether the Fundamental Change is a Make-Whole Fundamental Change, and, if so, the Effective
Date of such Make-Whole Fundamental Change;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
last date on which a Holder of Notes may exercise the purchase right pursuant to Section 9.1;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Fundamental Change Purchase Price;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Fundamental Change Purchase Date;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
applicable Conversion Rate and any adjustments to the applicable Conversion Rate resulting from the Fundamental Change (including as a
result of a Make-Whole Fundamental Change), if applicable;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(vii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;if
applicable, that the Notes with respect to which a Fundamental Change Purchase Notice has been delivered by a Purchaser may be converted
only if such Purchaser withdraws the Fundamental Change Purchase Notice;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(viii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;that
the Purchasers must exercise the purchase right prior to the Fundamental Change Expiration Time;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(ix)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;that
the Purchasers shall have the right to withdraw any Notes surrendered for purchase prior to the Fundamental Change Expiration Time; and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(x)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
procedures that Purchasers must follow to require the Company to purchase their Notes.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>No
failure of the Company to give the foregoing notices and no defect therein shall limit the Purchasers&#8217; repurchase rights or affect
the validity of the proceedings for the repurchase of the Notes pursuant to Section 9.1, except to the extent Purchaser is prejudiced
thereby.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchases
of Notes under Section 9.1 shall be made, at the option of a Purchaser thereof upon delivery to the Company by such Purchaser of a duly
completed notice (the &#8220;<U>Fundamental Change Purchase Notice</U>&#8221;), in the form set forth in Attachment 2 to the Form of
Note attached hereto as Exhibit A, prior to Close of Business on the Business Day immediately preceding the Fundamental Change Purchase
Date (the &#8220;<U>Fundamental Change Expiration Time</U>&#8221;).</P>


<!-- Field: Page; Sequence: 37 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Fundamental Change Purchase Notice in respect of any Notes to be purchased shall state:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.05pt">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the
portion of the principal amount of such Notes to be purchased, which must be an integral multiple of $1,000; and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;that
such Notes are to be purchased by the Company pursuant to the applicable provisions of the Notes and this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Upon
receipt by the Company of a Fundamental Change Purchase Notice specified in Section 9.1(b), the Purchaser of the Note in respect of which
such Fundamental Change Purchase Notice was given shall (unless such Fundamental Change Purchase Notice is withdrawn in accordance with
Section 9.1(g)) thereafter be entitled to receive solely the Fundamental Change Purchase Price, in cash, with respect to such Note. Such
Fundamental Change Purchase Price shall be paid to such Purchaser on the later of (x) the applicable Fundamental Change Purchase Date
(provided the conditions in this Section 9.1 have been satisfied, and subject to extensions to comply with applicable law) and (y) the
time of delivery of such Note to the Company by the Purchaser thereof in the manner required by Section 9.1 (which, for the avoidance
of doubt, may occur after the Fundamental Change Expiration Time).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
Fundamental Change Purchase Notice may be withdrawn (in whole or in part) by means of a written notice of withdrawal delivered to the
Company in accordance with the Fundamental Change Company Notice at any time prior to the Fundamental Change Expiration Time specifying:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.05pt">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the
principal amount of the withdrawn Notes, which must be an integral multiple of $1,000, with respect to which such notice of withdrawal
is being submitted;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;if
previously delivered, the certificate numbers of the withdrawn Notes; and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
principal amount, if any, of each Note that remains subject to the Fundamental Change Purchase Notice which must be an integral multiple
of <FONT STYLE="letter-spacing: -0.1pt">$1,000.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">The Company will promptly return to the respective Purchasers thereof any Notes
with respect to which a Fundamental Change Purchase Notice has been withdrawn in compliance with the provisions of this Section 9.1. If
not previously delivered, following the Fundamental Change Expiration Time, (unless such Fundamental Change Purchase Notice is withdrawn
in accordance with Section 9.1(g)), the Purchaser shall be obligated to deliver the subject Notes in accordance with Section 9.1.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 3.95pt 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">9.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Deposit
of Fundamental Change Purchase Price or Redemption Price</U>. Prior to 12:00 p.m., New York City time, on the later of (<U>x) Fundamental
Change Purchase Date or Redemption Date and</U> (y) the date the Purchaser delivers the subject Notes, the Company shall deposit with
the Purchasers an amount of money (in immediately available funds if deposited on such Business Day) sufficient to pay the Fundamental
Change Purchase Price or the Redemption Price, as applicable, of all the Notes or portions thereof that are to be purchased as of the
Fundamental Change Purchase Date or Redemption Date, as applicable. If the applicable Purchasers are wired cash sufficient to pay the
Fundamental Change Purchase Price or the Redemption Price of the Notes for which a Fundamental Change Purchase Notice or Redemption Notice
has been tendered and not withdrawn in accordance with this Agreement on the Fundamental Change Purchase Date or Redemption Date, as
applicable, then, as of such Fundamental Change Purchase Date or Redemption Date (a) such Notes will cease to be outstanding and interest
will cease to accrue thereon (whether or not such Notes have been delivered to the Company) and (b) all other rights of a Purchaser in
respect thereof will terminate (other than the right to receive the Fundamental Change Purchase Price or the Redemption Price, as applicable,
and any previously accrued and unpaid interest on such Notes upon delivery of such <FONT STYLE="letter-spacing: -0.1pt">Notes).</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 3.95pt 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.1pt"></FONT></P>

<!-- Field: Page; Sequence: 38 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 3.95pt 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.1pt"></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 3.95pt 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.1pt"><FONT STYLE="color: #010000">9.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Notes
Purchased or Redeemed in Whole or in Part</U>. Any Note that is to be purchased or redeemed pursuant to this Section 9, whether in whole
or in part, shall be surrendered to the Company (with due endorsement by, or a written instrument of transfer in form satisfactory to
the Company duly executed by, the Purchaser thereof or such Purchaser&#8217;s attorney duly authorized in writing) and, to the extent
that only a part of the Note so surrendered is to be purchased or redeemed, the Company shall execute and deliver to the Purchaser of
such Note, without service charge, a new Note or Notes, of any Authorized Denomination as requested by such Purchaser (or in the case
of a Redemption, the Company) in aggregate principal amount equal to, and in exchange for, the portion of the principal amount of the
Note so surrendered that is not purchased or redeemed.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 3.95pt 0 12pt; text-align: justify; text-indent: 0.5in">9.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Covenant
To Comply with Applicable Laws upon Purchase of Notes</U>. In connection with any offer to purchase Notes under Section 9.1, the Company
shall, in each case if required by law, (i) comply with Rule 13e-4, Regulation 14E and any other tender offer rules under the Exchange
Act that may then be applicable, (ii) file a Schedule TO or any other required schedule under the Exchange Act and (iii) otherwise comply
with all U.S. federal or state securities laws applicable to the Company in connection with such purchase offer, in each case, so as to
permit the rights and obligations under this Section 9 to be exercised in the time and in the manner specified under this Section 9.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 3.95pt 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">9.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Right
of the Company to Redeem the <FONT STYLE="letter-spacing: -0.1pt">Notes</FONT></U><FONT STYLE="letter-spacing: -0.1pt">.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
Company may not redeem the Notes at its option at any time before September 1, 2026.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Subject
to the terms of this Section 9.5, on or after September 1, 2026, the Company has the right, at its election, to redeem all, or any portion
of the Notes in an Authorized Denomination, at any time and from time to time during such period, for a cash purchase price equal to the
Redemption Price, but only if as of the applicable Redemption Notice Date until the related Redemption Date, inclusive, the Last Reported
Sale Price per share of Common Stock exceeds two hundred percent (200%) of the Conversion Price on each of at least twenty (20) Trading
Days (whether or not consecutive) during the thirty (30) consecutive Trading Days ending on, and including, the Trading Day immediately
before the Redemption Notice Date for such Redemption (the &#8220;<U>Redemption Price Condition</U>&#8221;). Notwithstanding anything
herein to the contrary, the Company shall not exercise its Redemption right, or otherwise send a Redemption Notice, with respect to any
Note pursuant to this Section 9.5 unless the Liquidity Conditions are satisfied with respect to such Redemption from the applicable Redemption
Notice Date until the related Redemption Date, inclusive.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
&#8220;<U>Redemption Date</U>&#8221; for any Redemption will be a Business Day of the Company&#8217;s choosing that is no more than twenty
(20), nor less than ten (10), Scheduled Trading Days after the Redemption Notice Date for such Redemption.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
&#8220;<U>Redemption Price</U>&#8221; for any Note called for Redemption is an amount in cash equal to the principal amount of such Note
plus accrued and unpaid interest on such Note to, but excluding, the Redemption Date for such Redemption.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 39 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
call any Notes for Redemption, the Company must send to each Purchaser of such Notes a written notice of such Redemption (a &#8220;<U>Redemption
Notice</U>&#8221;). Such Redemption Notice must state:<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.05pt">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>that
the Notes have been called for Redemption, and briefly describing the Company&#8217;s Redemption right under this Agreement;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.05pt">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the
Redemption Date for such <FONT STYLE="letter-spacing: -0.1pt">Redemption;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.05pt">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the
Redemption Price per $1,000 principal amount of Notes for <FONT STYLE="letter-spacing: -0.2pt">such</FONT> <FONT STYLE="letter-spacing: -0.1pt">Redemption;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.05pt">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>that
Notes called for Redemption may be converted at any <FONT STYLE="letter-spacing: -0.2pt">time</FONT> before the Close of Business on the
Business Day immediately before the Redemption Date (or, if the Company fails to pay the Redemption Price due on such Redemption Date
in full, at any time until such time as the Company pays such Redemption Price in full);</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.05pt">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the
Conversion Rate in effect on the Redemption Notice Date for such Redemption and a description and quantification of any adjustments to
the Conversion Rate that may result from such Redemption;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.05pt">(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>that
Notes called for Redemption must be delivered to the Company for the Purchaser thereof to be entitled to receive the Redemption Price;
and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.05pt">(vii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>that
the Liquidity Conditions are satisfied as of the applicable Redemption Notice Date and that such Redemption Notice shall be deemed automatically
rescinded with respect to such Holder if any of the Liquidity Conditions and/or the Price Condition are not satisfied (or waived in writing
by such Holder) at any time prior to the related Redemption <FONT STYLE="letter-spacing: -0.1pt">Date.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 3.95pt 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>If
less than all Notes then outstanding are called for Redemption, <FONT STYLE="letter-spacing: -0.1pt">then:</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.05pt">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the
Notes will be selected by the Company pro rata from each issuer based on the amount of Notes originally purchased by each Purchaser; and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;if
only a portion of a Note is subject to Redemption and such Note is converted in part following delivery of the Redemption Notice, then
the converted portion of such Note will be deemed to be from the portion of such Note that was subject to Redemption.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.1pt">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Without
limiting the Company&#8217;s obligation to deposit the Redemption Price by the time proscribed by Section 9.2, the Company will cause
the Redemption Price for a Note (or portion thereof) subject to Redemption to be paid to the Purchaser thereof on or before the later
of (i) the applicable Redemption Date; and (ii) the date such Note is delivered to the Company. Notes called for Redemption must be delivered
to the Company for the Purchaser thereof to be entitled to receive the Redemption Price.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">9.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT><U>Covenants</U>.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.1pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
Company shall file a preliminary proxy statement, substantially in a form which shall be provided to the Purchasers and McDermott Will
Schulte LLP for review, with the SEC within thirty (30) calendar days after the Closing Date, to seek stockholder approval at the next
special or annual meeting of stockholders of the Company (the &#8220;<U>Stockholder Meeting</U>&#8221;) to approve the Company&#8217;s
issuance of all of the Conversion Shares (assuming settlement of conversions solely in Common Stock) as described in this Agreement in
accordance with applicable law and the rules and regulations of the Nasdaq Capital Market without giving effect to the Exchange Cap (such
affirmative approval being referred to herein as the &#8220;<U>Stockholder Approval</U>&#8221;), and the Company shall promptly but in any
event prior to December 31, 2025 call and hold the Stockholder Meeting after filing such proxy statement, use its reasonable best efforts
to solicit its stockholders&#8217; approval of such resolutions, to cause the Board of Directors of the Company to recommend to the stockholders
that they approve such resolutions and to cause its officers and directors to vote their shares in favor of the Stockholder Approval.</P>


<!-- Field: Page; Sequence: 40 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"> The Company shall be obligated to use its reasonable best efforts to obtain the Stockholder Approval as promptly as practicable. If,
despite the Company&#8217;s reasonable best efforts the Stockholder Approval is not obtained at such Stockholder Meeting Deadline, the
Company shall cause an additional Stockholder Meeting to be held every ninety (90) days thereafter until such Stockholder Approval is
obtained.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.1pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Within
30 days after the Closing, the Company shall enter into an agreement with the Designated Agent in the form mutually agreed to by the
parties, in order to preserve to the extent possible the Company&#8217;s net operating losses (&#8220;<U>Net Operating Losses</U>&#8221;)
in accordance with Section 382 of the IRC.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
the date of this Agreement or prior to 9:00 A.M., New York City time, on the first (1st) Business Day immediately following the date
of this Agreement, the Company shall issue a press release or file with the Commission a Current Report on Form 8-K (the &#8220;<U>Disclosure
Document</U>&#8221;) disclosing all material terms of this Agreement and the Notes and disclosing any other material, non-public information
that the Company or any of its representatives, Affiliates, officers, directors, or employees or agents has provided to the Purchasers
or any of the Purchasers&#8217; Affiliates, attorneys, agents or representatives at any time prior to the issuance or filing of the Disclosure
Document. Within two (2) Business Days immediately following the date of this Agreement, the Company shall file with the Commission a
Current Report on Form 8-K attaching this Agreement (and all schedules and exhibits to this Agreement) and the Notes as exhibits on such
Current Report on Form 8-K. The Company shall provide the Purchasers with a draft of the Disclosure Document sufficiently in advance
to provide the Purchasers with a reasonable opportunity to review and provide comments to the Company with respect to the Disclosure
Document, which comments the Company shall consider in good faith. Upon the issuance of the Disclosure Document, the Purchasers and the
Purchasers&#8217; Affiliates, attorneys, agents and representatives shall not be in possession of any material, non-public information
received from the Company, any Subsidiary or any of their respective representatives, Affiliates, officers, directors, or employees or
agents. Each Purchaser, severally and not jointly with the other Purchasers, covenants that until the issuance or filing of the Disclosure
Document, such Purchaser will maintain the confidentiality of all disclosures made to it in connection with this transaction (including
the existence and terms of this transaction). Upon the issuance or filing of the Disclosure Document, each Purchaser shall no longer
be subject to any confidentiality or similar obligations under any current agreement, whether written or oral, with the Company, any
Subsidiary or any of their respective representatives, Affiliates, officers, directors, employees or agents. The Company understands
and confirms that such Purchaser and its Affiliates will rely on the foregoing representations in effecting transactions in securities
of the Company. Notwithstanding anything in this Agreement to the contrary, the Company (A) shall not publicly disclose the name of any
Purchaser or any of its Affiliates or advisers, or include the name of such Purchaser or any of its Affiliates or advisers in any press
release, without the prior written consent of such Purchaser and (B) shall not publicly disclose the name of any Purchaser or any of
its Affiliates or advisers, or include the name of such Purchaser or any of its Affiliates or advisers in any filing with the Commission
or any regulatory agency or trading market, without the prior written consent of such Purchaser, except (1) as required by the federal
securities laws, rules or regulations and (2) to the extent such disclosure is required by other laws, rules or regulations, at the request
of the staff of the Commission or regulatory agency or under the regulations of the Nasdaq Capital Market, in which case of clause (1)
or (2), the Company shall provide such Purchaser with prior written notice (including by e-mail) of such permitted disclosure, and shall
reasonably consult with such Purchaser regarding such disclosure.</P>


<!-- Field: Page; Sequence: 41 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000"><B>10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><B>SUCCESSOR
<FONT STYLE="letter-spacing: -0.1pt">COMPANY</FONT></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">10.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Company
May Consolidate, Etc. on Certain Terms</U>. The Company shall not amalgamate or consolidate with, consummate a binding share exchange
with, merge with or into or sell, convey, transfer or lease all or substantially all of the consolidated properties and assets of the
Company and its Subsidiaries, taken as a whole, to another Person or enter into a transaction that is a Fundamental Change, unless:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the
resulting, surviving transferee or successor Person (the &#8220;<U>Successor Company</U>&#8221;), if not the Company, shall be a corporation
organized or incorporated and existing under the laws of the United States of America, any State thereof or the District of Columbia,
and the Successor Company (if not the Company) shall expressly assume, by an amendment in form and substance reasonably acceptable to
the Requisite Purchasers, all of the obligations of the Company under the Notes and this Agreement; and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;immediately
after giving effect to such transaction, no Default or Event of Default shall have occurred and be continuing under this Agreement with
respect to the Notes.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Notwithstanding the foregoing,
in the event that upon the occurrence of any such amalgamation, consolidation, binding share exchange, merger, sale conveyance, transfer
or transaction that is a Fundamental Change permitted by this Section 10, the Notes would become convertible into, or exchangeable for,
securities issued by a Person that is the direct or indirect parent entity (the &#8220;<U>Successor Parent Entity</U>&#8221;) of the
resulting, surviving, transferee or successor corporation in such transaction, such Successor Parent Entity shall expressly assume, by
an amendment in form and substance reasonably acceptable to the Requisite Purchasers, all of the obligations of the Company under the
Notes and this Agreement, and such Successor Parent entity shall thereafter be deemed to be the &#8220;<U>Successor Company</U>&#8221;
for all purposes under this Agreement (including this Section 10) and the Notes.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">10.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Rights
of Successor Company</U>. Upon any such amalgamation, consolidation, merger, conveyance, share exchange, transfer, lease or transaction
that is a Fundamental Change, the Successor Company (if not the Company) shall succeed to, and may exercise every right and power of the
Company under this Agreement, and (except in the case of a lease) the Company shall be discharged from its obligations under the Notes
and this Agreement except in the case of any such lease.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">10.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Successor
Corporation to Be Substituted</U>. In case of any such amalgamation, consolidation, merger, share exchange, conveyance, transfer, lease
or transaction that is a Fundamental Change and upon the assumption by the Successor Company (if other than the Company), by an amendment
to this Agreement, executed and delivered to the Purchasers and reasonably satisfactory in form and substance to the Requisite Purchasers,
of the due and punctual payment of the principal of and premium (including any Fundamental Change Purchase Price and Redemption Price),
if any, accrued and unpaid interest, if any, on all of the Notes, the due and punctual delivery or payment, as the case may be, of any
consideration due upon conversion of the Notes and the due and punctual performance of all of the covenants and conditions of this Agreement
to be performed by the Company under this Agreement, such Successor Company shall succeed to and be substituted for, and may exercise
every right and power of, the Company under this Agreement, with the same effect as if it had been named herein as the party of the first
part. All the Notes so issued shall in all respects have the same legal rank and benefit under this Agreement as the Notes theretofore
or thereafter issued in accordance with the terms of this Agreement as though all of such Notes had been issued at the date of the execution
hereof. In the event of any such amalgamation, consolidation, merger, share exchange, conveyance, transfer
(but not in the case of a lease), or transaction that is a Fundamental Change, the Person named as the &#8220;Company&#8221; in the first
paragraph of this Agreement as of the date hereof or any successor that shall thereafter have become such in the manner prescribed in
this Section 10 may be dissolved, wound up and liquidated at any time thereafter and, except in the case of a lease, such Person shall
be released from its liabilities as obligor and maker of the Notes and from its obligations under this Agreement.</P>


<!-- Field: Page; Sequence: 42 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000"><B>11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><B><FONT STYLE="letter-spacing: -0.1pt">MISCELLANEOUS.</FONT></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">11.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Governing
Law; Jurisdiction; Waiver of Jury Trial</U>. This Agreement shall be governed in all respects by and construed in accordance with the
laws of the State of New York without regard to provisions regarding choice of laws. Each of the parties hereto hereby irrevocably and
unconditionally submits, for itself and its property, to the nonexclusive jurisdiction of any New York State court or Federal court of
the United States of America sitting in New York City, and any appellate court from any thereof, in any action or proceeding arising out
of or relating to this Agreement or any of the other Note Documents to which it is a party, or for recognition or enforcement of any judgment,
and each of the parties hereto hereby irrevocably and unconditionally agrees that all claims in respect of any such action or proceeding
may be heard and determined in any such New York State court or, to the fullest extent permitted by law, in such Federal court. Each of
the Company, the Designated Agent and the Purchasers irrevocably waives all right to trial by jury in any action, proceeding or counterclaim
(whether based on contract, tort or otherwise) arising out of or relating to any of the Note Documents or the actions of the Designated
Agent or any Purchaser in the negotiation, administration, performance or enforcement <FONT STYLE="letter-spacing: -0.1pt">thereof.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">11.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Successors
and <FONT STYLE="letter-spacing: -0.1pt">Assigns</FONT></U><FONT STYLE="letter-spacing: -0.1pt">.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Except
as otherwise expressly provided herein, the provisions hereof shall inure to the benefit of, and be binding upon, the successors and assigns
of the parties hereto. Except as contemplated by Section 10, without the prior written consent of the Requisite Purchasers, the Company
may not assign any of its rights or obligations under this Agreement or any Note, and any such purported assignment shall be void. Prior
to September 1, 2026, whether or not any Event of Default has occurred and is continuing, no Purchaser may assign or grant a participation
in its Note or its rights and obligations hereunder or under any Note to a third party that is not an Affiliate. On and after September
1, 2026, each Purchaser may assign or grant a participation in its Note or its rights and obligations hereunder or under any Note; <U>provided</U>,
that (i) with respect to any assignment, such Purchaser or any registered assign, as applicable, shall provide to the Company the relevant
documentation effecting the assignment and, for the avoidance of doubt, no such assignment shall be effective until recorded in the Register
in accordance with Section 11.2(b), (ii) any assignee shall agree to be bound by the terms of this Agreement and any other Note Document,
as applicable, and (iii) with respect to any grant of a participation right, the Purchaser or registered assign that grants such participation
right shall, acting solely for this purpose as a non-fiduciary agent of the Company, maintain a register on which it enters the name and
address of the participant and the principal amounts (and stated interest) of the participant&#8217;s interest in the Note.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
Company shall maintain a copy of the assignment documentation provided to it by any Purchaser (or any registered assign) and a register
for the recordation of the names and addresses of the Purchasers, and the principal amounts (and stated interest) of each Note owing to
each Purchaser (or any registered assign) pursuant to the terms hereof from time to time (the &#8220;<U>Register</U>&#8221;). The entries
in the Register shall be conclusive absent manifest error, and the Company and each Purchaser (and registered assign) shall treat each
Person whose name is recorded in the Register pursuant to the terms hereof as a Purchaser hereunder for all purposes of this Agreement.
The Register shall be available for inspection by any Purchaser (or registered assign) at any
reasonable time and from time to time upon reasonable prior notice.</P>


<!-- Field: Page; Sequence: 43 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">11.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Entire
Agreement</U>. This Agreement and the Notes, and the Exhibits and Schedules hereto and thereto (collectively, the &#8220;<U>Note Documents</U>&#8221;)
constitute the entire understanding and agreement between the parties with regard to the subjects hereof and thereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">11.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Notices</U>.
All notices, requests, waivers and other communications made pursuant to this Agreement shall be in writing and shall be deemed delivered,
given and received when delivered (by hand, by courier or express delivery service or by e-mail) to the address or e-mail address set
forth beneath the name of such party on its signature page to this Agreement (or to such other address or e-mail address as such party
will have specified in a written notice given to the other parties hereto). Notice shall be deemed given when sent electronically (via
email), provided that a confirming copy of such notice shall be sent in print form, unless the sender receives an acknowledgement of receipt
of the electronic notice (e.g., reply email). In the event that notice is given to the Company, a courtesy copy, which shall not constitute
notice, shall also be provided to DLA Piper LLP (US), 51 John F. Kennedy Parkway, Suite 120, Short Hills, New Jersey 07078, Attention:
Andrew P. Gilbert and Emilio Ragosa, E-mail: andrew.gilbert@us.dlapiper.com and emilio.ragosa@us.dlapiper.com. In the event that notice
is given to a Purchaser or to the Designated Agent, a courtesy copy, which shall not constitute notice, shall also be provided to <FONT STYLE="letter-spacing: -0.1pt">McDermott
Will Schulte LLP, 919 Third Avenue, New York, New York 10022, Attention: Eleazer</FONT> N. Klein, E-mail: <FONT STYLE="letter-spacing: -0.1pt">eleazer.klein@srz.com.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">11.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Amendments
and Termination</U>. Any term of this Agreement and any Note may be amended only with the written consent of the Company, the Designated
Agent and the Requisite Purchasers. However, no amendment may, without the consent of all affected Purchasers (a) reduce the percentage
of Purchasers required to take or approve any action hereunder or thereunder; (b) reduce the amount or change the time of payment of any
amount owing or payable with respect to any Note or change the rate of interest or the manner of calculation of interest payable with
respect to any Note; (c) alter or modify in any respect, or waive, the provisions with respect to the conversion or redemption of the
Notes; or (d) except as contemplated by Section 10 herein, consent to any assignment of the Company&#8217;s rights under the Note Documents.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">11.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Titles
and Subtitles</U>. The titles of the sections and clauses of this Agreement are for convenience of reference only and are not to be considered
in construing this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">11.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Counterparts</U>.
This Agreement may be executed in any number of counterparts, each of which shall be an original, but all of which together shall constitute
one instrument. Electronic delivery of an executed counterpart of a signature page (including, without limitation, by e-mail of a scanned
signature page or electronic signature via DocuSign) shall be effective as delivery of an original executed counterpart.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">11.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Severability.</U>
Should any provision of this Agreement be determined to be illegal or unenforceable, such determination shall not affect the remaining
provisions of this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">11.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Expenses</U>.
The Company agrees to reimburse the Designated Agent on demand for the reasonable costs and expenses of one counsel for the Designated
Agent actually incurred in connection with (i) the preparation, execution, delivery, administration, modification and amendment of, or
any consent or waiver under, the Note Documents; and (ii) the enforcement of the Note Documents, whether in any action, suit or litigation,
or any bankruptcy, insolvency or other similar proceeding affecting creditors&#8217; rights generally (including
the reasonable documented fees and expenses of counsel for the Designated Agent and each Purchaser with respect thereto).</P>


<!-- Field: Page; Sequence: 44 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">11.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Allocation
of Payments</U>. The Purchasers acknowledge that the Notes are <I>pari passu </I>obligations against each of the other Notes. Each payment
of interest or principal on the Notes shall be allocated among all of the Notes at the time outstanding in proportion, as nearly as practicable,
to the respective unpaid balances of principal outstanding thereunder. If any Purchaser shall, by exercising any right of setoff or counterclaim
or otherwise, obtain payment in respect of any principal of or interest under any of his, her or its Notes or other obligations hereunder
in an amount in excess of his, her or its pro rata share thereof as provided herein, then such Purchaser shall forthwith pay such excess
to the Designated Agent which amount the Designated Agent shall thereupon pay to the Purchasers on a pro rata basis.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">11.11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Interest
Rate Limitation</U>. Notwithstanding anything to the contrary contained in any Note Document, the interest paid or agreed to be paid under
the Note Documents shall not exceed the maximum rate of non-usurious interest permitted by applicable Law (the &#8220;<U>Maximum Rate</U>&#8221;).
If any Purchaser shall receive interest in an amount that exceeds the Maximum Rate, the excess interest shall be applied to the principal
of the Notes or, if it exceeds such unpaid principal, refunded to the Company. In determining whether the interest contracted for, charged,
or received by the Purchasers exceeds the Maximum Rate, such Person may, to the extent permitted by applicable law, (a) characterize any
payment that is not principal as an expense, fee, or premium rather than interest, (b) exclude voluntary prepayments and the effects thereof,
and (c) amortize, prorate, allocate, and spread in equal or unequal parts the total amount of interest throughout the contemplated term
of the obligations hereunder.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">11.12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Certain
Tax Matters</U>. Any and all payments by or on account of any obligation of the Company under the Notes or this Agreement shall be made
without deduction or withholding for any taxes, levies, imposts, duties, deductions, withholdings or assessments, fees or other charges
imposed by any governmental authority, including any interest, additions to tax or penalties applicable thereto (&#8220;<U>Taxes</U>&#8221;),
except as required by applicable law. If the Company is required by applicable law to withhold or deduct any Taxes from any such payment,
then the Company shall withhold or deduct such Taxes, the Company shall timely pay the full amount withheld or deducted to the relevant
taxing authority in accordance with applicable law, and the sum payable by the Company shall be increased as necessary so that after deduction
or withholding has been made for any such Tax (other than any such Tax that is an income Tax), including such deductions or withholdings
applicable to additional sums payable under this Section 11.12, the applicable recipient receive an amount equal to the sum it would have
received had no such deduction or withholding been made. Notwithstanding the foregoing, the increase of the sum payable described in the
immediately preceding sentence shall not be required with respect to payments by or on account of any obligation of the Company under
the Notes or this Agreement for Taxes withheld or deducted from such payments (A) to the extent such Taxes result from the failure of
the applicable recipient to provide to the Company (i) a valid properly executed Internal Revenue Service Form W-9 (if such recipient
is a U.S. person for U.S. federal income <FONT STYLE="letter-spacing: -0.25pt">tax</FONT> purposes) or (ii) a valid properly executed
appropriate Internal Revenue Service Form W-8 (if such recipient is not a U.S. person for U.S. federal income tax purposes) establishing
a complete exemption from U.S. federal tax withholding to the extent it is legally entitled to do so or (B) in the case of a Purchaser
(or registered assign) that is not a U.S. person for U.S. federal income tax purposes, to the extent such Taxes are U.S. federal withholding
Taxes imposed on amounts payable to or for the account of such person with respect to an applicable interest in a Note pursuant to a law
in effect on the date on which (i) such person acquires such interest in the Note or (ii) such person changes its lending office, except
in each case to the extent that amounts with respect to such Taxes were payable either to such person&#8217;s assignor immediately before
such person became a party hereto or to such person immediately before it changed its lending office. The Company agrees to pay any and all stamp, court or documentary,
intangible, recording, filing or similar Taxes that arise in respect of this Agreement or the Note.</P>


<!-- Field: Page; Sequence: 45 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">11.13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Mutilated,
Destroyed, Lost and Stolen Notes</U>. If any mutilated Note is surrendered to the Company, the Company shall execute and deliver in exchange
therefor a new Note of like tenor and principal amount and bearing a number not contemporaneously outstanding. If there shall be delivered
to the Company (i) evidence to its satisfaction of the destruction, loss or theft of any Note and (ii) such security or indemnity as may
be required by it to save it and any of its agents harmless and such other reasonable requirements as may be imposed by the Company as
permitted by Section 8-405 of the Uniform Commercial Code have been satisfied, then, in the absence of notice to the Company that such
Note has been acquired by a bona fide purchaser, the Company shall execute in lieu of any such destroyed, lost or stolen Note, a new Note
of like tenor and principal amount and bearing a number not contemporaneously outstanding.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">In case any such
mutilated, destroyed, lost or stolen Note has become or is about to become due and payable, the Company in its discretion may, instead
of issuing a new Note, pay such <FONT STYLE="letter-spacing: -0.1pt">Note.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Upon the issuance
of any new Note under this Section 11.13, the Company may require payment by the applicable Purchaser of a sum sufficient to cover any
tax or other governmental charge that may be imposed in relation thereto and any other expenses connected therewith.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Every new Note issued
pursuant to this Section 11.13 in lieu of any destroyed, lost or stolen Note shall constitute an original additional contractual obligation
of the Company, whether or not the destroyed, lost or stolen Note shall be at any time enforceable by anyone, and shall be entitled to
all the benefits of this Agreement equally and proportionately with any and all other Notes duly issued hereunder.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The provisions of this Section
11.13 are exclusive and shall preclude (to the extent lawful) all other rights and remedies with respect to the replacement or payment
of mutilated, destroyed, lost or stolen Notes.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">11.14&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Accounting
Matters</U>. It is the intent of the Parties that this Agreement and the Notes will not give rise to derivative or &#8220;mark-to-market&#8221;
liability accounting. To the extent that such accounting treatment is required, the Parties will use commercially reasonable efforts to
make such modifications to the Agreement and the Note as may be reasonably required to eliminate such accounting treatment, provided that
no such revisions shall substantively affect the rights or obligations of the Parties hereunder.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000"><B>12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><B><FONT STYLE="letter-spacing: -0.1pt">REGISTRATION</FONT>
RIGHTS OF <FONT STYLE="letter-spacing: -0.1pt">PURCHASERS.</FONT></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">12.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Mandatory
Registration</U>. The Company shall prepare, and, as soon as practicable but in no event later than 30 days after the Closing Date (the
&#8220;<U>Filing Deadline</U>&#8221;), file with the Commission a Registration Statement under the Securities Act on appropriate form
covering the resale of the full amount of the Conversion Shares (the &#8220;<U>Registrable Securities</U>&#8221;). The Company shall use
commercially reasonable efforts to have the Registration Statement declared effective by the Commission as soon as practicable, but in
no event later than the date (the &#8220;<U>Effectiveness Deadline</U>&#8221;), which shall be either: (i) in the event that the Commission
does not review the Registration Statement, 60 days after the Closing Date, or (ii) in the event that the Commission reviews the Registration
Statement, 90 days after the Closing Date (but in any event, no later than three Business Days following the Commission indicating that
it has no further comments on the Registration Statement). Subject to any comments from the staff of the Commission (the &#8220;<U>Staff</U>&#8221;),
such Registration Statement shall include the plan of distribution attached hereto as <U>Exhibit B</U>; provided, however, that no Purchaser shall
be named as an &#8220;underwriter&#8221; in the Registration Statement without the Purchaser&#8217;s prior written consent. Such Registration
Statement shall not include any shares of Common Stock or other securities for the account of any other holder without the prior written
consent of the Requisite Purchasers.</P>


<!-- Field: Page; Sequence: 46 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">12.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Effect
of Failure to File and Obtain and Maintain Effectiveness of Registration Statement</U>. If either: (a) a Registration Statement covering
all of the Registrable Securities required to be covered thereby and required to be filed by the Company pursuant to this Agreement is:
(i) not filed with the Commission on or before the Filing Deadline (a &#8220;<U>Filing Failure</U>&#8221;), or (ii) not declared effective
by the Commission on or before the Effectiveness Deadline (an &#8220;<U>Effectiveness Failure</U>&#8221;), or (b) on any day during the
Reporting Period and after the Effectiveness Date, sales of all of the Registrable Securities required to be included on such Registration
Statement cannot be made (other than (i) during an Allowable Grace Period or (ii) if the Registration Statement is on Form S-1, for a
period of 15 days following the date the Company files a post-effective amendment to incorporate the Company&#8217;s Annual Report on
Form 10-K) pursuant to such Registration Statement (including, without limitation, because of a failure to keep such Registration Statement
effective, to disclose such information as is necessary for sales to be made pursuant to such Registration Statement or to register a
sufficient number of shares of Common Stock) (a &#8220;<U>Maintenance Failure</U>&#8221;), then, in satisfaction of the damages to any
holder of Registrable Securities by reason of any such delay in or reduction of its ability to sell the underlying shares of Common Stock,
the Company shall pay to each holder of Registrable Securities relating to such Registration Statement an amount in cash equal to 1.0%
of the principal amount of the Notes held by such holder on each of the following dates: (x) the day of a Filing Failure and on every
thirtieth day (prorated for periods totaling less than 30 days) thereafter until such Filing Failure is cured; (y) the day of an Effectiveness
Failure and on every thirtieth day (prorated for periods totaling less than 30 days) thereafter until such Effectiveness Failure is cured;
and (z) the initial day of a Maintenance Failure and on every thirtieth day (prorated for periods totaling less than 30 days) thereafter
until such Maintenance Failure is cured. The payments to which a holder shall be entitled pursuant to this Section 12.2 are referred to
herein as &#8220;<U>Registration Delay Payments</U>&#8221;; provided that no Registration Delay Payments shall be required following the
termination of the Reporting Period, and provided further that in no event shall the aggregate Registration Delay Payments accruing under
this Section 12.2 exceed 6% of the principal amount of the Notes (i.e., corresponding to a total delay of up to six months). The first
such Registration Delay <FONT STYLE="letter-spacing: -0.1pt">Payment</FONT> shall be paid within three Business Days after the event or
failure giving rise to such Registration Delay Payment occurred and all other Registration Delay Payments shall be paid on the earlier
<FONT STYLE="letter-spacing: -0.25pt">of</FONT> (I) the last day of the calendar month during which such Registration Delay Payments are
incurred and (II) the third Business Day after the event or failure giving rise to the Registration Delay Payments is cured.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">12.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Related
Obligations</U>. At such time as the Company is obligated to file a Registration Statement with the Commission pursuant to Section 12.1
hereof, the Company will use commercially reasonable efforts to effect the registration of the Registrable Securities in accordance with
the intended method of disposition thereof and, pursuant thereto, the Company shall have the following obligations (to the extent applicable):</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
Company shall submit to the Commission, within two Business Days after the Company learns that no review of a particular Registration
Statement will be made by the staff of the Commission or that the staff has no further comments on a particular Registration Statement,
as the case may be, a request for acceleration of effectiveness of such Registration Statement to a time and date not later than two Business
Days after the submission of such request. The Company shall keep each Registration Statement effective pursuant to Rule 415 at all times
with respect to each Purchaser&#8217;s Registrable Securities until the expiration of the Reporting Period. The Company shall ensure that
each Registration Statement (including any amendments
or supplements thereto and prospectuses contained therein) shall not contain any untrue statement of a material fact or omit to state
a material fact required to be stated therein, or necessary to make the statements therein (in the case of prospectuses, in the light
of the circumstances in which they were made) not misleading.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT></FONT>The
Company shall prepare and file with the Commission such amendments (including post-effective amendments) and supplements to a Registration
Statement and the prospectus used in connection with such Registration Statement, which prospectus is to be filed pursuant to Rule 424
promulgated under the Securities Act, as may be necessary to keep such Registration Statement effective at all times during the Reporting
Period, and, during such period, comply with the provisions of the Securities Act with respect to the disposition of all Registrable Securities
of the Company covered by such Registration Statement until such time as all of such Registrable Securities shall have been disposed of
in accordance with the intended methods of disposition by the seller or sellers thereof as set forth in such Registration Statement. By
9:30 a.m. New York time on the Business Day following the date any Registration Statement is declared effective by the SEC, the Company
shall file with the SEC in accordance with Rule 424 under the Securities Act the final prospectus to be used in connection with sales
pursuant to such Registration Statement.</P>


<!-- Field: Page; Sequence: 47 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon
request of a Purchaser, the Company shall furnish to such Purchaser without charge, (i) promptly after the Registration Statement including
such Purchaser&#8217;s Registrable Securities is prepared and filed with the Commission, at least one copy of such Registration Statement
and any amendment(s) thereto, including financial statements and schedules, all documents incorporated therein by reference, and if requested
by the Purchaser, all exhibits and each preliminary prospectus, (ii) upon the effectiveness of any Registration Statement, 10 copies of
the prospectus included in such Registration Statement and all amendments and supplements thereto (or such other number of copies as the
Purchaser may reasonably request) and (iii) such other documents, including copies of any preliminary or final prospectus, as the Purchaser
may reasonably request from time to time in order to facilitate the disposition of the Registrable Securities.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company shall notify the Purchasers in writing of the happening of any event, as promptly as practicable after becoming aware of such
event, as a result of which the prospectus included in a Registration Statement, as then in effect, includes an untrue statement of a
material fact or omission to state a material fact required to be stated therein or necessary to make the statements therein, in the light
of the circumstances under which they were made, not misleading (provided that in no event shall such notice contain any material, nonpublic
information), and promptly prepare a supplement or amendment to such Registration Statement to correct such untrue statement or omission,
and upon request deliver 10 copies of such supplement or amendment to the Purchasers (or such other number of copies as the Purchasers
may reasonably request). Unless such information is publicly available, the Company shall also promptly notify the Purchasers in writing
(i) when a prospectus or any prospectus supplement or post-effective amendment has been filed, and when a Registration Statement or any
post- effective amendment has become effective (notification of such effectiveness shall be delivered to the Purchasers by email on the
same day of such effectiveness), (ii) of any request by the Commission for amendments or supplements to a Registration Statement or related
prospectus or related information, and (iii) of the Company&#8217;s reasonable determination that a post-effective amendment to a Registration
Statement would be appropriate.</P>

<P STYLE="text-indent: 0.5in; font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company shall use commercially reasonable efforts to prevent the issuance of any stop order or other suspension of effectiveness of a
Registration Statement, or the suspension of the qualification of any of the Registrable Securities for sale in any jurisdiction and,
if such an order or suspension is issued, to obtain the withdrawal
of such order or suspension at the earliest possible moment and to notify the Purchaser who holds Registrable Securities being sold of
the issuance of such order and the resolution thereof or its receipt of notice of the initiation or threat of any proceeding for such
purpose.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
a Purchaser is required under applicable securities law to be described in the Registration Statement as an underwriter, at the reasonable
request of the Purchaser, the Company shall furnish to the Purchaser, on the date of the effectiveness of the Registration Statement and
thereafter from time to time on such dates as the Purchaser may reasonably request, (i) a letter, dated such date, from the Company&#8217;s
independent certified public accountants in form and substance as is customarily given by independent certified public accountants to
underwriters in an underwritten public offering, addressed to the Purchaser, and (ii) an opinion, dated as of such date, of counsel representing
the Company for purposes of such Registration Statement, in form, scope and substance as is customarily given in an underwritten public
offering, addressed to the Purchaser.</P>


<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>


<!-- Field: Page; Sequence: 48 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-indent: 0.5in; font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
a Purchaser is required under applicable securities law to be described in the Registration Statement as an underwriter, upon the written
request of the Purchaser in connection with the Purchaser&#8217;s due diligence requirements, if any, the Company shall make available
for inspection by (i) the Purchaser and its legal counsel and (ii) one firm of accountants or other agents retained by the Purchaser (collectively,
the &#8220;<U>Inspectors</U>&#8221;), all pertinent financial and other records, and pertinent corporate documents and properties of the
Company (collectively, the &#8220;<U>Records</U>&#8221;), as shall be reasonably deemed necessary by each Inspector solely for the purpose
of establishing a due diligence defense under underwriter liability under the Securities Act, and cause the Company&#8217;s officers,
directors and employees to supply all information which any Inspector may reasonably request; provided, however, that each Inspector shall
agree to hold in strict confidence and shall not make any disclosure (except to the Purchaser) or use of any Record or other information
which the Company determines in good faith to be confidential, and of which determination the Inspectors are so notified, unless (a) the
disclosure of such Records is necessary to avoid or correct a misstatement or omission in any Registration Statement or is otherwise required
under the Securities Act, (b) the release of such Records is ordered pursuant to a final, non-appealable subpoena or order from a court
or government body of competent jurisdiction, or (c) the information in such Records has been made generally available to the public other
than by disclosure in violation of this Agreement. The Purchaser agrees that it shall, upon learning that disclosure of such Records is
sought in or by a court or governmental body of competent jurisdiction or through other means, give prompt notice to the Company and allow
the Company, at its expense, to undertake appropriate action to prevent disclosure of, or to obtain a protective order preventing disclosure
of, the Records deemed confidential. Nothing herein (or in any other confidentiality agreement between the Company and the Purchaser)
shall be deemed to limit the Purchaser&#8217;s ability to sell Registrable Securities in a manner which is otherwise consistent with Applicable
Laws.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
Company shall hold in confidence and not make any disclosure of information concerning the Purchasers provided to the Company unless (i)
disclosure of such information is necessary to comply with federal or state securities laws, (ii) the disclosure of such information is
necessary to avoid or correct a misstatement or omission in any Registration Statement, (iii) the release of such information is ordered
pursuant to a subpoena or other final, non-appealable order from a court or governmental body of competent jurisdiction or (iv) such information
has been made generally available to the public other than by disclosure in violation of this Agreement. The Company agrees that it shall,
upon learning that disclosure of such information concerning the Purchasers is sought in or by a court or governmental body of competent
jurisdiction or through other means, give prompt written notice to the Purchasers and allow the Purchasers, at each Purchaser&#8217;s
expense, to undertake appropriate action to prevent disclosure of, or to obtain a protective order preventing disclosure of, such information.</P>




<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company shall cooperate with the Purchasers and, to the extent applicable, facilitate the timely preparation and delivery of certificates
(not bearing any restrictive legend) representing the Registrable Securities to be offered pursuant to a Registration Statement and enable
such certificates to be in such denominations or amounts, as the case may be, as the Purchasers may reasonably request and registered
in such names as the Purchasers may request.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
requested by a Purchaser, the Company shall, as soon as practicable, (i) incorporate in a prospectus supplement or post-effective amendment
such information as the Purchaser reasonably requests to be included therein relating to the sale and distribution of Registrable Securities,
including, without limitation, information with respect to the number of Registrable Securities being offered or sold, the purchase price
being paid therefor and any other terms of the offering of the Registrable Securities to be sold in such offering; (ii) make all required
filings of such prospectus supplement or post-effective amendment after being notified of the matters to be incorporated in such prospectus
supplement or post-effective amendment; and (iii) supplement or make amendments to any Registration Statement if reasonably requested
by the Purchaser.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
Company shall use commercially reasonable efforts to cause the Registrable Securities covered by a Registration Statement to be registered
with or approved by such other governmental agencies or authorities as may be necessary to consummate the disposition of such Registrable
Securities.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company shall otherwise use commercially reasonable efforts to comply with all applicable rules and regulations of the Commission in connection
with any registration hereunder.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Within
two Business Days after a Registration Statement that covers Registrable Securities is declared effective by the Commission, the Company
shall deliver to the transfer agent for such Registrable Securities (with copies to the Purchasers) confirmation that such Registration
Statement has been declared effective by the Commission.</P>

<!-- Field: Page; Sequence: 49 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(n)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding
anything to the contrary herein, at any time after the Effectiveness Date, the Company may delay the disclosure of material, non-public
information concerning the Company the disclosure of which at the time is not, in the good faith opinion of the Board of Directors and
its counsel, in the best interest of the Company and, in the opinion of counsel to the Company, otherwise required (a &#8220;<U>Grace
Period</U>&#8221;); provided, that the Company shall promptly (i) notify the Purchasers in writing of the existence of material, non-public
information giving rise to a Grace Period (provided that in each notice the Company will not disclose the content of such material, non-public
information to the Purchasers) and the date on which the Grace Period will begin, and (ii) notify the Purchasers in writing of the date
on which <FONT STYLE="letter-spacing: -0.1pt">the Grace Period ends; and, provided further, that the Grace Periods shall not exceed an
aggregate </FONT>of 30 Trading Days during any 365-day period and the first day of any Grace Period must be at least 15 days after the
last day of any prior Grace Period (each, an &#8220;<U>Allowable Grace Period</U>&#8221;). For purposes of determining the length of a
Grace Period above, the Grace Period shall begin on and include the date the Purchasers receive the notice referred to in clause (i) and
shall end on and include the later of the date the Purchasers receive the notice referred to in clause (ii) and the date referred to in
such notice. The provisions of Section 12.3(e) hereof shall not be applicable during the period of any Allowable Grace Period. Upon expiration
of the Grace Period, the Company shall again be bound by the first sentence of Section 12.3(d) with respect to the information giving
rise thereto unless such material, non-public information is no longer applicable. Notwithstanding anything to the contrary, the Company
shall cause its transfer agent to deliver unlegended shares of Common Stock to a transferee of any Purchaser in accordance with the terms
of this Agreement in connection with any sale of Registrable Securities with respect to which a Purchaser has entered into a contract
for sale, and delivered a copy of the prospectus included as part of the applicable Registration Statement (unless an exemption
from such prospectus delivery requirement exists), prior to the Purchaser&#8217;s receipt of the notice of a Grace Period and for which
the Purchaser has not yet settled.</P>




<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="letter-spacing: -0.1pt">(o)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Neither
the Company nor any Subsidiary or affiliate thereof shall identify any Purchaser as an underwriter in any public disclosure or filing
with the Commission or any applicable Eligible Market without the prior written consent of such Purchaser, and any Purchaser being deemed
an underwriter by the Commission shall not relieve the Company of any obligations it has under this Agreement.</P>

<!-- Field: Page; Sequence: 50 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">12.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Obligations
of the <FONT STYLE="letter-spacing: -0.1pt">Purchasers</FONT></U><FONT STYLE="letter-spacing: -0.1pt">.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>At
least five Business Days prior to the first anticipated filing date of a Registration Statement, the Company shall notify each Purchaser
in writing of any information the Company requires from such Purchaser in order to have that Purchaser&#8217;s Registrable Securities
included in such Registration Statement. It shall be a condition precedent to the obligations of the Company to complete the registration
pursuant to this Agreement with respect to the Registrable Securities of a particular Purchaser that the Purchaser shall furnish to the
Company such information regarding itself, the Registrable Securities held by it and the intended method of disposition of the Registrable
Securities held by it as shall be reasonably required to effect the effectiveness of the registration of such Registrable Securities and
shall execute such documents in connection with such registration as the Company may reasonably request.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Each
Purchaser, by its acceptance of the Registrable Securities, agrees to cooperate with the Company as reasonably requested by the Company
in connection with the preparation and filing of any Registration Statement hereunder, unless the Purchaser has notified the Company in
writing of the Purchaser&#8217;s election to exclude all of the Purchaser&#8217;s Registrable Securities from such Registration Statement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Purchaser agrees that, upon receipt of any notice from the Company of the happening of any event of the kind described in Section 12.3(e)
or the first sentence of Section 12.3(d), the Purchaser will promptly discontinue disposition of Registrable Securities pursuant to any
Registration Statement(s) covering such Registrable Securities until the Purchaser&#8217;s receipt of the copies of the supplemented or
amended prospectus contemplated by Section 12.3(e) or the first sentence of Section 12.3(d) or receipt of notice that no supplement or
amendment is required. Notwithstanding anything to the contrary, the Company shall cause its transfer agent to deliver unlegended shares
of Common Stock to a transferee of the Purchaser in accordance with the terms of this Agreement in connection with any sale of Registrable
Securities with respect to which the Purchaser has entered into a contract for sale prior to the Purchaser&#8217;s receipt of a notice
from the Company of the happening of any event of the kind described in Section 12.3(e) or the first sentence of Section 12.3(d) and for
which the Purchaser has not yet settled.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Each
Purchaser covenants and agrees that it will comply with the prospectus delivery requirements of the Securities Act as applicable to it
or an exemption therefrom in connection with sales of Registrable Securities pursuant to the Registration Statement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">12.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Expenses
of Registration</U>. All reasonable expenses incurred in connection with registrations, filings or qualifications pursuant to this Section
12, including, without limitation, all registration, listing and qualifications fees, printers and accounting fees, and fees and disbursements
of counsel for the Company, shall be paid by the Company. Notwithstanding the foregoing, in no event shall the Company be responsible
for underwriting discounts, commissions, placement agent fees or other similar expenses payable with respect to Registrable Securities
being sold or offered for sale by the Purchasers.</P>


<!-- Field: Page; Sequence: 51 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">12.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Reports
under the Exchange Act</U>. With a view to making available to the Purchasers the benefits of Rule 144 promulgated under the Securities
Act or any other similar rule or regulation of the Commission that may at any time permit the Purchasers to sell securities of the Company
to the public without registration (&#8220;<U>Rule 144</U>&#8221;), the Company agrees to:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>make
and keep public information available, as those terms are understood and defined in Rule 144, during the Reporting Period;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;file
with the Commission in a timely manner all reports and other documents required of the Company under the Exchange Act; and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;furnish
to the Purchasers, so long as any Purchaser owns Registrable Securities, promptly upon request during the Reporting Period: (i) a written
statement by the Company, if true, that it has complied with the reporting requirements of Rule 144, the Securities Act and the Exchange
Act, (ii) a copy of the most recent annual or quarterly report of the Company and such other reports and documents so filed by the Company,
and (iii) such other information as may be reasonably requested to permit the Purchasers to sell such securities pursuant to Rule 144
without registration.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">12.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Assignment
of Registration Rights</U>. The rights under Section 12 shall be automatically assignable by a Purchaser to any transferee of all or any
portion of the Purchaser&#8217;s Registrable Securities if: (i) the Purchaser agrees in writing with the transferee or assignee to assign
such rights and a copy of such agreement is furnished to the Company within a reasonable time after such assignment; (ii) the Company
is, within a reasonable time after such transfer or <FONT STYLE="letter-spacing: -0.1pt">assignment, furnished with written notice of
(a) the name and address of such transferee or assignee </FONT>and (b) the securities with respect to which such registration rights are
being transferred or assigned; (iii) immediately following such transfer or assignment the further disposition of such securities by the
transferee or assignee is restricted under the Securities Act or applicable state securities laws; (iv) at or before the time the Company
receives the written notice contemplated by clause (ii) of this sentence the transferee or assignee agrees in writing with the Company
to be bound by all of the provisions contained herein; and (v) such transfer shall have been made in accordance with the applicable requirements
of this Agreement. Following any such transfer in accordance with this Section 12.7, the Company shall thereafter use commercially reasonable
efforts to amend or supplement the selling stockholder table contained in the Registration Statement to reflect such change in beneficial
ownership of the affected Registrable Securities.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">12.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="letter-spacing: -0.1pt"><U>Indemnification</U>.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Company
Indemnification</U>. The Company will indemnify each Purchaser who holds Registrable Securities (if Registrable Securities held by such
Purchaser are included in the securities as to which such registration is being effected), each of its officers and directors, partners,
members and each person controlling such Purchaser within the meaning of Section 15 of the Securities Act, against all expenses, claims,
losses, damages or liabilities (or actions in respect thereof), including any of the foregoing incurred in settlement of any litigation,
commenced or threatened, arising out of or based on (A) any untrue statement (or alleged untrue statement) of a material fact contained
in any Registration Statement, prospectus, offering circular or other document, or any amendment or supplement thereto, incident to any
such Registration Statement, or based on any omission (or alleged omission) to state therein a material fact required to be stated therein
or necessary to make the statements therein, in light of the circumstances in which they were made, not misleading, or (B) any violation
by the Company of the Securities Act, the Exchange Act, state securities laws or any rule or regulation promulgated under such laws applicable
to the Company in connection with any such registration; and in each case, the Company will reimburse each such Purchaser, each of
its officers and directors, partners, members and each person controlling such Purchaser, for any legal and any other expenses reasonably
incurred, as such expenses are incurred, in connection with investigating, preparing or defending any such claim, loss, damage, liability
or action, provided that the Company will not be liable in any such case to the extent that any such claim, loss, damage, liability or
expense arises out of or is based on (X) any untrue statement or omission or alleged untrue statement or omission made in reliance upon
and in conformity with written information furnished to the Company by an instrument duly executed by such Purchaser or controlling person,
and stated to be specifically for use therein, (Y) the use by a Purchaser of an outdated or defective prospectus after the Company has
notified such Purchaser in writing that the prospectus is outdated or defective or (Z) a Purchaser&#8217;s (or any other indemnified person&#8217;s)
failure to send or give a copy of the prospectus or supplement (as then amended or supplemented), if required, pursuant to Rule 172 under
the Securities Act (or any successor rule) to the Persons asserting an untrue statement or alleged untrue statement or alleged untrue
statement or omission or alleged omission at or prior to the written confirmation of the sale of Registrable Securities to such person
if such statement or omission was corrected in such prospectus or supplement.</P>


<!-- Field: Page; Sequence: 52 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Purchaser
Indemnification</U>. Each Purchaser holding Registrable Securities will, if Registrable Securities held by such Purchaser are included
in the securities as to which such registration is being effected, severally and not jointly, indemnify the Company, each of its directors
and officers, other holders of the Company&#8217;s securities covered by such Registration Statement, each person who controls the Company
within the meaning of Section 15 of the Securities Act, and each such holder, each of its officers and directors and each person controlling
such holder within the meaning of Section 15 of the Securities Act, against all claims, losses, damages and liabilities (or actions in
respect thereof) arising out of or based on: (A) any untrue statement (or alleged untrue statement) of a material fact contained in any
such Registration Statement, prospectus, offering circular or other document, or any omission (or alleged omission) to state therein a
material fact required to be stated therein or necessary to make the statements therein not misleading, to the extent, and only to the
extent, that such untrue statement (or alleged untrue statement) or omission (or alleged omission) is made in such Registration Statement,
prospectus, offering circular or other document in reliance upon and in conformity with written information furnished to the Company by
an instrument duly executed by such Purchaser and stated to be specifically for use therein, or (B) any violation by such Purchaser of
the Securities Act, the Exchange Act, state securities laws or any rule or regulation promulgated under such laws applicable to such Purchaser,
and in each case, such Purchaser will reimburse the Company, each other holder, and directors, officers, persons, underwriters or control
persons of the Company and the other holders for any legal or any other expenses <FONT STYLE="letter-spacing: -0.1pt">reasonably incurred,
as such expenses are incurred, in connection with investigating or defending</FONT> any such claim, loss, damage, liability or action;
provided, that the indemnity agreement contained in this Section 12.8(b) shall not apply to amounts paid in settlement of any such loss,
claim, damage, liability or action if such settlement is effected without the consent of such indemnifying Purchaser. The liability of
any Purchaser for indemnification under this Section 12.8(b) in its capacity as a seller of Registrable Securities shall not exceed the
amount of net proceeds to such Purchaser of the securities sold in any such registration.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Notice
and Procedure</U>. Each party entitled to indemnification under this Section 12.8 (each, an &#8220;<U>Indemnified Party</U>&#8221;) shall
give written notice to the party required to provide indemnification (the &#8220;<U>Indemnifying Party</U>&#8221;) promptly after such
Indemnified Party has actual knowledge of any claim as to which indemnity may be sought, and shall permit the Indemnifying Party to assume
the defense of any such claim or any litigation resulting therefrom, provided that counsel for the Indemnifying Party who shall conduct
the defense of such claim or litigation, shall be approved by the Indemnified Party (whose approval shall not unreasonably be withheld),
and the Indemnified Party may participate in such defense at such party&#8217;s expense, and provided further that the failure of any
Indemnified Party to give notice as provided herein shall not relieve the Indemnifying Party of its obligations under this Agreement
unless the failure to give such notice is materially prejudicial to an Indemnifying Party&#8217;s ability to defend such action and provided
further, that the Indemnifying Party shall not assume the defense for matters as to which there is a conflict of interest or there are
separate and different defenses. No Indemnifying Party, in the defense of any such claim or litigation, shall, except with the consent
of each Indemnified Party, consent to entry of any judgment or enter into any settlement which does not include as an unconditional term
thereof the giving by the claimant or plaintiff to such Indemnified Party of a release from all liability in respect to such claim or
litigation.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000; letter-spacing: -0.1pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Contribution</U>.
If the indemnification provided for in this Section 12.8 is held by a court of competent jurisdiction to be unavailable to an Indemnified
Party with respect to any losses, claims, damages or liabilities referred to herein, the Indemnifying Party, in lieu of indemnifying such
Indemnified Party thereunder, shall to the extent permitted by applicable law contribute to the amount paid or payable by such Indemnified
Party as a result of such loss, claim, damage or liability in such proportion as is appropriate to reflect the relative fault of the Indemnifying
Party on the one hand and of the Indemnified Party on the other in connection with the untrue statement or omission that resulted in such
loss, claim, damage or liability, as well as any other relevant equitable considerations. The relative fault of the Indemnifying Party
and of the Indemnified Party shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of
a material fact or the omission to state a material fact relates to information supplied by the Indemnifying Party or by the Indemnified
Party and the parties&#8217; relative intent, knowledge, access to information and opportunity to correct or prevent such statement or
omission; provided, that in no event shall any contribution by a Purchaser hereunder exceed the net proceeds from the offering received
by such Purchaser. The amount paid or payable by a party as a result of any loss, claim, damage or liability shall be deemed to include,
subject to the limitations set forth in this Agreement, any reasonable attorneys&#8217; or other reasonable fees or expenses incurred
by such party in connection with any proceeding to the extent such party would have been indemnified for such fees or expenses if the
indemnification provided for in this Section 12.8 was available to such party in accordance with its terms.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Survival</U>.
The obligations of the Company and the Purchasers under this Section 12.8 shall survive completion of any offering of Registrable Securities
in a Registration Statement and the termination of this Agreement. The indemnity and contribution agreements contained in this Section
12.8 are in addition to any liability that the Indemnifying Parties may have to the Indemnified Parties and are not in diminution or limitation
of other remedies or causes of action that the parties may have under this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 12pt; margin-right: 0; margin-bottom: 12pt; text-align: center">[<I>Signature
page <FONT STYLE="letter-spacing: -0.1pt">follows</FONT></I><FONT STYLE="letter-spacing: -0.1pt">]</FONT></P>




<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 3.95pt 0 12pt 17.95pt; text-align: justify; text-indent: 0.5in"></P>


<!-- Field: Page; Sequence: 54 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-size: 12pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><I>[Signature Page to Note Purchase Agreement]</I></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 3.95pt 0 12pt 17.95pt; text-align: justify; text-indent: 0.5in"><B>IN WITNESS
WHEREOF</B>, the parties have executed this Note Purchase Agreement to be effective as of the date first above written.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 0.7pt; padding-left: 0.7pt; text-align: left; text-indent: 0in"><B>HERON THERAPEUTICS, INC., as the <FONT STYLE="letter-spacing: -0.1pt">Company</FONT></B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 0.7pt; padding-left: 0.7pt; text-align: justify; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 0.7pt; padding-left: 0.7pt; text-align: justify; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 0.7pt; padding-left: 0.7pt; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="width: 8%; padding-right: 0.7pt; padding-left: 0.7pt; text-align: justify; text-indent: 0in">By:</TD>
    <TD STYLE="width: 42%; border-bottom: Black 1pt solid; padding-right: 0.7pt; padding-left: 0.7pt; text-align: justify; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt; text-align: justify; text-indent: 0in"><FONT STYLE="letter-spacing: -0.1pt">Name:</FONT></TD>
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt; text-align: justify; text-indent: 0in">Ira <FONT STYLE="letter-spacing: -0.1pt">Duarte</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt; text-align: justify; text-indent: 0in"><FONT STYLE="letter-spacing: -0.1pt">Title:</FONT></TD>
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt; text-align: justify; text-indent: 0in">Executive Vice President, Chief Financial Officer</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt; text-align: justify; text-indent: 0in"><FONT STYLE="letter-spacing: -0.1pt">Address:</FONT></TD>
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt; text-align: justify; text-indent: 0in">100 Regency Forest Drive, Suite 300 Cary, North Carolina 27518</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt; text-align: justify; text-indent: 0in"><FONT STYLE="letter-spacing: -0.1pt">Email:</FONT></TD>
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt; text-align: justify; text-indent: 0in"><FONT STYLE="letter-spacing: -0.1pt">iduarte@herontx.com</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 0.7pt; padding-left: 0.7pt">
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in"><FONT STYLE="letter-spacing: -0.1pt"><B>RUBRIC
    CAPITAL MANAGEMENT</B></FONT><B> <FONT STYLE="letter-spacing: -0.25pt">LP,</FONT></B></P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in"><B>AS MANAGER OR SUB-MANAGER ON BEHALF
    OF CERTAIN OF ITS FUNDS AND ACCOUNTS, as the Designated <FONT STYLE="letter-spacing: -0.2pt">Agent</FONT></B></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 0.7pt; padding-left: 0.7pt; text-align: justify; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 0.7pt; padding-left: 0.7pt; text-align: justify; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 0.7pt; padding-left: 0.7pt; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="width: 8%; padding-right: 0.7pt; padding-left: 0.7pt; text-align: justify; text-indent: 0in">By:</TD>
    <TD STYLE="width: 42%; border-bottom: Black 1pt solid; padding-right: 0.7pt; padding-left: 0.7pt; text-align: justify; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt; text-align: justify; text-indent: 0in"><FONT>Name:</FONT></TD>
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt; text-align: justify; text-indent: 0in">Michael <FONT>Nachmani</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt; text-align: justify; text-indent: 0in"><FONT>Title:</FONT></TD>
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt; text-align: justify; text-indent: 0in">Authorized Signatory</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt; text-align: justify; text-indent: 0in"><FONT STYLE="letter-spacing: -0.1pt">Address:</FONT></TD>
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt">
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">155 East 44<SUP>th</SUP> St., Suite
    <FONT STYLE="letter-spacing: -0.2pt">1630</FONT></P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT>New
    York, New York 10017</FONT></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt; text-align: justify; text-indent: 0in"><FONT>Attn:</FONT></TD>
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt; text-align: justify; text-indent: 0in">Brian Kleinhaus General <FONT STYLE="letter-spacing: -0.1pt">Counsel</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt; text-align: justify; text-indent: 0in"><FONT>Email:</FONT></TD>
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt; text-align: justify; text-indent: 0in"><FONT>brian@rubriccapital.com; phil@rubriccapital.com; michael@rubriccapital.com</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 55 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-size: 12pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><I>[Signature Page to Note Purchase Agreement]</I></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-right: 0; margin-bottom: 12pt; text-align: center"><FONT STYLE="text-decoration: underline solid; letter-spacing: -0.1pt"><B>Schedule
</B></FONT><B><FONT STYLE="text-decoration: underline solid; letter-spacing: -0.5pt">A</FONT></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 4.5pt; text-align: justify; text-indent: 31.5pt">The following
table sets forth the number of Additional Shares by which the Conversion Rate shall be increased pursuant to Section 4.6 based on the
Stock Price and the dates set forth below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.05pt 0 0 18.2pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.1pt"><B>Make-Whole
Fundamental </B></FONT><B>Change Effective</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.05pt 0 1.55pt 18.2pt; text-align: justify; text-indent: 0.5in"><B>&#9;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 12pt; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt; letter-spacing: -0.2pt"><B>Date</B></FONT></TD>
    <TD COLSPAN="9" STYLE="padding-top: 3.1pt; padding-bottom: 12pt; padding-left: 0.3pt; line-height: 10.95pt; text-align: center; text-indent: -0.15pt"><FONT STYLE="font-size: 10pt"><B>Stock <FONT STYLE="letter-spacing: -0.1pt">Price</FONT></B></FONT></TD></TR>
  <TR STYLE="border-top: Black 1pt solid; vertical-align: top; border-bottom: Black 1pt solid">
    <TD STYLE="border-right: Black 0.5pt solid; width: 16%; padding-bottom: 12pt; text-align: justify; text-indent: 0in; border-left: Black 0.5pt solid">&nbsp;</TD>
    <TD STYLE="border-right: Black 0.5pt solid; width: 8%; padding-top: 3.1pt; padding-bottom: 12pt; padding-left: 0.65pt; line-height: 10.95pt; text-align: center; text-indent: -0.65pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt"><B>$1.50</B></FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; width: 9%; padding-top: 3.1pt; padding-bottom: 12pt; padding-left: 0.85pt; line-height: 10.95pt; text-align: center; text-indent: -0.1pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt"><B>$1.75</B></FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; width: 10%; padding-top: 3.1pt; padding-bottom: 12pt; padding-left: 0.7pt; line-height: 10.95pt; text-align: center; text-indent: -0.7pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt"><B>$2.00</B></FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; width: 10%; padding-top: 3.1pt; padding-bottom: 12pt; padding-left: 0.55pt; line-height: 10.95pt; text-align: center; text-indent: -0.55pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt"><B>$2.50</B></FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; width: 10%; padding-top: 3.1pt; padding-bottom: 12pt; padding-left: 0.55pt; line-height: 10.95pt; text-align: center; text-indent: -0.55pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt"><B>$3.00</B></FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; width: 10%; padding-top: 3.1pt; padding-bottom: 12pt; padding-left: 0.7pt; line-height: 10.95pt; text-align: center; text-indent: -0.7pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt"><B>$3.60</B></FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; width: 9%; padding-top: 3.1pt; padding-bottom: 12pt; padding-left: 0.55pt; line-height: 10.95pt; text-align: center; text-indent: -0.55pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt"><B>$5.00</B></FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; width: 9%; padding-top: 3.1pt; padding-bottom: 12pt; padding-left: 0.55pt; line-height: 10.95pt; text-align: center; text-indent: -0.55pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt"><B>$7.50</B></FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; width: 9%; padding-top: 3.1pt; padding-bottom: 12pt; padding-left: 0.3pt; line-height: 10.95pt; text-align: center; text-indent: -0.15pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt"><B>$10.00</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 3.25pt; padding-bottom: 12pt; padding-left: 0.65pt; line-height: 10.85pt; text-align: center; text-indent: 0in; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt">Aug 7, <FONT STYLE="letter-spacing: -0.2pt">2025</FONT></FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 3.25pt; padding-bottom: 12pt; padding-left: 0.65pt; line-height: 10.85pt; text-align: center; text-indent: 0.85pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">77.7777</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 3.25pt; padding-bottom: 12pt; padding-left: 0.85pt; line-height: 10.85pt; text-align: center; text-indent: -0.1pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">66.6686</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 3.25pt; padding-bottom: 12pt; padding-left: 0.7pt; line-height: 10.85pt; text-align: center; text-indent: -0.7pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">51.9194</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 3.25pt; padding-bottom: 12pt; padding-left: 0.55pt; line-height: 10.85pt; text-align: center; text-indent: -0.55pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">30.4352</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 3.25pt; padding-bottom: 12pt; padding-left: 0.55pt; line-height: 10.85pt; text-align: center; text-indent: -0.55pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">18.1882</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 3.25pt; padding-bottom: 12pt; padding-left: 0.7pt; line-height: 10.85pt; text-align: center; text-indent: -0.7pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">10.6772</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 3.25pt; padding-bottom: 12pt; padding-left: 0.55pt; line-height: 10.85pt; text-align: center; text-indent: -0.55pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">4.4822</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 3.25pt; padding-bottom: 12pt; padding-left: 0.55pt; line-height: 10.85pt; text-align: center; text-indent: -0.55pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">1.1861</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 3.25pt; padding-bottom: 12pt; padding-left: 0.3pt; line-height: 10.85pt; text-align: center; text-indent: -0.15pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">0.0196</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.65pt; line-height: 10.85pt; text-align: center; text-indent: 0in; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt">March 1, <FONT STYLE="letter-spacing: -0.2pt">2026</FONT></FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.65pt; line-height: 10.85pt; text-align: center; text-indent: 0.85pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">77.7777</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.85pt; line-height: 10.85pt; text-align: center; text-indent: -0.1pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">66.6686</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.7pt; line-height: 10.85pt; text-align: center; text-indent: -0.7pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">51.5227</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.55pt; line-height: 10.85pt; text-align: center; text-indent: -0.55pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">27.7350</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.55pt; line-height: 10.85pt; text-align: center; text-indent: -0.55pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">14.2780</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.7pt; line-height: 10.85pt; text-align: center; text-indent: -0.7pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">6.7748</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.55pt; line-height: 10.85pt; text-align: center; text-indent: -0.55pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">2.4074</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.55pt; line-height: 10.85pt; text-align: center; text-indent: -0.55pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">0.6746</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.3pt; line-height: 10.85pt; text-align: center; text-indent: -0.15pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">0.0000</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.65pt; line-height: 10.85pt; text-align: center; text-indent: 0in; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt">September 1, <FONT STYLE="letter-spacing: -0.2pt">2026</FONT></FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.65pt; line-height: 10.85pt; text-align: center; text-indent: 0.85pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">77.7777</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.85pt; line-height: 10.85pt; text-align: center; text-indent: -0.1pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">66.6686</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.7pt; line-height: 10.85pt; text-align: center; text-indent: -0.7pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">51.1260</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.55pt; line-height: 10.85pt; text-align: center; text-indent: -0.55pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">26.7540</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.55pt; line-height: 10.85pt; text-align: center; text-indent: -0.55pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">10.3880</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.7pt; line-height: 10.85pt; text-align: center; text-indent: -0.7pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">0.0000</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.55pt; line-height: 10.85pt; text-align: center; text-indent: -0.55pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">0.0000</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.55pt; line-height: 10.85pt; text-align: center; text-indent: -0.55pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">0.0000</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.3pt; line-height: 10.85pt; text-align: center; text-indent: -0.15pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">0.0000</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.65pt; line-height: 10.85pt; text-align: center; text-indent: 0in; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt">September 1, <FONT STYLE="letter-spacing: -0.2pt">2027</FONT></FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.65pt; line-height: 10.85pt; text-align: center; text-indent: 0.85pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">77.7777</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.85pt; line-height: 10.85pt; text-align: center; text-indent: -0.1pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">66.6686</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.7pt; line-height: 10.85pt; text-align: center; text-indent: -0.7pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">50.9860</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.55pt; line-height: 10.85pt; text-align: center; text-indent: -0.55pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">26.2493</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.55pt; line-height: 10.85pt; text-align: center; text-indent: -0.55pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">10.1677</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.7pt; line-height: 10.85pt; text-align: center; text-indent: -0.7pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">0.0000</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.55pt; line-height: 10.85pt; text-align: center; text-indent: -0.55pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">0.0000</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.55pt; line-height: 10.85pt; text-align: center; text-indent: -0.55pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">0.0000</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.3pt; line-height: 10.85pt; text-align: center; text-indent: -0.15pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">0.0000</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 3.35pt; padding-bottom: 12pt; padding-left: 0.65pt; line-height: 10.85pt; text-align: center; text-indent: 0in; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt">September 1, <FONT STYLE="letter-spacing: -0.2pt">2028</FONT></FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 3.35pt; padding-bottom: 12pt; padding-left: 0.65pt; line-height: 10.85pt; text-align: center; text-indent: 0.85pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">77.7777</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 3.35pt; padding-bottom: 12pt; padding-left: 0.85pt; line-height: 10.85pt; text-align: center; text-indent: -0.1pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">66.6686</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 3.35pt; padding-bottom: 12pt; padding-left: 0.7pt; line-height: 10.85pt; text-align: center; text-indent: -0.7pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">49.1004</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 3.35pt; padding-bottom: 12pt; padding-left: 0.55pt; line-height: 10.85pt; text-align: center; text-indent: -0.55pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">24.5059</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 3.35pt; padding-bottom: 12pt; padding-left: 0.55pt; line-height: 10.85pt; text-align: center; text-indent: -0.55pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">9.4230</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 3.35pt; padding-bottom: 12pt; padding-left: 0.7pt; line-height: 10.85pt; text-align: center; text-indent: -0.7pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">0.0000</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 3.35pt; padding-bottom: 12pt; padding-left: 0.55pt; line-height: 10.85pt; text-align: center; text-indent: -0.55pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">0.0000</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 3.35pt; padding-bottom: 12pt; padding-left: 0.55pt; line-height: 10.85pt; text-align: center; text-indent: -0.55pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">0.0000</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 3.35pt; padding-bottom: 12pt; padding-left: 0.3pt; line-height: 10.85pt; text-align: center; text-indent: -0.15pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">0.0000</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 0.5pt solid; border-left: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.65pt; line-height: 10.85pt; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt">September 1, <FONT STYLE="letter-spacing: -0.2pt">2029</FONT></FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; border-left: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.65pt; line-height: 10.85pt; text-align: center; text-indent: 0.85pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">77.7777</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; border-left: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.85pt; line-height: 10.85pt; text-align: center; text-indent: -0.1pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">64.9358</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; border-left: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.7pt; line-height: 10.85pt; text-align: center; text-indent: -0.7pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">42.9104</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; border-left: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.55pt; line-height: 10.85pt; text-align: center; text-indent: -0.55pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">19.8022</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; border-left: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.55pt; line-height: 10.85pt; text-align: center; text-indent: -0.55pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">7.3919</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.7pt; line-height: 10.85pt; text-align: center; text-indent: -0.7pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">0.0000</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.55pt; line-height: 10.85pt; text-align: center; text-indent: -0.55pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">0.0000</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.55pt; line-height: 10.85pt; text-align: center; text-indent: -0.55pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">0.0000</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.3pt; line-height: 10.85pt; text-align: center; text-indent: -0.15pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">0.0000</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.65pt; line-height: 10.85pt; text-align: center; text-indent: 0in; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt">September 1, <FONT STYLE="letter-spacing: -0.2pt">2030</FONT></FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.65pt; line-height: 10.85pt; text-align: center; text-indent: 0.85pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">77.7777</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.85pt; line-height: 10.85pt; text-align: center; text-indent: -0.1pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">48.1885</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.7pt; line-height: 10.85pt; text-align: center; text-indent: -0.7pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">25.5322</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.55pt; line-height: 10.85pt; text-align: center; text-indent: -0.55pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">8.3713</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.55pt; line-height: 10.85pt; text-align: center; text-indent: -0.55pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">2.7268</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.7pt; line-height: 10.85pt; text-align: center; text-indent: -0.7pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">0.0000</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.55pt; line-height: 10.85pt; text-align: center; text-indent: -0.55pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">0.0000</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.55pt; line-height: 10.85pt; text-align: center; text-indent: -0.55pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">0.0000</FONT></TD>
    <TD STYLE="border-right: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.3pt; line-height: 10.85pt; text-align: center; text-indent: -0.15pt; border-left: Black 0.5pt solid"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">0.0000</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 0.5pt solid; border-right: Black 0.5pt solid; border-left: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.65pt; line-height: 10.95pt; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt">March 1, <FONT STYLE="letter-spacing: -0.2pt">2031</FONT></FONT></TD>
    <TD STYLE="border-bottom: Black 0.5pt solid; border-right: Black 0.5pt solid; border-left: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.65pt; line-height: 10.95pt; text-align: center; text-indent: 0.85pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">77.7777</FONT></TD>
    <TD STYLE="border-bottom: Black 0.5pt solid; border-right: Black 0.5pt solid; border-left: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.85pt; line-height: 10.95pt; text-align: center; text-indent: -0.1pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">15.8730</FONT></TD>
    <TD STYLE="border-bottom: Black 0.5pt solid; border-right: Black 0.5pt solid; border-left: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.7pt; line-height: 10.95pt; text-align: center; text-indent: -0.7pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">0.0000</FONT></TD>
    <TD STYLE="border-bottom: Black 0.5pt solid; border-right: Black 0.5pt solid; border-left: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.55pt; line-height: 10.95pt; text-align: center; text-indent: -0.55pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">0.0000</FONT></TD>
    <TD STYLE="border-bottom: Black 0.5pt solid; border-right: Black 0.5pt solid; border-left: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.55pt; line-height: 10.95pt; text-align: center; text-indent: -0.55pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">0.0000</FONT></TD>
    <TD STYLE="border-bottom: Black 0.5pt solid; border-right: Black 0.5pt solid; border-left: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.7pt; line-height: 10.95pt; text-align: center; text-indent: -0.7pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">0.0000</FONT></TD>
    <TD STYLE="border-bottom: Black 0.5pt solid; border-right: Black 0.5pt solid; border-left: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.55pt; line-height: 10.95pt; text-align: center; text-indent: -0.55pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">0.0000</FONT></TD>
    <TD STYLE="border-bottom: Black 0.5pt solid; border-right: Black 0.5pt solid; border-left: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.55pt; line-height: 10.95pt; text-align: center; text-indent: -0.55pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">0.0000</FONT></TD>
    <TD STYLE="border-bottom: Black 0.5pt solid; border-right: Black 0.5pt solid; border-left: Black 0.5pt solid; padding-top: 4.8pt; padding-bottom: 12pt; padding-left: 0.3pt; line-height: 10.95pt; text-align: center; text-indent: -0.15pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">0.0000</FONT></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 56 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 3.95pt; margin-right: 0; margin-bottom: 12pt; text-align: center"><FONT STYLE="letter-spacing: -0.1pt"><B>EXHIBIT</B></FONT><B>
<FONT STYLE="letter-spacing: -0.5pt">A<BR>
<BR>
</FONT>FORM OF NOTE [FORM OF FACE OF NOTE]</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>THIS NOTE AND THE COMMON
STOCK, IF ANY, ISSUABLE UPON CONVERSION OF THIS NOTE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#8220;SECURITIES
ACT&#8221;), AND ACCORDINGLY, PRIOR TO THE RESALE RESTRICTION TERMINATION DATE (AS DEFINED BELOW), MAY NOT BE OFFERED, SOLD, PLEDGED OR
OTHERWISE TRANSFERRED EXCEPT IN ACCORDANCE WITH THE FOLLOWING SENTENCE. BY ITS ACQUISITION HEREOF OR OF A BENEFICIAL INTEREST HEREIN,
THE ACQUIRER:</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 60pt"></TD><TD STYLE="width: 0.5in"><FONT STYLE="letter-spacing: -0.05pt">(1)</FONT></TD><TD STYLE="text-align: justify"><B>REPRESENTS THAT IT AND ANY ACCOUNT FOR WHICH IT IS ACTING IS A &#8220;QUALIFIED INSTITUTIONAL BUYER&#8221;
(WITHIN THE MEANING OF RULE 144A UNDER THE SECURITIES ACT) AND THAT IT EXERCISES SOLE INVESTMENT DISCRETION WITH RESPECT TO EACH SUCH
ACCOUNT, AND</B></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 60pt"></TD><TD STYLE="width: 0.5in"><FONT STYLE="letter-spacing: -0.05pt">(2)</FONT></TD><TD STYLE="text-align: justify"><B>AGREES FOR THE BENEFIT OF THE COMPANY THAT IT WILL NOT OFFER, SELL, PLEDGE OR OTHERWISE TRANSFER THIS
NOTE OR ANY BENEFICIAL INTEREST HEREIN PRIOR TO THE RESALE RESTRICTION TERMINATION DATE (AS DEFINED BELOW), EXCEPT:</B></TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.05pt"><B>(A)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><B>TO
HERON THERAPEUTICS, INC. (THE &#8220;COMPANY&#8221;) OR ANY SUBSIDIARY THEREOF, OR</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.05pt"><B>(B)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><B>PURSUANT
TO A REGISTRATION STATEMENT WHICH HAS BECOME EFFECTIVE UNDER THE SECURITIES ACT, OR</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.05pt"><B>(C)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><B>TO
A QUALIFIED INSTITUTIONAL BUYER IN COMPLIANCE WITH RULE 144A UNDER THE SECURITIES ACT, OR</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.05pt"><B>(D)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><B>PURSUANT
TO AN EXEMPTION FROM REGISTRATION PROVIDED BY RULE 144 UNDER THE SECURITIES ACT OR ANY OTHER AVAILABLE EXEMPTION FROM THE REGISTRATION
REQUIREMENTS OF THE SECURITIES ACT.</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>THE &#8220;RESALE RESTRICTION
TERMINATION DATE&#8221; MEANS THE DATE: THAT IS AT LEAST ONE YEAR AFTER THE LAST ORIGINAL ISSUANCE DATE OF THE <FONT STYLE="letter-spacing: -0.1pt">NOTES.</FONT></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.1pt"><B>PRIOR
TO THE REGISTRATION OF ANY TRANSFER IN ACCORDANCE WITH (2)(D) </B></FONT><B>ABOVE, THE COMPANY RESERVES THE RIGHT TO REQUIRE THE DELIVERY
OF SUCH LEGAL OPINIONS, CERTIFICATIONS OR OTHER EVIDENCE AS MAY REASONABLY BE REQUIRED IN ORDER TO DETERMINE THAT THE PROPOSED TRANSFER
IS BEING MADE IN COMPLIANCE WITH THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS. NO REPRESENTATION IS MADE AS TO THE AVAILABILITY
OF ANY EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT.</B></P>


<!-- Field: Page; Sequence: 57 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in">Heron Therapeutics, <FONT STYLE="letter-spacing: -0.2pt">Inc.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in">5.0% Convertible Senior
Notes due 2031</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in">Principal Amount $35,000,000</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in">Heron Therapeutics, Inc., a Delaware corporation (the &#8220;<B>Company</B>&#8221;), promises
to pay to Rubric Capital Management LP or registered assigns, the principal amount of thirty-five million dollars ($35,000,000), on February
March 1, 2031 (the &#8220;<B>Maturity Date</B>&#8221;).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in">Interest Payment Dates:
March 1 and September 1, commencing March 1, 2026.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in">Additional provisions of this Note are set forth on the other side of this Note.</P>


<!-- Field: Page; Sequence: 58 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 3.95pt 0 12pt; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF,
Heron Therapeutics, Inc. has caused this instrument to be signed manually or electronically by one of its duly authorized Officers.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><B>HERON THERAPEUTICS, <FONT STYLE="letter-spacing: -0.2pt">INC.</FONT></B></P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="letter-spacing: -0.2pt">&nbsp;</FONT></P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="letter-spacing: -0.2pt">&nbsp;</FONT></P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="letter-spacing: -0.2pt">By: ______________________________________<U></U></FONT></P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="letter-spacing: -0.1pt">Name:</FONT></P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="letter-spacing: -0.1pt">Title:</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 59 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 3.95pt 0 12pt 70.05pt; text-align: center; text-indent: 0.5in"><B>[FORM OF
REVERSE OF <FONT STYLE="letter-spacing: -0.2pt">NOTE]</FONT></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Heron Therapeutics, <FONT STYLE="letter-spacing: -0.2pt">Inc.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">5.0% Convertible Senior Notes
due <FONT STYLE="letter-spacing: -0.2pt">2031</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">This Note is one of a duly
authorized issue of securities of the Company (herein called the &#8220;<B>Notes</B>&#8221;), issued under the Note Purchase Agreement
dated as of August 8, 2025 (the &#8220;<B>Note Purchase Agreement</B>&#8221;) by and among the Company and the Purchasers party thereto,
and reference is hereby made to the Note Purchase Agreement for a statement of the respective rights, limitations of rights, duties and
immunities thereunder of the Company and the holders of the Notes and of the terms upon which the Notes are, and are to be, authenticated
and delivered. In the event of a conflict between the terms of the Note Purchase Agreement and this Note, the terms of the Note Purchase
Agreement shall govern.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The Company will pay cash
interest on the unpaid principal amount of this Note at a rate of 5.0% per year until maturity, provided that the Company has the right,
at its election, upon at least <FONT STYLE="letter-spacing: -0.2pt">five (5) Business Day prior written notice to the Purchasers, to
pay all accrued and unpaid interest prior to September 1, 2026 in new Notes at a rate of 7.0% per year. Interest will accrue from the
most recent date on which interest has been paid or duly provided for or, if no interest has been paid or duly provided for, from, and
including, September 1, 2025. Interest on the Notes shall be computed on the basis of a 360-day year consisting of twelve 30-day months.
No interest shall be paid with respect to Notes surrendered for conversion.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">This Note does not benefit
from a sinking <FONT>fund.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">As provided in and
subject to the provisions of the Note Purchase Agreement, upon the occurrence of a Fundamental Change the holder of this Note will have
the right, at such holder&#8217;s option, to require the Company to purchase this Note, or any portion of this Note such that the principal
amount of this Note that is not purchased equals $1,000 or an integral multiple of $1,000 in excess thereof, on the Fundamental Change
Purchase Date at a price equal to the Fundamental Change Purchase Price for such Fundamental Change Purchase Date.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">As provided in and subject
to the provisions of the Note Purchase Agreement, the holder hereof has the right, at its option, to convert this Note or a portion of
this Note such that the principal amount of this Note that is not converted equals $1,000 or an integral multiple of $1,000 in excess
thereof, at such holder&#8217;s option as indicated in the applicable Notice of Conversion, into cash, shares of Common Stock or a combination
of cash and shares of Common Stock, together, if applicable, with cash in lieu of fractional interests in Common Stock as determined in
accordance with Article 4 of the Note Purchase Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">As provided in and subject
to the provisions of the Note Purchase Agreement, the Company has the right to redeem the Notes.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The Company will pay cash
amounts in money of the United States that at the time of payment is legal tender for payment of public and private debts.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify; text-indent: 0.5in"></P>


<!-- Field: Page; Sequence: 60 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-indent: 0.5in; font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify">The Note Purchase Agreement
permits, with certain exceptions as therein provided, the amendment thereof and the modification of the rights and obligations of the
Company and <FONT STYLE="letter-spacing: -0.25pt">the</FONT> rights of the holders of the Notes to be effected under
the Note Purchase Agreement at any time by the Company, the Designated Agent and the Requisite Purchasers. The Note Purchase Agreement
also contains provisions permitting the Required Purchasers to waive certain past Defaults under the Note Purchase Agreement and their
consequences. Any such waiver by the holder of this Note shall be conclusive and binding upon such holder and upon all future holders
of this Note and of any Note issued upon the registration of transfer hereof or in exchange herefor or in lieu hereof, whether or not
notation of such consent or waiver is made upon this Note.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">As provided in and subject
to the provisions of the Note Purchase Agreement, the holder of this Note shall not have the right to institute any proceeding with respect
to the Note Purchase Agreement, or for the appointment of a receiver or trustee, or for any other remedy thereunder, unless such holder
shall have previously given the Designated Agent written notice of a continuing Event of Default with respect to the Note, Purchasers
holding at least 25% of the aggregate principal amount of the then Outstanding Notes deliver to the Designated Agent a written request
that the Designated Agent pursue a remedy with respect to such Event of Default and offered the Designated Agent indemnity satisfactory
to it, and the Designated Agent shall have failed to institute any such proceeding, for 60 days after receipt of such notice, request
and offer of indemnity, and shall not have received from the Required Purchasers a direction inconsistent with such request. The foregoing
shall not apply to any suit instituted by the holder of this Note for the enforcement of any payment of the principal hereof, premium,
if any, or interest hereon, the Fundamental Change Purchase Price and the amount of Common Stock due upon conversion of this Note or after
the respective due dates expressed in the Note Purchase Agreement and such other Events of Defaults described in the Note Purchase Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">No reference herein
to the Note Purchase Agreement and no provision of this Note or of the Note Purchase Agreement shall alter or impair the obligation of
the Company, which is absolute and unconditional, to pay or deliver, as the case may be, the principal of (including the Fundamental Change
Purchase Price), premium, interest on and the amount of Common Stock due upon conversion of this Note at the time, place and rate, and
in the coin and currency herein <FONT STYLE="letter-spacing: -0.1pt">prescribed.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">As provided in the Note Purchase
Agreement and subject to certain limitations therein set forth, the transfer of this Note is registrable in the Register, upon surrender
of this Note for registration of transfer to the Company, duly endorsed by, or accompanied by a written instrument of transfer in form
satisfactory to the Company duly executed by, the holder hereof or its attorney duly authorized in writing, and thereupon a new Note of
this series and of like tenor for the same aggregate principal amount will be issued to the designated transferee.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The Notes are issuable only
in registered form without coupons in denominations of $1,000 and integral multiples of $1,000 in excess thereof. As provided in the Note
Purchase Agreement and subject to certain limitations therein set forth, the Notes are exchangeable for a like aggregate principal amount
of Notes and of like tenor of a different authorized denomination, as requested by the holder surrendering the same.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Prior to due presentment
of this Note for registration of transfer, the Company and any agent of the Company may treat the Person in whose name the Note is registered
as the owner hereof <FONT STYLE="letter-spacing: -0.25pt">for</FONT> all purposes, whether or not this Note be overdue, and neither the
Company nor any such agent shall be affected by notice to the contrary.</P>


<!-- Field: Page; Sequence: 61 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify; text-indent: 0.5in">Customary abbreviations may
be used in the name of a holder or an assignee, such as TEN COM (= tenants in common), TEN ENT (= tenants by the entirety), JT TEN (=
joint tenants with rights of survivorship and not as tenants in common), CUST (= custodian) and U/G/M/A (= Uniform Gift to Minors Act).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">No service charge shall be
made for any such registration of transfer or exchange, but the Company may require payment of a sum sufficient to cover any tax or other
governmental charge payable in connection therewith.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">All defined terms used in
this Note that are defined in the Note Purchase Agreement shall have the meanings assigned to them in the Note Purchase Agreement. If
any provision of this Note limits, qualifies or conflicts with a provision of the Note Purchase Agreement, such provision of the Note
Purchase Agreement shall control.</P>


<!-- Field: Page; Sequence: 62 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 3.95pt 0 12pt; text-align: right; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.25pt"><B>ATTACHMENT</B></FONT><B>
<FONT STYLE="letter-spacing: -0.5pt">1</FONT></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>[FORM OF NOTICE OF <FONT STYLE="letter-spacing: -0.1pt">CONVERSION]</FONT></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left; text-indent: 0.5in">To: Heron Therapeutics, <FONT STYLE="letter-spacing: -0.2pt">Inc.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The undersigned owner of
5.0% Convertible Senior Notes due 2031 (the &#8220;Notes&#8221;) of Heron Therapeutics, Inc. (the &#8220;Company&#8221;) hereby irrevocably
exercises the option to convert the Notes, or a portion hereof (whose principal amount equals $1,000 or an integral multiple of $1,000
in excess thereof) below designated, at the Company&#8217;s option, into cash, shares of common stock, par value $0.01 per share (&#8220;Common
Stock&#8221;) or a combination of cash and shares of Common Stock as indicated below, together, if applicable, with cash in lieu of fractional
interests in Common Stock as determined in accordance with the terms of that certain Note Purchase Agreement, dated August 8, 2025, by
and between the Company and Rubric Capital Management LP, as agent for the Purchasers (the &#8220;Note Purchase Agreement&#8221;), referred
to in the Notes, and directs that any cash payable and any Common Stock issuable and deliverable upon conversion, together with any Notes
representing any unconverted principal amount hereof, be paid and/or issued and/or delivered, as the case may be, to the registered holder
hereof unless a different name is indicated below.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">If any Common Stock is to
be issued in the name of a Person other than the undersigned, the undersigned will pay all transfer taxes payable with respect to such
issuance and transfer as set forth in the Note Purchase Agreement. All capitalized terms used herein and not otherwise defined have the
meaning given to such terms in the Note Purchase Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify; text-indent: 0.5in">Principal amount to
be converted to be settled in <FONT STYLE="letter-spacing: -0.1pt">cash:</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.5pt">$_____________________________ </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify; text-indent: 0.5in">and/or</P>

<P STYLE="font: 12pt/13.8pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify; text-indent: 0.5in">Principal amount to be converted
to be settled in shares of Common <FONT STYLE="letter-spacing: -0.1pt">Stock:</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify; text-indent: 0.5in">$
______________________________</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify; text-indent: 0.5in">Dated: <U>&#9;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: justify; text-indent: 0.5in"><FONT>____________________________&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify; text-indent: 0.5in"><FONT>Signature(s)</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify; text-indent: 0.5in">(Sign exactly as your name
appears on the other side of this <FONT>Note)</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify; text-indent: 0.5in">Signature <FONT>Guarantee</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 6pt; text-align: justify; text-indent: 0.5in">(Signature(s) must be guaranteed
by an institution which is a member of one of the following recognized signature Guarantee Programs:</P>


<!-- Field: Page; Sequence: 63 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.25in; text-align: justify; text-indent: 0.5in">The Notes Transfer
Agent Medallion Program (STAMP); (ii) The New York Stock Exchange Medallion Program (MNSP); (iii) The Stock Exchange Medallion Program
(SEMP) or (iv) another guarantee program acceptable to the Trustee.)</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.25in; text-align: justify; text-indent: 0.5in">Fill in if a
check is to be issued, or shares of Common Stock or Notes are to be registered, otherwise than to or in the name of the registered Holder.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-right: 0; margin-bottom: 12pt; text-align: justify">(Name)
(Address)</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 12pt; text-align: justify; text-indent: 0.5in">Please
print name and address (including zip code) (Social Security or other Taxpayer Identifying Number) Dated:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0; text-align: justify; text-indent: 0.5in"><FONT>____________________________&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 12pt; text-align: justify; text-indent: 0.5in">Signature(s)</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 12pt; text-align: justify; text-indent: 0.5in">(Sign exactly
as such Person&#8217;s name appears <FONT STYLE="letter-spacing: -0.1pt">above)</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 12pt; text-align: justify; text-indent: 0.5in">Signature <FONT STYLE="letter-spacing: -0.1pt">Guarantee</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 12pt; text-align: justify; text-indent: 0.5in">(Signature(s)
must be guaranteed by an institution which is a member of one of the following recognized signature Guarantee Programs:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 12pt; text-align: justify; text-indent: 0.5in">The Notes Transfer
Agent Medallion Program (STAMP); (ii) The New York Stock Exchange Medallion Program (MNSP); (iii) The Stock Exchange Medallion Program
(SEMP) or (iv) another guarantee program acceptable to the Trustee.)</P>


<!-- Field: Page; Sequence: 64 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 3.95pt 0 12pt; text-align: right; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.25pt"><B>ATTACHMENT</B></FONT><B>
<FONT STYLE="letter-spacing: -0.5pt">2</FONT></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><B>[FORM OF FUNDAMENTAL CHANGE
PURCHASE <FONT STYLE="letter-spacing: -0.1pt">NOTICE]</FONT></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify; text-indent: 0in">To:&nbsp;&nbsp;Heron Therapeutics <FONT STYLE="letter-spacing: -0.2pt">Inc.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify; text-indent: 0.5in">The undersigned registered
owner of this Note hereby requests and instructs Heron Therapeutics Inc. to pay to the registered holder hereof, in accordance with the
applicable provisions of the Note Purchase Agreement referred to in this Note, the Fundamental Change Purchase Price on the Fundamental
Change Purchase Date pursuant to Section 9.1 of such Note Purchase <FONT STYLE="letter-spacing: -0.1pt">Agreement.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: justify; text-indent: 0in">Principal amount to be purchased
(if less than <FONT>all):</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="letter-spacing: -0.5pt">$</FONT><U>&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 12pt/186% Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: justify; text-indent: 0in">Certificate number (if
Notes are in certificated form)</P>

<P STYLE="font: 12pt/186% Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: justify; text-indent: 0in"><FONT STYLE="letter-spacing: -0.1pt">Dated: </FONT><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;</U></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 139.5pt">&nbsp;</P>

<P STYLE="margin: 0 0 0pt; font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="letter-spacing: -0.1pt"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-left: 0; text-align: justify; text-indent: 0in"><FONT STYLE="letter-spacing: -0.1pt">Signature(s)</FONT></P>

<P STYLE="font: 12pt/273% Times New Roman, Times, Serif; margin: 0.05pt 0 12pt; text-align: justify; text-indent: 0in">(Sign exactly as
your name appears on the other side of this Note)</P>

<P STYLE="font: 12pt/273% Times New Roman, Times, Serif; margin: 0.05pt 0 12pt; text-align: justify; text-indent: 0in">Social Security or Other Taxpayer Identification Number</P>


<!-- Field: Page; Sequence: 65 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 3.95pt 0 12pt; text-align: right; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.25pt"><B>ATTACHMENT</B></FONT><B>
<FONT STYLE="letter-spacing: -0.5pt">3</FONT></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><B>[FORM OF ASSIGNMENT AND
<FONT STYLE="letter-spacing: -0.1pt">TRANSFER]</FONT></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">For value <FONT STYLE="letter-spacing: -0.1pt">received,</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.1pt">____________________________&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 1.35pt 0 12pt; text-align: justify; text-indent: 0.5in">hereby sell(s), assign(s)
and transfer(s) <FONT STYLE="letter-spacing: -0.2pt">unto</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(Please insert social security
or Taxpayer Identification Number of <FONT STYLE="letter-spacing: -0.1pt">assignee)</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0pt 12pt; text-align: justify; text-indent: 40pt">the within Note, and hereby
irrevocably constitutes and appoints to transfer the said Note on the books of the Company, with full power of substitution in the premises.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The undersigned hereby certifies
that such transfer complies with Section 11.2 of the Note Purchase Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">In connection with any transfer
of the within Note occurring prior to the Resale Restriction Termination Date, as defined in the such Note, the undersigned confirms
that such Note is being <FONT STYLE="letter-spacing: -0.1pt">transferred:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&#9744;</TD><TD STYLE="text-align: justify">To
Heron Therapeutics, Inc. or a subsidiary thereof; or
                                                                                                                                         <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                                                                                         <TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></TD><TD STYLE="text-align: justify">Pursuant to a registration statement which has become effective under the Securities Act of 1933, as amended;
or</TD></TR>
            </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></TD><TD STYLE="text-align: justify">To a qualified institutional buyer in compliance with Rule 144A under the Securities Act of 1933, as amended;
or</TD></TR>
            </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></TD><TD STYLE="text-align: justify">Pursuant to an exemption from registration provided by Rule 144 under the Securities Act of 1933, as amended,
or any other available exemption from the registration requirements of the Securities Act of 1933, as amended.</TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in">TO BE COMPLETED BY PURCHASER
IF THE THIRD BOX ABOVE IS <FONT STYLE="letter-spacing: -0.1pt">CHECKED</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The undersigned represents
and warrants that it is purchasing this Note for its own account or an account with respect to which it exercises sole investment discretion
and that it and any such account is a &#8220;qualified institutional buyer&#8221; within the meaning of Rule 144A under the Securities
Act and is aware that the sale to it is being made in reliance on Rule 144A and acknowledges that it has received such information regarding
the Company as the undersigned has requested pursuant to Rule 144A or has determined not to request such information and that it is aware
that the transferor is relying upon the undersigned&#8217;s foregoing representations in order to claim the exemption from registration
provided by Rule 144A.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 1.35pt 0 0; text-align: justify; text-indent: 139.5pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><BR>
Date <FONT STYLE="letter-spacing: -0.1pt">Signed:</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>


<!-- Field: Page; Sequence: 66 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">Unless one of the above boxes is checked,
the Company will refuse to register any of the Notes evidenced by this certificate in the name of any Person other than the
registered holder thereof, provided that if the fourth box is checked, the Company may require, prior to registering any such
transfer of the Notes, in its sole discretion, such legal opinions, certifications and other <FONT STYLE="letter-spacing: -0.1pt">information</FONT>
as the Company may reasonably request to confirm that such transfer is being made pursuant to an exemption from, or in a transaction
not subject to, the registration requirements of the Securities <FONT STYLE="letter-spacing: -0.2pt">Act.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">If none of the foregoing
boxes is checked, the Company shall not be obligated to register this Note in the name of any Person other than the holder hereof unless
and until the conditions to any such transfer of registration set forth herein shall have been satisfied.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.1pt">Dated:</FONT><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;</U></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Signature(s)</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(Sign exactly <FONT>as
your name appears on the other side of this Note)</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT>Signature
Guarantee</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT>(Signature(s) must be guaranteed by an institution which is a member of one of the following recognized signature Guarantee
Programs: (i) The Notes Transfer Agent Medallion Program (STAMP); (ii) The New York Stock Exchange Medallion Program (MNSP); (iii) The
Stock Exchange Medallion Program (SEMP) or (iv) another guarantee program acceptable to the Trustee)</FONT></P>


<!-- Field: Page; Sequence: 67 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 3.95pt 0 12pt; text-align: center; text-indent: 0in"><B>EXHIBIT <FONT STYLE="letter-spacing: -0.6pt">B</FONT></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><B>PLAN OF <FONT STYLE="letter-spacing: -0.1pt">DISTRIBUTION</FONT></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The selling stockholders,
which shall include donees, pledgees, transferees or other successors-in-interest selling shares of common stock or interests in shares
of common stock received after the date of this prospectus from a selling stockholder as a gift, pledge, partnership distribution or other
transfer, may, from time to time, sell, transfer or otherwise dispose of any or all of their shares of common stock or interests in shares
of common stock on any stock exchange, market or trading facility on which the shares are traded or in private transactions. These dispositions
may be at fixed prices, at prevailing market prices at the time of sale, at prices related to the prevailing market price, at varying
prices determined at the time of sale, or at negotiated <FONT STYLE="letter-spacing: -0.1pt">prices.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.25in; text-align: justify; text-indent: 0.5in">The selling stockholders
may use any one or more of the following methods when disposing of shares or interests therein:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">ordinary brokerage transactions and transactions in which the broker-dealer solicits <FONT STYLE="letter-spacing: -0.1pt">purchasers;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 11.95pt; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">block trades in which the broker-dealer will attempt to sell the shares as agent, but may position and
resell a portion of the block as principal to facilitate the transaction;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 11.9pt; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">purchases by a broker-dealer as principal and resale by the broker-dealer for its own <FONT STYLE="letter-spacing: -0.1pt">account;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 12.1pt; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 17.95pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">an exchange distribution in accordance with the rules of the applicable <FONT STYLE="letter-spacing: -0.1pt">exchange;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 11.9pt; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 17.95pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">privately negotiated <FONT STYLE="letter-spacing: -0.1pt">transactions;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 12.1pt; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 17.95pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">short <FONT STYLE="letter-spacing: -0.1pt">sales;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 11.8pt; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">through the writing or settlement of options or other hedging transactions, whether through an options
exchange or otherwise;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 11.95pt; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">through agreements between broker-dealers and the selling stockholders to sell a specified number of such
shares at a stipulated price per share;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 12.05pt; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 17.95pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">a combination of any such methods of sale; <FONT STYLE="letter-spacing: -0.25pt">and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 11.95pt; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 17.95pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">any other method permitted by applicable <FONT STYLE="letter-spacing: -0.2pt">law.</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.25in; text-align: justify; text-indent: 0.5in">The selling
stockholders may, from time to time, pledge or grant a security interest in some or all of the shares of common stock owned by them and,
if they default in the performance of their secured obligations, the pledgees or secured parties may offer and sell the shares of common
stock, from time to time, under this prospectus, or under an amendment to this prospectus under Rule 424(b) or other applicable provision
of the Securities Act amending the list of <FONT STYLE="letter-spacing: -0.1pt">selling</FONT> stockholders to include the pledgee, transferee
or other successors in interest as selling stockholders under this prospectus. The selling stockholders also may transfer the shares of
common stock in other circumstances, in which case the pledgees, transferees or other successors in interest will be the selling beneficial
owners for purposes of this prospectus.</P>


<!-- Field: Page; Sequence: 68 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 0.25in; text-align: justify; text-indent: 0.5in">In connection
with the sale of our common stock or interests therein, the selling stockholders may enter into hedging transactions with broker-dealers
or other financial institutions, which may in turn engage in short sales of the common stock in the course of hedging the positions they
assume. The selling stockholders may also sell shares of our common stock short and deliver these securities to close out their short
positions, or loan or pledge the common stock to broker-dealers that in turn may sell these securities. The selling stockholders may also
enter into options or other transactions with broker-dealers or other financial institutions or the creation of one or more derivative
securities which require the delivery to each such broker-dealer or other financial institution of shares offered by this prospectus,
which shares such broker-dealer or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect
such transaction).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.25in; text-align: justify; text-indent: 0.5in">The aggregate
proceeds to the selling stockholders from the sale of the common stock offered by them will be the purchase price of the common stock
less discounts or commissions, if any. Each of the selling stockholders reserves the right to accept and, together with its agents from
time to time, to reject, in whole or in part, any proposed purchase of common stock to be made directly or through agents. We will not
receive any of the proceeds from this offering.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.25in; text-align: justify; text-indent: 0.5in">The selling
stockholders also may resell all or a portion of the shares in open market transactions in reliance upon Rule 144 under the Securities
Act of 1933, provided that they meet the criteria and conform to the requirements of that rule.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.25in; text-align: justify; text-indent: 0.5in">The selling
stockholders and any underwriters, broker-dealers or agents that participate in the sale of the common stock or interests therein may
be &#8220;underwriters&#8221; within the meaning of Section 2(11) of the Securities Act. Any discounts, commissions, concessions or profit
they earn on any resale of the shares may be underwriting discounts and commissions under the Securities Act. Selling stockholders who
are &#8220;underwriters&#8221; within the meaning of Section 2(11) of the Securities Act will be subject to the prospectus delivery requirements
of the Securities Act.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.25in; text-align: justify; text-indent: 0.5in">To the extent
required, the shares of our common stock to be sold, the names of the selling stockholders, the respective purchase prices and public
offering prices, the names of any agents, dealer or underwriter, and any applicable commissions or discounts with respect to a particular
<FONT STYLE="letter-spacing: -0.1pt">offer will be set forth in an accompanying prospectus supplement or, if appropriate, a post-effective
</FONT>amendment to the registration statement that includes this prospectus.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.25in; text-align: justify; text-indent: 0.5in">In order to comply
with the securities laws of some states, if applicable, the common stock may be sold in these jurisdictions only through registered or
licensed brokers or dealers. In addition, in some states the common stock may not be sold unless it has been registered or qualified for
sale or an exemption from registration or qualification requirements is available and is complied with.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.25in; text-align: justify; text-indent: 0.5in">We have advised
the selling stockholders that the anti-manipulation rules of Regulation M under the Exchange Act may apply to sales of shares in the market
and to the activities of the selling stockholders and their affiliates. In addition, to the extent applicable we will make copies of this
prospectus (as it may be supplemented or amended from time to time) available to the selling stockholders for the purpose of satisfying
the prospectus delivery requirements of the Securities Act. The selling stockholders may indemnify any broker-dealer that participates
in transactions involving the sale of the shares against certain liabilities, including liabilities arising under the Securities Act.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.25in; text-align: justify; text-indent: 0.5in">We have agreed
to indemnify the selling stockholders against liabilities, including liabilities under the Securities Act and state securities laws,
relating to the registration of the shares offered by this prospectus.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.25in; text-align: justify; text-indent: 0.5in">We have agreed with the selling stockholders to keep the registration
statement of which this prospectus constitutes a part effective until the earlier of (1) such time as all of the shares covered by this
prospectus have been disposed of pursuant to and in accordance with the registration statement or (2) the date on which all of the shares
may be sold without restriction pursuant to Rule 144 of the Securities Act.</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.4
<SEQUENCE>5
<FILENAME>p25-1788exhibit99_4.htm
<DESCRIPTION>COOPERATION AGREEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 12pt Times New Roman, Times, Serif">

<P STYLE="margin: 0pt"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 3.95pt 17.8pt 0 0; text-align: right"><B><I>Execution <FONT STYLE="letter-spacing: -0.1pt">Version</FONT></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 3.95pt 17.8pt 0 0; text-align: right"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 17.95pt 0 0; text-align: center"><FONT STYLE="letter-spacing: -0.1pt"><B><U>COOPERATION
AGREEMENT</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 17.95pt 0 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 21.75pt 0 0; text-indent: 0.5in">This Cooperation Agreement, dated as of
August 8, 2025 (this &#8220;<U>Agreement</U>&#8221;), is made by and among Heron Therapeutics, Inc., a Delaware corporation (the &#8220;<U>Company</U>&#8221;)
and Rubric Capital Management LP, a Delaware limited partnership (the &#8220;<U>Investor</U>&#8221;). The Company and the Investor are
collectively herein referred to as the &#8220;<U>Parties</U>&#8221; and individually as a &#8220;<U>Party</U>.&#8221; Capitalized terms
used herein and not otherwise defined have the meanings ascribed to them in <U>Section 21</U> below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 21.75pt 0 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 17.95pt 0 0; text-align: center"><FONT STYLE="letter-spacing: -0.1pt"><B><U>RECITALS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 17.95pt 0 0; text-align: center"><FONT STYLE="letter-spacing: -0.1pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 15.75pt 0 0; text-indent: 0.5in">WHEREAS, the Company and the Investor have
engaged in various discussions and communications concerning the Company; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 15.75pt 0 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 21.75pt 0 0; text-indent: 0.5in">WHEREAS, the Company and the Investor have
determined to come to an agreement with respect to certain matters relating to the composition of the Board of Directors of the Company
(the &#8220;<U>Board</U>&#8221;) and certain other matters, as provided in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 21.75pt 0 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 17.95pt 0 0; text-align: center"><FONT STYLE="letter-spacing: -0.1pt"><B><U>AGREEMENT</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 17.95pt 0 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 15.75pt 0 0; text-indent: 0.5in">NOW, THEREFORE, in consideration of the
foregoing premises and the mutual covenants and agreements contained herein, and for other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, the Parties, intending to be legally bound hereby, agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 15.75pt 0 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">Section <FONT STYLE="letter-spacing: -0.25pt">1.</FONT>&#9;<U>Board
Composition and Related <FONT STYLE="letter-spacing: -0.1pt">Agreements</FONT></U><FONT STYLE="letter-spacing: -0.1pt">.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 107.95pt; text-indent: -35.95pt"><FONT STYLE="letter-spacing: -0.1pt">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Board <FONT STYLE="letter-spacing: -0.1pt">Composition</FONT></U><FONT STYLE="letter-spacing: -0.1pt">.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 20.1pt 0 0; text-indent: 1.5in"><FONT STYLE="letter-spacing: -0.05pt">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>As of the closing of the purchase and sale of the shares of common stock, par value $0.01 per share (the &#8220;<U>Common
Stock</U>&#8221;) and shares of Series A Convertible Preferred Stock, par value $0.01 per share (the &#8220;<U>Preferred Stock</U>&#8221;)
of the Company pursuant to that Note Purchase Agreement, by and among the Company, the purchasers thereto, and the Investor as designated
agent for the purchasers, dated August 8, 2025 (the &#8220;<U>Purchase Agreement</U>&#8221;), the Board and all applicable committees
of the Board shall have taken all necessary actions to (x) fix the size of the Board at seven (7) directors and (y) appoint a director
nominated by the Investor to be named at closing (the &#8220;<U>Investor Appointee</U>&#8221;) as a director of the Company. During the
period commencing with the date of this Agreement through the expiration of the Cooperation Period, the Board and all applicable committees
of the Board shall not increase the size of the Board to more than seven (7) directors, unless mutually agreed to in writing by the Company
and the Investor.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 21.1pt 0 0; text-indent: 1.5in"><FONT STYLE="letter-spacing: -0.05pt">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company agrees that, upon appointment to the Board, the Investor Appointee shall receive (i) the same benefits of director
and officer insurance as all other non-management directors on the Board, (ii) the same compensation for his or her service as a director
as the compensation received by other non-management directors on the Board, and  &#8239;such other benefits on the same basis as all other
non-management directors on the <FONT STYLE="letter-spacing: -0.1pt">Board.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 20.55pt 0 0; text-indent: 1in"><FONT STYLE="letter-spacing: -0.1pt">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>New Director Nominations</U>. The Company&#8217;s slate of nominees for the election of directors of the Company at the
Company&#8217;s 2026 annual meeting of stockholders (the &#8220;<U>2026 Annual Meeting</U>&#8221;) shall include the Investor Appointee
and no more than six (6) other persons as nominees. The Company shall recommend, support and solicit proxies in favor of the election
of the Investor Appointee at the 2026 Annual Meeting in the same manner as it recommends, supports and solicits proxies in favor of the
election of the Company&#8217;s other nominees at the 2026 Annual Meeting.</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 107.95pt; text-indent: -35.95pt"><FONT STYLE="letter-spacing: -0.1pt">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT> <U>Replacement <FONT STYLE="letter-spacing: -0.1pt">Directors</FONT></U><FONT STYLE="letter-spacing: -0.1pt">.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 26.25pt 0 0; text-indent: 1.5in"><FONT STYLE="letter-spacing: -0.05pt">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Following the date of this Agreement, if the Investor Appointee is unable or unwilling to serve as a director for any reason,
then the Investor shall have the ability to recommend a substitute person to replace such Investor Appointee, in accordance with, and
subject to, this <U>Section 1(c)</U>.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 28pt 0 0; text-indent: 1.5in"><FONT STYLE="letter-spacing: -0.05pt">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Except as otherwise specified in this Agreement, if a replacement Director (a &#8220;<U>Replacement Director</U>&#8221;)
is appointed to the Board pursuant to this <U>Section 1(c)</U>, all references in this Agreement to the term &#8220;Investor Appointee&#8221;
will include such Replacement Director(s), as applicable.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 28pt 0 0; text-indent: 1.5in"><FONT STYLE="letter-spacing: -0.05pt">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The appointment of any Replacement Director shall be subject <FONT STYLE="letter-spacing: -0.25pt">to </FONT>(A) the execution
and delivery by such Replacement Director of (x) a fully completed copy of the Company&#8217;s standard director and officer questionnaire
and other reasonable and customary director onboarding documentation required by the Company in connection with the appointment or election
of all new non-management Board members, and (y) a written acknowledgment that such Replacement Director agrees to be bound by all Company
Policies (defined below), (B) such Replacement Director qualifying as &#8220;independent&#8221; pursuant to SEC rules and regulations
and applicable stock exchange listing standards and (C) the Board determining such Replacement Director to be reasonably acceptable (such
acceptance not to be unreasonably <FONT STYLE="letter-spacing: -0.1pt">withheld).</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 17.85pt 0 0; text-indent: 1.5in"><FONT STYLE="letter-spacing: -0.05pt">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Nominating and Corporate Governance Committee, acting reasonably and in good faith, shall make its determination and
recommendation regarding whether any candidate for Replacement Director so qualifies within five (5) Business Days of the Investor&#8217;s
recommendation. If the Nominating and Corporate Governance Committee does not accept a substitute person recommended by the Investor as
a Replacement Director, then the Investor will have the right to recommend additional substitute person(s) whose appointment will be subject
to the Nominating and Corporate Governance Committee recommending such person in accordance with the procedures described in this <U>Section
1(c)</U>. Upon the recommendation of a candidate for Replacement Director by the Nominating and Corporate Governance Committee, the Board
shall review and vote on the appointment of such candidate to the Board no later than five (5) Business Days after the Nominating and
Corporate Governance Committee&#8217;s recommendation of such candidate; <U>provided</U>, that if the Board does not approve and appoint
such candidate for Replacement Director to the Board (such approval not to be unreasonably withheld), the Parties shall continue to follow
the procedures described in this <U>Section 1(c)(iv)</U> until a Replacement Director is approved and appointed to the Board.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 19.65pt 0 0; text-indent: 1.5in"><FONT STYLE="letter-spacing: -0.05pt">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>If, at any time following the date of this Agreement, the Investor&#8217;s aggregate Beneficial Ownership is less than the
lesser of (x) 10% of the then-outstanding shares of Common Stock and (y) 50% of the Conversion Shares (as defined in the Purchase Agreement)
(subject to adjustment for stock splits, reclassifications, combinations and similar adjustments) (the &#8220;<U>Investor Minimum Ownership
Level</U>&#8221;), then the Investor shall immediately and irrevocably lose its rights under this <U>Section 1(c)</U> to recommend or
appoint a Replacement Director with respect to the Investor Appointee. For purposes of this Section 1(c)(v), the shares of Common Stock
underlying the Preferred Stock purchased pursuant to the Securities Purchase Agreement, dated as of the date hereof, by and among the
Company and each purchaser identified on the signature pages thereto (the &#8220;<U>Securities Purchase Agreement</U>&#8221;) and the
Notes purchased pursuant to the Purchase Agreement shall be deemed to be Beneficially Owned regardless of any limitation on conversion
or right of the Company to settle in conversions in cash.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 107.95pt; text-indent: -35.95pt"><FONT STYLE="letter-spacing: -0.1pt">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Additional Agreements</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 17.9pt 0 0; text-indent: 1.5in"><FONT STYLE="letter-spacing: -0.05pt">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Investor agrees (A) to cause its controlled Affiliates and Representatives to comply with the terms of this Agreement
and (B) that it shall be responsible for any breach of this Agreement by any such controlled Affiliate. A breach of this Agreement by
a controlled Affiliate or Representative of any member of the Investor, if such controlled Affiliate is not a Party hereto, shall be deemed
to occur if such controlled Affiliate or Representative engages in conduct that would constitute a breach of this Agreement if such controlled
Affiliate or Representative were a Party hereto to the same extent as the Investor.</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 15.75pt 0 0; text-indent: 1.5in"><FONT STYLE="letter-spacing: -0.05pt">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT> During the Cooperation Period, the Investor agrees that it shall, and shall cause each of its controlled Affiliates to,
appear in person or by proxy at each annual or special meeting of the stockholders of the Company (each, a &#8220;<U>Stockholder Meeting</U>&#8221;)
and vote all Voting Securities beneficially owned, directly or indirectly, by the Investor or such controlled Affiliate (or which the
Investor or such Affiliate has the right or ability to vote) at such meeting (A) in favor of the slate of directors recommended by the
Board, (B) against the election of any nominee for director not approved, recommended and nominated by the Board for election at any such
meeting, and (C) in accordance with the Board&#8217;s recommendation with respect to any other matter presented at such meeting; <U>provided</U>,
<U>however</U>, that if Institutional Shareholder Services Inc. (&#8220;<U>ISS</U>&#8221;) or Glass Lewis &amp; Co., LLC (&#8220;<U>Glass
Lewis</U>&#8221;) make a recommendation that differs from the recommendation of the Board with respect to any proposal submitted to the
Company&#8217;s stockholders at any Stockholder Meeting (other than as related to the election or removal of directors), the Investor
shall be permitted to vote in accordance with such ISS or Glass Lewis recommendation; <U>provided</U>, <U>further</U>, that the Investor
shall be permitted to vote in its sole discretion with respect to any proposals relating to an Extraordinary Transaction that requires
a vote of the Company&#8217;s stockholders.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 19.25pt 0 0; text-indent: 1.5in"><FONT STYLE="letter-spacing: -0.05pt">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>During the Cooperation Period, the Investor will notify the Company within two (2) Business Days of such time as the Investor
in the aggregate Beneficially Owns less than the Investor Minimum Ownership Level. Such information provided to the Company will be kept
strictly confidential unless required to be disclosed pursuant to law, legal process, subpoena, the rules of any stock exchange or any
legal requirement or as part of a response to a request for information from any governmental authority with jurisdiction over the <FONT STYLE="letter-spacing: -0.1pt">Company.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 25.25pt 0 0; text-indent: 0.5in">Section 2.&#9;<U>Standstill Provisions</U>.
During the Cooperation Period, the Investor shall not, and shall cause each of its controlled Affiliates not to, directly or indirectly,
alone or in concert with others (including through any Representative of any member of the Investor or any of its controlled Affiliates),
without the prior written consent of the Company:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 18.25pt 0 0; text-indent: 1in"><FONT STYLE="font-size: 12pt; letter-spacing: -0.1pt">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; letter-spacing: -0.1pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>(i) acquire, cause to be acquired, or offer, seek or agree to acquire, whether by purchase, tender or exchange offer, through the
acquisition of control of another person, by joining or forming a partnership, limited partnership, syndicate or other group (including
any group of persons that would be treated as a single &#8220;person&#8221; under Section 13(d) of the Securities Exchange Act of 1934,
as amended (together with the rules and regulations promulgated thereunder, the &#8220;<U>Exchange Act</U>&#8221;)), through swap or hedging
transactions or otherwise (the taking of any such action, an &#8220;<U>Acquisition</U>&#8221;), Beneficial Ownership of any securities
or assets of the Company (or any direct or indirect rights or options to acquire such ownership, including voting rights decoupled from
the underlying Voting Securities) such that after giving effect to any such Acquisition, the Investor or any of its controlled Affiliates
holds, directly or indirectly, an aggregate Beneficial Ownership in excess of 19.99% of the then outstanding Voting Securities (<I>provided
that</I>, for the avoidance of doubt, nothing in the foregoing shall not restrict the exercise of any securities of the Issuer received
by the Investor under the Purchase Agreement or the Securities Purchase Agreement ); (ii) effect or seek to effect, offer or propose to
effect, cause or participate in, or in any way assist, knowingly facilitate or knowingly encourage any other Person to effect or seek,
offer or propose to effect or participate in an Extraordinary Transaction (but nothing in this <U>Section 2(a)</U> shall prohibit any
member of the Investor or any of its controlled Affiliates from tendering into (or failing to tender into) a tender or exchange offer,
receiving payment or other consideration for securities of the Company, voting its Voting Securities &#8220;for&#8221; or &#8220;against&#8221;
any Extraordinary Transaction, or otherwise participating in any such transaction on the same basis as other stockholders of the Company,
or from participating in any such transaction that has been approved by the Board);</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 18.6pt 0 0; text-indent: 1in"><FONT STYLE="font-size: 12pt; letter-spacing: -0.1pt">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; letter-spacing: -0.1pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>(i) nominate, give notice of an intent to nominate, or recommend for nomination a person for election to the Board (other than
pursuant to <U>Section 1</U>) or take any action in respect of the removal of any director, (ii) knowingly seek or knowingly encourage
any person to submit any nomination in furtherance of a &#8220;contested solicitation&#8221; or take any other action in respect of the
election or removal of any director, (iii) submit, or knowingly seek or knowingly encourage the submission of, any stockholder proposal
(pursuant to Rule 14a-8 or otherwise) for consideration at, or bring any other business before, any Stockholder Meeting, (iv) request,
or knowingly initiate, knowingly encourage or participate in any request, to call a Stockholder Meeting, (v) seek to amend any provision
of the Company&#8217;s Certificate of Incorporation, as amended, or Amended and Restated Bylaws (the &#8220;<U>Bylaws</U>&#8221;), or
(vi) take any action similar to the foregoing with respect to any subsidiary of the Company; <U>provided</U>, <U>however</U>, that nothing
in this Agreement shall prevent the Investor or its controlled Affiliates from taking actions in furtherance of identifying director candidates
in connection with the 2026 Annual Meeting a reasonable time before the Cooperation Period expires on the Trigger Date, so long as such
actions do not create a public disclosure obligation for the Investor or the Company and are
undertaken on a basis reasonably designed to be confidential and in accordance in all material respects with any member of the Investor&#8217;s
normal practices in the circumstances;</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 21.75pt 0 0"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 19.75pt 0 0; text-indent: 1in"><FONT STYLE="font-size: 12pt; letter-spacing: -0.1pt">(c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; letter-spacing: -0.1pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>solicit any proxy, consent or other authority to vote of stockholders or conduct any other referendum (binding or non-binding)
(including any &#8220;withhold,&#8221; &#8220;vote no&#8221; or similar campaign) with respect to, or from the holders of, Voting Securities,
or become a &#8220;participant&#8221; (as such term is defined in Instruction 3 to Item 4 of Schedule 14A promulgated under the Exchange
Act) in, or knowingly assist, advise, initiate, knowingly encourage or knowingly influence any person (other than the Company) in, any
&#8220;solicitation&#8221; of any proxy, consent or other authority to vote any Voting Securities (other than such assistance, advice,
encouragement or influence that is consistent with the Board&#8217;s recommendation in connection with such matter); <U>provided</U>,
<U>however</U>, that the foregoing shall not restrict any member of the Investor from stating how it intends to vote with respect to any
Extraordinary Transaction, if any, in accordance with <U>Section 1(e)(ii)</U> and the reasons therefor;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 21.95pt 0 0; text-indent: 1in"><FONT STYLE="font-size: 12pt; letter-spacing: -0.1pt">(d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; letter-spacing: -0.1pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>(i) grant any proxy, consent or other authority to vote with respect to any matters (other than to the named proxies included in
the Company&#8217;s proxy card for any Stockholder Meeting) or (ii) deposit or agree or propose to deposit any securities of the Company
in any voting trust or similar arrangement, or subject any securities of the Company to any agreement or arrangement with respect to the
voting of such securities (including a voting agreement or pooling arrangement), other than (A) any such voting trust or arrangement solely
for the purpose of delivering to the Company or its designee a proxy, consent, or other authority to vote in connection with a solicitation
made by or on behalf of the Company or (B) customary brokerage accounts, margin accounts and prime brokerage accounts;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 28.35pt 0 0; text-indent: 1in"><FONT STYLE="font-size: 12pt; letter-spacing: -0.1pt">(e)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; letter-spacing: -0.1pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>knowingly encourage, advise or knowingly influence any person, or knowingly assist any person in so knowingly encouraging, advising
or knowingly influencing any person, with respect to the giving or withholding of any proxy, consent or authority to vote any Voting Securities
or in conducting any referendum (binding or non-binding) (including any &#8220;withhold,&#8221; &#8220;vote no&#8221; or similar campaign);
<U>provided</U>, <U>however</U>, that the foregoing shall not restrict any member of the Investor from stating how it intends to vote
with respect to an Extraordinary Transaction, if any, in accordance with <U>Section 1(e)(ii)</U> and the reasons therefor;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 24.65pt 0 0; text-indent: 1in"><FONT STYLE="font-size: 12pt; letter-spacing: -0.1pt">(f)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; letter-spacing: -0.1pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>form, join, knowingly encourage the formation of, or in any way participate in any partnership, limited partnership, syndicate
or group (within the meaning of Section 13(d)(3) of the Exchange Act) with respect to any Voting Securities (other than a group that includes
all or some of the members of the Investor or a group that the Investor is part of as of the date of this Agreement, but does not include
any other entities or persons that are not members of the Investor as of the date hereof; <U>provided</U>, <U>however</U>, that nothing
herein shall limit the ability of a controlled Affiliate of the Investor to join such group following the execution of this Agreement,
so long as any such controlled Affiliate agrees to be bound by the terms and conditions of this Agreement);</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 27.25pt 0 0; text-indent: 1in"><FONT STYLE="font-size: 12pt; letter-spacing: -0.1pt">(g)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; letter-spacing: -0.1pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>publicly make or publicly advance any request or proposal to amend, modify or waive any provision of this Agreement, or take any
action challenging the validity or enforceability of any provision of or obligation arising under this Agreement; <U>provided</U>, that
the Investor may make confidential requests to the Board to amend, modify or waive any provision of this Agreement, which the Board may
accept or reject in its sole and absolute discretion (it being understood and agreed that the Board shall consider in good faith any waiver
requests to the Acquisition limits set forth in <U>Section 2(a)</U> in the event of any registered securities offerings made by the Company),
so long as any such request is not publicly disclosed by the Investor and is made by the Investor in a manner that is not reasonably expected
to require, and that does not require, the public disclosure thereof by the Company, the Investor or any other person;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 28.95pt 0 0; text-indent: 1in"><FONT STYLE="font-size: 12pt; letter-spacing: -0.1pt">(h)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; letter-spacing: -0.1pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>make a request for a list of the Company&#8217;s stockholders or for any books and records of the Company whether pursuant to Section
220 of the Delaware General Corporation Law or otherwise; or</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 31.55pt 0 0; text-indent: 1in"><FONT STYLE="font-size: 12pt; letter-spacing: -0.1pt">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; letter-spacing: -0.1pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>enter into any discussion, negotiation, agreement, arrangement or understanding concerning any of the foregoing (other than this
Agreement) or knowingly encourage, assist, solicit, seek or seek to cause any person to undertake any action inconsistent with this <U>Section
2</U>.</P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Notwithstanding anything to the contrary contained in <U>Section 2</U>
or elsewhere in this <FONT STYLE="letter-spacing: -0.1pt">Agreement, </FONT>(A) nothing in this Agreement will prohibit the Investor or
its controlled Affiliates from making any public or private statement or announcement with respect to any Extraordinary Transaction that
is publicly announced by the Company or a third party; (B) the Investor shall not be prohibited or restricted from communicating privately
with the Chief Executive Officer of the Company, the Board or any director of the Company regarding any matter, so long as such communications
are not intended to, and would not reasonably be expected to, require any public disclosure of such communications by any Party; (C) nothing
in this Agreement will prohibit the Investor or its controlled Affiliates from making confidential communications to any of their current
or prospective investors or clients, in their capacities as such; <U>provided that</U> such conversations would not otherwise violate
this Section 2; and (D) no Party shall be prohibited from taking any action necessary to comply with any law, rule or regulation or any
action required by any governmental or regulatory authority or stock exchange that has, or may have, jurisdiction over such Party, <I>provided
</I>that a breach by such Party of this Agreement is not the cause of the applicable requirement. Furthermore, for the avoidance of doubt,
notwithstanding anything in this Agreement to the contrary, nothing in this Agreement shall be deemed to limit the exercise in good faith
by the Investor Appointee (or a Replacement Director) of such person&#8217;s fiduciary duties solely in such person&#8217;s capacity as
a director of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 15.75pt 0 0">Notwithstanding any of the foregoing, the restrictions in this
Section 2 shall terminate automatically upon the occurrence of any material breach of this Agreement by the Company upon five (5) business
days&#8217; written notice by the Investor to the Company if such breach has not been cured within such notice period, <I>provided that
</I>the Investor is not in material breach of this Agreement at the time such notice is given or prior to the end of the notice period.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 19.15pt 0 0; text-indent: 0.5in">Section 3.&#9;<U>Representations and Warranties
of All Parties</U>. Each Party represents and warrants to the other Parties that (a) such Party has all requisite power and authority
to execute and deliver this Agreement and to perform its obligations hereunder, (b) this Agreement has been duly and validly authorized,
executed and delivered by it and is a valid and binding obligation of such Party, enforceable against such Party in accordance with its
terms (subject to applicable bankruptcy and similar laws relating to creditors&#8217; rights and to general equity principles) and (c)
this Agreement will not result in a material violation of any (i) term or condition of any agreement to which such person is a party or
by which such Party may otherwise be bound or (ii) law, rule, license, regulation, judgment, order or decree governing or affecting such
Party.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">Section <FONT STYLE="letter-spacing: -0.25pt">4.</FONT>&#9;<U>Representations
and Warranties of the <FONT STYLE="letter-spacing: -0.1pt">Investor</FONT></U><FONT STYLE="letter-spacing: -0.1pt">.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 28.7pt 0 0; text-indent: 1in"><FONT STYLE="font-size: 12pt; letter-spacing: -0.1pt">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; letter-spacing: -0.1pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Investor represents, warrants and covenants to the Company that, as of the date of this Agreement, the Investor and its Affiliates
and/or managed funds collectively beneficially own and are entitled to vote an aggregate number of shares of Common Stock as disclosed
to the Company and does not have any Synthetic Position (other than the shares of Common Stock Beneficially Owned as set forth in this
<U>Section 4(a</U>) or any securities purchased under the Purchase Agreement or that certain Securities Purchase Agreement in any Voting
<FONT STYLE="letter-spacing: -0.1pt">Securities.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 27.8pt 0 0; text-indent: 1in"><FONT STYLE="font-size: 12pt; letter-spacing: -0.1pt">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; letter-spacing: -0.1pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Investor represents, warrants and covenants to the Company that Investor is not or will not become party to any agreement,
arrangement or understanding (whether written or oral) with the Investor Appointee or any Replacement Director with respect to such person&#8217;s
service as a director on the Board, including any such agreement, arrangement or understanding with respect to how such person should
or would vote or act on any issue or question as a director.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 17.85pt 0 0; text-indent: 0.5in">Section 5.&#9;<U>Press Release; Communications</U>.
Promptly following the execution of this Agreement, the Company shall issue a mutually agreeable press release announcing certain terms
of this Agreement. During the Cooperation Period and subject to the terms of this Agreement, neither the Company (including the Board
or any committee thereof) nor the Investor shall make or cause to be made, and the Company and the Investor will cause their respective
controlled Affiliates not to make or cause to be made, any public announcement or statement with respect to the subject matter of this
Agreement that is inconsistent with or contrary to the terms of this Agreement without the prior written consent of the other Party. The
Company acknowledges and agrees that the Investor may file this Agreement as an exhibit to its Schedule 13D. The Company shall be given
a reasonable opportunity to review and comment on any Schedule 13D amendment filing made by the Investor (including any separate filings
made by individual members thereto) with respect to this Agreement, and the Investor shall give reasonable consideration to any comments
of the Company. The Investor acknowledges and agrees that the Company may file this Agreement and file or furnish the Press Release with
the SEC as exhibits to a Current Report on Form 8-K and other filings with the SEC. The Investor shall be given a reasonable opportunity
to review and comment on any Current Report on Form 8-K or other filing with the SEC made by the Company with respect to this Agreement,
and the Company shall give reasonable consideration to any comments of the Investor.</P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 18.85pt 0 0; text-indent: 0.5in">Section 6.&#9;<U>Expenses</U>. Each Party
shall be responsible for its own fees and expenses incurred in connection with the negotiation, execution and effectuation of this Agreement
and the transactions contemplated hereby; except that the Company will reimburse the Investor for its reasonable, documented out-of-pocket
expenses incurred in connection with seeking representation on the Board and the negotiation and entry into this Agreement, in an amount
not to exceed $200,000.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 26.7pt 0 0; text-indent: 0.5in">Section 7.&#9;<U>Company Policies</U>. The
Parties hereto acknowledge that the Investor Appointee, upon election or appointment to the Board, will serve as a member of the Board
and will be governed by the same protections and obligations regarding confidentiality, conflicts of interest, related party transactions,
fiduciary duties, codes of conduct, trading and disclosure policies, director resignation policy, and other governance guidelines and
policies of the Company as other directors (collectively, the &#8220;<U>Company Policies</U>&#8221;), and shall have the same rights and
benefits, including with respect to insurance, indemnification, compensation and fees, as are applicable to all non-employee directors
of the Company. The Company represents and warrants that all Company Policies currently in effect are publicly available on the Company&#8217;s
website or have otherwise been provided in writing to the Investor. The Company acknowledges and agrees that (i) no Company Policy shall
in any way inhibit any Board members (including the Investor Appointee) from communicating with the Investor so long as they comply with
applicable law, their confidentiality obligations to the Company, their fiduciary duties to the Company and the Governance Guidelines
in their capacity as Board members, and (ii) no Company Policy shall apply to the Investor and its controlled Affiliates, including Company
Policies with respect to trading in the Company&#8217;s securities, as the Investor and its controlled Affiliates are not directors or
employees of the Company.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 19.65pt 0 0; text-indent: 0.5in">Section 8.&#9;<U>Non-Disparagement</U>.
Each of the Parties covenants and agrees that, during the Cooperation Period, neither it nor any of its respective controlled Affiliates,
Representatives, or any of its or its controlled Affiliates&#8217; Representatives, successors or assigns shall in any way publicly (or
in any way reasonably expected to be made public) disparage, comment negatively upon, slander, criticize, attempt to discredit, call into
disrepute, defame or otherwise make or cause to be made any public statements or statements reasonably expected to be made public that
would reasonably be expected to damage the business or reputation of the other Party or such other Party&#8217;s subsidiaries, controlled
Affiliates, officers (including any current or former officer of a Party or a Party&#8217;s subsidiaries), directors (including any current
or former director of a Party or a Party&#8217;s subsidiaries) or employees or any of their businesses, products or services. Each Party
shall use its commercially reasonable efforts to cause its and its controlled Affiliates&#8217; Representatives to comply with this Section
8. Nothing in this Section 8 will be deemed to prevent either the Company or the Investor from complying with its respective disclosure
obligations under law, legal process, subpoena, the rules of any stock exchange or any legal requirement or as part of a response to a
request for information from any governmental authority with jurisdiction over the Party from whom information is sought.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 21.75pt 0 0; text-indent: 0.5in">Section 9.&#9;<U>Termination</U>. Except
as otherwise provided in this Agreement and unless otherwise mutually agreed in writing by each Party, this Agreement shall terminate
on the earlier of (i) the expiration of the Cooperation Period and (ii) a Change of Control of the Company. Notwithstanding the foregoing,
<U>Sections 6</U> and <U>11</U> through <U>21</U> shall survive the termination or expiration of this Agreement. No termination of this
Agreement shall relieve any Party from liability for any breach of this Agreement prior to such termination.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 26.8pt 0 0; text-indent: 0.5in">Section 10.&#9;<U>Severability</U>. If any
term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, void or unenforceable,
the remainder of the terms, provisions, covenants and restrictions of this Agreement shall remain in full force and effect and shall in
no way be affected, impaired or invalidated. Each Party agrees to use its commercially reasonable best efforts to agree upon and substitute
a valid and enforceable term, provision, covenant or restriction for any of such that is held invalid, void or unenforceable by a court
of competent jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 26.8pt 0 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 25.55pt 0 0; text-indent: 0.5in">Section 11.&#9;<U>Notices</U>. Any notices,
consents, determinations, waivers or other communications required or permitted to be given under the terms of this Agreement must be
in writing and will be deemed to have been delivered (i) upon receipt, when delivered personally, (ii) upon confirmation of receipt, when
sent by e-mail (<U>provided</U>, that such confirmation is not automatically generated), or (iii) one (1) Business Day after deposit with
a nationally recognized overnight delivery service, in each case properly addressed to the Party to receive the same. The addresses for
such communications shall be:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><I>If to the <FONT STYLE="letter-spacing: -0.1pt">Company:</FONT></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-size: 12pt">Heron Therapeutics, <FONT STYLE="letter-spacing: -0.2pt">Inc.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 248.75pt 0 0.5in"><FONT STYLE="font-size: 12pt">100 Regency Forest Drive,
Suite 300<BR>
Cary, North Carolina 27518</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 105.05pt 0 0.5in"><FONT STYLE="font-size: 12pt">Attention: Ira Duarte,
Executive Vice President, Chief Financial Officer<BR>
E-mail: iduarte@herontx.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 105.05pt 0 0.5in"><FONT STYLE="font-size: 12pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-size: 12pt"><I>with a copy (which shall not
constitute notice) <FONT STYLE="letter-spacing: -0.25pt">to:</FONT></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-size: 12pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-size: 12pt">DLA Piper LLP <FONT STYLE="letter-spacing: -0.2pt">(US)<BR>
</FONT>51 John F. Kennedy Parkway, Suite 120<BR>
Short Hills, New Jersey 07078<BR>
Attention: Andrew P. Gilbert and Emilio <FONT STYLE="letter-spacing: -0.1pt">Ragosa<BR>
E-mail: andrew.gilbert@us.dlapiper.com; emilio.ragosa@us.dlapiper.com</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-size: 12pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-size: 12pt"><I>If to the <FONT STYLE="letter-spacing: -0.1pt">Investor:</FONT></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-size: 12pt; letter-spacing: -0.1pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 264.4pt 0 0.5in"><FONT STYLE="font-size: 12pt">c/o Rubric Capital Management
LP<BR>
155 East 44th St, Suite 1630<BR>
<FONT STYLE="letter-spacing: -0.1pt">New York, New York 10017<BR>
</FONT>Attention: Brian Kleinhaus, General Counsel E-mail: brian@rubriccapital.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 264.4pt 0 0.5in"><FONT STYLE="font-size: 12pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-size: 12pt"><I>with a copy (which shall not
constitute notice) <FONT STYLE="letter-spacing: -0.25pt">to:</FONT></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-size: 12pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 157.5pt 0 0.5in"><FONT STYLE="font-size: 12pt">McDermott Will &amp; Schulte
LLP<BR>
919 Third Avenue<BR>
<FONT STYLE="letter-spacing: -0.1pt">New York, New York 10022<BR>
</FONT>Attention: Ele Klein; Adriana <FONT STYLE="letter-spacing: -0.1pt">Schwartz</FONT></FONT><FONT STYLE="letter-spacing: -0.1pt"><BR>
<FONT STYLE="font-size: 12pt">E-mail: Eleazer.Klein@srz.com; Adriana.Schwartz@srz.com</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 157.5pt 0 0.5in"><FONT STYLE="letter-spacing: -0.1pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 157.5pt 0 0.5in">Section 12.&#9;<U>Injunctive Relief; Fees</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 157.5pt 0 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 21.75pt 0 0; text-indent: 1in"><FONT STYLE="font-size: 12pt; letter-spacing: -0.1pt">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; letter-spacing: -0.1pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Each Party acknowledges and agrees that any breach of any provision of this Agreement shall cause the other Party irreparable harm
which would not be adequately compensable by money damages. Accordingly, in the event of a breach or threatened breach by a Party of any
provision of this Agreement, the other Party shall be entitled to seek the remedies of injunction or other preliminary or equitable relief,
without having to prove irreparable harm or actual damages or post a bond or other security. The foregoing right shall be in addition
to such other rights or remedies that may be available to the non-breaching Party for such breach or threatened breach, including the
recovery of money damages.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 22.45pt 0 0; text-indent: 1in"><FONT STYLE="font-size: 12pt; letter-spacing: -0.1pt">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; letter-spacing: -0.1pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If a Party institutes any legal suit, action, or proceeding against the other Party to enforce this Agreement (or obtain any other
remedy regarding any breach of this Agreement) or arising out of or relating to this Agreement, including contract, equity, tort, fraud,
and statutory claims, the prevailing Party in the suit, action, or proceeding is entitled to receive, and the non-prevailing Party shall
pay, in addition to all other remedies to which the prevailing Party may be entitled, the costs and expenses incurred by the prevailing
Party in conducting the suit, action, or proceeding, including actual attorneys&#8217; fees and expenses, even if not recoverable by law.</P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 18.35pt 0 0; text-indent: 0.5in">Section 13.&#9;<U>Governing Law; Jurisdiction;
Jury Waiver</U>. This Agreement and all actions, proceedings or counterclaims (whether based on contract, tort or otherwise) arising out
of or relating to this Agreement or any action of the Company or the Investor in the negotiation, administration, performance or enforcement
hereof shall be governed by and construed and enforced in accordance with the laws of the State of Delaware without giving effect to any
choice or conflict of laws provision or rule (whether of the State of Delaware or any other jurisdiction) that would cause the application
of the laws of any jurisdiction other than the State of Delaware. Each Party irrevocably agrees that any legal action or proceeding with
respect to this Agreement and any rights and obligations arising hereunder, or for recognition and enforcement of any judgment in respect
of this Agreement and any rights and obligations arising hereunder brought by the other Party or its successors or assigns, shall be brought
and determined exclusively in the Delaware Court of Chancery and any state appellate court therefrom within the State of Delaware (or,
if the Delaware Court of Chancery declines to accept jurisdiction over a particular matter, any federal court within the State of Delaware)
(the &#8220;<U>Chosen Courts</U>&#8221;). Each Party hereby irrevocably submits with regard to any such action or proceeding for itself
and in respect of its property, generally and unconditionally, to the personal jurisdiction of the Chosen Courts and agrees that it will
not bring any action relating to this Agreement in any court other than the Chosen Courts. Each Party hereby irrevocably waives, and agrees
not to assert in any action or proceeding with respect to this Agreement, (a) any claim that it is not personally subject to the jurisdiction
of the Chosen Courts for any reason, (b) any claim that it or its property is exempt or immune from jurisdiction of any Chosen Court or
from any legal process commenced in the Chosen Courts (whether through service of notice, attachment prior to judgment, attachment in
aid of execution of judgment, execution of judgment or otherwise) and to the fullest extent permitted by applicable legal requirements,
any claim that (i) the suit, action or proceeding in any Chosen Court is brought in an inconvenient forum, (ii) the venue of such suit,
action or proceeding is improper or (iii) this Agreement, or the subject matter hereof, may not be enforced in or by the Chosen Courts.
EACH PARTY HERETO HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATED TO THIS
AGREEMENT.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 18.35pt 0 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 21.75pt 0 0; text-indent: 0.5in">Section 14.&#9;<U>Counterparts; Electronic
Transmission</U>. This Agreement may be executed in two or more counterparts, which together shall constitute a single agreement. Any
signature to this Agreement transmitted by facsimile transmission, by electronic mail in &#8220;portable document format&#8221; (&#8220;.pdf&#8221;)
form or by any other electronic means intended to preserve the original graphic and pictorial appearance of a document, shall have the
same effect as physical delivery of the paper document bearing the original signature.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 21.75pt 0 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 21.75pt 0 0; text-indent: 0.5in">Section 15.&#9;<U>No Waiver</U>. Any waiver
by any Party of a breach of any provision of this Agreement shall not operate as or be construed to be a waiver of any other breach of
such provision or of any breach of any other provision of this Agreement. The failure of a Party to insist upon strict adherence to any
term of this Agreement on one or more occasions shall not be considered a waiver of, or deprive that Party of the right thereafter to
insist upon strict adherence to, that term or any other term of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 21.75pt 0 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 25.25pt 0 0; text-indent: 0.5in">Section 16.&#9;<U>Entire Agreement; Amendments</U>.
This Agreement contains the entire understanding of the Parties with respect to the subject matter hereof. This Agreement may only be
amended pursuant to a written agreement executed by each Party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 25.25pt 0 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 23.7pt 0 0; text-indent: 0.5in">Section 17.&#9;<U>Successors and Assigns</U>.
This Agreement may not be transferred or assigned by any Party without the prior written consent of the other Party. Any purported assignment
without such consent is null and void. Subject to the foregoing, this Agreement shall be binding upon, inure to the benefit of, and be
enforceable by and against the permitted successors and assigns of each Party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 23.7pt 0 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 20.25pt 0 0; text-indent: 0.5in">Section 18.&#9;<U>No Joint Liability.</U>
Notwithstanding anything to the contrary in this Agreement, all representations, warranties, covenants, liabilities and obligations under
this Agreement are several, and not joint, except among the members of the Investor collectively as a Party to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 20.25pt 0 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0.4in 0 0; text-indent: 0.5in">Section 19.&#9;<U>No Third-Party Beneficiaries</U>.
This Agreement is solely for the benefit of the Parties and is not enforceable by any other person.</P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 22.75pt 0 0; text-indent: 0.5in">Section 20.&#9;<U>Interpretation and Construction</U>.
Each Party acknowledges that it has been represented by independent counsel of its choice throughout all negotiations that have preceded
the execution of this Agreement, and that it has executed the same with the advice of said independent counsel. Each Party and its counsel
cooperated and participated in the drafting and preparation of this Agreement and the documents referred to herein, and any and all drafts
relating thereto exchanged among the parties shall be deemed the work product of all of the Parties and may not be construed against any
Party by reason of its drafting or preparation. Accordingly, any rule of law or any legal decision that would require interpretation of
any ambiguities in this Agreement against any Party that drafted or prepared it is of no application and is hereby expressly waived by
each Party, and any controversy over any interpretation of this Agreement shall be decided without regards to events of drafting or preparation.
The section headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation
of this Agreement. In this Agreement, (i) the word &#8220;including&#8221; (in its various forms) means &#8220;including, without limitation,&#8221;
(ii) the words &#8220;hereunder,&#8221; &#8220;hereof,&#8221; &#8220;hereto&#8221; and words of similar import are references to this
Agreement as a whole and not to any particular provision of this Agreement, and (iii) the word &#8220;or&#8221; is not exclusive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 22.75pt 0 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">Section <FONT STYLE="letter-spacing: -0.25pt">21.</FONT>&#9;<U>Certain
Defined Terms</U>. For purposes of this <FONT STYLE="letter-spacing: -0.1pt">Agreement:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 23.8pt 0 0; text-indent: 1in"><FONT STYLE="font-size: 12pt; letter-spacing: -0.1pt">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; letter-spacing: -0.1pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&#8220;<U>Affiliate</U>&#8221; has the meaning set forth in Rule 12b-2 promulgated by the SEC under the Exchange Act, and shall
include all persons or entities that at any time during the term of this Agreement become Affiliates of any person or entity referred
to in this Agreement; <U>provided</U>, <U>however</U>, that the term &#8220;Affiliate&#8221; shall not include any publicly-traded portfolio
company in which any member of the Investor has a minority or non-controlling investment; <U>provided</U>, <U>further</U>, that, for purposes
of this Agreement, the Investor shall not be deemed an Affiliate of the Company and the Company shall not be deemed an Affiliate of any
member of the Investor.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 23.4pt 12pt 0; text-indent: 1in"><FONT STYLE="font-size: 12pt; letter-spacing: -0.1pt">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; letter-spacing: -0.1pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&#8220;<U>Beneficial Ownership</U>&#8221; has the meaning of such term under or as used in Rule 13d-3 promulgated by the SEC under
the Exchange Act. A person shall be deemed to be the &#8220;<U>Beneficial Owner</U>&#8221; of, or to &#8220;<U>beneficially own</U>,&#8221;
any securities that such person has Beneficial Ownership of. For purposes of this Agreement, references to the aggregate Beneficial Ownership
of the Investor shall be determined irrespective of whether the members thereto remain as part of a &#8220;group&#8221; for purposes of
the Exchange Act.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 23.4pt 12pt 0; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; letter-spacing: -0.1pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&#8220;<U>Business Day</U>&#8221; means any day that is not (i) a Saturday, (ii) a Sunday <FONT STYLE="letter-spacing: -0.25pt">or
(iii) other day on which commercial banks in the State of New York are authorized or required to be closed by applicable law.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 23.4pt 12pt 0; text-indent: 1in"><FONT STYLE="letter-spacing: -0.25pt"></FONT><FONT STYLE="font-size: 12pt; letter-spacing: -0.1pt">(d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; letter-spacing: -0.1pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&#8220;<U>Change of Control</U>&#8221; means, with respect to the Company, any transaction or series of related transactions in
which a person or a group becomes the Beneficial Owner of Voting Securities of the Company constituting 50% or more of the total voting
power of the <FONT STYLE="letter-spacing: -0.1pt">Company.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 23.4pt 12pt 0; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; letter-spacing: -0.1pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&#8220;<U>Common Stock</U>&#8221; means the common stock, $0.01 par value per share, of the Company.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 23.4pt 12pt 0; text-indent: 1in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; letter-spacing: -0.1pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;Cooperation Period&rdquo; means the period commencing with the execution of this Agreement and ending on the Trigger Date.&nbsp;&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 30.3pt 0 0; text-indent: 1in"><FONT STYLE="font-size: 12pt; letter-spacing: -0.1pt">(g)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; letter-spacing: -0.1pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&#8220;<U>Extraordinary Transaction</U>&#8221; means any merger, acquisition, tender or exchange offer, recapitalization, reorganization,
financing, liquidation, disposition of all or substantially all of the assets of the Company, spin-off, split-off, or other business combination
or similar transaction involving the Company.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 32.5pt 0 0; text-indent: 1in"><FONT STYLE="font-size: 12pt; letter-spacing: -0.1pt">(h)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; letter-spacing: -0.1pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&#8220;<U>Trigger Date</U>&#8221; means the date that is the earlier of (i) thirty (30) days prior to the deadline for nomination
of directors and stockholder proposals pursuant to the Bylaws for the 2026 Annual Meeting, (ii) February 12, 2026, and (iii) one hundred
and twenty (120) days prior to the first anniversary of the 2025 Annual <FONT STYLE="letter-spacing: -0.1pt">Meeting.</FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 22.95pt 0 0; text-indent: 1in"><FONT STYLE="font-size: 12pt; letter-spacing: -0.05pt">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; letter-spacing: -0.05pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> &#8220;<U>Representatives</U>&#8221; means, as to any person, such person&#8217;s and its and their respective directors, officers,
employees, partners, members, managers, agents or other representatives, in each case, acting on its behalf; <U>provided</U>, <U>however</U>,
that any reference to &#8220;controlled Affiliates&#8217; Representatives&#8221; shall not include such controlled Affiliate&#8217;s employees.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 35.95pt"><FONT STYLE="font-size: 12pt; letter-spacing: -0.05pt">(j)</FONT></TD><TD>&#8220;<U>SEC</U>&#8221; means the U.S. Securities and Exchange <FONT STYLE="letter-spacing: -0.1pt">Commission.</FONT></TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 19.1pt 0 0; text-indent: 1in"><FONT STYLE="font-size: 12pt; letter-spacing: -0.05pt">(k)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; letter-spacing: -0.05pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&#8220;<U>Synthetic Position</U>&#8221; means any option, warrant, convertible security, stock appreciation right or other security,
contract right or derivative position or similar right (including any &#8220;swap&#8221; transaction with respect to any security, other
than a broad based market basket or index) (each of the foregoing, a &#8220;<U>Derivative</U>&#8221;), whether or not presently exercisable,
that has an exercise or conversion privilege or a settlement payment or mechanism at a price related to the value of Voting Securities
or a value determined in whole or in part with reference to, or derived in whole or in part from, the value of Voting Securities and that
increases in value as the market price or value of Voting Securities increases or that provides an opportunity, directly or indirectly,
to profit or share in any profit derived from any increase in the value of Voting Securities, in each case regardless of whether (x) it
conveys any voting rights in such Voting Securities to any person, (y) it is required to be or capable of being settled, in whole or in
part, in Voting Securities, or (z) any person (including the holder of such Synthetic Position) may have entered into other transactions
that hedge its economic effect.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 20pt 0 0; text-indent: 1in"><FONT STYLE="font-size: 12pt; letter-spacing: -0.05pt">(l)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; letter-spacing: -0.05pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&#8220;<U>Voting Securities</U>&#8221; means the Common Stock and any other securities of the Company entitled to vote in the election
of directors; <I>provided that </I>as it pertains to any obligations of the Investor and any of its controlled Affiliates hereunder, &#8220;Voting
Securities&#8221; will not include any securities contained in any index fund, exchange traded fund, benchmark fund or broad basket of
securities which may contain or otherwise reflect the performance of, but not primarily consist of, securities or other interests of the
Company.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">[<I>Signature Pages <FONT STYLE="letter-spacing: -0.1pt">Follow</FONT></I><FONT STYLE="letter-spacing: -0.1pt">]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.25in 0 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 25.25pt 0 0; text-indent: 0.5in">IN WITNESS WHEREOF, each Party has executed
this Agreement or caused the same to be executed by its duly authorized representative as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 25.25pt 0 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 225.8pt"><FONT STYLE="letter-spacing: -0.1pt"><B>HERON THERAPEUTICS,</B></FONT><B>
<FONT STYLE="letter-spacing: -0.2pt">INC.</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 225.8pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 9pt 0 225.8pt"><FONT STYLE="letter-spacing: -0.2pt">By:</FONT>&#9;<U> __________________________________</U><BR>
Name: Ira Duarte<BR> <FONT STYLE="letter-spacing: -0.1pt">Title:</FONT>&#9;Executive Vice President, Chief Financial <FONT STYLE="letter-spacing: -0.1pt">Officer</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 9pt 0 225.8pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 17.95pt 0 0; text-align: center">[<I>Signature Page to Cooperation <FONT STYLE="letter-spacing: -0.1pt">Agreement</FONT></I><FONT STYLE="letter-spacing: -0.1pt">]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 17.95pt 0 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 15.75pt 0 0; text-indent: 0.5in">IN WITNESS WHEREOF, each Party has executed
this Agreement or caused the same to be executed by its duly authorized representative as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 15.75pt 0 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 0 239.15pt; text-align: left"><FONT STYLE="text-decoration: none; letter-spacing: -0.1pt">RUBRIC
CAPITAL MANAGEMENT</FONT> <FONT STYLE="text-decoration: none; letter-spacing: -0.25pt">LP</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0 239.15pt; text-align: left"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 239.1pt"></TD><TD STYLE="width: 35.3pt"><FONT STYLE="letter-spacing: -0.2pt">By:</FONT></TD><TD STYLE="padding-right: 29.3pt">Rubric Capital Management GP LLC, its General Partner</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 29.3pt 0 274.4pt; text-indent: -35.3pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 239.15pt"><FONT STYLE="letter-spacing: -0.25pt">By:</FONT>&#9;<U>________________________________</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 239.15pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 105.05pt 0 239.15pt">Name: Michael Nachmani<BR>
Title: Authorized Signatory</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 105.05pt 0 239.15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.25in 0 0.1pt; text-align: center">[<I>Signature Page to Cooperation <FONT STYLE="letter-spacing: -0.1pt">Agreement</FONT></I><FONT STYLE="letter-spacing: -0.1pt">]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.25in 0 0.1pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.25in 0 0.1pt; text-align: center">&nbsp;</P>



<P STYLE="margin: 0pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
